text,label
"Featured Topics H5 Bird Flu: Current Situation Hand Hygiene as a Family Activity Living with Diabetes How to Prevent Norovirus About Dementia Risk Factors for PneumoniaA to Z News All News - OCT 31Salmonella outbreak linked to moringa leaf, an ingredient in powdered supplements - OCT 30CDC continues to note illnesses despite product recalls and asks consumers to check for recalled foods in Listeria outbreak linked to prepared meals - OCT 06CDC Immunization Schedule Adopts Individual-Based Decision-Making for COVID-19 and Standalone Vaccination for Chickenpox in Toddlers - SEP 30Statement from Laura Chanchien Parajón, MD, MPH, Director (Acting), CDC's National Center for Chronic Disease Prevention and Health Promotion, on the passing of Suzy Ellis, Tips From Former Smokers® participant - SEP 26Listeria Outbreak to include more Prepared Foods Scientific Journals Science at CDC To make science and data easier for broad audiences to interpret, CDC is translating science into practical, easy to understand policy by clarifying and presenting scientific language so that anyone can understand it and standardizing guideline development across the agency.",1
"Report an Accessibility Problem The Centers for Disease Control and Prevention is committed to making its electronic and information technologies accessible to individuals with disabilities by meeting or exceeding the requirements of Section 508 of the Rehabilitation Act (29 U.S.C. 794d), as amended in 1998. Section 508 is a federal law that requires agencies to provide individuals with disabilities equal access to electronic information and data comparable to those who do not have disabilities, unless an undue burden would be imposed on the agency. The Section 508 standards are the technical requirements and criteria that are used to measure conformance within this law. More information on Section 508 and the technical standards can be found at www.section508.gov. If you would like to report an accessibility problem with the CDC website, please e-mail the CDC Webmaster using the form below. Be sure to specify the web page or file being referenced in reporting the accessibility issue. In 1998, Congress amended the Rehabilitation Act to require federal agencies to make their electronic and information technology accessible to people with disabilities. Inaccessible technology interferes with an individual′s ability to obtain and use information quickly and easily.",1
"Section 508 was enacted to eliminate barriers in information technology, to make available new opportunities for people with disabilities, and to encourage development of technologies that will help achieve these goals. The law applies to all Federal agencies when they develop, procure, maintain, or use electronic and information technology. Under Section 508 (29 USC 794d), agencies must give disabled employees and members of the public access to information that is comparable to the access available to others. Section 508 (29 U.S.C. § 794d) requires that CDC, as a federal agency, provide electronic and information technology products that are accessible to people with disabilities. Under Section 508, CDC and other federal agencies must give disabled employees and members of the public access to this technology that is comparable to the access available to others. The law applies to all Federal agencies when they develop, procure, maintain, or use electronic and information technology. CDC is committed to providing resources that are accessible to people of all abilities. If you find that any of our information products, including what you see on this site, are not in compliance with Section 508, please contact us by e-mail or phone at (404) 639-3534. When you contact us, please refer to the specific information found to be non-compliant. This will help us address the issue more quickly.",1
"Language Assistance Services – CDC In November of 2023, the U.S. Department of Health and Human Services (HHS) updated its 2013 Language Access Plan in an effort to “ensure greater access to the life-saving services that HHS provides for people with Limited English Proficiency (LEP) and people with disabilities.” Consistent with the updated HHS plan, CDC launched a 2024 plan which outlines the action steps the agency will take to meet the language access needs of the public while continuing to support communities that may be underserved and improving access to information for people with LEP and people with disabilities. The strategic actions within the CDC plan prioritize efforts that will advance language accessibility to public health information and the agency’s communication with the public. The plan can be found online here: Español (Spanish) ATENCIÓN: Si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-800-232-4636. Los Centros para el Control y la Prevención de Enfermedades (CDC) de los EE. UU. cumplen con las leyes federales de derechos civiles aplicables y no discriminan por motivos de raza, color, nacionalidad, edad, discapacidad o sexo. Los CDC no excluyen a las personas ni las trata de forma diferente debido a su origen étnico, color, nacionalidad, edad, discapacidad o sexo.",1
"Los CDC: - Proporcionan asistencia y servicios gratuitos a las personas con discapacidades para que se comuniquen de manera eficaz con nosotros; algunos de esos servicios son: - Intérpretes de lenguaje de señas capacitados. - Información escrita en otros formatos (letra grande, audio, formatos electrónicos accesibles, otros formatos). - Proporcionan servicios lingüísticos gratuitos a las personas cuyo idioma materno no es el inglés; algunos de esos servicios son: - Intérpretes capacitados. - Información escrita en otros idiomas. Si necesita recibir estos servicios, comuníquese con los CDC al 1-800-232-4636. Si considera que el Departamento de Salud y Servicios Humanos (HHS) no le proporcionó estos servicios o lo discriminó de otra manera por motivos de origen étnico, color, nacionalidad, edad, discapacidad o sexo, puede presentar un reclamo a la Oficina de Derechos Civiles (Office for Civil Rights) del Departamento de Salud y Servicios Humanos de los EE. UU.",1
"de manera electrónica a través del portal de “Office for Civil Rights Complaint”, disponible en o bien, por correo postal a la siguiente dirección o por teléfono a los números que figuran a continuación: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 繁體中文 (Chinese) 注意：如果您使用繁體中文，您可以免費獲得語言援助服務。請致電 1-877-696-6775。 U.S. Department of Health and Human Services（HHS、美國衛生及公共服務部）遵守適用的聯邦民權法律規定、不因種族、膚色、民族血統、年齡、殘障或性別而歧視任何人。HHS 不因種族、膚色、民族血統、年齡、殘障或性別而排斥任何人或以不同的方式對待他們。 HHS - 向殘障人士免費提供各種援助和服務、以幫助他們與我們進行有效溝通、如： - 合格的手語翻譯員 - 以其他格式提供的書面資訊（大號字體、音訊、無障礙電子格式、其他格式） - 向母語非英語的人員免費提供各種語言服務，如： - 合格的翻譯員 - 以其他語言書寫的資訊 如果您需要此類服務、請聯絡 HHS 撥打 1-877-696-6775 如果您認為 HHS 未能提供此類服務或者因種族、膚色、民族血統、年齡、殘障或性別而透過其他方式歧視您、您可以向U.S. Department of Health and Human Services的 Office for Civil Rights（民權辦公室）提交民權投訴、透過 Office for Civil Rights Complaint Portal 以電子方式投訴： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019、800-537-7697 (TDD)（聾人用電信設備） Tiếng Việt (Vietnamese) CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-877-696-6775. U.S. Department of Health and Human Services (HHS, Bộ Y Tế và Dịch Vụ Nhân Sinh Hoa Kỳ) tuân thủ luật dân quyền hiện hành của Liên bang và không phân biệt đối xử dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính.",1
"HHS không loại trừ mọi người hoặc đối xử với họ khác biệt vì chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính. HHS: - Cung cấp dịch vụ hỗ trợ miễn phí cho những người khuyết tật để giao tiếp với chúng tôi có hiệu quả, như: - Thông dịch viên ngôn ngữ ký hiệu đủ năng lực - Thông tin bằng văn bản ở các định dạng khác (chữ in lớn, âm thanh, định dạng điện tử có thể tiếp cận, các định dạng khác) - Cung cấp miễn phí các dịch vụ ngôn ngữ cho những người có ngôn ngữ chính không phải là tiếng Anh, như: - Thông dịch viên đủ năng lực - Thông tin được trình bày bằng ngôn ngữ khác Nếu bạn cần những dịch vụ này, hãy liên hệ HHS theo số 1-877-696-6775. Nếu bạn tin rằng HHS không cung cấp những dịch vụ này hoặc phân biệt đối xử theo cách khác dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính, bạn có thể nộp đơn khiếu nại với U.S. Department of Health and Human Services, Office for Civil Rights (Văn Phòng Dân Quyền) bằng hình thức điện tử qua Office for Civil Rights Complaint Portal, có trên trang hoặc qua đường bưu điện hoặc bằng điện thoại tại: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 한국어 (Korean) 주의: 한국어를 사용하시는 경우, 언어 지원 서비스를 무료로 이용하실 수 있습니다. 1-877-696-6775 번으로 전화해 주십시오. Department of Health and Human Services (HHS, 보건복지부)은(는) 관련 연방 공민권법을 준수하며 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 차별하지 않습니다.",1
"HHS은(는) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 누군가를 배제하거나 다른 방식으로 대우하지 않습니다. HHS: - 장애인들이 저희와 효과적으로 의사소통할 수 있도록 다음과 같은 무료 지원과 서비스를 제공합니다. - 자격있는 수화 통역자 - 다른 형식의 서면 정보(큰 활자, 음성, 사용 가능한 전자 형식, 기타 형식) - 주로 사용하는 언어가 영어가 아닌 이들에게는 다음과 같은 무료 언어 서비스를 제공합니다. - 자격있는 통역자 - 다른 언어로 작성된 서면 정보 이러한 서비스가 필요하시면 HHS에 -877-696-6775번으로 연락하십시오. HHS 이(가) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 이러한 서비스를 제공하지 않거나 다른 방식으로 차별했다고 생각하시는 경우, 를 통한 전자 방식 또는 우편이나 전화로 Department of Health and Human Services, Office for Civil Rights (시민권 사무국)에 민원을 제출할 수 있습니다. 주소 및 연락처는 다음과 같습니다. U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Tagalog PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa 1-877-696-6775. Sumusunod ang U.S. Department of Health and Human Services (HHS, Kagawaran ng Mga Serbisyong Pangkalusugan at Pantao ng U.S.) sa mga naaangkop na Pampederal na batas sa karapatang sibil at hindi nandidiskrimina batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian. Ang HHS ay hindi nagtatangi ng mga tao o hindi nagpapakita ng ibang pakikitungo dahil sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian.",1
"Ang HHS ay: - Nagbibigay ng mga libreng tulong at serbisyo sa mga taong may kapansanan upang mahusay silang makipag-ugnayan sa amin, gaya ng: - Mga kwalipikadong interpreter ng sign language - Nakasulat na impormasyon sa iba pang mga format (malaking print, audio, mga naa-access na electronic na format, iba pang mga format) - Nagbibigay ng mga libreng serbisyo sa wika sa mga taong hindi Ingles ang pangunahing wika, gaya ng: - Mga kwalipikadong interpreter - Impormasyong nakasulat sa iba pang mga wika Kung kailangan mo ang mga serbisyong ito, makipag-ugnayan kay HHS sa 1-877-696-6775. Kung naniniwala kang hindi naibigay ng HHS ang mga serbisyong ito o nandiskrimina ito sa ibang paraan batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian, maaari kang maghain ng karaingan sa U.S. Department of Health and Human Services, Office for Civil Rights (Tanggapan para sa Mga Karapatang Sibil), sa electronic na paraan sa Office for Civil Rights Complaint Portal, na makikita sa o sa pamamagitan ng koreo o telepono sa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Русский (Russian) ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Министерство здравоохранения и социальных служб США) соблюдает применимое федеральное законодательство в области гражданских прав и не допускает дискриминации по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS не исключает людей и не относится к ним по-разному из-за расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS: - Для эффективного взаимодействия предоставляет безвозмездную помощь и оказывает услуги людям с ограниченными возможностями, а именно: - услуги квалифицированных сурдопереводчиков; - письменную информацию в других форматах (крупный шрифт, аудио формат, доступные электронные форматы, прочие форматы). - Предоставляет бесплатные услуги перевода людям, для которых английский не является основным языком, а именно: - услуги квалифицированных переводчиков; - письменную информацию на других языках. Если вы нуждаетесь в таких услугах, обратитесь к HHS по телефону 1-877-696-6775.",1
"Если вы считаете, что в HHS вам не предоставили указанных услуг или иным образом дискриминировали вас по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола, вы можете подать жалобу в U.S. Department of Health and Human Services, Office for Civil Rights (Управление по гражданским правам), в электронном виде через Office for Civil Rights Complaint Portal, доступный по ссылке: по почте или по телефону: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) العربية (Arabic) ملحوظة: إذا كنت تتحدث اذكر اللغة، فإن خدمات المساعدة اللغوية تتوافر لك بالمجان. اتصل برقم .1-877-696-6775 تلتزم HHS) Department of Health and Human Services, وزارة الخدمات الصحية والبشرية) بقوانين الحقوق المدنية الفدرالية المعمول بها ولا تميز على أساس العرق أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.",1
"لا تستبعد HHS الأشخاص أو تعاملهم على نحو مختلف بسبب النوع أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.. :HHS - توفر مساعدات وخدمات مجانية للأشخاص من ذوي الإعاقات للتواصل بصورة فعالة معنا، مثل: - مترجمي لغة إشارة مؤهلين - معلومات كتابية بتنسيقات أخرى (مطبوعة بأحرف كبيرة، مواد صوتية، تنسيقات إلكترونية متيسرة، وغير ذلك من التنسيقات) - توفر خدمات لغوية مجانية للأشخاص الذين لغتهم الأساسية ليست الإنجليزية، مثل: - مترجمين مؤهلين - معلومات مكتوبة بلغات أخرى إذا كنت بحاجة لهذه الخدمات، اتصل بـ HHS على الرقم .1-877-696-6775 إذا كنت تعتقد أن HHS قد أخفقت في توفير تلك الخدمات أو أنها قد ميزت بطريقة أخرى على أساس العرق أو اللون أو الأصل Department of Health and Human Services، مكتب Office for Civil Rights (مكتب الحقوق المدنية)، من خلال مكتب Office for Civil Rights Complaint Portal، المتوفر على الرابط أو بالبريد أو الهاتف على: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (رقم هاتف الصم والبكم) Kreyòl Ayisyen (Haitian Creole) ATANSYON: Si w pale Kreyòl Ayisyen, gen sèvis èd pou lang ki disponib gratis pou ou. Rele 1-877-696-6775. U.S. Department of Health and Human Services, (HHS, Ministè Sèvis Sante ak Imen Ameriken) konfòm ak lwa sou dwa sivil Federal ki aplikab yo e li pa fè diskriminasyon sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks. HHS pa ekskli moun oswa trete yo nan fason ki diferan akoz ras, koulè, peyi orijin, laj, enfimite oswa sèks yo.",1
"HHS: - Bay èd ak sèvis gratis pou moun ki andikape pou yo kominike avèk nou nan fason ki efikas, tankou: - Enèprèt langaj siy ki kalifye - Enfòmasyon ekri nan lòt fòma (gwo lèt, odyo, fòma elektwonik ki aksesib, lòt fòma) - Bay sèvis lang gratis a moun lang prensipal yo pa Anglè, tankou: - Enèprèt kalifye - Enfòmasyon ki ekri nan lòt lang Si w bezwen sèvis sa yo, kontakte HHS nan 1-877-696-6775. Si w kwè HHS pa t bay sèvis sa yo oswa te fè diskriminasyon nan yon lòt fason sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks, ou ka depoze yon plent nan: U.S. Department of Health and Human Services, Office for Civil Rights (Biwo Dwa Sivil) atravè Office for Civil Rights Portal, pa mwayen elektwonik ki disponib nan oswa pa lapòs oswa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Français (French) ATTENTION: Si vous parlez français, des services d’aide linguistique vous sont proposés gratuitement. Appelez le 1-877-696-6775. L’U.S. Department of Health and Human Services (HHS, Département de la Santé et des Services Sociaux des États-Unis) respecte les lois fédérales en vigueur relatives aux droits civiques et ne pratique aucune discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou un handicap.",1
"HHS n’exclut et ne traite aucune personne différemment en raison de sa race, sa couleur de peau, son origine nationale, son âge, son sexe ou son handicap. HHS: - Fournit gratuitement des aides et services aux personnes handicapées afin de permettre une communication efficace avec nous, par exemple: - Interprètes qualifiés en langue des signes - Informations écrites dans d’autres formats (gros caractères, audio, formats électroniques accessibles, autres formats) - Fournit gratuitement des services linguistiques aux personnes dont la langue principale n’est pas l’anglais, par exemple: - Interprètes qualifiés - Informations écrites dans d’autres langues Si vous avez besoin de ces services, contactez HHS au 1-877-696-6775. Si vous pensez que HHS n’a pas fourni ces services ou a fait preuve d’une autre forme de discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou le handicap, vous pouvez déposer une réclamation auprès de l’U.S. Department of Health and Human Services, l’Office for Civil Rights (Bureau des Droits Civiques), par voie électronique via l’Office for Civil Rights Complaint Portal, disponible à l’adresse par courrier ou par téléphone à: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Polski (Polish) UWAGA: Jeżeli mówisz po polsku, możesz skorzystać z bezpłatnej pomocy językowej. Zadzwoń pod numer 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Departament Zdrowia i Opieki Społecznej Stanów Zjednoczonych) postępuje zgodnie z obowiązującymi federalnymi prawami obywatelskimi i nie dopuszcza się dyskryminacji ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS nie wyklucza żadnych osób i nie stosuje różnego traktowania ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS: - Zapewnia bezpłatną pomoc i usługi osobom niepełnosprawnym w celu umożliwienia skutecznej komunikacji, na przykład: - Wykwalifikowanych tłumaczy języka migowego - Informacje na piśmie w różnych formatach (duży druk, audio, dostępne formaty elektroniczne, inne formaty) - Zapewnia bezpłatne usługi językowe dla osób, dla których angielski nie jest pierwszym językiem, na przykład: - Wykwalifikowanych tłumaczy - Informacje na piśmie w innych językach Jeżeli chcesz skorzystać z tych usług, skontaktuj się z HHS pod numerem 1-877-696-6775.",1
"Jeżeli uważasz, że HHS nie świadczy tych usług lub w inny sposób dopuszcza się dyskryminacji ze względu na rasę, koloru skóry, pochodzenie, wiek, niepełnosprawność bądź płeć, możesz złożyć skargę do: U.S. Department of Health and Human Services, Office for Civil Rights (Biuro Praw Obywatelskich), drogą elektroniczną za pośrednictwem Office for Civil Rights Complaint Portal na stronie pocztą tradycyjną lub dzwoniąc pod numer telefonu: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Português (Portuguese) O U.S. Department of Health and Human Services (HHS, Departamento de Saúde e dos Serviços Humanos dos Estados Unidos da América) cumpre as leis de direitos civis federais aplicáveis e não exerce discriminação com base na raça, cor, nacionalidade, idade, deficiência ou sexo. HHS não exclui ou trata de forma diferente devido à raça, cor, nacionalidade, idade, deficiência ou sexo.",1
"HHS: - Faculta ajuda e serviços gratuitos a pessoas com dificuldades de comunicar de forma eficaz connosco, tais como: - Intérpretes de língua gestual qualificados - Informação escrita noutros formatos (impressão maior, áudio, formatos electrónicos acessíveis, outros formatos) - Faculta serviços linguísticas grátis a pessoas cuja língua principal não é inglês, tais como: - Intérpretes qualificados - Informação escrita noutros idiomas Se necessita destes serviços, contacte HHS através do número 1-877-696-6775. Se considera que a HHS não cumpriu estes serviços ou exerceu discriminação de outra forma com base na raça, cor, nacionalidade, idade, deficiência ou sexo, pode apresentar uma reclamação junto de: U.S. Department of Health and Human Services, Office for Civil Rights (Gabinete de Direitos Civis), por via electrónica através do Office for Civil Rights Complaint Portal, disponível em ou por correio ou telefone: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Italiano (Italian) ATTENZIONE: In caso la lingua parlata sia l’italiano, sono disponibili servizi di assistenza linguistica gratuiti. Chiamare il numero 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Dipartimento statunitense per la salute e i servizi umani) è conforme a tutte le leggi federali vigenti in materia di diritti civili e non pone in essere discriminazioni sulla base di razza, colore, origine nazionale, età, disabilità o sesso. HHS non esclude le persone o le tratta diversamente a causa di razza, colore, origine nazionale, età, disabilità o sesso. HHS: - Offre sostegni e servizi gratuiti alle persone affette da disabilità per comunicare con noi in modo efficace, quali: - Interpreti qualificati nella lingua dei segni - Informazioni scritte in altri formati (stampe a grandi caratteri, audio, formati elettronici accessibili, altri formati) - Offre servizi linguistici gratuiti alle persone la cui lingua primaria non è l’inglese, quali: - Interpreti qualificati - Informazioni scritte in altre lingue In caso si necessiti di tali servizi, contattare HHS al numero 1-877-696-6775.",1
"In caso si ritenga che HHS non abbia offerto tali servizi o abbia posto in essere discriminazioni in altri modi sulla base di razza, colore, origine nazionale, età, disabilità o sesso, è possibile presentare una vertenza a: U.S. Department of Health and Human, Office for Civil Rights (Ufficio per i diritti civili), elettronicamente mediante l’Office for Civil Rights Complaint Portal, disponibile all’indirizzo oppure a mezzo posta o telefono all’attenzione di: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Deutsch (German) ACHTUNG: Wenn Sie Deutsch sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen zur Verfügung. Rufnummer: 1-877-696-6775. Das Department of Health and Human Services (HHS, U.S.-Gesundheitsministerium) erfüllt geltenden bundesstaatliche Menschenrechtsgesetze und lehnt jegliche Diskriminierung aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. lehnt den Ausschluss oder die unterschiedliche Behandlung von Menschen aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. HHS: - Bietet kostenlose Hilfe und Dienstleistungen für Menschen mit Behinderung zur effektiven Kommunikation, wie z.",1
"B.: - Qualifizierte Gebärdensprachen-Dolmetscher - Schriftliche Informationen in anderen Formaten (große Ausdrucke, Audio, zugängliche elektronische Formate, sonstige Formate) - Bietet kostenlose Sprachdienste für Menschen, deren Hauptsprache nicht Englisch ist, wie z. B.: - Qualifizierte Dolmetscher - Schriftliche Informationen in anderen Sprachen Sollten Sie diese Dienstleistungen benötigen, so wenden Sie sich an das HHS unter 1-877-696-6775.",1
"Sollten Sie der Ansicht sein, dass HHS es versäumte, diese Dienstleistungen anzubieten, oder auf sonstige Weise aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht diskriminierte, so können Sie eine Beschwerde einreichen bei: Department of Health and Human Services, Office for Civil Rights (Amt für Bürgerrechte), elektronisch über das Office for Civil Rights Complaint Portal, zugänglich über oder per Post oder telefonisch an: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 日本語 (Japanese) 注意事項：日本語を話される場合、無料の言語支援をご利用いただけます。1-877-696-6775 まで、お電話にてご連絡ください。 U.S. Department of Health and Human Services（HHS、保健社会福祉省）は適用される連邦公民権法を遵守し、人種、肌の色、出身国、年齢、障害、または性別に基づく差別をいたしません。HHS は人種、肌の色、出身国、年齢、障害、または性別を理由として人を排除したり、異なる扱いをいたしません。 HHS: - 効果的にコミュニケーションを図るため、障害のある人に以下の支援やサポートを無料で提供いたします。 - 資格ある手話通訳者 - その他形式の文字情報（大きな活字、音声信号、手軽な電子形式、その他） - 英語を母語としない人へ以下の言語サービスを無料で提供いたします。 - 資格ある通訳者 - 英語以外の言語で書かれた情報 これらのサービスを必要とされる場合は、HHS（1-877-696-6775）までご連絡ください。 HHS がこれらのサービスの提供を怠ったり、人種、肌の色、出身国、年齢、障害、または性別に基づいた何らかの方法で差別したと思われる場合、こちらまで苦情を申し立てることができます。また、公民権に関する苦情は、U.S.",1
"Department of Health and Human ServicesのOffice for Civil Rights（公民権局）へ、Office for Civil Rights Complaint Portal から電子申請するか、以下へ郵便または電話で申し立てることもできます： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) فارسی (Farsi) توجه: اگر به زبان فارسی گفتگو می کنید، تسهیلات زبانی بصورت رایگان برای شما فراهم می باشد. با .1-877-696-6775 تماس بگیرید HHS) U.S. Department of Health and Human Services, وزارت بهداشت و خدمات انسانی آمریکا) از قوانین حقوق مدنی فدرال مربوطه تبعیت می کند و هیچگونه تبعیضی بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد قایل نمی شود. HHS بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد ایشان را از خدمات محروم نمی کند و با آنها برخورد متفاوتی ندارد.",1
":HHS - برای افرادی که ناتوانی دارند، برای برقرار کردن ارتباط موثر، کمک هایی بطور رایگان فراهم می کند، مانند: - مترجمین واجد شرایط زبان اشاره - اطلاعات نوشتاری به فرمت های دیگر (چاپ با حروف درشت، صوتی، فرمت های الکترونیک قابل دسترسی ساده، و فرمت های دیگر) - برای افرادی که زبان اولیه شان انگلیسی نیست خدمات زبانی رایگان ارایه می کند، مانند: - مترجمین شفاهی واجد شرایط - اطلاعات نوشتاری به زبانهای دیگر اگر به چنین خدماتی نیاز دارید، با HHS به 1-877-696-6775 تماس بگیرید اگر معتقدید که HHS چنین خدماتی را به شما ارایه نداده و یا اینکه به شکلی دیگر به دلیل نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت درمورد شما تبعیض قایل شده می توانید شکواییه ای به این آدرس ثبت کنید: اگر احساس می کنید که HHS این خدمات را به شما ارایه نکرده و یا به هر شکلی بدلیل نژاد، رنگ پوست، اصلیت ملی، سن، معلولیت یا جنسیت شما را مورد تبعیض قرار داده، می توانید نزد U.S. Department of Health and Human Services، Office for Civil Rights (اداره حمایت از حقوق مدنی)، شکواییه خود را ثبت نمایید. دسترسی الکترونیکی به این اداره از طریق Office for Civil Rights Complaint Portal به آدرس یا تماس از طریق ایمیل یا تلفن با آدرس زیر میسر است: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) English ATTENTION: If you do not speak English, language assistance services are available to you free of charge.",1
"Call 1-800-232-4636 Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The CDC nondiscrimination notice lists the services available to you and how to file a complaint if you feel that CDC has failed to provide these services or discriminated in another way.",1
"Language Assistance Services – CDC In November of 2023, the U.S. Department of Health and Human Services (HHS) updated its 2013 Language Access Plan in an effort to “ensure greater access to the life-saving services that HHS provides for people with Limited English Proficiency (LEP) and people with disabilities.” Consistent with the updated HHS plan, CDC launched a 2024 plan which outlines the action steps the agency will take to meet the language access needs of the public while continuing to support communities that may be underserved and improving access to information for people with LEP and people with disabilities. The strategic actions within the CDC plan prioritize efforts that will advance language accessibility to public health information and the agency’s communication with the public. The plan can be found online here: Español (Spanish) ATENCIÓN: Si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-800-232-4636. Los Centros para el Control y la Prevención de Enfermedades (CDC) de los EE. UU. cumplen con las leyes federales de derechos civiles aplicables y no discriminan por motivos de raza, color, nacionalidad, edad, discapacidad o sexo. Los CDC no excluyen a las personas ni las trata de forma diferente debido a su origen étnico, color, nacionalidad, edad, discapacidad o sexo.",1
"Los CDC: - Proporcionan asistencia y servicios gratuitos a las personas con discapacidades para que se comuniquen de manera eficaz con nosotros; algunos de esos servicios son: - Intérpretes de lenguaje de señas capacitados. - Información escrita en otros formatos (letra grande, audio, formatos electrónicos accesibles, otros formatos). - Proporcionan servicios lingüísticos gratuitos a las personas cuyo idioma materno no es el inglés; algunos de esos servicios son: - Intérpretes capacitados. - Información escrita en otros idiomas. Si necesita recibir estos servicios, comuníquese con los CDC al 1-800-232-4636. Si considera que el Departamento de Salud y Servicios Humanos (HHS) no le proporcionó estos servicios o lo discriminó de otra manera por motivos de origen étnico, color, nacionalidad, edad, discapacidad o sexo, puede presentar un reclamo a la Oficina de Derechos Civiles (Office for Civil Rights) del Departamento de Salud y Servicios Humanos de los EE. UU.",1
"de manera electrónica a través del portal de “Office for Civil Rights Complaint”, disponible en o bien, por correo postal a la siguiente dirección o por teléfono a los números que figuran a continuación: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 繁體中文 (Chinese) 注意：如果您使用繁體中文，您可以免費獲得語言援助服務。請致電 1-877-696-6775。 U.S. Department of Health and Human Services（HHS、美國衛生及公共服務部）遵守適用的聯邦民權法律規定、不因種族、膚色、民族血統、年齡、殘障或性別而歧視任何人。HHS 不因種族、膚色、民族血統、年齡、殘障或性別而排斥任何人或以不同的方式對待他們。 HHS - 向殘障人士免費提供各種援助和服務、以幫助他們與我們進行有效溝通、如： - 合格的手語翻譯員 - 以其他格式提供的書面資訊（大號字體、音訊、無障礙電子格式、其他格式） - 向母語非英語的人員免費提供各種語言服務，如： - 合格的翻譯員 - 以其他語言書寫的資訊 如果您需要此類服務、請聯絡 HHS 撥打 1-877-696-6775 如果您認為 HHS 未能提供此類服務或者因種族、膚色、民族血統、年齡、殘障或性別而透過其他方式歧視您、您可以向U.S. Department of Health and Human Services的 Office for Civil Rights（民權辦公室）提交民權投訴、透過 Office for Civil Rights Complaint Portal 以電子方式投訴： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019、800-537-7697 (TDD)（聾人用電信設備） Tiếng Việt (Vietnamese) CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-877-696-6775. U.S. Department of Health and Human Services (HHS, Bộ Y Tế và Dịch Vụ Nhân Sinh Hoa Kỳ) tuân thủ luật dân quyền hiện hành của Liên bang và không phân biệt đối xử dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính.",1
"HHS không loại trừ mọi người hoặc đối xử với họ khác biệt vì chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính. HHS: - Cung cấp dịch vụ hỗ trợ miễn phí cho những người khuyết tật để giao tiếp với chúng tôi có hiệu quả, như: - Thông dịch viên ngôn ngữ ký hiệu đủ năng lực - Thông tin bằng văn bản ở các định dạng khác (chữ in lớn, âm thanh, định dạng điện tử có thể tiếp cận, các định dạng khác) - Cung cấp miễn phí các dịch vụ ngôn ngữ cho những người có ngôn ngữ chính không phải là tiếng Anh, như: - Thông dịch viên đủ năng lực - Thông tin được trình bày bằng ngôn ngữ khác Nếu bạn cần những dịch vụ này, hãy liên hệ HHS theo số 1-877-696-6775. Nếu bạn tin rằng HHS không cung cấp những dịch vụ này hoặc phân biệt đối xử theo cách khác dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính, bạn có thể nộp đơn khiếu nại với U.S. Department of Health and Human Services, Office for Civil Rights (Văn Phòng Dân Quyền) bằng hình thức điện tử qua Office for Civil Rights Complaint Portal, có trên trang hoặc qua đường bưu điện hoặc bằng điện thoại tại: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 한국어 (Korean) 주의: 한국어를 사용하시는 경우, 언어 지원 서비스를 무료로 이용하실 수 있습니다. 1-877-696-6775 번으로 전화해 주십시오. Department of Health and Human Services (HHS, 보건복지부)은(는) 관련 연방 공민권법을 준수하며 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 차별하지 않습니다.",1
"HHS은(는) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 누군가를 배제하거나 다른 방식으로 대우하지 않습니다. HHS: - 장애인들이 저희와 효과적으로 의사소통할 수 있도록 다음과 같은 무료 지원과 서비스를 제공합니다. - 자격있는 수화 통역자 - 다른 형식의 서면 정보(큰 활자, 음성, 사용 가능한 전자 형식, 기타 형식) - 주로 사용하는 언어가 영어가 아닌 이들에게는 다음과 같은 무료 언어 서비스를 제공합니다. - 자격있는 통역자 - 다른 언어로 작성된 서면 정보 이러한 서비스가 필요하시면 HHS에 -877-696-6775번으로 연락하십시오. HHS 이(가) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 이러한 서비스를 제공하지 않거나 다른 방식으로 차별했다고 생각하시는 경우, 를 통한 전자 방식 또는 우편이나 전화로 Department of Health and Human Services, Office for Civil Rights (시민권 사무국)에 민원을 제출할 수 있습니다. 주소 및 연락처는 다음과 같습니다. U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Tagalog PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa 1-877-696-6775. Sumusunod ang U.S. Department of Health and Human Services (HHS, Kagawaran ng Mga Serbisyong Pangkalusugan at Pantao ng U.S.) sa mga naaangkop na Pampederal na batas sa karapatang sibil at hindi nandidiskrimina batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian. Ang HHS ay hindi nagtatangi ng mga tao o hindi nagpapakita ng ibang pakikitungo dahil sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian.",1
"Ang HHS ay: - Nagbibigay ng mga libreng tulong at serbisyo sa mga taong may kapansanan upang mahusay silang makipag-ugnayan sa amin, gaya ng: - Mga kwalipikadong interpreter ng sign language - Nakasulat na impormasyon sa iba pang mga format (malaking print, audio, mga naa-access na electronic na format, iba pang mga format) - Nagbibigay ng mga libreng serbisyo sa wika sa mga taong hindi Ingles ang pangunahing wika, gaya ng: - Mga kwalipikadong interpreter - Impormasyong nakasulat sa iba pang mga wika Kung kailangan mo ang mga serbisyong ito, makipag-ugnayan kay HHS sa 1-877-696-6775. Kung naniniwala kang hindi naibigay ng HHS ang mga serbisyong ito o nandiskrimina ito sa ibang paraan batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian, maaari kang maghain ng karaingan sa U.S. Department of Health and Human Services, Office for Civil Rights (Tanggapan para sa Mga Karapatang Sibil), sa electronic na paraan sa Office for Civil Rights Complaint Portal, na makikita sa o sa pamamagitan ng koreo o telepono sa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Русский (Russian) ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Министерство здравоохранения и социальных служб США) соблюдает применимое федеральное законодательство в области гражданских прав и не допускает дискриминации по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS не исключает людей и не относится к ним по-разному из-за расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS: - Для эффективного взаимодействия предоставляет безвозмездную помощь и оказывает услуги людям с ограниченными возможностями, а именно: - услуги квалифицированных сурдопереводчиков; - письменную информацию в других форматах (крупный шрифт, аудио формат, доступные электронные форматы, прочие форматы). - Предоставляет бесплатные услуги перевода людям, для которых английский не является основным языком, а именно: - услуги квалифицированных переводчиков; - письменную информацию на других языках. Если вы нуждаетесь в таких услугах, обратитесь к HHS по телефону 1-877-696-6775.",1
"Если вы считаете, что в HHS вам не предоставили указанных услуг или иным образом дискриминировали вас по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола, вы можете подать жалобу в U.S. Department of Health and Human Services, Office for Civil Rights (Управление по гражданским правам), в электронном виде через Office for Civil Rights Complaint Portal, доступный по ссылке: по почте или по телефону: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) العربية (Arabic) ملحوظة: إذا كنت تتحدث اذكر اللغة، فإن خدمات المساعدة اللغوية تتوافر لك بالمجان. اتصل برقم .1-877-696-6775 تلتزم HHS) Department of Health and Human Services, وزارة الخدمات الصحية والبشرية) بقوانين الحقوق المدنية الفدرالية المعمول بها ولا تميز على أساس العرق أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.",1
"لا تستبعد HHS الأشخاص أو تعاملهم على نحو مختلف بسبب النوع أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.. :HHS - توفر مساعدات وخدمات مجانية للأشخاص من ذوي الإعاقات للتواصل بصورة فعالة معنا، مثل: - مترجمي لغة إشارة مؤهلين - معلومات كتابية بتنسيقات أخرى (مطبوعة بأحرف كبيرة، مواد صوتية، تنسيقات إلكترونية متيسرة، وغير ذلك من التنسيقات) - توفر خدمات لغوية مجانية للأشخاص الذين لغتهم الأساسية ليست الإنجليزية، مثل: - مترجمين مؤهلين - معلومات مكتوبة بلغات أخرى إذا كنت بحاجة لهذه الخدمات، اتصل بـ HHS على الرقم .1-877-696-6775 إذا كنت تعتقد أن HHS قد أخفقت في توفير تلك الخدمات أو أنها قد ميزت بطريقة أخرى على أساس العرق أو اللون أو الأصل Department of Health and Human Services، مكتب Office for Civil Rights (مكتب الحقوق المدنية)، من خلال مكتب Office for Civil Rights Complaint Portal، المتوفر على الرابط أو بالبريد أو الهاتف على: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (رقم هاتف الصم والبكم) Kreyòl Ayisyen (Haitian Creole) ATANSYON: Si w pale Kreyòl Ayisyen, gen sèvis èd pou lang ki disponib gratis pou ou. Rele 1-877-696-6775. U.S. Department of Health and Human Services, (HHS, Ministè Sèvis Sante ak Imen Ameriken) konfòm ak lwa sou dwa sivil Federal ki aplikab yo e li pa fè diskriminasyon sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks. HHS pa ekskli moun oswa trete yo nan fason ki diferan akoz ras, koulè, peyi orijin, laj, enfimite oswa sèks yo.",1
"HHS: - Bay èd ak sèvis gratis pou moun ki andikape pou yo kominike avèk nou nan fason ki efikas, tankou: - Enèprèt langaj siy ki kalifye - Enfòmasyon ekri nan lòt fòma (gwo lèt, odyo, fòma elektwonik ki aksesib, lòt fòma) - Bay sèvis lang gratis a moun lang prensipal yo pa Anglè, tankou: - Enèprèt kalifye - Enfòmasyon ki ekri nan lòt lang Si w bezwen sèvis sa yo, kontakte HHS nan 1-877-696-6775. Si w kwè HHS pa t bay sèvis sa yo oswa te fè diskriminasyon nan yon lòt fason sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks, ou ka depoze yon plent nan: U.S. Department of Health and Human Services, Office for Civil Rights (Biwo Dwa Sivil) atravè Office for Civil Rights Portal, pa mwayen elektwonik ki disponib nan oswa pa lapòs oswa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Français (French) ATTENTION: Si vous parlez français, des services d’aide linguistique vous sont proposés gratuitement. Appelez le 1-877-696-6775. L’U.S. Department of Health and Human Services (HHS, Département de la Santé et des Services Sociaux des États-Unis) respecte les lois fédérales en vigueur relatives aux droits civiques et ne pratique aucune discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou un handicap.",1
"HHS n’exclut et ne traite aucune personne différemment en raison de sa race, sa couleur de peau, son origine nationale, son âge, son sexe ou son handicap. HHS: - Fournit gratuitement des aides et services aux personnes handicapées afin de permettre une communication efficace avec nous, par exemple: - Interprètes qualifiés en langue des signes - Informations écrites dans d’autres formats (gros caractères, audio, formats électroniques accessibles, autres formats) - Fournit gratuitement des services linguistiques aux personnes dont la langue principale n’est pas l’anglais, par exemple: - Interprètes qualifiés - Informations écrites dans d’autres langues Si vous avez besoin de ces services, contactez HHS au 1-877-696-6775. Si vous pensez que HHS n’a pas fourni ces services ou a fait preuve d’une autre forme de discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou le handicap, vous pouvez déposer une réclamation auprès de l’U.S. Department of Health and Human Services, l’Office for Civil Rights (Bureau des Droits Civiques), par voie électronique via l’Office for Civil Rights Complaint Portal, disponible à l’adresse par courrier ou par téléphone à: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Polski (Polish) UWAGA: Jeżeli mówisz po polsku, możesz skorzystać z bezpłatnej pomocy językowej. Zadzwoń pod numer 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Departament Zdrowia i Opieki Społecznej Stanów Zjednoczonych) postępuje zgodnie z obowiązującymi federalnymi prawami obywatelskimi i nie dopuszcza się dyskryminacji ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS nie wyklucza żadnych osób i nie stosuje różnego traktowania ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS: - Zapewnia bezpłatną pomoc i usługi osobom niepełnosprawnym w celu umożliwienia skutecznej komunikacji, na przykład: - Wykwalifikowanych tłumaczy języka migowego - Informacje na piśmie w różnych formatach (duży druk, audio, dostępne formaty elektroniczne, inne formaty) - Zapewnia bezpłatne usługi językowe dla osób, dla których angielski nie jest pierwszym językiem, na przykład: - Wykwalifikowanych tłumaczy - Informacje na piśmie w innych językach Jeżeli chcesz skorzystać z tych usług, skontaktuj się z HHS pod numerem 1-877-696-6775.",1
"Jeżeli uważasz, że HHS nie świadczy tych usług lub w inny sposób dopuszcza się dyskryminacji ze względu na rasę, koloru skóry, pochodzenie, wiek, niepełnosprawność bądź płeć, możesz złożyć skargę do: U.S. Department of Health and Human Services, Office for Civil Rights (Biuro Praw Obywatelskich), drogą elektroniczną za pośrednictwem Office for Civil Rights Complaint Portal na stronie pocztą tradycyjną lub dzwoniąc pod numer telefonu: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Português (Portuguese) O U.S. Department of Health and Human Services (HHS, Departamento de Saúde e dos Serviços Humanos dos Estados Unidos da América) cumpre as leis de direitos civis federais aplicáveis e não exerce discriminação com base na raça, cor, nacionalidade, idade, deficiência ou sexo. HHS não exclui ou trata de forma diferente devido à raça, cor, nacionalidade, idade, deficiência ou sexo.",1
"HHS: - Faculta ajuda e serviços gratuitos a pessoas com dificuldades de comunicar de forma eficaz connosco, tais como: - Intérpretes de língua gestual qualificados - Informação escrita noutros formatos (impressão maior, áudio, formatos electrónicos acessíveis, outros formatos) - Faculta serviços linguísticas grátis a pessoas cuja língua principal não é inglês, tais como: - Intérpretes qualificados - Informação escrita noutros idiomas Se necessita destes serviços, contacte HHS através do número 1-877-696-6775. Se considera que a HHS não cumpriu estes serviços ou exerceu discriminação de outra forma com base na raça, cor, nacionalidade, idade, deficiência ou sexo, pode apresentar uma reclamação junto de: U.S. Department of Health and Human Services, Office for Civil Rights (Gabinete de Direitos Civis), por via electrónica através do Office for Civil Rights Complaint Portal, disponível em ou por correio ou telefone: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Italiano (Italian) ATTENZIONE: In caso la lingua parlata sia l’italiano, sono disponibili servizi di assistenza linguistica gratuiti. Chiamare il numero 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Dipartimento statunitense per la salute e i servizi umani) è conforme a tutte le leggi federali vigenti in materia di diritti civili e non pone in essere discriminazioni sulla base di razza, colore, origine nazionale, età, disabilità o sesso. HHS non esclude le persone o le tratta diversamente a causa di razza, colore, origine nazionale, età, disabilità o sesso. HHS: - Offre sostegni e servizi gratuiti alle persone affette da disabilità per comunicare con noi in modo efficace, quali: - Interpreti qualificati nella lingua dei segni - Informazioni scritte in altri formati (stampe a grandi caratteri, audio, formati elettronici accessibili, altri formati) - Offre servizi linguistici gratuiti alle persone la cui lingua primaria non è l’inglese, quali: - Interpreti qualificati - Informazioni scritte in altre lingue In caso si necessiti di tali servizi, contattare HHS al numero 1-877-696-6775.",1
"In caso si ritenga che HHS non abbia offerto tali servizi o abbia posto in essere discriminazioni in altri modi sulla base di razza, colore, origine nazionale, età, disabilità o sesso, è possibile presentare una vertenza a: U.S. Department of Health and Human, Office for Civil Rights (Ufficio per i diritti civili), elettronicamente mediante l’Office for Civil Rights Complaint Portal, disponibile all’indirizzo oppure a mezzo posta o telefono all’attenzione di: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Deutsch (German) ACHTUNG: Wenn Sie Deutsch sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen zur Verfügung. Rufnummer: 1-877-696-6775. Das Department of Health and Human Services (HHS, U.S.-Gesundheitsministerium) erfüllt geltenden bundesstaatliche Menschenrechtsgesetze und lehnt jegliche Diskriminierung aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. lehnt den Ausschluss oder die unterschiedliche Behandlung von Menschen aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. HHS: - Bietet kostenlose Hilfe und Dienstleistungen für Menschen mit Behinderung zur effektiven Kommunikation, wie z.",1
"B.: - Qualifizierte Gebärdensprachen-Dolmetscher - Schriftliche Informationen in anderen Formaten (große Ausdrucke, Audio, zugängliche elektronische Formate, sonstige Formate) - Bietet kostenlose Sprachdienste für Menschen, deren Hauptsprache nicht Englisch ist, wie z. B.: - Qualifizierte Dolmetscher - Schriftliche Informationen in anderen Sprachen Sollten Sie diese Dienstleistungen benötigen, so wenden Sie sich an das HHS unter 1-877-696-6775.",1
"Sollten Sie der Ansicht sein, dass HHS es versäumte, diese Dienstleistungen anzubieten, oder auf sonstige Weise aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht diskriminierte, so können Sie eine Beschwerde einreichen bei: Department of Health and Human Services, Office for Civil Rights (Amt für Bürgerrechte), elektronisch über das Office for Civil Rights Complaint Portal, zugänglich über oder per Post oder telefonisch an: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 日本語 (Japanese) 注意事項：日本語を話される場合、無料の言語支援をご利用いただけます。1-877-696-6775 まで、お電話にてご連絡ください。 U.S. Department of Health and Human Services（HHS、保健社会福祉省）は適用される連邦公民権法を遵守し、人種、肌の色、出身国、年齢、障害、または性別に基づく差別をいたしません。HHS は人種、肌の色、出身国、年齢、障害、または性別を理由として人を排除したり、異なる扱いをいたしません。 HHS: - 効果的にコミュニケーションを図るため、障害のある人に以下の支援やサポートを無料で提供いたします。 - 資格ある手話通訳者 - その他形式の文字情報（大きな活字、音声信号、手軽な電子形式、その他） - 英語を母語としない人へ以下の言語サービスを無料で提供いたします。 - 資格ある通訳者 - 英語以外の言語で書かれた情報 これらのサービスを必要とされる場合は、HHS（1-877-696-6775）までご連絡ください。 HHS がこれらのサービスの提供を怠ったり、人種、肌の色、出身国、年齢、障害、または性別に基づいた何らかの方法で差別したと思われる場合、こちらまで苦情を申し立てることができます。また、公民権に関する苦情は、U.S.",1
"Department of Health and Human ServicesのOffice for Civil Rights（公民権局）へ、Office for Civil Rights Complaint Portal から電子申請するか、以下へ郵便または電話で申し立てることもできます： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) فارسی (Farsi) توجه: اگر به زبان فارسی گفتگو می کنید، تسهیلات زبانی بصورت رایگان برای شما فراهم می باشد. با .1-877-696-6775 تماس بگیرید HHS) U.S. Department of Health and Human Services, وزارت بهداشت و خدمات انسانی آمریکا) از قوانین حقوق مدنی فدرال مربوطه تبعیت می کند و هیچگونه تبعیضی بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد قایل نمی شود. HHS بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد ایشان را از خدمات محروم نمی کند و با آنها برخورد متفاوتی ندارد.",1
":HHS - برای افرادی که ناتوانی دارند، برای برقرار کردن ارتباط موثر، کمک هایی بطور رایگان فراهم می کند، مانند: - مترجمین واجد شرایط زبان اشاره - اطلاعات نوشتاری به فرمت های دیگر (چاپ با حروف درشت، صوتی، فرمت های الکترونیک قابل دسترسی ساده، و فرمت های دیگر) - برای افرادی که زبان اولیه شان انگلیسی نیست خدمات زبانی رایگان ارایه می کند، مانند: - مترجمین شفاهی واجد شرایط - اطلاعات نوشتاری به زبانهای دیگر اگر به چنین خدماتی نیاز دارید، با HHS به 1-877-696-6775 تماس بگیرید اگر معتقدید که HHS چنین خدماتی را به شما ارایه نداده و یا اینکه به شکلی دیگر به دلیل نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت درمورد شما تبعیض قایل شده می توانید شکواییه ای به این آدرس ثبت کنید: اگر احساس می کنید که HHS این خدمات را به شما ارایه نکرده و یا به هر شکلی بدلیل نژاد، رنگ پوست، اصلیت ملی، سن، معلولیت یا جنسیت شما را مورد تبعیض قرار داده، می توانید نزد U.S. Department of Health and Human Services، Office for Civil Rights (اداره حمایت از حقوق مدنی)، شکواییه خود را ثبت نمایید. دسترسی الکترونیکی به این اداره از طریق Office for Civil Rights Complaint Portal به آدرس یا تماس از طریق ایمیل یا تلفن با آدرس زیر میسر است: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) English ATTENTION: If you do not speak English, language assistance services are available to you free of charge.",1
"Call 1-800-232-4636 Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The CDC nondiscrimination notice lists the services available to you and how to file a complaint if you feel that CDC has failed to provide these services or discriminated in another way.",1
"Temas destacados Influenza aviar H5: situación actual Tipos de virus de la influenza Vivir con diabetes Cómo prevenir los norovirus Las infecciones de oído La neumoníaDe la A a la Z Noticias Todas las noticias - SEP 24Declaración de Laura Chanchien Parajón, MD, MPH, directora (interina) del Centro Nacional para la Prevención de Enfermedades Crónicas y Promoción de la Salud de los CDC, sobre el fallecimiento de Michael Fletcher, participante de la campaña Consejos de exfumadores® - SEP 08Se notificaron ciertas comidas de entrega a domicilio de Metabolic Meals en la investigación en curso sobre un brote de Salmonella - AGO 29Casi 100 personas enfermas en brote de Salmonella vinculado a huevos retirados del mercado - AGO 12Declaración del Departamento de Salud y Servicios Humanos de los Estados Unidos",1
"Statement Statement from Laura Chanchien Parajón, MD, MPH, Director (Acting), CDC's National Center for Chronic Disease Prevention and Health Promotion, on the passing of Suzy Ellis, Tips From Former Smokers® participant We are deeply saddened by the passing of Suzy Ellis, a participant in CDC's Tips From Former Smokers® campaign and devoted mother, voracious reader, and entrepreneur. At the age of 57, Suzy suffered a stroke, which her doctors linked to her many years of smoking. It was then that she quit smoking and eventually shared the story of her experience with CDC for the Tips campaign. Suzy believed that tobacco education campaigns like Tips could make a difference, encouraging people who had never smoked not to start, and showing those who did smoke that quitting was possible. We extend our deepest condolences to Suzy's family, her friends, and all who cared about her. Suzy's Tips Videos:",1
"Key points Getting vaccinated is one of the safest ways for you to protect your health. Vaccines help prevent getting and spreading serious diseases that could result in poor health, missed work, medical bills, and not being able to care for family. All adults need these routine vaccines Everyone should make sure they're up to date on these routine vaccines: - COVID-19 vaccine - Flu vaccine (influenza) - Tdap vaccine (tetanus, diphtheria, and whooping cough) or Td vaccine (tetanus, diphtheria) You may need other vaccines, too Review the sections below to learn what other vaccines you may need based on: - Age - Life events, job, or travel - Health conditions Recommended vaccine schedule for adults Life Events, Job, and Travel Get Personalized Recommendations Pregnancy Get the whooping cough vaccine during each pregnancy - Tdap vaccine — between 27 and 36 weeks of pregnancy to help protect your baby against whooping cough Make sure you're up to date on other vaccines, too - COVID-19 vaccine - Flu vaccine especially if you're pregnant during flu season, which is October through May - Hepatitis B vaccine Talk with your ob-gyn or midwife to find out which vaccines are recommended to help protect you and your baby. Learn more about Pregnancy and Vaccination.",1
"Healthcare workers Vaccines you need If you work directly with patients or handle material that could spread infection, you should get appropriate vaccines to reduce the chance that you will get or spread vaccine-preventable diseases. All healthcare workers should make sure they're up to date on these vaccines: - COVID-19 vaccine - Chickenpox vaccine (varicella) - Flu vaccine - Hepatitis B vaccine - Meningococcal vaccine – especially lab workers who work with Neisseria Meningitidis - MMR vaccine (measles, mumps, and rubella) - Tdap or Td International travelers Get vaccinated before you travel The vaccines recommended or required for an international traveler depend on several factors, including age, health, and itinerary. Take these steps to make sure you are prepared for your trip: - Make sure you are up-to-date with all recommended vaccines. Talk with your healthcare provider and get any vaccines that you may have missed. Take a short quiz and get a list of vaccines you may need based on your lifestyle, travel habits, and other factors. - Learn the recommended and required vaccines for your destination. Visit Travelers' Health: Destinations for more information about recommendations and requirements for the locations you will be visiting during your travel. - Get vaccinated at least 4 to 6 weeks before your trip. Planning ahead will give you enough time to build up immunity and get best protection.",1
"Find a travel clinic: Many state and local health departments provide travel vaccinations. Get more travel vaccination information as well as where to find travel vaccinations at CDC's Travelers' Health Clinic page. Immigrants, refugees and international adoptions Immigrants Whether you are applying for an immigrant visa overseas or for legal permanent residence within the United States, you need to meet the vaccination criteria for U.S. immigration. Refugees Refugees are not required to have vaccinations before arrival in the United States, but you can start getting certain vaccinations through the vaccination program for U.S.-bound refugees. International adoptions - Adoptees 10 years of age and under: Immigration law allows for adoptive parents to sign an affidavit stating they will be vaccinated after arrival to the United States. - Adoptees over 10 years of age: Immigration law requires proof of vaccination during the overseas medical examination. - Parents or close contacts traveling internationally to adopt a child: Make sure you are fully vaccinated according to CDC's ACIP recommendations. Some vaccine-preventable diseases, such as hepatitis A, are more common in other countries than the United States. - Get more international adoption health guidance. Health Conditions Asplenia (without a functioning spleen) Vaccines are especially critical for people with chronic health conditions such as asplenia to protect them from vaccine-preventable diseases.",1
"Make sure you're up to date on these vaccines: - Hib vaccine (Haemophilus influenzae type b) - Meningococcal vaccines – both MenACWY and MenB - Pneumococcal vaccine Diabetes, type 1 and type 2 People with diabetes (both type 1 and type 2) are at higher risk for serious problems, including hospitalization or death, from certain vaccine-preventable diseases. Vaccines are one of the safest ways for you to protect your health, even if you are taking prescription medications. Make sure you're up to date on this vaccine: Heart disease, stroke or other cardiovascular diseases People with heart disease and those who have suffered stroke are at higher risk for serious problems or complications from certain vaccine preventable diseases. Other vaccine-preventable diseases, like the flu, can even increase the risk of another heart attack. Make sure you're up to date on this vaccine: HIV infection Vaccines are especially critical for people with chronic health conditions such as HIV infection. Vaccine recommendations may differ based on CD4 count.",1
"Make sure you're up to date on these vaccines: - Hepatitis A vaccine - Hepatitis B vaccine - Meningococcal conjugate vaccine (MenACWY) - Pneumococcal vaccine - Shingles vaccine If your CD4 count is 200 or greater: AIn addition to the vaccines listed above, you may need these vaccines: - Chickenpox vaccine – recommended for all adults born in 1980 or later - MMR vaccine – recommended for all adults born in 1957 or later Liver disease Vaccines are especially critical for people with health conditions such as liver disease. Getting vaccinated is one of the safest ways for you to protect your health, even if you are taking prescription medications for liver disease. Make sure you're up to date on these vaccines: Lung disease (Including Asthma or COPD) People with lung disease (including asthma or COPD) are at higher risk for serious problems, including hospitalization or death, from certain vaccine-preventable diseases. Getting vaccinated is one of the safest ways for you to protect your health, even if you are taking prescription medications for your condition. Make sure you're up to date on this vaccine: End-stage renal (kidney) disease Getting vaccinated is one of the safest ways for you to protect your health, even if you are taking prescription medications for end-stage renal (kidney) disease or on hemodialysis.",1
"Make sure you're up to date on these vaccines: Weakened immune system (excluding HIV infection) Vaccines you need Vaccines are especially critical for people with a weakened immune system from diseases such as cancer or patients taking immunosuppressive drugs. Having a weakened immune system means that it is more difficult to fight off infections or diseases in the body. Adults with weakened immune systems caused by immunocompromising conditions such as cancer should make sure they're up to date on these vaccines: - Hib vaccine – Recommended for adults with complement deficiency, which is a specific type of immune deficiency, and for adults who have received a hematopoietic stem cell transplant (HSCT, or a bone marrow transplant) - Pneumococcal vaccines - Meningococcal vaccines (MenACWY and MenB) – Recommended for adults with complement deficiency, which is a specific type of immune deficiency - Shingles vaccine You may need other vaccines, too You may need other vaccines based on your age or other factors, too. Talk with your doctor to find out which vaccines are recommended for you.",1
"These may include: - Chickenpox vaccine – recommended for all adults born in 1980 or later - Hepatitis B vaccine – recommended for all adults up through 59 years of age, and for some adults 60 years of age and older with known risk factors - HPV vaccine – recommended for all adults up through 26 years of age, and for some adults aged 27 through 45 years - MMR vaccine – recommended for all adults born in 1957 or later - Shingles vaccine – recommended for all adults 50 years of age and older - If CD4 percentages are available, CD4 percentage should be 15% or greater.",1
"What to know - This page provides essential information about seasonal influenza (flu) vaccines, including their purpose and effectiveness. - Everyone 6 months and older should get a flu vaccine every season with rare exceptions. - Vaccination is particularly important for people who are at higher risk of serious complications from flu. - People with egg allergy may receive any vaccine (egg-based or non-egg-based) that is otherwise appropriate for their age and health status. - Flu vaccine prevents millions of illnesses and flu-related doctor's visits each year. Benefits of flu vaccination Flu vaccination can keep you from getting sick with flu. - Flu vaccine prevents millions of illnesses and flu-related doctor's visits each year. For example, during 2019-2020, the last flu season prior to the COVID-19 pandemic, flu vaccination prevented an estimated 7 million influenza illnesses, 3 million influenza-associated medical visits, 100,000 influenza-associated hospitalizations, and 7,000 influenza-associated deaths in the United States. - During seasons when flu vaccine viruses are similar to circulating flu viruses, flu vaccine has been shown to reduce the risk of having to go to the doctor with flu by 40% to 60%. Vaccines and people with egg allergies People with egg allergy may receive any vaccine (egg-based or non-egg-based) that is otherwise appropriate for their age and health status.",1
"Why getting vaccinated is important Influenza (flu) is a potentially serious disease that can lead to hospitalization and sometimes even death. Every flu season is different, and flu can affect people differently, but during typical flu seasons, millions of people get flu, hundreds of thousands of people are hospitalized and thousands to tens of thousands of people die from flu-related causes. Flu can mean a few days of feeling bad and missing work, school, or family events, or it can result in more serious illness. Who should get vaccinated Everyone 6 months and older should get a flu vaccine every season with rare exceptions. Vaccination is particularly important for people who are at higher risk of serious complications from influenza.",1
"At a glance - A report by the U.S. Surgeon General provides the latest science on what helps people quit smoking for good—and why quitting is so important. - If you smoke, quitting is one of the best things you can do for your health. A real story Tiffany R. learned early in life that cigarettes cause premature death and disease: her mother died of smoking-related lung cancer when Tiffany was just 16. Tiffany, a participant in CDC's Tips From Former Smokers® (Tips) ad campaign, said that she felt alone and afraid during her mother's illness. ""And I felt it could have been prevented,"" she said. Even so, Tiffany herself wasn't able to quit smoking for good until her own daughter turned 16. ""I didn't want my daughter to think, 'Wow, my mother loves cigarette smoking more than she cares about me,'"" she said. A new report by the U.S. Surgeon General provides the latest science on what helps people like Tiffany quit smoking for good—and why quitting is so important. One of the most important actions people can take to improve their health is to quit smoking, no matter how old they are or how long they've been smoking. Proven ways to quit Cigarette smoking is still the leading preventable cause of disease and death in the United States, killing almost half a million Americans every year. Smoking-related disease costs the nation more than $300 billion every year, and as Tiffany knows, hurts families as well. Luckily, the report highlights ways to quit that are backed up by science.",1
"Counseling and medication are each effective by themselves, but when used together, they can more than double your chance of successfully quitting. There are many safe, proven medications—including five kinds of nicotine replacement therapy (NRT) and two non-NRT prescription medicines. Evidence in the report shows that combining long-acting NRT such as nicotine patches with short-acting NRT such as nicotine gum or lozenges can also raise your chances of quitting. Nearly 70% of people who smoke cigarettes want to quit. Tiffany had tried before, each time learning something new about herself. However, when she finally succeeded in quitting, she did it by following the directions included with her nicotine patches, making sure to use them the right way. Stronger science, same advice This report is the first Surgeon General's report since 1990 to focus solely on the health benefits of quitting smoking. Much more research is available about those benefits since the last Surgeon General's report on quitting. The fact remains that if you smoke, quitting smoking entirely is still the best way to improve your current and future health: - It can increase your life expectancy up to 10 years and make it easier to enjoy life. - The risk for some smoking-related illnesses—including heart disease, stroke, and chronic obstructive pulmonary disease (COPD)—goes down after you quit.",1
"- Quitting also lowers risk of 12 types of cancer over time, including cancers of the lung, larynx (voice box), mouth and throat, esophagus, pancreas, bladder, stomach, colon and rectum, liver, cervix, and kidney, plus a type of blood cancer called acute myeloid leukemia. The report also suggests that cancer survivors can reduce their risk of dying from cancer by quitting smoking. - If you already have coronary heart disease, quitting can lower your risk of dying from it, getting a new type of heart disease, or having the disease come back. - Quitting smoking can also lower or delay loss of lung function and slows down the progress of COPD. The report makes it clear that pregnant women who quit smoking not only improve their own health, but also their newborns'. Cigarette smoking and secondhand smoke exposure make it more likely that women will have serious medical issues during pregnancy. Babies born to mothers who smoke are more likely to have lower birth weight and to die in the first year of life. If you are pregnant or planning to become pregnant, one of the best things you can do for yourself and your baby is to quit smoking. Read more: The Surgeon General's Report - Smoking Cessation: A Report of the Surgeon General [PDF–10MB] - Executive Summary [PDF–305 KB] - What You Need To Know About Quitting Smoking (Consumer Guide) [PDF–7.72 MB Fact sheets Everyone can help improve health Everyone, including employers and health care workers, can support people in quitting.",1
"Some strategies that the report shows motivate people to quit include: - Employers offering insurance that covers quit-smoking treatment and putting in place smokefree workplace policies. - Smokefree policies in restaurants and bars. - Hard-hitting mass media campaigns. - State or federal governments raising cigarette prices. - Requiring visual warnings on cigarette packages showing smoking-related disease. - Funding sustainable state tobacco control programs. Counseling and treatment from health care professionals such as doctors, nurses, and pharmacists also can also help people quit. Even though more doctors are talking to their patients about quitting smoking, only about 60% of adults who smoke get quitting advice from health care professionals. Finally, if you have a friend or loved one who wants to quit, you can help, too. Encourage them to talk to their doctor and direct them toward resources that can keep them on track in their quit journey. Help spread the word! Join the conversation and share content with your networks. Follow @CDCTobaccoFree and @Surgeon_General on Twitter. Get more information on the CDC Tobacco Free Facebook page and the Surgeon General's Facebook page. More help than ever Whether you want to quit smoking or want to help someone quit, you can find more resources today than ever before. You can find counseling in person or by phone. You can get most forms of NRT over the counter, though you might need a prescription to get insurance coverage.",1
"Your doctor can prescribe other medications that help lower your desire to smoke and fight cravings. You can also get help by calling a quitline. Quitlines are a free, convenient, and confidential source of support and information. There are smartphone apps and texting programs you can use to track your progress and carry support wherever you go. Quitting smoking is not easy, but it is possible, especially with proven, safe treatments. Tiffany found her reason to start her journey to better health right in her own family. Wherever you find yours, let it guide you to all the available resources for quitting, and toward a healthier future. Free quitting resources Telephone - 1-800-QUIT-NOW - 1-855-DÉJELO-YA (Español) - 1-800-838-8917 (中文) - 1-800-556-5564 (한국어) - 1-800-778-8440 (Tiếng Việt) Smartphone apps and text - Text QUITNOW to 333888 (Message and data rates may apply.) - quitSTART app Web",1
"What to know - CDC’s Respiratory Virus Guidance provides strategies you can use to help protect yourself and others from health risks caused by COVID-19 and other respiratory viruses. - These actions can help you lower the risk of COVID-19 transmission (spreading or catching COVID-19) and lower the risk of severe illness if you get sick. Core Prevention Strategies CDC recommends that all people use core prevention strategies to protect themselves and others from COVID-19: - Stay up to date with COVID-19 vaccines. - Although vaccinated people sometimes get infected with the virus that causes COVID-19, staying up to date on COVID-19 vaccines significantly lowers the risk of getting very sick, being hospitalized, or dying from COVID-19. - Practice good hygiene (practices that improve cleanliness) - Take steps for cleaner air When you are sick: - Use precautions to prevent spread, including staying home and away from others (including people you live with who are not sick) if you have respiratory symptoms. - Learn when you can go back to your normal activities. - Seek health care promptly for testing and/or treatment if you have risk factors for severe illness. Treatment may help lower your risk of severe illness, but it needs to be started within a few days of when your symptoms begin. Additional Prevention Strategies In addition, there are other prevention strategies that you can choose to further protect yourself and others.",1
"- Wearing a mask and putting distance between yourself and others can help lower the risk of COVID-19 transmission. - Testing for COVID-19 can help you decide what to do next, like getting treatment to reduce your risk of severe illness and taking steps to lower your chances of spreading COVID-19 to others. What to watch out for Using these prevention strategies can be especially helpful when: - Respiratory viruses, such as COVID-19, flu, and RSV, are causing a lot of illness in your community - You or those around you have risk factors for severe illness - You or those around you were recently exposed to a respiratory virus, are sick, or are recovering",1
"Language Assistance Services – CDC In November of 2023, the U.S. Department of Health and Human Services (HHS) updated its 2013 Language Access Plan in an effort to “ensure greater access to the life-saving services that HHS provides for people with Limited English Proficiency (LEP) and people with disabilities.” Consistent with the updated HHS plan, CDC launched a 2024 plan which outlines the action steps the agency will take to meet the language access needs of the public while continuing to support communities that may be underserved and improving access to information for people with LEP and people with disabilities. The strategic actions within the CDC plan prioritize efforts that will advance language accessibility to public health information and the agency’s communication with the public. The plan can be found online here: Español (Spanish) ATENCIÓN: Si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-800-232-4636. Los Centros para el Control y la Prevención de Enfermedades (CDC) de los EE. UU. cumplen con las leyes federales de derechos civiles aplicables y no discriminan por motivos de raza, color, nacionalidad, edad, discapacidad o sexo. Los CDC no excluyen a las personas ni las trata de forma diferente debido a su origen étnico, color, nacionalidad, edad, discapacidad o sexo.",1
"Los CDC: - Proporcionan asistencia y servicios gratuitos a las personas con discapacidades para que se comuniquen de manera eficaz con nosotros; algunos de esos servicios son: - Intérpretes de lenguaje de señas capacitados. - Información escrita en otros formatos (letra grande, audio, formatos electrónicos accesibles, otros formatos). - Proporcionan servicios lingüísticos gratuitos a las personas cuyo idioma materno no es el inglés; algunos de esos servicios son: - Intérpretes capacitados. - Información escrita en otros idiomas. Si necesita recibir estos servicios, comuníquese con los CDC al 1-800-232-4636. Si considera que el Departamento de Salud y Servicios Humanos (HHS) no le proporcionó estos servicios o lo discriminó de otra manera por motivos de origen étnico, color, nacionalidad, edad, discapacidad o sexo, puede presentar un reclamo a la Oficina de Derechos Civiles (Office for Civil Rights) del Departamento de Salud y Servicios Humanos de los EE. UU.",1
"de manera electrónica a través del portal de “Office for Civil Rights Complaint”, disponible en o bien, por correo postal a la siguiente dirección o por teléfono a los números que figuran a continuación: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 繁體中文 (Chinese) 注意：如果您使用繁體中文，您可以免費獲得語言援助服務。請致電 1-877-696-6775。 U.S. Department of Health and Human Services（HHS、美國衛生及公共服務部）遵守適用的聯邦民權法律規定、不因種族、膚色、民族血統、年齡、殘障或性別而歧視任何人。HHS 不因種族、膚色、民族血統、年齡、殘障或性別而排斥任何人或以不同的方式對待他們。 HHS - 向殘障人士免費提供各種援助和服務、以幫助他們與我們進行有效溝通、如： - 合格的手語翻譯員 - 以其他格式提供的書面資訊（大號字體、音訊、無障礙電子格式、其他格式） - 向母語非英語的人員免費提供各種語言服務，如： - 合格的翻譯員 - 以其他語言書寫的資訊 如果您需要此類服務、請聯絡 HHS 撥打 1-877-696-6775 如果您認為 HHS 未能提供此類服務或者因種族、膚色、民族血統、年齡、殘障或性別而透過其他方式歧視您、您可以向U.S. Department of Health and Human Services的 Office for Civil Rights（民權辦公室）提交民權投訴、透過 Office for Civil Rights Complaint Portal 以電子方式投訴： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019、800-537-7697 (TDD)（聾人用電信設備） Tiếng Việt (Vietnamese) CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-877-696-6775. U.S. Department of Health and Human Services (HHS, Bộ Y Tế và Dịch Vụ Nhân Sinh Hoa Kỳ) tuân thủ luật dân quyền hiện hành của Liên bang và không phân biệt đối xử dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính.",1
"HHS không loại trừ mọi người hoặc đối xử với họ khác biệt vì chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính. HHS: - Cung cấp dịch vụ hỗ trợ miễn phí cho những người khuyết tật để giao tiếp với chúng tôi có hiệu quả, như: - Thông dịch viên ngôn ngữ ký hiệu đủ năng lực - Thông tin bằng văn bản ở các định dạng khác (chữ in lớn, âm thanh, định dạng điện tử có thể tiếp cận, các định dạng khác) - Cung cấp miễn phí các dịch vụ ngôn ngữ cho những người có ngôn ngữ chính không phải là tiếng Anh, như: - Thông dịch viên đủ năng lực - Thông tin được trình bày bằng ngôn ngữ khác Nếu bạn cần những dịch vụ này, hãy liên hệ HHS theo số 1-877-696-6775. Nếu bạn tin rằng HHS không cung cấp những dịch vụ này hoặc phân biệt đối xử theo cách khác dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính, bạn có thể nộp đơn khiếu nại với U.S. Department of Health and Human Services, Office for Civil Rights (Văn Phòng Dân Quyền) bằng hình thức điện tử qua Office for Civil Rights Complaint Portal, có trên trang hoặc qua đường bưu điện hoặc bằng điện thoại tại: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 한국어 (Korean) 주의: 한국어를 사용하시는 경우, 언어 지원 서비스를 무료로 이용하실 수 있습니다. 1-877-696-6775 번으로 전화해 주십시오. Department of Health and Human Services (HHS, 보건복지부)은(는) 관련 연방 공민권법을 준수하며 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 차별하지 않습니다.",1
"HHS은(는) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 누군가를 배제하거나 다른 방식으로 대우하지 않습니다. HHS: - 장애인들이 저희와 효과적으로 의사소통할 수 있도록 다음과 같은 무료 지원과 서비스를 제공합니다. - 자격있는 수화 통역자 - 다른 형식의 서면 정보(큰 활자, 음성, 사용 가능한 전자 형식, 기타 형식) - 주로 사용하는 언어가 영어가 아닌 이들에게는 다음과 같은 무료 언어 서비스를 제공합니다. - 자격있는 통역자 - 다른 언어로 작성된 서면 정보 이러한 서비스가 필요하시면 HHS에 -877-696-6775번으로 연락하십시오. HHS 이(가) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 이러한 서비스를 제공하지 않거나 다른 방식으로 차별했다고 생각하시는 경우, 를 통한 전자 방식 또는 우편이나 전화로 Department of Health and Human Services, Office for Civil Rights (시민권 사무국)에 민원을 제출할 수 있습니다. 주소 및 연락처는 다음과 같습니다. U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Tagalog PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa 1-877-696-6775. Sumusunod ang U.S. Department of Health and Human Services (HHS, Kagawaran ng Mga Serbisyong Pangkalusugan at Pantao ng U.S.) sa mga naaangkop na Pampederal na batas sa karapatang sibil at hindi nandidiskrimina batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian. Ang HHS ay hindi nagtatangi ng mga tao o hindi nagpapakita ng ibang pakikitungo dahil sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian.",1
"Ang HHS ay: - Nagbibigay ng mga libreng tulong at serbisyo sa mga taong may kapansanan upang mahusay silang makipag-ugnayan sa amin, gaya ng: - Mga kwalipikadong interpreter ng sign language - Nakasulat na impormasyon sa iba pang mga format (malaking print, audio, mga naa-access na electronic na format, iba pang mga format) - Nagbibigay ng mga libreng serbisyo sa wika sa mga taong hindi Ingles ang pangunahing wika, gaya ng: - Mga kwalipikadong interpreter - Impormasyong nakasulat sa iba pang mga wika Kung kailangan mo ang mga serbisyong ito, makipag-ugnayan kay HHS sa 1-877-696-6775. Kung naniniwala kang hindi naibigay ng HHS ang mga serbisyong ito o nandiskrimina ito sa ibang paraan batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian, maaari kang maghain ng karaingan sa U.S. Department of Health and Human Services, Office for Civil Rights (Tanggapan para sa Mga Karapatang Sibil), sa electronic na paraan sa Office for Civil Rights Complaint Portal, na makikita sa o sa pamamagitan ng koreo o telepono sa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Русский (Russian) ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Министерство здравоохранения и социальных служб США) соблюдает применимое федеральное законодательство в области гражданских прав и не допускает дискриминации по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS не исключает людей и не относится к ним по-разному из-за расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS: - Для эффективного взаимодействия предоставляет безвозмездную помощь и оказывает услуги людям с ограниченными возможностями, а именно: - услуги квалифицированных сурдопереводчиков; - письменную информацию в других форматах (крупный шрифт, аудио формат, доступные электронные форматы, прочие форматы). - Предоставляет бесплатные услуги перевода людям, для которых английский не является основным языком, а именно: - услуги квалифицированных переводчиков; - письменную информацию на других языках. Если вы нуждаетесь в таких услугах, обратитесь к HHS по телефону 1-877-696-6775.",1
"Если вы считаете, что в HHS вам не предоставили указанных услуг или иным образом дискриминировали вас по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола, вы можете подать жалобу в U.S. Department of Health and Human Services, Office for Civil Rights (Управление по гражданским правам), в электронном виде через Office for Civil Rights Complaint Portal, доступный по ссылке: по почте или по телефону: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) العربية (Arabic) ملحوظة: إذا كنت تتحدث اذكر اللغة، فإن خدمات المساعدة اللغوية تتوافر لك بالمجان. اتصل برقم .1-877-696-6775 تلتزم HHS) Department of Health and Human Services, وزارة الخدمات الصحية والبشرية) بقوانين الحقوق المدنية الفدرالية المعمول بها ولا تميز على أساس العرق أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.",1
"لا تستبعد HHS الأشخاص أو تعاملهم على نحو مختلف بسبب النوع أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.. :HHS - توفر مساعدات وخدمات مجانية للأشخاص من ذوي الإعاقات للتواصل بصورة فعالة معنا، مثل: - مترجمي لغة إشارة مؤهلين - معلومات كتابية بتنسيقات أخرى (مطبوعة بأحرف كبيرة، مواد صوتية، تنسيقات إلكترونية متيسرة، وغير ذلك من التنسيقات) - توفر خدمات لغوية مجانية للأشخاص الذين لغتهم الأساسية ليست الإنجليزية، مثل: - مترجمين مؤهلين - معلومات مكتوبة بلغات أخرى إذا كنت بحاجة لهذه الخدمات، اتصل بـ HHS على الرقم .1-877-696-6775 إذا كنت تعتقد أن HHS قد أخفقت في توفير تلك الخدمات أو أنها قد ميزت بطريقة أخرى على أساس العرق أو اللون أو الأصل Department of Health and Human Services، مكتب Office for Civil Rights (مكتب الحقوق المدنية)، من خلال مكتب Office for Civil Rights Complaint Portal، المتوفر على الرابط أو بالبريد أو الهاتف على: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (رقم هاتف الصم والبكم) Kreyòl Ayisyen (Haitian Creole) ATANSYON: Si w pale Kreyòl Ayisyen, gen sèvis èd pou lang ki disponib gratis pou ou. Rele 1-877-696-6775. U.S. Department of Health and Human Services, (HHS, Ministè Sèvis Sante ak Imen Ameriken) konfòm ak lwa sou dwa sivil Federal ki aplikab yo e li pa fè diskriminasyon sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks. HHS pa ekskli moun oswa trete yo nan fason ki diferan akoz ras, koulè, peyi orijin, laj, enfimite oswa sèks yo.",1
"HHS: - Bay èd ak sèvis gratis pou moun ki andikape pou yo kominike avèk nou nan fason ki efikas, tankou: - Enèprèt langaj siy ki kalifye - Enfòmasyon ekri nan lòt fòma (gwo lèt, odyo, fòma elektwonik ki aksesib, lòt fòma) - Bay sèvis lang gratis a moun lang prensipal yo pa Anglè, tankou: - Enèprèt kalifye - Enfòmasyon ki ekri nan lòt lang Si w bezwen sèvis sa yo, kontakte HHS nan 1-877-696-6775. Si w kwè HHS pa t bay sèvis sa yo oswa te fè diskriminasyon nan yon lòt fason sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks, ou ka depoze yon plent nan: U.S. Department of Health and Human Services, Office for Civil Rights (Biwo Dwa Sivil) atravè Office for Civil Rights Portal, pa mwayen elektwonik ki disponib nan oswa pa lapòs oswa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Français (French) ATTENTION: Si vous parlez français, des services d’aide linguistique vous sont proposés gratuitement. Appelez le 1-877-696-6775. L’U.S. Department of Health and Human Services (HHS, Département de la Santé et des Services Sociaux des États-Unis) respecte les lois fédérales en vigueur relatives aux droits civiques et ne pratique aucune discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou un handicap.",1
"HHS n’exclut et ne traite aucune personne différemment en raison de sa race, sa couleur de peau, son origine nationale, son âge, son sexe ou son handicap. HHS: - Fournit gratuitement des aides et services aux personnes handicapées afin de permettre une communication efficace avec nous, par exemple: - Interprètes qualifiés en langue des signes - Informations écrites dans d’autres formats (gros caractères, audio, formats électroniques accessibles, autres formats) - Fournit gratuitement des services linguistiques aux personnes dont la langue principale n’est pas l’anglais, par exemple: - Interprètes qualifiés - Informations écrites dans d’autres langues Si vous avez besoin de ces services, contactez HHS au 1-877-696-6775. Si vous pensez que HHS n’a pas fourni ces services ou a fait preuve d’une autre forme de discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou le handicap, vous pouvez déposer une réclamation auprès de l’U.S. Department of Health and Human Services, l’Office for Civil Rights (Bureau des Droits Civiques), par voie électronique via l’Office for Civil Rights Complaint Portal, disponible à l’adresse par courrier ou par téléphone à: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Polski (Polish) UWAGA: Jeżeli mówisz po polsku, możesz skorzystać z bezpłatnej pomocy językowej. Zadzwoń pod numer 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Departament Zdrowia i Opieki Społecznej Stanów Zjednoczonych) postępuje zgodnie z obowiązującymi federalnymi prawami obywatelskimi i nie dopuszcza się dyskryminacji ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS nie wyklucza żadnych osób i nie stosuje różnego traktowania ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS: - Zapewnia bezpłatną pomoc i usługi osobom niepełnosprawnym w celu umożliwienia skutecznej komunikacji, na przykład: - Wykwalifikowanych tłumaczy języka migowego - Informacje na piśmie w różnych formatach (duży druk, audio, dostępne formaty elektroniczne, inne formaty) - Zapewnia bezpłatne usługi językowe dla osób, dla których angielski nie jest pierwszym językiem, na przykład: - Wykwalifikowanych tłumaczy - Informacje na piśmie w innych językach Jeżeli chcesz skorzystać z tych usług, skontaktuj się z HHS pod numerem 1-877-696-6775.",1
"Jeżeli uważasz, że HHS nie świadczy tych usług lub w inny sposób dopuszcza się dyskryminacji ze względu na rasę, koloru skóry, pochodzenie, wiek, niepełnosprawność bądź płeć, możesz złożyć skargę do: U.S. Department of Health and Human Services, Office for Civil Rights (Biuro Praw Obywatelskich), drogą elektroniczną za pośrednictwem Office for Civil Rights Complaint Portal na stronie pocztą tradycyjną lub dzwoniąc pod numer telefonu: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Português (Portuguese) O U.S. Department of Health and Human Services (HHS, Departamento de Saúde e dos Serviços Humanos dos Estados Unidos da América) cumpre as leis de direitos civis federais aplicáveis e não exerce discriminação com base na raça, cor, nacionalidade, idade, deficiência ou sexo. HHS não exclui ou trata de forma diferente devido à raça, cor, nacionalidade, idade, deficiência ou sexo.",1
"HHS: - Faculta ajuda e serviços gratuitos a pessoas com dificuldades de comunicar de forma eficaz connosco, tais como: - Intérpretes de língua gestual qualificados - Informação escrita noutros formatos (impressão maior, áudio, formatos electrónicos acessíveis, outros formatos) - Faculta serviços linguísticas grátis a pessoas cuja língua principal não é inglês, tais como: - Intérpretes qualificados - Informação escrita noutros idiomas Se necessita destes serviços, contacte HHS através do número 1-877-696-6775. Se considera que a HHS não cumpriu estes serviços ou exerceu discriminação de outra forma com base na raça, cor, nacionalidade, idade, deficiência ou sexo, pode apresentar uma reclamação junto de: U.S. Department of Health and Human Services, Office for Civil Rights (Gabinete de Direitos Civis), por via electrónica através do Office for Civil Rights Complaint Portal, disponível em ou por correio ou telefone: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Italiano (Italian) ATTENZIONE: In caso la lingua parlata sia l’italiano, sono disponibili servizi di assistenza linguistica gratuiti. Chiamare il numero 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Dipartimento statunitense per la salute e i servizi umani) è conforme a tutte le leggi federali vigenti in materia di diritti civili e non pone in essere discriminazioni sulla base di razza, colore, origine nazionale, età, disabilità o sesso. HHS non esclude le persone o le tratta diversamente a causa di razza, colore, origine nazionale, età, disabilità o sesso. HHS: - Offre sostegni e servizi gratuiti alle persone affette da disabilità per comunicare con noi in modo efficace, quali: - Interpreti qualificati nella lingua dei segni - Informazioni scritte in altri formati (stampe a grandi caratteri, audio, formati elettronici accessibili, altri formati) - Offre servizi linguistici gratuiti alle persone la cui lingua primaria non è l’inglese, quali: - Interpreti qualificati - Informazioni scritte in altre lingue In caso si necessiti di tali servizi, contattare HHS al numero 1-877-696-6775.",1
"In caso si ritenga che HHS non abbia offerto tali servizi o abbia posto in essere discriminazioni in altri modi sulla base di razza, colore, origine nazionale, età, disabilità o sesso, è possibile presentare una vertenza a: U.S. Department of Health and Human, Office for Civil Rights (Ufficio per i diritti civili), elettronicamente mediante l’Office for Civil Rights Complaint Portal, disponibile all’indirizzo oppure a mezzo posta o telefono all’attenzione di: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Deutsch (German) ACHTUNG: Wenn Sie Deutsch sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen zur Verfügung. Rufnummer: 1-877-696-6775. Das Department of Health and Human Services (HHS, U.S.-Gesundheitsministerium) erfüllt geltenden bundesstaatliche Menschenrechtsgesetze und lehnt jegliche Diskriminierung aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. lehnt den Ausschluss oder die unterschiedliche Behandlung von Menschen aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. HHS: - Bietet kostenlose Hilfe und Dienstleistungen für Menschen mit Behinderung zur effektiven Kommunikation, wie z.",1
"B.: - Qualifizierte Gebärdensprachen-Dolmetscher - Schriftliche Informationen in anderen Formaten (große Ausdrucke, Audio, zugängliche elektronische Formate, sonstige Formate) - Bietet kostenlose Sprachdienste für Menschen, deren Hauptsprache nicht Englisch ist, wie z. B.: - Qualifizierte Dolmetscher - Schriftliche Informationen in anderen Sprachen Sollten Sie diese Dienstleistungen benötigen, so wenden Sie sich an das HHS unter 1-877-696-6775.",1
"Sollten Sie der Ansicht sein, dass HHS es versäumte, diese Dienstleistungen anzubieten, oder auf sonstige Weise aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht diskriminierte, so können Sie eine Beschwerde einreichen bei: Department of Health and Human Services, Office for Civil Rights (Amt für Bürgerrechte), elektronisch über das Office for Civil Rights Complaint Portal, zugänglich über oder per Post oder telefonisch an: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 日本語 (Japanese) 注意事項：日本語を話される場合、無料の言語支援をご利用いただけます。1-877-696-6775 まで、お電話にてご連絡ください。 U.S. Department of Health and Human Services（HHS、保健社会福祉省）は適用される連邦公民権法を遵守し、人種、肌の色、出身国、年齢、障害、または性別に基づく差別をいたしません。HHS は人種、肌の色、出身国、年齢、障害、または性別を理由として人を排除したり、異なる扱いをいたしません。 HHS: - 効果的にコミュニケーションを図るため、障害のある人に以下の支援やサポートを無料で提供いたします。 - 資格ある手話通訳者 - その他形式の文字情報（大きな活字、音声信号、手軽な電子形式、その他） - 英語を母語としない人へ以下の言語サービスを無料で提供いたします。 - 資格ある通訳者 - 英語以外の言語で書かれた情報 これらのサービスを必要とされる場合は、HHS（1-877-696-6775）までご連絡ください。 HHS がこれらのサービスの提供を怠ったり、人種、肌の色、出身国、年齢、障害、または性別に基づいた何らかの方法で差別したと思われる場合、こちらまで苦情を申し立てることができます。また、公民権に関する苦情は、U.S.",1
"Department of Health and Human ServicesのOffice for Civil Rights（公民権局）へ、Office for Civil Rights Complaint Portal から電子申請するか、以下へ郵便または電話で申し立てることもできます： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) فارسی (Farsi) توجه: اگر به زبان فارسی گفتگو می کنید، تسهیلات زبانی بصورت رایگان برای شما فراهم می باشد. با .1-877-696-6775 تماس بگیرید HHS) U.S. Department of Health and Human Services, وزارت بهداشت و خدمات انسانی آمریکا) از قوانین حقوق مدنی فدرال مربوطه تبعیت می کند و هیچگونه تبعیضی بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد قایل نمی شود. HHS بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد ایشان را از خدمات محروم نمی کند و با آنها برخورد متفاوتی ندارد.",1
":HHS - برای افرادی که ناتوانی دارند، برای برقرار کردن ارتباط موثر، کمک هایی بطور رایگان فراهم می کند، مانند: - مترجمین واجد شرایط زبان اشاره - اطلاعات نوشتاری به فرمت های دیگر (چاپ با حروف درشت، صوتی، فرمت های الکترونیک قابل دسترسی ساده، و فرمت های دیگر) - برای افرادی که زبان اولیه شان انگلیسی نیست خدمات زبانی رایگان ارایه می کند، مانند: - مترجمین شفاهی واجد شرایط - اطلاعات نوشتاری به زبانهای دیگر اگر به چنین خدماتی نیاز دارید، با HHS به 1-877-696-6775 تماس بگیرید اگر معتقدید که HHS چنین خدماتی را به شما ارایه نداده و یا اینکه به شکلی دیگر به دلیل نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت درمورد شما تبعیض قایل شده می توانید شکواییه ای به این آدرس ثبت کنید: اگر احساس می کنید که HHS این خدمات را به شما ارایه نکرده و یا به هر شکلی بدلیل نژاد، رنگ پوست، اصلیت ملی، سن، معلولیت یا جنسیت شما را مورد تبعیض قرار داده، می توانید نزد U.S. Department of Health and Human Services، Office for Civil Rights (اداره حمایت از حقوق مدنی)، شکواییه خود را ثبت نمایید. دسترسی الکترونیکی به این اداره از طریق Office for Civil Rights Complaint Portal به آدرس یا تماس از طریق ایمیل یا تلفن با آدرس زیر میسر است: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) English ATTENTION: If you do not speak English, language assistance services are available to you free of charge.",1
"Call 1-800-232-4636 Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The CDC nondiscrimination notice lists the services available to you and how to file a complaint if you feel that CDC has failed to provide these services or discriminated in another way.",1
"At a glance The Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and state and local partners are investigating a link between blood lead levels (BLLs) ≥3.5 µg/dL in children consuming certain cinnamon-containing apple purée and applesauce products. Update FDA product testing has also identified high levels of chromium, in addition to lead, in cinnamon samples and recalled applesauce pouch products. (See for a list of affected products.) Potential health effects Consumers should be aware of these elevated levels of chromium and lead found in the cinnamon applesauce pouches and the potential for adverse health effects. Chromium is a naturally occurring element with trace levels normally found in the diet. The most common forms of chromium found in chromium compounds are trivalent chromium [chromium (III)] and hexavalent chromium [chromium (VI)]. Chromium (III) is considered an essential nutrient and can be found in a normal diet and in some dietary supplements. Chronic, prolonged exposure to chromium (VI) in occupational settings through inhalation and skin exposure has also been associated with chronic lung disease and ulceration of skin and mucous membranes. Chromium (VI) is a known carcinogen. The exact form of chromium in the recalled applesauce products is unclear. However, lead chromate has previously been reported as a contaminant in spices and foods.",1
"There is limited information about health effects from consuming food contaminated with chromium compounds such as lead chromate. The main health problems seen in laboratory animals following ingestion of chromium (VI) compounds are irritation and ulcers (in the stomach and small intestine) and anemia. However, the health effects of eating food contaminated with chromium (VI), in the form of lead chromate, are not well understood. Chromium (VI) compounds may be converted to chromium (III) in acidic environments. It is difficult to predict the amount of chromium (VI) and chromium (III) absorbed from ingestion of contaminated food. While the health effects of chromium are difficult to predict in this scenario, we know that there is no safe level of lead. CDC recommends discarding all affected products and not eating any of them. Anyone who may have eaten the affected products should talk with their healthcare provider. What can I do? Do not eat cinnamon-containing apple purée or applesauce products included in the FDA recall announcements. Anyone who may have eaten the affected products should talk with their healthcare provider. Medical treatment for chromium exposure focuses on treating symptoms. There is no specific antidote to treat chromium exposure and there is no evidence to support the use of chelation therapy. Additionally, if you suspect that you or your child may have been exposed to lead, talk with your healthcare provider about getting a blood lead test.",1
"Healthcare providers and most local health departments can test for lead in the blood. Many private insurance policies cover the cost of testing for lead in the blood. The cost of blood lead testing for children enrolled in Medicaid is covered by the Centers for Medicare & Medicaid Services. More information Information about FDA's investigation, with current updates, can be found on the FDA website, Investigation of Elevated Lead Levels: Cinnamon Applesauce Pouches (November 2023) | FDA. For more information on chromium, ToxFAQsTM for Chromium Information for Clinicians can be found on the COCA Now webpage, Update on High Blood Lead Levels in Children Consuming Recalled Cinnamon Applesauce Pouches and Potential Chromium Exposure Fast facts Data updated on October 23, 2024. CDC has received the following reports from state and local health departments: - Total Cases: 566 - Confirmed Cases: 130 - Probable Cases: 401 - Suspect Cases: 35 - Confirmed Cases: 130 - States: (44 total) AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, (plus Washington D.C. and Puerto Rico) - Recall: Yes - Investigation status: Inactive Cases are reported to the CDC through state health departments. State health departments receive reports of potential cases from various sources, and then follow up to determine whether the case definition is met.",1
"In order to be considered in CDC's case count, the person must have had a blood lead level of 3.5 ug/dL or higher measured within 3 months after consuming a recalled WanaBana, Schnucks, or Weis brand fruit purée product after November 2022. Based on the amount of information available, CDC asks states to further classify cases as ""suspect"", ""probable"", and ""confirmed"". As the investigation progresses, cases might be assigned to different case categories. What you should do - Do not eat any recalled apple cinnamon fruit puree pouches. Throw them away or return them to where you bought them. - Call your healthcare provider about getting a blood test for lead if you or your children may have consumed recalled products. What businesses should do - Do not sell or serve recalled apple cinnamon fruit puree pouches. - To properly discard the product, retailers should carefully open the pouch and empty the content into a trash can before discarding the packaging to prevent others from salvaging recalled products from the trash. - Clean up any spills after discarding the product, and then wash your hands. CDC case definition CDC asks states to classify cases as ""suspect,"" ""probable,"" or ""confirmed"" based on several factors. CDC accepts the state's classification.",1
"CDC defines a person with a ""suspect"" case as anyone with a blood lead level of 3.5 μg/dL or higher detected through capillary or unspecified testing (not yet confirmed through venous blood testing) within three months of consuming a recalled product. Capillary and venous testing are both commonly used to test blood for lead levels. However, capillary testing might give a falsely high result. Venous testing is more accurate. CDC defines a person with a ""probable"" case as anyone with a blood lead level of 3.5 μg/dL or higher detected through venous testing within three months of consuming a recalled product. People with a ""probable"" case: - might not have had a follow-up assessment to rule out other potential sources of lead exposure or - might have had a follow-up assessment completed, but the results indicated there were other potential sources of lead exposure (for example., lead-based paint). CDC defines a person with a ""confirmed case"" as anyone with a blood lead level of 3.5 μg/dL or higher: - Detected through venous testing within three months of consuming a recalled product and - must have had a follow-up assessment that ruled out other potential sources as the likely cause of lead exposure. Please note that as the investigation progresses, cases might move to different case categories. For example, a state may initially classify a case as ""suspect,"" but later determine that the case meets the criteria for being a ""confirmed"" case.",1
"In addition, these simplified definitions might not capture all the nuances of the case definition. We ask that states use our official case definition when classifying cases submitted to CDC. For more information, see CDC's Lead and Chromium Poisoning Outbreak Linked to Cinnamon Applesauce Pouches – Case Definition. Please note that CDC and FDA have different data sources, so the counts reported by each agency might not match. In addition, some people who were affected by the contaminated product might be counted in numbers reported by both FDA and CDC, so the numbers should not be added together. FDA relies on self-reported information submitted by healthcare providers, consumers, and some state partners who submitted an adverse event report to FDA. The reports were submitted as an initial step in determining if a product is a potential shared source of exposure amongst complainants. Symptoms of lead exposure Children with lead exposure may have no apparent acute symptoms. However, even low levels of lead have been associated with learning and behavior problems, hearing and speech problems, and slowed growth and development. This can show up as lower IQ, decreased ability to pay attention, and underperformance in school.",1
"Children who are exposed to large amounts of lead may develop symptoms of acute lead poisoning, including - Abdominal pain, constipation, and nausea - Anemia - Weakness and fatigue - Severe neurological symptoms (including seizures, encephalopathy, and coma) If parents suspect that a child may have been exposed to lead, they should talk to their child's healthcare provider about getting a blood lead test. Healthcare providers and most local health departments can test for lead in the blood. Many private insurance policies cover the cost of testing for lead in the blood. The cost of blood lead testing for children enrolled in Medicaid is covered by the Centers for Medicare & Medicaid Services. The health effects of exposure are more harmful to children less than six years of age because their bodies are still developing and growing rapidly. Young children also tend to put their hands or other objects, which may be contaminated with lead dust, into their mouths, so they are more likely to be exposed to lead than older children. See also - CDC: Recall on Cinnamon Applesauce Pouches That Have High Lead and Chromium Levels - FDA: Investigation of Elevated Lead Levels: Cinnamon Applesauce Pouches (November 2023) - FDA: WanaBana Recalls WanaBana, Weis, and Schnucks Apple Cinnamon Fruit Purée Pouches & Cinnamon Apple Sauce Due to Elevated Lead Levels - HAN: High Blood Lead Levels in Children Consuming Recalled Cinnamon Applesauce Pouches",1
"Key points - Lyme disease is a bacterial infection spread to people through the bite of blacklegged ticks. - Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system. - Lyme disease is most common in the Northeast, mid-Atlantic, and upper-Midwest regions of the United States. Overview In the United States, Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It occurs most commonly in the Northeast, mid-Atlantic, and upper-Midwest regions. Lyme disease bacteria are spread to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system. Lyme disease is diagnosed based on symptoms, physical findings (e.g., rash), and the possibility of exposure to infected ticks. Laboratory testing is helpful if used correctly and performed with FDA-cleared tests. Most cases of Lyme disease can be treated successfully with a few weeks of antibiotics. Signs and symptoms Untreated Lyme disease can produce a wide range of symptoms, depending on the stage of infection. These include fever, rash, facial paralysis, an irregular heartbeat, and arthritis.",1
"How it spreads Lyme disease bacteria causing human infection in the United States are spread to people by blacklegged (Ixodes) ticks. Prevention Prevent tick bites The best defense against Lyme disease is to prevent tick bites. This will reduce your risk of other tickborne diseases as well. What to do after a tick bite Remove attached ticks as soon as possible. Depending on the type of tick and how long it was attached, antibiotic prophylaxis might help to prevent Lyme disease. Call your doctor if you develop fever, rash, or other symptoms. Video: Preventing Lyme Disease in Children A Virginia mom shares how her daughter got a high-risk tick bite while playing on her backyard playset and the steps she took to prevent Lyme disease. Find accessibility information for the video. Testing and diagnosis CDC recommends the use of FDA-cleared antibody tests for laboratory diagnosis of Lyme disease. What CDC is doing CDC has a program of service, research, and education focusing on the prevention and control of Lyme disease. Activities of this program include: - Maintaining and analyzing national surveillance data for Lyme disease - Conducting epidemiologic investigations - Offering diagnostic and reference laboratory services - Developing and testing strategies for the control and prevention of this disease - Supporting education of the public and healthcare providers",1
"Key points - Prediabetes is a serious health condition, and 1 in 3 US adults has it. - With early action, you can reverse prediabetes to prevent or delay type 2 diabetes. - Find out if you have a high risk for prediabetes by taking the 1-minute risk test. What is prediabetes? Before developing type 2 diabetes, most people have prediabetes. This is when their blood sugar is higher than normal but not high enough yet for a type 2 diabetes diagnosis. In the United States, about 98 million adults have prediabetes; that's 1 in 3 people. There are usually no signs when you have prediabetes, which is why 81% of people don't know they have it. You can have prediabetes for years and not know. Ready to find out where you stand? Take the 1-minute prediabetes risk test. If your score shows you have a high risk of prediabetes, visit your doctor for a simple blood test to confirm your result. You can reverse prediabetes Risk factors Anyone can develop prediabetes at any age, but you may have a higher risk if you: - Have a family history of type 2 diabetes. - Are over age 45. - Have overweight or obesity. - Had gestational diabetes (diabetes when pregnant). - Have high blood pressure. - Are a Hispanic/Latino, Black, Asian American, or Native American person. Join the lifestyle change program If your doctor confirms you have prediabetes, join the CDC-recognized National Diabetes Prevention Program (National DPP) lifestyle change program.",1
"You'll learn how to make lasting lifestyle changes to prevent or delay type 2 diabetes: - Work with a trained Lifestyle Coach, who will help you take small, manageable steps that fit into your life. - Discover how to eat healthy and add more physical activity into your day. - Find out how to manage stress, stay motivated, and solve problems to maintain your progress. Ready to get started? Find a lifestyle change program near you or online.",1
"At a glance Overview of the structure of CDC’s Centers, Offices, and Institutes and leadership biographies for each. Organizational Structure CDC is one of the major operating components of the Department of Health and Human Services. View CDC's Official Mission Statements/Organizational Charts to learn more about CDC's organizational structure. CDC Federal Advisory Committees Information Federal advisory committees are a key component of CDC's overall strategy to achieve stakeholder and public engagement in its efforts and commitment to improve people's health.",1
"CDC Centers and Institute and Leadership - Center for Forecasting and Outbreak Analytics (CFA) - Global Health Center (GHC) - National Center on Birth Defects and Developmental Disabilities (NCBDDD) - National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) - National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) - National Center for Environmental Health (NCEH)/ Agency for Toxic Substances and Disease Registry (ATSDR) - National Center for Health Statistics (NCHS) - National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) - National Center for Immunization and Respiratory Diseases (NCIRD) - National Center for Injury Prevention and Control (NCIPC) - National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce (NCSTLTPHIW) - National Institute for Occupational Safety and Health (NIOSH) CDC Offices and Leadership - CDC Washington Office (CDC/W) - Office of Budget Policy and Appropriations (OBPA) - Office of Communications (OC) - Office of the Chief Operating Officer (OCOO) - Office of the Chief of Staff (OCS) - Office of Laboratory Systems and Response (OLSR) - Office of Minority Health (OMH) - Office of Policy, Performance, and Evaluation (OPPE) - Office of Public Health Data, Surveillance, and Technology (OPHDST) - Office of Readiness and Response (ORR) - Office of Science (OS)",1
"What to know - Dementia is a condition that makes someone unable to remember, think clearly, or make decisions while doing everyday activities. - Alzheimer’s disease is the most common type of dementia. - Learn about the different types of dementia. Overview Dementia Dementia is not a specific disease. It is an overall term that describes a decline in mental ability that interferes with daily life. It affects memory, thinking, and behavior. People with dementia often have symptoms like trouble remembering, thinking, or making everyday decisions. These symptoms tend to get worse over time. There are many types of dementia. - Alzheimer’s disease is the most common type of dementia. - Each form of dementia has a different cause. Though dementia mostly affects older adults, it is not a part of normal aging. A growing problem An estimated 6.7 million older adults have Alzheimer's disease in the United States. That number is expected to double by 2060. [1] Most common types Alzheimer's disease Alzheimer's is the most common type of dementia. It accounts for 60% to 80% of cases1. Cause: Many factors play a role in causing Alzheimer's, including genetics, behaviors, and habits.2 Symptoms: Symptoms include problems with short-term memory, paying bills, preparing meals, remembering appointments, or getting lost in familiar areas. Risks: Having a close relative (like a parent or sibling) with Alzheimer's disease increases a person's chance of developing it.",1
"However, there are many things you can do to reduce your risk, such as being physically active, and controlling your blood pressure.3 Vascular dementia Vascular dementia is the second most common type of dementia. It accounts for about 5%−10% of cases. Cause: Vascular dementia results from strokes or other problems with blood flow to the brain. Symptoms gradually become worse as blood vessels get damaged. Symptoms: Symptoms vary depending on the area of the brain that is affected. Risks: Other conditions that damage blood vessels can also increase a person's risk of developing vascular dementia. These include diabetes, high blood pressure, and high cholesterol. Lewy body dementia Lewy body dementia can cause problems with thinking, movement, behavior, and mood. Cause: This type of dementia is caused by abnormal deposits of a protein in the brain, called ""Lewy bodies."" These deposits affect chemicals in the brain. Symptoms: This type of dementia may cause memory loss, as well as movement or balance issues like stiffness or trembling. Many people with this type of dementia also experience daytime sleepiness, confusion, staring spells, sleep disturbances, or visual hallucinations. Risks: Researchers have not yet identified specific genes or risk factors linked to Lewy body dementia. Most people diagnosed have no family history of the disorder. Fronto-temporal dementia Frontotemporal dementia (FTD) affects the frontal (front) and temporal (side) lobes in the front of the brain.",1
"It often leads to changes in personality and behavior. FTD is a common cause of dementia that affects younger people. Cause: FTD is the result of damage to nerve cells in the frontal and temporal lobes of the brain. Symptoms: A person with FTD may experience increasing difficulty planning or organizing activities. They may act inappropriately in social or work settings and have trouble communicating with others. Risks: About one-third of all FTD cases are inherited through genes. Having a family history of FTD or a similar disorder are the only known risk factors. Mixed dementia More than one type of dementia can affect the brain at the same time. For example, a person may have Alzheimer's disease and vascular dementia. It is not always obvious that a person has mixed dementia. Testing and diagnosis Importance of testing If you think you or a loved one may have dementia, talk to a health care provider. The provider can work with you to figure out the problem and what might be causing it. - Some memory problems may be caused by treatable conditions. These problems can be reversed when the underlying condition is treated. Examples include: - Side effects of medication. - Increased brain pressure. - Vitamin deficiency. - Thyroid hormone imbalance. - Side effects of medication. - Some memory problems may be due to dementia. The sooner you can diagnose dementia, the sooner you can begin to treat it to slow its progression.",1
"Types of testing Health care providers will: - Look for problems with attention, memory, problem solving, and other brain functions to understand the problem. - Assess your brain to figure out the underlying cause. Assessment may include taking a medical history and tests such as: - A physical exam and diagnostic tests. - Neurological exam. - Depression screening. - Blood tests. - Brain scans, like computed tomography (CT) or magnetic resonance imaging (MRI). Treatment for dementia The type of treatment used for dementia depends on the underlying cause. - Symptom relief: There are prescription drugs that temporarily ease some symptoms. Most of these drugs work best for people in the early or middle stages of dementia. - Delay disease: There are other prescription drugs that can slow the progression of dementia. - Alzheimer’s Association. 2024 Alzheimer’s disease facts and figures. Alzheimers Dement. 2024;20(5):3708-3821. doi:10.1002/alz.13809 - Omura JD, McGuire LC, Patel R, et al. Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019. MMWR Morb Mortal Wkly Rep 2022;71:680–685. DOI: - The Alzheimer's Association. Risk Reduction. Accessed August 26, 2024. - Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024;404(10452). doi:",1
"What to know - The new CDC.gov is live and ready to use. - Experience enhanced usability, improved content, and reduced clutter. - If you need to access older content, visit the archive or view the site snapshot. A New CDC.gov We are excited to share the new CDC.gov! The new CDC.gov is based on testing with site users. As a result, we've streamlined it for the general public, public health professionals, and healthcare providers to find clear, up-to-date information. By also reducing duplicative and outdated content, our new site aims to provide information that is easier for you to find and understand. Take a Walkthrough of the New CDC.gov What you can expect As you browse the website, you will notice: - A fresh, new look and feel with better readability. - Page summaries to help you better understand what information is on each page. - Streamlined information and easier access to content as a result of clean-up efforts across the site. - New navigation and an improved user experience. - Audience breakouts that tailor and organize content for public health professionals, healthcare providers, and the general public. These enhancements underscore CDC's commitment to provide clear and effective communication to our users, delivering crucial health information how and when you need it. These changes to our site were inspired by substantial input and feedback from our web users. Thank you for shaping the new CDC.gov!",1
"Throughout 2024, CDC will continue improving and optimizing its web content. Accessing older content Because we have cleaned up our site, some previous CDC.gov content is not available on the new site. However, if this is important to you, we have provided two options to find older content: - Snapshot2024.cdc.gov allows you to see CDC.gov exactly as it was before launch. - This will be available until November 29, 2024. - This will be available until November 29, 2024. - Archive.cdc.gov is where CDC will host archival versions of key content previously available on CDC.gov. - You can use the search bar to find earlier versions of past content to view, print, or save. - This will be available indefinitely. - You can use the search bar to find earlier versions of past content to view, print, or save. Keep in mind that content in the website snapshot or archive is no longer updated and may not reflect the latest information. Changes to URLs The new CDC.gov includes link changes which will automatically direct users from old URLs to the new corresponding webpage. If a webpage doesn't have a replacement or alternative piece of content, a ""Page Not Found"" notice will appear. If you are linking to CDC.gov pages, email us at IMTech@cdc.gov for help adjusting your links and access the advanced URL mapping file.",1
"What to know CDC serves the American public—individuals, families, and communities—who rely on accurate data, health guidance, and preventive measures. CDC priorities statement As the world's premier public health institute, the U.S. Centers for Disease Control and Prevention (CDC) is at the front lines of public health threats to Americans, even when those threats emerge overseas. CDC must aim to protect the lives of all Americans, advancing health through science, technology, and innovation. CDC must lead with integrity to prevent and protect from diseases, detect emerging threats, both domestically and internationally, and drive state-of-the-art solutions—empowering communities and strengthening public health systems for a safer, healthier nation. CDC serves the American public—individuals, families, and communities—who rely on accurate data, health guidance, and preventive measures. CDC also serves healthcare providers, researchers, policymakers, businesses, state and local health agencies, and global health partners that rely on CDC for data and guidance to scale improved health outcomes for all Americans at home and abroad. To strengthen public confidence and lead a modern public health system, CDC must be anchored in a set of core values that reflect the evolving needs and expectations of Americans. Public trust in CDC must be restored through transparency and reliance on evidence-based scientific data and analysis.",1
"Americans benefit from practical, science-driven steps to protect their health and further expect proactive, fast responses to health risks. America additionally needs a public health system that embraces innovation and a modernized infrastructure. Understanding the fundamental role CDC plays in the public health sphere, the following Priorities Statement illustrates the overall direction of CDC, in furtherance of the goals of the President and the Department of Health and Human Services (HHS) Secretary. The following is not an exhaustive list of CDC priorities but is, instead, a roadmap highlighting goals and priorities, all through the lens of providing Gold-Standard Science, as envisioned in the Make America Healthy Again Commission Report and the Make Our Children Healthy Again Strategy. President Trump and HHS Secretary Kennedy are committed to restoring trust, transparency, and credibility to CDC. CDC is committed to those goals and is likewise committed to ensuring that its leadership and all decisions are public facing and more accountable. CDC is committed to strengthening our public health system and restoring it to its core mission of protecting Americans from infectious and communicable diseases and investing in innovation to prevent, detect, and respond to such public health threats. CDC is further committed to ensuring that any outbreaks—including any response to those outbreaks—is addressed transparently and with evidenced-based data.",1
"CDC is specifically prioritizing a commitment to: gold-standard science;1 global leadership; rebuilding trust, transparency, and credibility; rapid, evidence-based responses to crises; vaccine safety and efficacy research; advancing our understanding of autism spectrum disorder (ASD), neurodevelopmental disorders (NDDs), and chronic disease; modernizing public health infrastructure while enhancing our approach to health data; and otherwise ensuring compliance with the goals and priorities of the Trump Administration and HHS. A commitment to gold-standard science and ensuring trust, transparency, and credibility Public trust in CDC and public health has declined in recent years due to inconsistent messaging, lack of transparency, and challenges in responding appropriately to emerging health threats. Dwindling public trust has undermined CDC's ability to lead effectively during crises and has weakened public adherence to health recommendations. Strengthening and sustaining this trust is essential to CDC's mission, as it enables rapid decision-making, stronger partnerships, and coordinated national responses in times of crisis. More broadly, sustained trust ensures communities engage with prevention efforts, support science-based guidance, and contribute to a healthier, more resilient nation. Credibility is not just about better communication, it is foundational to CDC's long-term impact, effectiveness, and legitimacy.",1
"CDC will achieve this trust and credibility by making its leadership more public-facing and accountable to Americans; improving data transparency and ensuring all recommendations are backed by clear, publicly accessible evidence; and establishing processes to ensure integrity in scientific decision-making. As illustrated by the Trump Administration's Executive Order on ""Restoring Gold Standard Science,"" CDC will conduct all science in a manner that is reproducible; transparent; communicative of error and uncertainty; collaborative and interdisciplinary; skeptical of its findings and assumptions; structured for falsifiability of hypotheses; subject to unbiased peer review; accepting of negative results as positive outcomes; and without conflicts of interest. CDC is committed to restoring a gold standard for science to ensure that federally funded research is transparent, rigorous, and impactful, and that all decisions are informed by the most credible, reliable, and impartial scientific evidence available. CDC is committed to restoring Americans' faith in the scientific enterprise and institutions that create and apply scientific knowledge in service of the public good. Employing gold-standard science methodologies will spur innovation, translate discovery to success, and ensure continued American strength and global leadership in technology.",1
"A commitment to global leadership CDC's Global Health Center addresses global challenges such as HIV, tuberculosis, vaccine-preventable diseases, and emergency and refugee health. When a viral hemorrhagic fever is identified, such as Ebola, CDC is first to confirm the diagnosis and provide guidance on how to contain the virus within a country and to prevent it from entering the United States. Strategically located in 63 countries around the globe, CDC also serves another 20 countries from these hubs. As a major partner in implementing the PEPFAR program, CDC receives 40% of the resources and implements 60 percent of the program. Across the globe and often with external organizations, CDC is a trusted partner identifying risks early, sending out teams to combat highly infectious disease, training local clinical and public health staff, providing Personal Protective Equipment, vaccine and medicines, and offering advice to Americans abroad as well as supporting international Governments and Ministries of Health leadership and response. As part of an evolving system of response, the Biothreat Radar Detection program seeks out samples from wastewater and international travelers to know real-time when a new infection poses a risk to America. In addition, CDC receives infectious samples from around the globe offering rapid testing and surveillance to prepare for flu at home and guide rapid response for highly infectious diseases where they start and can travel around the globe.",1
"Through lessons learned from COVID-19, CDC has advanced its capacities to lead the world in keeping us safe here and abroad. A commitment to ensuring rapid, evidence-based responses to crises Public health emergencies need fast, coordinated, transparent, and evidence-based responses. Delays in data collection, fragmented decision-making, inconsistent guidance, and gaps in risk communication undermine the nation's ability to contain threats and protect lives. Ensuring rapid, science-driven responses is critical to minimizing harm, maintaining public trust, and restoring stability. To meet this goal, CDC must continue to strengthen its emergency response systems by streamlining internal processes, improving risk communication strategies, and ensuring that laboratory capacity is fully equipped and tested—capable of rapidly developing and deploying scalable diagnostics during crises. Embedding structures for real-time learning, independent after-action reviews, and the application of lessons learned will ensure that each crisis response is smarter, faster, and more effective than the last. To meet the challenges of today and anticipate the challenges of tomorrow, CDC must evolve into a high-performing, mission-driven organization that embraces innovation and streamlines operations.",1
"Modernizing internal operations will ensure CDC is not only effective in crisis but consistently excellent in execution, delivering faster decisions, smarter resource use, and a greater impact for Americans. A commitment to vaccine safety and efficacy research Gold-Standard Science will be applied to all intramural and extramural CDC vaccine safety and efficacy research. CDC will ensure that CDC vaccine efficacy and safety databases and datasets as well as future contracts, grants, cooperative agreements, and the like, for such datasets and databases are available through the least burdensome public use data agreements to restore trust and improve efficacy and safety through transparency and accountability. CDC will also preserve all internal datasets, protocols, programs and adjustments to databases and datasets for public access and reproducibility. A commitment to advancing our understanding of the causes of autism spectrum disorder (ASD), neurodevelopmental disorders (NDDs), and chronic disease CDC is committed to conducting its own research while also partnering with other federal agencies and outside researchers and institutions to understand the etiology of the ASD and NDD epidemics. CDC will utilize existing and new data resources both within and outside of CDC to better understand factors associated with the increases in ASD, NDD, and chronic diseases that are plaguing our children and adults.",1
"CDC data indicates that ASD diagnoses have increased over the past 25 years from 1 in 150 to nearly 1 in 31. A commitment to modernizing public health infrastructure and enhancing our approach to health data Modernizing public health infrastructure is essential to building a faster, smarter, and more cost-effective health system—one that can detect and respond to outbreaks in real time, leverage advanced technologies, and deliver community-driven solutions. By investing in modern tools, integrated data, and state-of-the-art capabilities, CDC can lead a transformation that not only strengthens day-to-day operations but also ensures the nation is prepared for future health emergencies. CDC's traditional data silos are being replaced with robust, integrated data that fosters interdisciplinary research to get faster, more robust results for Americans. Enhancing CDC's (and HHS's) approach to health data must recognize that the states serve as key partners and must be encouraged to maintain robust and up-do-date health data systems. There must be a shared responsibility across federal and state governments, while emphasizing the subsidiarity principle that public health functions should be performed at the lowest effective level of governance (the concept of subsidiarity), with federal structures offering support where scale or specialized expertise is required and as required by statute.",1
"Network governance highlights the importance of collaborative, interdependent nodes (state-based service units, federal expertise, and Health Data Utilities (HDUs)) working through shared standards rather than hierarchical command. Systems resilience frames the need for redundancy, adaptability, and transformability, ensuring that CDC can withstand shocks, respond to emerging public health crises, and evolve as public health challenges change. Collectively, these principles guide a strategy that positions public health as local in action, national in standards, and global in preparedness, while leveraging existing assets such as the Consumer Food Data System (CFDS) and Epidemic Intelligence Service (EIS) officers and modernizing infrastructure through HDUs. Conflicts of interest The public must know that unbiased science—evaluated through a transparent process and insulated from conflicts of interest—guides the recommendations of our health agencies, and CDC-funded programs and activities carried out by Federal partners. CDC will deprioritize funding for programs that present conflicts of interest or otherwise compromise their objectivity or integrity in carrying out CDC-funded programs. Immigration Consistent with applicable federal law, Federal funds should not be used to encourage or support illegal immigration. Protecting life and the family CDC programs will not use taxpayer funds to fund or promote elective abortions, consistent with the Hyde Amendment.",1
"CDC will promote the dignity of human life at all stages of development, improve maternal health care, and strengthen the family. Ending disorder on America's streets CDC grants will prioritize evidence-based programs and deprioritize programs that fail to achieve adequate outcomes, including so-called ""harm reduction"" or ""safe consumption"" efforts that only facilitate illegal drug use and its attendant harm, consistent with SAMHSA guidance issued on July 29, 2025. CDC will deprioritize support for ""housing first"" policies that fail to ensure accountability and fail to promote treatment, recovery, and self-sufficiency. CDC will increase competition among grantees through broadening the applicant pool and hold grantees to higher standards of effectiveness in reducing homelessness and increasing public safety. CDC will ensure that its funds reduce rather than promote homelessness by supporting, to the maximum extent permitted by applicable federal law, comprehensive services for individuals with serious mental illness and substance use disorder, including crisis intervention services. CDC does not support drug injection sites for illegal drugs, or so-called ""safe consumption sites,"" or the use or distribution of illegal drugs and associated paraphernalia.",1
"To the extent allowable by applicable federal law, CDC intends to give priority to grantees in States and municipalities that actively meet the below criteria: (i) enforce prohibitions on open illicit drug use; (ii) enforce prohibitions on urban camping and loitering; (iii) enforce prohibitions on urban squatting; (iv) enforce, and where necessary, adopt, standards that address individuals who are a danger to themselves or others and suffer from serious mental illness or substance use disorder, or who are living on the streets and cannot care for themselves, through assisted outpatient treatment or by moving them into treatment centers or other appropriate facilities via civil commitment or other available means, to the maximum extent permitted by law; or (v) substantially implement and comply with, to the extent required, the registration and notification obligations of the Sex Offender Registry and Notification Act, particularly in the case of registered sex offenders with no fixed address, including by adequately mapping and checking the location of homeless sex offenders. Gender ideology and protecting children CDC believes the health and safety of children must be the highest priority. HHS released a comprehensive review of the evidence and best practices for promoting the health of children and adolescents with gender dysphoria.",1
"This review, informed by an evidence-based medicine approach, found medical interventions, such as puberty blockers, cross-sex hormones, and surgeries, that attempt to transition minors away from their sex are unsupported by the evidence and have an unfavorable risk/benefit profile. Based on that evidence, it is a CDC priority to protect children from these practices, and, to the extent allowable by applicable federal law and any relevant court orders, CDC programs will deprioritize programs that engage in these practices where permissible. CDC funds will also not support the costs of such practices where not required by the law or court order. HHS released guidance promulgating sex-based definitions rooted in biological truth. It is a CDC priority to recognize that a person's sex as either male or female is unchangeable and determined by objective biology, and to ensure CDC programs accurately reflect science, including the biological reality of sex. DEI To the extent permitted by law, CDC will deprioritize diversity, equity, and inclusion (DEI) initiatives that prioritize group identity over individual merit. CDC believes opportunities should be based on character, effort, and ability, not race or other group identity. CDC is committed to restoring merit-based opportunities and removing unlawful discriminatory practices (including unlawful proxies for racial discrimination).",1
"CDC has previously invested substantially in ideologically-laden concepts like health equity—mainly on identifying and documenting worse health outcomes for minority populations. This has not translated into measurable improved health for minority populations, and in many cases has undermined core American values. CDC will prioritize efforts that go beyond the use of ideologically laden concepts to focusing on solution-oriented approaches. This includes actively testing, advancing, scaling, and implementing innovative evidence-based interventions and treatments that address poor health outcomes, including the root causes of Americans' chronic disease epidemic. Parental rights CDC believes parents are the primary decision-makers in their children's education and should have full authority over what their children are taught. School policies should include transparency and choice, and curricula should emphasize knowledge, critical thinking, and civic responsibility, without imposing ideas that may conflict with parents' political, religious, or social beliefs. CDC will prioritize funding Federal partners that protect parental rights and provide maximum transparency to parents and the public. CDC will implement these priorities consistent with applicable laws, regulations, court orders, and any required procedures. - Executive Order 14303",1
"Language Assistance Services – CDC In November of 2023, the U.S. Department of Health and Human Services (HHS) updated its 2013 Language Access Plan in an effort to “ensure greater access to the life-saving services that HHS provides for people with Limited English Proficiency (LEP) and people with disabilities.” Consistent with the updated HHS plan, CDC launched a 2024 plan which outlines the action steps the agency will take to meet the language access needs of the public while continuing to support communities that may be underserved and improving access to information for people with LEP and people with disabilities. The strategic actions within the CDC plan prioritize efforts that will advance language accessibility to public health information and the agency’s communication with the public. The plan can be found online here: Español (Spanish) ATENCIÓN: Si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-800-232-4636. Los Centros para el Control y la Prevención de Enfermedades (CDC) de los EE. UU. cumplen con las leyes federales de derechos civiles aplicables y no discriminan por motivos de raza, color, nacionalidad, edad, discapacidad o sexo. Los CDC no excluyen a las personas ni las trata de forma diferente debido a su origen étnico, color, nacionalidad, edad, discapacidad o sexo.",1
"Los CDC: - Proporcionan asistencia y servicios gratuitos a las personas con discapacidades para que se comuniquen de manera eficaz con nosotros; algunos de esos servicios son: - Intérpretes de lenguaje de señas capacitados. - Información escrita en otros formatos (letra grande, audio, formatos electrónicos accesibles, otros formatos). - Proporcionan servicios lingüísticos gratuitos a las personas cuyo idioma materno no es el inglés; algunos de esos servicios son: - Intérpretes capacitados. - Información escrita en otros idiomas. Si necesita recibir estos servicios, comuníquese con los CDC al 1-800-232-4636. Si considera que el Departamento de Salud y Servicios Humanos (HHS) no le proporcionó estos servicios o lo discriminó de otra manera por motivos de origen étnico, color, nacionalidad, edad, discapacidad o sexo, puede presentar un reclamo a la Oficina de Derechos Civiles (Office for Civil Rights) del Departamento de Salud y Servicios Humanos de los EE. UU.",1
"de manera electrónica a través del portal de “Office for Civil Rights Complaint”, disponible en o bien, por correo postal a la siguiente dirección o por teléfono a los números que figuran a continuación: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 繁體中文 (Chinese) 注意：如果您使用繁體中文，您可以免費獲得語言援助服務。請致電 1-877-696-6775。 U.S. Department of Health and Human Services（HHS、美國衛生及公共服務部）遵守適用的聯邦民權法律規定、不因種族、膚色、民族血統、年齡、殘障或性別而歧視任何人。HHS 不因種族、膚色、民族血統、年齡、殘障或性別而排斥任何人或以不同的方式對待他們。 HHS - 向殘障人士免費提供各種援助和服務、以幫助他們與我們進行有效溝通、如： - 合格的手語翻譯員 - 以其他格式提供的書面資訊（大號字體、音訊、無障礙電子格式、其他格式） - 向母語非英語的人員免費提供各種語言服務，如： - 合格的翻譯員 - 以其他語言書寫的資訊 如果您需要此類服務、請聯絡 HHS 撥打 1-877-696-6775 如果您認為 HHS 未能提供此類服務或者因種族、膚色、民族血統、年齡、殘障或性別而透過其他方式歧視您、您可以向U.S. Department of Health and Human Services的 Office for Civil Rights（民權辦公室）提交民權投訴、透過 Office for Civil Rights Complaint Portal 以電子方式投訴： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019、800-537-7697 (TDD)（聾人用電信設備） Tiếng Việt (Vietnamese) CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-877-696-6775. U.S. Department of Health and Human Services (HHS, Bộ Y Tế và Dịch Vụ Nhân Sinh Hoa Kỳ) tuân thủ luật dân quyền hiện hành của Liên bang và không phân biệt đối xử dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính.",1
"HHS không loại trừ mọi người hoặc đối xử với họ khác biệt vì chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính. HHS: - Cung cấp dịch vụ hỗ trợ miễn phí cho những người khuyết tật để giao tiếp với chúng tôi có hiệu quả, như: - Thông dịch viên ngôn ngữ ký hiệu đủ năng lực - Thông tin bằng văn bản ở các định dạng khác (chữ in lớn, âm thanh, định dạng điện tử có thể tiếp cận, các định dạng khác) - Cung cấp miễn phí các dịch vụ ngôn ngữ cho những người có ngôn ngữ chính không phải là tiếng Anh, như: - Thông dịch viên đủ năng lực - Thông tin được trình bày bằng ngôn ngữ khác Nếu bạn cần những dịch vụ này, hãy liên hệ HHS theo số 1-877-696-6775. Nếu bạn tin rằng HHS không cung cấp những dịch vụ này hoặc phân biệt đối xử theo cách khác dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính, bạn có thể nộp đơn khiếu nại với U.S. Department of Health and Human Services, Office for Civil Rights (Văn Phòng Dân Quyền) bằng hình thức điện tử qua Office for Civil Rights Complaint Portal, có trên trang hoặc qua đường bưu điện hoặc bằng điện thoại tại: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 한국어 (Korean) 주의: 한국어를 사용하시는 경우, 언어 지원 서비스를 무료로 이용하실 수 있습니다. 1-877-696-6775 번으로 전화해 주십시오. Department of Health and Human Services (HHS, 보건복지부)은(는) 관련 연방 공민권법을 준수하며 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 차별하지 않습니다.",1
"HHS은(는) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 누군가를 배제하거나 다른 방식으로 대우하지 않습니다. HHS: - 장애인들이 저희와 효과적으로 의사소통할 수 있도록 다음과 같은 무료 지원과 서비스를 제공합니다. - 자격있는 수화 통역자 - 다른 형식의 서면 정보(큰 활자, 음성, 사용 가능한 전자 형식, 기타 형식) - 주로 사용하는 언어가 영어가 아닌 이들에게는 다음과 같은 무료 언어 서비스를 제공합니다. - 자격있는 통역자 - 다른 언어로 작성된 서면 정보 이러한 서비스가 필요하시면 HHS에 -877-696-6775번으로 연락하십시오. HHS 이(가) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 이러한 서비스를 제공하지 않거나 다른 방식으로 차별했다고 생각하시는 경우, 를 통한 전자 방식 또는 우편이나 전화로 Department of Health and Human Services, Office for Civil Rights (시민권 사무국)에 민원을 제출할 수 있습니다. 주소 및 연락처는 다음과 같습니다. U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Tagalog PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa 1-877-696-6775. Sumusunod ang U.S. Department of Health and Human Services (HHS, Kagawaran ng Mga Serbisyong Pangkalusugan at Pantao ng U.S.) sa mga naaangkop na Pampederal na batas sa karapatang sibil at hindi nandidiskrimina batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian. Ang HHS ay hindi nagtatangi ng mga tao o hindi nagpapakita ng ibang pakikitungo dahil sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian.",1
"Ang HHS ay: - Nagbibigay ng mga libreng tulong at serbisyo sa mga taong may kapansanan upang mahusay silang makipag-ugnayan sa amin, gaya ng: - Mga kwalipikadong interpreter ng sign language - Nakasulat na impormasyon sa iba pang mga format (malaking print, audio, mga naa-access na electronic na format, iba pang mga format) - Nagbibigay ng mga libreng serbisyo sa wika sa mga taong hindi Ingles ang pangunahing wika, gaya ng: - Mga kwalipikadong interpreter - Impormasyong nakasulat sa iba pang mga wika Kung kailangan mo ang mga serbisyong ito, makipag-ugnayan kay HHS sa 1-877-696-6775. Kung naniniwala kang hindi naibigay ng HHS ang mga serbisyong ito o nandiskrimina ito sa ibang paraan batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian, maaari kang maghain ng karaingan sa U.S. Department of Health and Human Services, Office for Civil Rights (Tanggapan para sa Mga Karapatang Sibil), sa electronic na paraan sa Office for Civil Rights Complaint Portal, na makikita sa o sa pamamagitan ng koreo o telepono sa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Русский (Russian) ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Министерство здравоохранения и социальных служб США) соблюдает применимое федеральное законодательство в области гражданских прав и не допускает дискриминации по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS не исключает людей и не относится к ним по-разному из-за расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS: - Для эффективного взаимодействия предоставляет безвозмездную помощь и оказывает услуги людям с ограниченными возможностями, а именно: - услуги квалифицированных сурдопереводчиков; - письменную информацию в других форматах (крупный шрифт, аудио формат, доступные электронные форматы, прочие форматы). - Предоставляет бесплатные услуги перевода людям, для которых английский не является основным языком, а именно: - услуги квалифицированных переводчиков; - письменную информацию на других языках. Если вы нуждаетесь в таких услугах, обратитесь к HHS по телефону 1-877-696-6775.",1
"Если вы считаете, что в HHS вам не предоставили указанных услуг или иным образом дискриминировали вас по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола, вы можете подать жалобу в U.S. Department of Health and Human Services, Office for Civil Rights (Управление по гражданским правам), в электронном виде через Office for Civil Rights Complaint Portal, доступный по ссылке: по почте или по телефону: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) العربية (Arabic) ملحوظة: إذا كنت تتحدث اذكر اللغة، فإن خدمات المساعدة اللغوية تتوافر لك بالمجان. اتصل برقم .1-877-696-6775 تلتزم HHS) Department of Health and Human Services, وزارة الخدمات الصحية والبشرية) بقوانين الحقوق المدنية الفدرالية المعمول بها ولا تميز على أساس العرق أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.",1
"لا تستبعد HHS الأشخاص أو تعاملهم على نحو مختلف بسبب النوع أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.. :HHS - توفر مساعدات وخدمات مجانية للأشخاص من ذوي الإعاقات للتواصل بصورة فعالة معنا، مثل: - مترجمي لغة إشارة مؤهلين - معلومات كتابية بتنسيقات أخرى (مطبوعة بأحرف كبيرة، مواد صوتية، تنسيقات إلكترونية متيسرة، وغير ذلك من التنسيقات) - توفر خدمات لغوية مجانية للأشخاص الذين لغتهم الأساسية ليست الإنجليزية، مثل: - مترجمين مؤهلين - معلومات مكتوبة بلغات أخرى إذا كنت بحاجة لهذه الخدمات، اتصل بـ HHS على الرقم .1-877-696-6775 إذا كنت تعتقد أن HHS قد أخفقت في توفير تلك الخدمات أو أنها قد ميزت بطريقة أخرى على أساس العرق أو اللون أو الأصل Department of Health and Human Services، مكتب Office for Civil Rights (مكتب الحقوق المدنية)، من خلال مكتب Office for Civil Rights Complaint Portal، المتوفر على الرابط أو بالبريد أو الهاتف على: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (رقم هاتف الصم والبكم) Kreyòl Ayisyen (Haitian Creole) ATANSYON: Si w pale Kreyòl Ayisyen, gen sèvis èd pou lang ki disponib gratis pou ou. Rele 1-877-696-6775. U.S. Department of Health and Human Services, (HHS, Ministè Sèvis Sante ak Imen Ameriken) konfòm ak lwa sou dwa sivil Federal ki aplikab yo e li pa fè diskriminasyon sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks. HHS pa ekskli moun oswa trete yo nan fason ki diferan akoz ras, koulè, peyi orijin, laj, enfimite oswa sèks yo.",1
"HHS: - Bay èd ak sèvis gratis pou moun ki andikape pou yo kominike avèk nou nan fason ki efikas, tankou: - Enèprèt langaj siy ki kalifye - Enfòmasyon ekri nan lòt fòma (gwo lèt, odyo, fòma elektwonik ki aksesib, lòt fòma) - Bay sèvis lang gratis a moun lang prensipal yo pa Anglè, tankou: - Enèprèt kalifye - Enfòmasyon ki ekri nan lòt lang Si w bezwen sèvis sa yo, kontakte HHS nan 1-877-696-6775. Si w kwè HHS pa t bay sèvis sa yo oswa te fè diskriminasyon nan yon lòt fason sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks, ou ka depoze yon plent nan: U.S. Department of Health and Human Services, Office for Civil Rights (Biwo Dwa Sivil) atravè Office for Civil Rights Portal, pa mwayen elektwonik ki disponib nan oswa pa lapòs oswa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Français (French) ATTENTION: Si vous parlez français, des services d’aide linguistique vous sont proposés gratuitement. Appelez le 1-877-696-6775. L’U.S. Department of Health and Human Services (HHS, Département de la Santé et des Services Sociaux des États-Unis) respecte les lois fédérales en vigueur relatives aux droits civiques et ne pratique aucune discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou un handicap.",1
"HHS n’exclut et ne traite aucune personne différemment en raison de sa race, sa couleur de peau, son origine nationale, son âge, son sexe ou son handicap. HHS: - Fournit gratuitement des aides et services aux personnes handicapées afin de permettre une communication efficace avec nous, par exemple: - Interprètes qualifiés en langue des signes - Informations écrites dans d’autres formats (gros caractères, audio, formats électroniques accessibles, autres formats) - Fournit gratuitement des services linguistiques aux personnes dont la langue principale n’est pas l’anglais, par exemple: - Interprètes qualifiés - Informations écrites dans d’autres langues Si vous avez besoin de ces services, contactez HHS au 1-877-696-6775. Si vous pensez que HHS n’a pas fourni ces services ou a fait preuve d’une autre forme de discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou le handicap, vous pouvez déposer une réclamation auprès de l’U.S. Department of Health and Human Services, l’Office for Civil Rights (Bureau des Droits Civiques), par voie électronique via l’Office for Civil Rights Complaint Portal, disponible à l’adresse par courrier ou par téléphone à: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Polski (Polish) UWAGA: Jeżeli mówisz po polsku, możesz skorzystać z bezpłatnej pomocy językowej. Zadzwoń pod numer 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Departament Zdrowia i Opieki Społecznej Stanów Zjednoczonych) postępuje zgodnie z obowiązującymi federalnymi prawami obywatelskimi i nie dopuszcza się dyskryminacji ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS nie wyklucza żadnych osób i nie stosuje różnego traktowania ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS: - Zapewnia bezpłatną pomoc i usługi osobom niepełnosprawnym w celu umożliwienia skutecznej komunikacji, na przykład: - Wykwalifikowanych tłumaczy języka migowego - Informacje na piśmie w różnych formatach (duży druk, audio, dostępne formaty elektroniczne, inne formaty) - Zapewnia bezpłatne usługi językowe dla osób, dla których angielski nie jest pierwszym językiem, na przykład: - Wykwalifikowanych tłumaczy - Informacje na piśmie w innych językach Jeżeli chcesz skorzystać z tych usług, skontaktuj się z HHS pod numerem 1-877-696-6775.",1
"Jeżeli uważasz, że HHS nie świadczy tych usług lub w inny sposób dopuszcza się dyskryminacji ze względu na rasę, koloru skóry, pochodzenie, wiek, niepełnosprawność bądź płeć, możesz złożyć skargę do: U.S. Department of Health and Human Services, Office for Civil Rights (Biuro Praw Obywatelskich), drogą elektroniczną za pośrednictwem Office for Civil Rights Complaint Portal na stronie pocztą tradycyjną lub dzwoniąc pod numer telefonu: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Português (Portuguese) O U.S. Department of Health and Human Services (HHS, Departamento de Saúde e dos Serviços Humanos dos Estados Unidos da América) cumpre as leis de direitos civis federais aplicáveis e não exerce discriminação com base na raça, cor, nacionalidade, idade, deficiência ou sexo. HHS não exclui ou trata de forma diferente devido à raça, cor, nacionalidade, idade, deficiência ou sexo.",1
"HHS: - Faculta ajuda e serviços gratuitos a pessoas com dificuldades de comunicar de forma eficaz connosco, tais como: - Intérpretes de língua gestual qualificados - Informação escrita noutros formatos (impressão maior, áudio, formatos electrónicos acessíveis, outros formatos) - Faculta serviços linguísticas grátis a pessoas cuja língua principal não é inglês, tais como: - Intérpretes qualificados - Informação escrita noutros idiomas Se necessita destes serviços, contacte HHS através do número 1-877-696-6775. Se considera que a HHS não cumpriu estes serviços ou exerceu discriminação de outra forma com base na raça, cor, nacionalidade, idade, deficiência ou sexo, pode apresentar uma reclamação junto de: U.S. Department of Health and Human Services, Office for Civil Rights (Gabinete de Direitos Civis), por via electrónica através do Office for Civil Rights Complaint Portal, disponível em ou por correio ou telefone: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Italiano (Italian) ATTENZIONE: In caso la lingua parlata sia l’italiano, sono disponibili servizi di assistenza linguistica gratuiti. Chiamare il numero 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Dipartimento statunitense per la salute e i servizi umani) è conforme a tutte le leggi federali vigenti in materia di diritti civili e non pone in essere discriminazioni sulla base di razza, colore, origine nazionale, età, disabilità o sesso. HHS non esclude le persone o le tratta diversamente a causa di razza, colore, origine nazionale, età, disabilità o sesso. HHS: - Offre sostegni e servizi gratuiti alle persone affette da disabilità per comunicare con noi in modo efficace, quali: - Interpreti qualificati nella lingua dei segni - Informazioni scritte in altri formati (stampe a grandi caratteri, audio, formati elettronici accessibili, altri formati) - Offre servizi linguistici gratuiti alle persone la cui lingua primaria non è l’inglese, quali: - Interpreti qualificati - Informazioni scritte in altre lingue In caso si necessiti di tali servizi, contattare HHS al numero 1-877-696-6775.",1
"In caso si ritenga che HHS non abbia offerto tali servizi o abbia posto in essere discriminazioni in altri modi sulla base di razza, colore, origine nazionale, età, disabilità o sesso, è possibile presentare una vertenza a: U.S. Department of Health and Human, Office for Civil Rights (Ufficio per i diritti civili), elettronicamente mediante l’Office for Civil Rights Complaint Portal, disponibile all’indirizzo oppure a mezzo posta o telefono all’attenzione di: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Deutsch (German) ACHTUNG: Wenn Sie Deutsch sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen zur Verfügung. Rufnummer: 1-877-696-6775. Das Department of Health and Human Services (HHS, U.S.-Gesundheitsministerium) erfüllt geltenden bundesstaatliche Menschenrechtsgesetze und lehnt jegliche Diskriminierung aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. lehnt den Ausschluss oder die unterschiedliche Behandlung von Menschen aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. HHS: - Bietet kostenlose Hilfe und Dienstleistungen für Menschen mit Behinderung zur effektiven Kommunikation, wie z.",1
"B.: - Qualifizierte Gebärdensprachen-Dolmetscher - Schriftliche Informationen in anderen Formaten (große Ausdrucke, Audio, zugängliche elektronische Formate, sonstige Formate) - Bietet kostenlose Sprachdienste für Menschen, deren Hauptsprache nicht Englisch ist, wie z. B.: - Qualifizierte Dolmetscher - Schriftliche Informationen in anderen Sprachen Sollten Sie diese Dienstleistungen benötigen, so wenden Sie sich an das HHS unter 1-877-696-6775.",1
"Sollten Sie der Ansicht sein, dass HHS es versäumte, diese Dienstleistungen anzubieten, oder auf sonstige Weise aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht diskriminierte, so können Sie eine Beschwerde einreichen bei: Department of Health and Human Services, Office for Civil Rights (Amt für Bürgerrechte), elektronisch über das Office for Civil Rights Complaint Portal, zugänglich über oder per Post oder telefonisch an: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 日本語 (Japanese) 注意事項：日本語を話される場合、無料の言語支援をご利用いただけます。1-877-696-6775 まで、お電話にてご連絡ください。 U.S. Department of Health and Human Services（HHS、保健社会福祉省）は適用される連邦公民権法を遵守し、人種、肌の色、出身国、年齢、障害、または性別に基づく差別をいたしません。HHS は人種、肌の色、出身国、年齢、障害、または性別を理由として人を排除したり、異なる扱いをいたしません。 HHS: - 効果的にコミュニケーションを図るため、障害のある人に以下の支援やサポートを無料で提供いたします。 - 資格ある手話通訳者 - その他形式の文字情報（大きな活字、音声信号、手軽な電子形式、その他） - 英語を母語としない人へ以下の言語サービスを無料で提供いたします。 - 資格ある通訳者 - 英語以外の言語で書かれた情報 これらのサービスを必要とされる場合は、HHS（1-877-696-6775）までご連絡ください。 HHS がこれらのサービスの提供を怠ったり、人種、肌の色、出身国、年齢、障害、または性別に基づいた何らかの方法で差別したと思われる場合、こちらまで苦情を申し立てることができます。また、公民権に関する苦情は、U.S.",1
"Department of Health and Human ServicesのOffice for Civil Rights（公民権局）へ、Office for Civil Rights Complaint Portal から電子申請するか、以下へ郵便または電話で申し立てることもできます： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) فارسی (Farsi) توجه: اگر به زبان فارسی گفتگو می کنید، تسهیلات زبانی بصورت رایگان برای شما فراهم می باشد. با .1-877-696-6775 تماس بگیرید HHS) U.S. Department of Health and Human Services, وزارت بهداشت و خدمات انسانی آمریکا) از قوانین حقوق مدنی فدرال مربوطه تبعیت می کند و هیچگونه تبعیضی بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد قایل نمی شود. HHS بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد ایشان را از خدمات محروم نمی کند و با آنها برخورد متفاوتی ندارد.",1
":HHS - برای افرادی که ناتوانی دارند، برای برقرار کردن ارتباط موثر، کمک هایی بطور رایگان فراهم می کند، مانند: - مترجمین واجد شرایط زبان اشاره - اطلاعات نوشتاری به فرمت های دیگر (چاپ با حروف درشت، صوتی، فرمت های الکترونیک قابل دسترسی ساده، و فرمت های دیگر) - برای افرادی که زبان اولیه شان انگلیسی نیست خدمات زبانی رایگان ارایه می کند، مانند: - مترجمین شفاهی واجد شرایط - اطلاعات نوشتاری به زبانهای دیگر اگر به چنین خدماتی نیاز دارید، با HHS به 1-877-696-6775 تماس بگیرید اگر معتقدید که HHS چنین خدماتی را به شما ارایه نداده و یا اینکه به شکلی دیگر به دلیل نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت درمورد شما تبعیض قایل شده می توانید شکواییه ای به این آدرس ثبت کنید: اگر احساس می کنید که HHS این خدمات را به شما ارایه نکرده و یا به هر شکلی بدلیل نژاد، رنگ پوست، اصلیت ملی، سن، معلولیت یا جنسیت شما را مورد تبعیض قرار داده، می توانید نزد U.S. Department of Health and Human Services، Office for Civil Rights (اداره حمایت از حقوق مدنی)، شکواییه خود را ثبت نمایید. دسترسی الکترونیکی به این اداره از طریق Office for Civil Rights Complaint Portal به آدرس یا تماس از طریق ایمیل یا تلفن با آدرس زیر میسر است: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) English ATTENTION: If you do not speak English, language assistance services are available to you free of charge.",1
"Call 1-800-232-4636 Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The CDC nondiscrimination notice lists the services available to you and how to file a complaint if you feel that CDC has failed to provide these services or discriminated in another way.",1
"At a glance CDC advances two coequal and interrelated priorities: to strengthen safety and scientific excellence of every CDC laboratory. The director for the Office of Laboratory Systems and Response is the senior official who serves as the single point of accountability for laboratory science and safety at CDC. Director for the Office of Laboratory Systems and Response Learn more about Dr. Salerno on CDC’s leadership page. CDC Activities to Strengthen Safety and Scientific Excellence in CDC Laboratories Overseeing Safety in CDC Laboratories CDC is committed to continually improving its culture of safety in its laboratories where transparency and accountability are valued; staff receive complete, comprehensive, and cutting-edge safety training; the safety of a procedure or project is considered before all else; and potential safety issues are quickly and openly addressed. While working with dangerous pathogens, chemicals, and toxins always carries a degree of risk, CDC is committed to identifying, mitigating, reducing, and eliminating these risks in every feasible way to protect the safety of its staff and the American public. The Office of Laboratory Systems and Response (OLSR) oversees biological, chemical, and radiation safety at CDC laboratories. The OLSR safety inspectors visit CDC laboratories annually to ensure that their practices, procedures, and equipment meet key safety standards.",1
"The oversight includes ensuring that CDC laboratories are in full compliance with the requirements of the Federal Select Agent Program, which regulates the possession, use, and transfer of biological select agents and toxins. The OLSR also manages CDC’s Animal Care and Use Program Office (ACUPO), assuring CDC compliance with guidance and regulations for the responsible care of research animals at CDC. Providing the Standards and Guidance on Biosafety CDC co-authors the foundational biosafety manual Biosafety in Microbiological and Biomedical Laboratories (BMBL), in partnership with the National Institutes of Health (NIH). Now in its 6th Edition, the BMBL has become the standard guidance for biosafety practices in laboratories across the country. Supporting Animal Care and Use in CDC Laboratory Research CDC has a legal and moral responsibility to ensure that the animals entrusted to our care are treated in accordance with the highest standards of animal welfare and care. Research studies involving animals conducted at or supported by CDC must comply with the Animal Welfare Act (AWA) regulations promulgated by the United States Department of Agriculture (USDA) under Title 9, Code of Federal Regulations, Parts 1-3 as well as the Public Health Service Policy on Humane Care and Use of Laboratory Animals (PHS Policy) administered by the National Institutes of Health (NIH), Office of Laboratory Animal Welfare (OLAW).",1
"As an OLAW Assured institution, all CDC animal studies adhere to the Guide for the Care and Use of Laboratory Animals. In addition, all animal studies must be approved by and conducted in accordance with the policies set forth by the Institutional Animal Care and Use Committee (IACUC), an oversight body mandated by the AWA to review all research studies involving animals at CDC to ensure compliance with animal welfare standards. CDC is also voluntarily accredited with the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), demonstrating CDC’s highest commitment to animal welfare and going above and beyond what is required by federal law. Learn more about some of the regulatory and ethical standards governing research with animals at CDC Advancing the “Science of Laboratory Safety” CDC is committed to advancing the “science of laboratory safety”—applying the same rigorous scientific methods to the safety of CDC’s laboratories that CDC uses to confront threats to the public’s health. To spur the science of safety in CDC laboratories, OLSR supports CDC laboratories to advance innovative research or solutions to laboratory safety challenges. Advancing Laboratory Scientific Excellence One of the tenets of CDC's Pledge to the American People is that CDC will ""base all public health decisions on the highest quality scientific data that is derived openly and objectively.""",1
"OLSR is committed to ensuring that CDC laboratories continue to fulfill this pledge and serve as a model for scientific excellence and quality. The scientific data produced by CDC's laboratories provides a crucial foundation for sound, evidence-based public health decision-making across the country. OLSR aids this work by providing CDC laboratories with leadership and technical expertise that both supports, and helps to advance excellence in laboratory science throughout CDC. OLSR supports this work by providing oversight and coordination of laboratory quality management and training programs for CDC laboratories. OLSR establishes teams responsible for developing agency-level plans, policies, guidelines, manuals, and tools for implementation of quality management programs within Centers, Institutes and Offices, and for the continual improvement of laboratory quality and safety training for CDC staff. Fostering the Next Generation of Laboratory Leaders CDC's Laboratory Leadership Service (LLS) is a fellowship program that prepares early career laboratory scientists to become future laboratory leaders. The fellowship combines competency-based public health laboratory training with practical, applied investigations and service. LLS will provide CDC and public health laboratories across the country with a pool of expertly trained laboratory scientists poised to meet the evolving challenges of laboratory science and safety.",1
"Learn more about CDC's Laboratory Leadership Service Providing State-of-the-Art Laboratory Trainings Maximizing the safety and impact of CDC's laboratories requires a workforce of laboratory scientists trained in state-of-the-art techniques and technology. In partnership with the Division of Laboratory Systems and Safe Labs Program, OLSR supports the development of a comprehensive training curriculum to ensure that CDC's laboratory scientists are equipped to meet current and future public health challenges. In 2019, CDC opened a state-of-the-art laboratory training facility where these trainings could be held. The 4,760 square-foot facility was designed to provide hands-on training to laboratory scientists with access to high containment laboratories. This space offers CDC laboratory programs a facility to test new protocols and equipment in a realistic laboratory setting in the absence of pathogens.",1
"At a glance Overview of the structure of CDC’s Centers, Offices, and Institutes and leadership biographies for each. Organizational Structure CDC is one of the major operating components of the Department of Health and Human Services. View CDC's Official Mission Statements/Organizational Charts to learn more about CDC's organizational structure. CDC Federal Advisory Committees Information Federal advisory committees are a key component of CDC's overall strategy to achieve stakeholder and public engagement in its efforts and commitment to improve people's health.",1
"CDC Centers and Institute and Leadership - Center for Forecasting and Outbreak Analytics (CFA) - Global Health Center (GHC) - National Center on Birth Defects and Developmental Disabilities (NCBDDD) - National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) - National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) - National Center for Environmental Health (NCEH)/ Agency for Toxic Substances and Disease Registry (ATSDR) - National Center for Health Statistics (NCHS) - National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) - National Center for Immunization and Respiratory Diseases (NCIRD) - National Center for Injury Prevention and Control (NCIPC) - National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce (NCSTLTPHIW) - National Institute for Occupational Safety and Health (NIOSH) CDC Offices and Leadership - CDC Washington Office (CDC/W) - Office of Budget Policy and Appropriations (OBPA) - Office of Communications (OC) - Office of the Chief Operating Officer (OCOO) - Office of the Chief of Staff (OCS) - Office of Laboratory Systems and Response (OLSR) - Office of Minority Health (OMH) - Office of Policy, Performance, and Evaluation (OPPE) - Office of Public Health Data, Surveillance, and Technology (OPHDST) - Office of Readiness and Response (ORR) - Office of Science (OS)",1
"David J. Sencer CDC Museum The David J. Sencer CDC Museum is temporarily closed. Please visit this site for reopening update. Ever wonder how CDC scientists merge old-fashioned detective work with high-tech science to crack the cases of mystery diseases? Get the Story! Visit the David J. Sencer CDC Museum at CDC Headquarters. This unique museum features award-winning permanent and changing exhibitions that focus on a variety of public health topics, as well as the history of CDC. The museum is free and open to the public so we would like to see you soon. Now on Display Follow @CDCMuseum for the latest news about exhibitions, programming, and events. Global Health Chronicles was launched in collaboration with Emory University’s Libraries, Global Health Institute, and Rollins School of Public Health. The web site is a series of “Chronicles,” each dealing with a different subject. - Hours: Monday: 9 a.m. – 5 p.m. Tuesday: 9 a.m. – 5 p.m. Wednesday: 9 a.m. – 5 p.m. Thursday: 9 a.m. – 7 p.m. Friday: 9 a.m. -5 p.m. Closed weekends & federal holidays - Admission & Parking: Please note that visitor access requires advance approval. Kindly allow at least three business days for processing before your visit. Always Free Government–issued photo ID required for adults over the age of 18 Passport required for non-U.S. citizens - Weapons are prohibited. All vehicles will be inspected.",1
"- Location: 1600 Clifton Road NE Atlanta, GA 30329 - Phone: 404-639-0830 - Tour Questions: museumtours@cdc.gov",1
"Key points - Most human cases of bird flu, caused by avian influenza A(H5) virus, in the United States have been mild, so far, and most were in people who had known exposure to sick or infected animals. - The severity of illness associated with bird flu has ranged from mild to severe, including death. - The reported signs and symptoms of bird flu in humans have varied. Eye redness has been the predominant symptom among recent U.S. cases of avian influenza A(H5) virus infection. Respiratory symptoms and fever were also reported. - The possibility of human infections with avian influenza virus that result in severe illness remains and underscores the importance of ongoing prevention and surveillance efforts. Mild symptoms Mild signs and symptoms of bird flu in people may include: - eye redness and irritation (conjunctivitis) - mild fever (temperature of 100ºF [37.8ºC] or greater) or feeling feverish*, - cough - sore throat - runny or stuffy nose - muscle or body aches - headaches - fatigue Eye redness has been the predominant symptom among recent U.S. cases of avian influenza A(H5) virus infection. Less common symptoms include diarrhea, nausea, or vomiting.",1
"*Fever may not always be present Signs and symptoms of moderate to severe disease Signs and symptoms of moderate to severe disease from bird flu in people may include: - high fever or other symptoms listed above that limit or prevent usual activity - shortness of breath or difficulty breathing - altered consciousness - seizures Complications Complications of bird flu can include but are not limited to: - pneumonia, - respiratory failure, - acute respiratory distress syndrome, - acute kidney injury - multi-organ failure (respiratory and kidney failure), - sepsis, septic shock - and inflammation of the brain (meningoencephalitis) Timing Onset of Symptoms The time from when a person is exposed and infected with avian influenza A(H5) viruses to when respiratory symptoms begin is about three days but can range from about 2 to 7 days. However, eye symptoms such as redness and irritation can occur one to two days after exposure and infection with an avian influenza A(H5) virus. Period when people are contagious - The period of contagiousness for person with mild illness due to bird flu is not well understood but thought to be similar to seasonal flu. - People are thought to be most contagious during the first few days of their illness. - People with severe disease (e.g., pneumonia) requiring hospitalization may have high levels of virus in the lower respiratory tract and may be contagious for several weeks.",1
"How long bird flu illness lasts Bird flu usually lasts a few days to less than two weeks, but how long symptoms last can vary by person. People who are severely ill (for example, intubated for severe pneumonia and respiratory failure) may be sick for several weeks.",1
"Language Assistance Services – CDC In November of 2023, the U.S. Department of Health and Human Services (HHS) updated its 2013 Language Access Plan in an effort to “ensure greater access to the life-saving services that HHS provides for people with Limited English Proficiency (LEP) and people with disabilities.” Consistent with the updated HHS plan, CDC launched a 2024 plan which outlines the action steps the agency will take to meet the language access needs of the public while continuing to support communities that may be underserved and improving access to information for people with LEP and people with disabilities. The strategic actions within the CDC plan prioritize efforts that will advance language accessibility to public health information and the agency’s communication with the public. The plan can be found online here: Español (Spanish) ATENCIÓN: Si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-800-232-4636. Los Centros para el Control y la Prevención de Enfermedades (CDC) de los EE. UU. cumplen con las leyes federales de derechos civiles aplicables y no discriminan por motivos de raza, color, nacionalidad, edad, discapacidad o sexo. Los CDC no excluyen a las personas ni las trata de forma diferente debido a su origen étnico, color, nacionalidad, edad, discapacidad o sexo.",1
"Los CDC: - Proporcionan asistencia y servicios gratuitos a las personas con discapacidades para que se comuniquen de manera eficaz con nosotros; algunos de esos servicios son: - Intérpretes de lenguaje de señas capacitados. - Información escrita en otros formatos (letra grande, audio, formatos electrónicos accesibles, otros formatos). - Proporcionan servicios lingüísticos gratuitos a las personas cuyo idioma materno no es el inglés; algunos de esos servicios son: - Intérpretes capacitados. - Información escrita en otros idiomas. Si necesita recibir estos servicios, comuníquese con los CDC al 1-800-232-4636. Si considera que el Departamento de Salud y Servicios Humanos (HHS) no le proporcionó estos servicios o lo discriminó de otra manera por motivos de origen étnico, color, nacionalidad, edad, discapacidad o sexo, puede presentar un reclamo a la Oficina de Derechos Civiles (Office for Civil Rights) del Departamento de Salud y Servicios Humanos de los EE. UU.",1
"de manera electrónica a través del portal de “Office for Civil Rights Complaint”, disponible en o bien, por correo postal a la siguiente dirección o por teléfono a los números que figuran a continuación: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 繁體中文 (Chinese) 注意：如果您使用繁體中文，您可以免費獲得語言援助服務。請致電 1-877-696-6775。 U.S. Department of Health and Human Services（HHS、美國衛生及公共服務部）遵守適用的聯邦民權法律規定、不因種族、膚色、民族血統、年齡、殘障或性別而歧視任何人。HHS 不因種族、膚色、民族血統、年齡、殘障或性別而排斥任何人或以不同的方式對待他們。 HHS - 向殘障人士免費提供各種援助和服務、以幫助他們與我們進行有效溝通、如： - 合格的手語翻譯員 - 以其他格式提供的書面資訊（大號字體、音訊、無障礙電子格式、其他格式） - 向母語非英語的人員免費提供各種語言服務，如： - 合格的翻譯員 - 以其他語言書寫的資訊 如果您需要此類服務、請聯絡 HHS 撥打 1-877-696-6775 如果您認為 HHS 未能提供此類服務或者因種族、膚色、民族血統、年齡、殘障或性別而透過其他方式歧視您、您可以向U.S. Department of Health and Human Services的 Office for Civil Rights（民權辦公室）提交民權投訴、透過 Office for Civil Rights Complaint Portal 以電子方式投訴： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019、800-537-7697 (TDD)（聾人用電信設備） Tiếng Việt (Vietnamese) CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-877-696-6775. U.S. Department of Health and Human Services (HHS, Bộ Y Tế và Dịch Vụ Nhân Sinh Hoa Kỳ) tuân thủ luật dân quyền hiện hành của Liên bang và không phân biệt đối xử dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính.",1
"HHS không loại trừ mọi người hoặc đối xử với họ khác biệt vì chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính. HHS: - Cung cấp dịch vụ hỗ trợ miễn phí cho những người khuyết tật để giao tiếp với chúng tôi có hiệu quả, như: - Thông dịch viên ngôn ngữ ký hiệu đủ năng lực - Thông tin bằng văn bản ở các định dạng khác (chữ in lớn, âm thanh, định dạng điện tử có thể tiếp cận, các định dạng khác) - Cung cấp miễn phí các dịch vụ ngôn ngữ cho những người có ngôn ngữ chính không phải là tiếng Anh, như: - Thông dịch viên đủ năng lực - Thông tin được trình bày bằng ngôn ngữ khác Nếu bạn cần những dịch vụ này, hãy liên hệ HHS theo số 1-877-696-6775. Nếu bạn tin rằng HHS không cung cấp những dịch vụ này hoặc phân biệt đối xử theo cách khác dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính, bạn có thể nộp đơn khiếu nại với U.S. Department of Health and Human Services, Office for Civil Rights (Văn Phòng Dân Quyền) bằng hình thức điện tử qua Office for Civil Rights Complaint Portal, có trên trang hoặc qua đường bưu điện hoặc bằng điện thoại tại: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 한국어 (Korean) 주의: 한국어를 사용하시는 경우, 언어 지원 서비스를 무료로 이용하실 수 있습니다. 1-877-696-6775 번으로 전화해 주십시오. Department of Health and Human Services (HHS, 보건복지부)은(는) 관련 연방 공민권법을 준수하며 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 차별하지 않습니다.",1
"HHS은(는) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 누군가를 배제하거나 다른 방식으로 대우하지 않습니다. HHS: - 장애인들이 저희와 효과적으로 의사소통할 수 있도록 다음과 같은 무료 지원과 서비스를 제공합니다. - 자격있는 수화 통역자 - 다른 형식의 서면 정보(큰 활자, 음성, 사용 가능한 전자 형식, 기타 형식) - 주로 사용하는 언어가 영어가 아닌 이들에게는 다음과 같은 무료 언어 서비스를 제공합니다. - 자격있는 통역자 - 다른 언어로 작성된 서면 정보 이러한 서비스가 필요하시면 HHS에 -877-696-6775번으로 연락하십시오. HHS 이(가) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 이러한 서비스를 제공하지 않거나 다른 방식으로 차별했다고 생각하시는 경우, 를 통한 전자 방식 또는 우편이나 전화로 Department of Health and Human Services, Office for Civil Rights (시민권 사무국)에 민원을 제출할 수 있습니다. 주소 및 연락처는 다음과 같습니다. U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Tagalog PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa 1-877-696-6775. Sumusunod ang U.S. Department of Health and Human Services (HHS, Kagawaran ng Mga Serbisyong Pangkalusugan at Pantao ng U.S.) sa mga naaangkop na Pampederal na batas sa karapatang sibil at hindi nandidiskrimina batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian. Ang HHS ay hindi nagtatangi ng mga tao o hindi nagpapakita ng ibang pakikitungo dahil sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian.",1
"Ang HHS ay: - Nagbibigay ng mga libreng tulong at serbisyo sa mga taong may kapansanan upang mahusay silang makipag-ugnayan sa amin, gaya ng: - Mga kwalipikadong interpreter ng sign language - Nakasulat na impormasyon sa iba pang mga format (malaking print, audio, mga naa-access na electronic na format, iba pang mga format) - Nagbibigay ng mga libreng serbisyo sa wika sa mga taong hindi Ingles ang pangunahing wika, gaya ng: - Mga kwalipikadong interpreter - Impormasyong nakasulat sa iba pang mga wika Kung kailangan mo ang mga serbisyong ito, makipag-ugnayan kay HHS sa 1-877-696-6775. Kung naniniwala kang hindi naibigay ng HHS ang mga serbisyong ito o nandiskrimina ito sa ibang paraan batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian, maaari kang maghain ng karaingan sa U.S. Department of Health and Human Services, Office for Civil Rights (Tanggapan para sa Mga Karapatang Sibil), sa electronic na paraan sa Office for Civil Rights Complaint Portal, na makikita sa o sa pamamagitan ng koreo o telepono sa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Русский (Russian) ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Министерство здравоохранения и социальных служб США) соблюдает применимое федеральное законодательство в области гражданских прав и не допускает дискриминации по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS не исключает людей и не относится к ним по-разному из-за расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS: - Для эффективного взаимодействия предоставляет безвозмездную помощь и оказывает услуги людям с ограниченными возможностями, а именно: - услуги квалифицированных сурдопереводчиков; - письменную информацию в других форматах (крупный шрифт, аудио формат, доступные электронные форматы, прочие форматы). - Предоставляет бесплатные услуги перевода людям, для которых английский не является основным языком, а именно: - услуги квалифицированных переводчиков; - письменную информацию на других языках. Если вы нуждаетесь в таких услугах, обратитесь к HHS по телефону 1-877-696-6775.",1
"Если вы считаете, что в HHS вам не предоставили указанных услуг или иным образом дискриминировали вас по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола, вы можете подать жалобу в U.S. Department of Health and Human Services, Office for Civil Rights (Управление по гражданским правам), в электронном виде через Office for Civil Rights Complaint Portal, доступный по ссылке: по почте или по телефону: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) العربية (Arabic) ملحوظة: إذا كنت تتحدث اذكر اللغة، فإن خدمات المساعدة اللغوية تتوافر لك بالمجان. اتصل برقم .1-877-696-6775 تلتزم HHS) Department of Health and Human Services, وزارة الخدمات الصحية والبشرية) بقوانين الحقوق المدنية الفدرالية المعمول بها ولا تميز على أساس العرق أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.",1
"لا تستبعد HHS الأشخاص أو تعاملهم على نحو مختلف بسبب النوع أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.. :HHS - توفر مساعدات وخدمات مجانية للأشخاص من ذوي الإعاقات للتواصل بصورة فعالة معنا، مثل: - مترجمي لغة إشارة مؤهلين - معلومات كتابية بتنسيقات أخرى (مطبوعة بأحرف كبيرة، مواد صوتية، تنسيقات إلكترونية متيسرة، وغير ذلك من التنسيقات) - توفر خدمات لغوية مجانية للأشخاص الذين لغتهم الأساسية ليست الإنجليزية، مثل: - مترجمين مؤهلين - معلومات مكتوبة بلغات أخرى إذا كنت بحاجة لهذه الخدمات، اتصل بـ HHS على الرقم .1-877-696-6775 إذا كنت تعتقد أن HHS قد أخفقت في توفير تلك الخدمات أو أنها قد ميزت بطريقة أخرى على أساس العرق أو اللون أو الأصل Department of Health and Human Services، مكتب Office for Civil Rights (مكتب الحقوق المدنية)، من خلال مكتب Office for Civil Rights Complaint Portal، المتوفر على الرابط أو بالبريد أو الهاتف على: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (رقم هاتف الصم والبكم) Kreyòl Ayisyen (Haitian Creole) ATANSYON: Si w pale Kreyòl Ayisyen, gen sèvis èd pou lang ki disponib gratis pou ou. Rele 1-877-696-6775. U.S. Department of Health and Human Services, (HHS, Ministè Sèvis Sante ak Imen Ameriken) konfòm ak lwa sou dwa sivil Federal ki aplikab yo e li pa fè diskriminasyon sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks. HHS pa ekskli moun oswa trete yo nan fason ki diferan akoz ras, koulè, peyi orijin, laj, enfimite oswa sèks yo.",1
"HHS: - Bay èd ak sèvis gratis pou moun ki andikape pou yo kominike avèk nou nan fason ki efikas, tankou: - Enèprèt langaj siy ki kalifye - Enfòmasyon ekri nan lòt fòma (gwo lèt, odyo, fòma elektwonik ki aksesib, lòt fòma) - Bay sèvis lang gratis a moun lang prensipal yo pa Anglè, tankou: - Enèprèt kalifye - Enfòmasyon ki ekri nan lòt lang Si w bezwen sèvis sa yo, kontakte HHS nan 1-877-696-6775. Si w kwè HHS pa t bay sèvis sa yo oswa te fè diskriminasyon nan yon lòt fason sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks, ou ka depoze yon plent nan: U.S. Department of Health and Human Services, Office for Civil Rights (Biwo Dwa Sivil) atravè Office for Civil Rights Portal, pa mwayen elektwonik ki disponib nan oswa pa lapòs oswa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Français (French) ATTENTION: Si vous parlez français, des services d’aide linguistique vous sont proposés gratuitement. Appelez le 1-877-696-6775. L’U.S. Department of Health and Human Services (HHS, Département de la Santé et des Services Sociaux des États-Unis) respecte les lois fédérales en vigueur relatives aux droits civiques et ne pratique aucune discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou un handicap.",1
"HHS n’exclut et ne traite aucune personne différemment en raison de sa race, sa couleur de peau, son origine nationale, son âge, son sexe ou son handicap. HHS: - Fournit gratuitement des aides et services aux personnes handicapées afin de permettre une communication efficace avec nous, par exemple: - Interprètes qualifiés en langue des signes - Informations écrites dans d’autres formats (gros caractères, audio, formats électroniques accessibles, autres formats) - Fournit gratuitement des services linguistiques aux personnes dont la langue principale n’est pas l’anglais, par exemple: - Interprètes qualifiés - Informations écrites dans d’autres langues Si vous avez besoin de ces services, contactez HHS au 1-877-696-6775. Si vous pensez que HHS n’a pas fourni ces services ou a fait preuve d’une autre forme de discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou le handicap, vous pouvez déposer une réclamation auprès de l’U.S. Department of Health and Human Services, l’Office for Civil Rights (Bureau des Droits Civiques), par voie électronique via l’Office for Civil Rights Complaint Portal, disponible à l’adresse par courrier ou par téléphone à: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Polski (Polish) UWAGA: Jeżeli mówisz po polsku, możesz skorzystać z bezpłatnej pomocy językowej. Zadzwoń pod numer 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Departament Zdrowia i Opieki Społecznej Stanów Zjednoczonych) postępuje zgodnie z obowiązującymi federalnymi prawami obywatelskimi i nie dopuszcza się dyskryminacji ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS nie wyklucza żadnych osób i nie stosuje różnego traktowania ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS: - Zapewnia bezpłatną pomoc i usługi osobom niepełnosprawnym w celu umożliwienia skutecznej komunikacji, na przykład: - Wykwalifikowanych tłumaczy języka migowego - Informacje na piśmie w różnych formatach (duży druk, audio, dostępne formaty elektroniczne, inne formaty) - Zapewnia bezpłatne usługi językowe dla osób, dla których angielski nie jest pierwszym językiem, na przykład: - Wykwalifikowanych tłumaczy - Informacje na piśmie w innych językach Jeżeli chcesz skorzystać z tych usług, skontaktuj się z HHS pod numerem 1-877-696-6775.",1
"Jeżeli uważasz, że HHS nie świadczy tych usług lub w inny sposób dopuszcza się dyskryminacji ze względu na rasę, koloru skóry, pochodzenie, wiek, niepełnosprawność bądź płeć, możesz złożyć skargę do: U.S. Department of Health and Human Services, Office for Civil Rights (Biuro Praw Obywatelskich), drogą elektroniczną za pośrednictwem Office for Civil Rights Complaint Portal na stronie pocztą tradycyjną lub dzwoniąc pod numer telefonu: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Português (Portuguese) O U.S. Department of Health and Human Services (HHS, Departamento de Saúde e dos Serviços Humanos dos Estados Unidos da América) cumpre as leis de direitos civis federais aplicáveis e não exerce discriminação com base na raça, cor, nacionalidade, idade, deficiência ou sexo. HHS não exclui ou trata de forma diferente devido à raça, cor, nacionalidade, idade, deficiência ou sexo.",1
"HHS: - Faculta ajuda e serviços gratuitos a pessoas com dificuldades de comunicar de forma eficaz connosco, tais como: - Intérpretes de língua gestual qualificados - Informação escrita noutros formatos (impressão maior, áudio, formatos electrónicos acessíveis, outros formatos) - Faculta serviços linguísticas grátis a pessoas cuja língua principal não é inglês, tais como: - Intérpretes qualificados - Informação escrita noutros idiomas Se necessita destes serviços, contacte HHS através do número 1-877-696-6775. Se considera que a HHS não cumpriu estes serviços ou exerceu discriminação de outra forma com base na raça, cor, nacionalidade, idade, deficiência ou sexo, pode apresentar uma reclamação junto de: U.S. Department of Health and Human Services, Office for Civil Rights (Gabinete de Direitos Civis), por via electrónica através do Office for Civil Rights Complaint Portal, disponível em ou por correio ou telefone: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Italiano (Italian) ATTENZIONE: In caso la lingua parlata sia l’italiano, sono disponibili servizi di assistenza linguistica gratuiti. Chiamare il numero 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Dipartimento statunitense per la salute e i servizi umani) è conforme a tutte le leggi federali vigenti in materia di diritti civili e non pone in essere discriminazioni sulla base di razza, colore, origine nazionale, età, disabilità o sesso. HHS non esclude le persone o le tratta diversamente a causa di razza, colore, origine nazionale, età, disabilità o sesso. HHS: - Offre sostegni e servizi gratuiti alle persone affette da disabilità per comunicare con noi in modo efficace, quali: - Interpreti qualificati nella lingua dei segni - Informazioni scritte in altri formati (stampe a grandi caratteri, audio, formati elettronici accessibili, altri formati) - Offre servizi linguistici gratuiti alle persone la cui lingua primaria non è l’inglese, quali: - Interpreti qualificati - Informazioni scritte in altre lingue In caso si necessiti di tali servizi, contattare HHS al numero 1-877-696-6775.",1
"In caso si ritenga che HHS non abbia offerto tali servizi o abbia posto in essere discriminazioni in altri modi sulla base di razza, colore, origine nazionale, età, disabilità o sesso, è possibile presentare una vertenza a: U.S. Department of Health and Human, Office for Civil Rights (Ufficio per i diritti civili), elettronicamente mediante l’Office for Civil Rights Complaint Portal, disponibile all’indirizzo oppure a mezzo posta o telefono all’attenzione di: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Deutsch (German) ACHTUNG: Wenn Sie Deutsch sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen zur Verfügung. Rufnummer: 1-877-696-6775. Das Department of Health and Human Services (HHS, U.S.-Gesundheitsministerium) erfüllt geltenden bundesstaatliche Menschenrechtsgesetze und lehnt jegliche Diskriminierung aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. lehnt den Ausschluss oder die unterschiedliche Behandlung von Menschen aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. HHS: - Bietet kostenlose Hilfe und Dienstleistungen für Menschen mit Behinderung zur effektiven Kommunikation, wie z.",1
"B.: - Qualifizierte Gebärdensprachen-Dolmetscher - Schriftliche Informationen in anderen Formaten (große Ausdrucke, Audio, zugängliche elektronische Formate, sonstige Formate) - Bietet kostenlose Sprachdienste für Menschen, deren Hauptsprache nicht Englisch ist, wie z. B.: - Qualifizierte Dolmetscher - Schriftliche Informationen in anderen Sprachen Sollten Sie diese Dienstleistungen benötigen, so wenden Sie sich an das HHS unter 1-877-696-6775.",1
"Sollten Sie der Ansicht sein, dass HHS es versäumte, diese Dienstleistungen anzubieten, oder auf sonstige Weise aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht diskriminierte, so können Sie eine Beschwerde einreichen bei: Department of Health and Human Services, Office for Civil Rights (Amt für Bürgerrechte), elektronisch über das Office for Civil Rights Complaint Portal, zugänglich über oder per Post oder telefonisch an: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 日本語 (Japanese) 注意事項：日本語を話される場合、無料の言語支援をご利用いただけます。1-877-696-6775 まで、お電話にてご連絡ください。 U.S. Department of Health and Human Services（HHS、保健社会福祉省）は適用される連邦公民権法を遵守し、人種、肌の色、出身国、年齢、障害、または性別に基づく差別をいたしません。HHS は人種、肌の色、出身国、年齢、障害、または性別を理由として人を排除したり、異なる扱いをいたしません。 HHS: - 効果的にコミュニケーションを図るため、障害のある人に以下の支援やサポートを無料で提供いたします。 - 資格ある手話通訳者 - その他形式の文字情報（大きな活字、音声信号、手軽な電子形式、その他） - 英語を母語としない人へ以下の言語サービスを無料で提供いたします。 - 資格ある通訳者 - 英語以外の言語で書かれた情報 これらのサービスを必要とされる場合は、HHS（1-877-696-6775）までご連絡ください。 HHS がこれらのサービスの提供を怠ったり、人種、肌の色、出身国、年齢、障害、または性別に基づいた何らかの方法で差別したと思われる場合、こちらまで苦情を申し立てることができます。また、公民権に関する苦情は、U.S.",1
"Department of Health and Human ServicesのOffice for Civil Rights（公民権局）へ、Office for Civil Rights Complaint Portal から電子申請するか、以下へ郵便または電話で申し立てることもできます： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) فارسی (Farsi) توجه: اگر به زبان فارسی گفتگو می کنید، تسهیلات زبانی بصورت رایگان برای شما فراهم می باشد. با .1-877-696-6775 تماس بگیرید HHS) U.S. Department of Health and Human Services, وزارت بهداشت و خدمات انسانی آمریکا) از قوانین حقوق مدنی فدرال مربوطه تبعیت می کند و هیچگونه تبعیضی بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد قایل نمی شود. HHS بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد ایشان را از خدمات محروم نمی کند و با آنها برخورد متفاوتی ندارد.",1
":HHS - برای افرادی که ناتوانی دارند، برای برقرار کردن ارتباط موثر، کمک هایی بطور رایگان فراهم می کند، مانند: - مترجمین واجد شرایط زبان اشاره - اطلاعات نوشتاری به فرمت های دیگر (چاپ با حروف درشت، صوتی، فرمت های الکترونیک قابل دسترسی ساده، و فرمت های دیگر) - برای افرادی که زبان اولیه شان انگلیسی نیست خدمات زبانی رایگان ارایه می کند، مانند: - مترجمین شفاهی واجد شرایط - اطلاعات نوشتاری به زبانهای دیگر اگر به چنین خدماتی نیاز دارید، با HHS به 1-877-696-6775 تماس بگیرید اگر معتقدید که HHS چنین خدماتی را به شما ارایه نداده و یا اینکه به شکلی دیگر به دلیل نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت درمورد شما تبعیض قایل شده می توانید شکواییه ای به این آدرس ثبت کنید: اگر احساس می کنید که HHS این خدمات را به شما ارایه نکرده و یا به هر شکلی بدلیل نژاد، رنگ پوست، اصلیت ملی، سن، معلولیت یا جنسیت شما را مورد تبعیض قرار داده، می توانید نزد U.S. Department of Health and Human Services، Office for Civil Rights (اداره حمایت از حقوق مدنی)، شکواییه خود را ثبت نمایید. دسترسی الکترونیکی به این اداره از طریق Office for Civil Rights Complaint Portal به آدرس یا تماس از طریق ایمیل یا تلفن با آدرس زیر میسر است: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) English ATTENTION: If you do not speak English, language assistance services are available to you free of charge.",1
"Call 1-800-232-4636 Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The CDC nondiscrimination notice lists the services available to you and how to file a complaint if you feel that CDC has failed to provide these services or discriminated in another way.",1
"Language Assistance Services – CDC In November of 2023, the U.S. Department of Health and Human Services (HHS) updated its 2013 Language Access Plan in an effort to “ensure greater access to the life-saving services that HHS provides for people with Limited English Proficiency (LEP) and people with disabilities.” Consistent with the updated HHS plan, CDC launched a 2024 plan which outlines the action steps the agency will take to meet the language access needs of the public while continuing to support communities that may be underserved and improving access to information for people with LEP and people with disabilities. The strategic actions within the CDC plan prioritize efforts that will advance language accessibility to public health information and the agency’s communication with the public. The plan can be found online here: Español (Spanish) ATENCIÓN: Si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-800-232-4636. Los Centros para el Control y la Prevención de Enfermedades (CDC) de los EE. UU. cumplen con las leyes federales de derechos civiles aplicables y no discriminan por motivos de raza, color, nacionalidad, edad, discapacidad o sexo. Los CDC no excluyen a las personas ni las trata de forma diferente debido a su origen étnico, color, nacionalidad, edad, discapacidad o sexo.",1
"Los CDC: - Proporcionan asistencia y servicios gratuitos a las personas con discapacidades para que se comuniquen de manera eficaz con nosotros; algunos de esos servicios son: - Intérpretes de lenguaje de señas capacitados. - Información escrita en otros formatos (letra grande, audio, formatos electrónicos accesibles, otros formatos). - Proporcionan servicios lingüísticos gratuitos a las personas cuyo idioma materno no es el inglés; algunos de esos servicios son: - Intérpretes capacitados. - Información escrita en otros idiomas. Si necesita recibir estos servicios, comuníquese con los CDC al 1-800-232-4636. Si considera que el Departamento de Salud y Servicios Humanos (HHS) no le proporcionó estos servicios o lo discriminó de otra manera por motivos de origen étnico, color, nacionalidad, edad, discapacidad o sexo, puede presentar un reclamo a la Oficina de Derechos Civiles (Office for Civil Rights) del Departamento de Salud y Servicios Humanos de los EE. UU.",1
"de manera electrónica a través del portal de “Office for Civil Rights Complaint”, disponible en o bien, por correo postal a la siguiente dirección o por teléfono a los números que figuran a continuación: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 繁體中文 (Chinese) 注意：如果您使用繁體中文，您可以免費獲得語言援助服務。請致電 1-877-696-6775。 U.S. Department of Health and Human Services（HHS、美國衛生及公共服務部）遵守適用的聯邦民權法律規定、不因種族、膚色、民族血統、年齡、殘障或性別而歧視任何人。HHS 不因種族、膚色、民族血統、年齡、殘障或性別而排斥任何人或以不同的方式對待他們。 HHS - 向殘障人士免費提供各種援助和服務、以幫助他們與我們進行有效溝通、如： - 合格的手語翻譯員 - 以其他格式提供的書面資訊（大號字體、音訊、無障礙電子格式、其他格式） - 向母語非英語的人員免費提供各種語言服務，如： - 合格的翻譯員 - 以其他語言書寫的資訊 如果您需要此類服務、請聯絡 HHS 撥打 1-877-696-6775 如果您認為 HHS 未能提供此類服務或者因種族、膚色、民族血統、年齡、殘障或性別而透過其他方式歧視您、您可以向U.S. Department of Health and Human Services的 Office for Civil Rights（民權辦公室）提交民權投訴、透過 Office for Civil Rights Complaint Portal 以電子方式投訴： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019、800-537-7697 (TDD)（聾人用電信設備） Tiếng Việt (Vietnamese) CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-877-696-6775. U.S. Department of Health and Human Services (HHS, Bộ Y Tế và Dịch Vụ Nhân Sinh Hoa Kỳ) tuân thủ luật dân quyền hiện hành của Liên bang và không phân biệt đối xử dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính.",1
"HHS không loại trừ mọi người hoặc đối xử với họ khác biệt vì chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính. HHS: - Cung cấp dịch vụ hỗ trợ miễn phí cho những người khuyết tật để giao tiếp với chúng tôi có hiệu quả, như: - Thông dịch viên ngôn ngữ ký hiệu đủ năng lực - Thông tin bằng văn bản ở các định dạng khác (chữ in lớn, âm thanh, định dạng điện tử có thể tiếp cận, các định dạng khác) - Cung cấp miễn phí các dịch vụ ngôn ngữ cho những người có ngôn ngữ chính không phải là tiếng Anh, như: - Thông dịch viên đủ năng lực - Thông tin được trình bày bằng ngôn ngữ khác Nếu bạn cần những dịch vụ này, hãy liên hệ HHS theo số 1-877-696-6775. Nếu bạn tin rằng HHS không cung cấp những dịch vụ này hoặc phân biệt đối xử theo cách khác dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính, bạn có thể nộp đơn khiếu nại với U.S. Department of Health and Human Services, Office for Civil Rights (Văn Phòng Dân Quyền) bằng hình thức điện tử qua Office for Civil Rights Complaint Portal, có trên trang hoặc qua đường bưu điện hoặc bằng điện thoại tại: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 한국어 (Korean) 주의: 한국어를 사용하시는 경우, 언어 지원 서비스를 무료로 이용하실 수 있습니다. 1-877-696-6775 번으로 전화해 주십시오. Department of Health and Human Services (HHS, 보건복지부)은(는) 관련 연방 공민권법을 준수하며 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 차별하지 않습니다.",1
"HHS은(는) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 누군가를 배제하거나 다른 방식으로 대우하지 않습니다. HHS: - 장애인들이 저희와 효과적으로 의사소통할 수 있도록 다음과 같은 무료 지원과 서비스를 제공합니다. - 자격있는 수화 통역자 - 다른 형식의 서면 정보(큰 활자, 음성, 사용 가능한 전자 형식, 기타 형식) - 주로 사용하는 언어가 영어가 아닌 이들에게는 다음과 같은 무료 언어 서비스를 제공합니다. - 자격있는 통역자 - 다른 언어로 작성된 서면 정보 이러한 서비스가 필요하시면 HHS에 -877-696-6775번으로 연락하십시오. HHS 이(가) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 이러한 서비스를 제공하지 않거나 다른 방식으로 차별했다고 생각하시는 경우, 를 통한 전자 방식 또는 우편이나 전화로 Department of Health and Human Services, Office for Civil Rights (시민권 사무국)에 민원을 제출할 수 있습니다. 주소 및 연락처는 다음과 같습니다. U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Tagalog PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa 1-877-696-6775. Sumusunod ang U.S. Department of Health and Human Services (HHS, Kagawaran ng Mga Serbisyong Pangkalusugan at Pantao ng U.S.) sa mga naaangkop na Pampederal na batas sa karapatang sibil at hindi nandidiskrimina batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian. Ang HHS ay hindi nagtatangi ng mga tao o hindi nagpapakita ng ibang pakikitungo dahil sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian.",1
"Ang HHS ay: - Nagbibigay ng mga libreng tulong at serbisyo sa mga taong may kapansanan upang mahusay silang makipag-ugnayan sa amin, gaya ng: - Mga kwalipikadong interpreter ng sign language - Nakasulat na impormasyon sa iba pang mga format (malaking print, audio, mga naa-access na electronic na format, iba pang mga format) - Nagbibigay ng mga libreng serbisyo sa wika sa mga taong hindi Ingles ang pangunahing wika, gaya ng: - Mga kwalipikadong interpreter - Impormasyong nakasulat sa iba pang mga wika Kung kailangan mo ang mga serbisyong ito, makipag-ugnayan kay HHS sa 1-877-696-6775. Kung naniniwala kang hindi naibigay ng HHS ang mga serbisyong ito o nandiskrimina ito sa ibang paraan batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian, maaari kang maghain ng karaingan sa U.S. Department of Health and Human Services, Office for Civil Rights (Tanggapan para sa Mga Karapatang Sibil), sa electronic na paraan sa Office for Civil Rights Complaint Portal, na makikita sa o sa pamamagitan ng koreo o telepono sa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Русский (Russian) ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Министерство здравоохранения и социальных служб США) соблюдает применимое федеральное законодательство в области гражданских прав и не допускает дискриминации по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS не исключает людей и не относится к ним по-разному из-за расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS: - Для эффективного взаимодействия предоставляет безвозмездную помощь и оказывает услуги людям с ограниченными возможностями, а именно: - услуги квалифицированных сурдопереводчиков; - письменную информацию в других форматах (крупный шрифт, аудио формат, доступные электронные форматы, прочие форматы). - Предоставляет бесплатные услуги перевода людям, для которых английский не является основным языком, а именно: - услуги квалифицированных переводчиков; - письменную информацию на других языках. Если вы нуждаетесь в таких услугах, обратитесь к HHS по телефону 1-877-696-6775.",1
"Если вы считаете, что в HHS вам не предоставили указанных услуг или иным образом дискриминировали вас по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола, вы можете подать жалобу в U.S. Department of Health and Human Services, Office for Civil Rights (Управление по гражданским правам), в электронном виде через Office for Civil Rights Complaint Portal, доступный по ссылке: по почте или по телефону: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) العربية (Arabic) ملحوظة: إذا كنت تتحدث اذكر اللغة، فإن خدمات المساعدة اللغوية تتوافر لك بالمجان. اتصل برقم .1-877-696-6775 تلتزم HHS) Department of Health and Human Services, وزارة الخدمات الصحية والبشرية) بقوانين الحقوق المدنية الفدرالية المعمول بها ولا تميز على أساس العرق أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.",1
"لا تستبعد HHS الأشخاص أو تعاملهم على نحو مختلف بسبب النوع أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.. :HHS - توفر مساعدات وخدمات مجانية للأشخاص من ذوي الإعاقات للتواصل بصورة فعالة معنا، مثل: - مترجمي لغة إشارة مؤهلين - معلومات كتابية بتنسيقات أخرى (مطبوعة بأحرف كبيرة، مواد صوتية، تنسيقات إلكترونية متيسرة، وغير ذلك من التنسيقات) - توفر خدمات لغوية مجانية للأشخاص الذين لغتهم الأساسية ليست الإنجليزية، مثل: - مترجمين مؤهلين - معلومات مكتوبة بلغات أخرى إذا كنت بحاجة لهذه الخدمات، اتصل بـ HHS على الرقم .1-877-696-6775 إذا كنت تعتقد أن HHS قد أخفقت في توفير تلك الخدمات أو أنها قد ميزت بطريقة أخرى على أساس العرق أو اللون أو الأصل Department of Health and Human Services، مكتب Office for Civil Rights (مكتب الحقوق المدنية)، من خلال مكتب Office for Civil Rights Complaint Portal، المتوفر على الرابط أو بالبريد أو الهاتف على: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (رقم هاتف الصم والبكم) Kreyòl Ayisyen (Haitian Creole) ATANSYON: Si w pale Kreyòl Ayisyen, gen sèvis èd pou lang ki disponib gratis pou ou. Rele 1-877-696-6775. U.S. Department of Health and Human Services, (HHS, Ministè Sèvis Sante ak Imen Ameriken) konfòm ak lwa sou dwa sivil Federal ki aplikab yo e li pa fè diskriminasyon sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks. HHS pa ekskli moun oswa trete yo nan fason ki diferan akoz ras, koulè, peyi orijin, laj, enfimite oswa sèks yo.",1
"HHS: - Bay èd ak sèvis gratis pou moun ki andikape pou yo kominike avèk nou nan fason ki efikas, tankou: - Enèprèt langaj siy ki kalifye - Enfòmasyon ekri nan lòt fòma (gwo lèt, odyo, fòma elektwonik ki aksesib, lòt fòma) - Bay sèvis lang gratis a moun lang prensipal yo pa Anglè, tankou: - Enèprèt kalifye - Enfòmasyon ki ekri nan lòt lang Si w bezwen sèvis sa yo, kontakte HHS nan 1-877-696-6775. Si w kwè HHS pa t bay sèvis sa yo oswa te fè diskriminasyon nan yon lòt fason sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks, ou ka depoze yon plent nan: U.S. Department of Health and Human Services, Office for Civil Rights (Biwo Dwa Sivil) atravè Office for Civil Rights Portal, pa mwayen elektwonik ki disponib nan oswa pa lapòs oswa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Français (French) ATTENTION: Si vous parlez français, des services d’aide linguistique vous sont proposés gratuitement. Appelez le 1-877-696-6775. L’U.S. Department of Health and Human Services (HHS, Département de la Santé et des Services Sociaux des États-Unis) respecte les lois fédérales en vigueur relatives aux droits civiques et ne pratique aucune discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou un handicap.",1
"HHS n’exclut et ne traite aucune personne différemment en raison de sa race, sa couleur de peau, son origine nationale, son âge, son sexe ou son handicap. HHS: - Fournit gratuitement des aides et services aux personnes handicapées afin de permettre une communication efficace avec nous, par exemple: - Interprètes qualifiés en langue des signes - Informations écrites dans d’autres formats (gros caractères, audio, formats électroniques accessibles, autres formats) - Fournit gratuitement des services linguistiques aux personnes dont la langue principale n’est pas l’anglais, par exemple: - Interprètes qualifiés - Informations écrites dans d’autres langues Si vous avez besoin de ces services, contactez HHS au 1-877-696-6775. Si vous pensez que HHS n’a pas fourni ces services ou a fait preuve d’une autre forme de discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou le handicap, vous pouvez déposer une réclamation auprès de l’U.S. Department of Health and Human Services, l’Office for Civil Rights (Bureau des Droits Civiques), par voie électronique via l’Office for Civil Rights Complaint Portal, disponible à l’adresse par courrier ou par téléphone à: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Polski (Polish) UWAGA: Jeżeli mówisz po polsku, możesz skorzystać z bezpłatnej pomocy językowej. Zadzwoń pod numer 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Departament Zdrowia i Opieki Społecznej Stanów Zjednoczonych) postępuje zgodnie z obowiązującymi federalnymi prawami obywatelskimi i nie dopuszcza się dyskryminacji ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS nie wyklucza żadnych osób i nie stosuje różnego traktowania ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS: - Zapewnia bezpłatną pomoc i usługi osobom niepełnosprawnym w celu umożliwienia skutecznej komunikacji, na przykład: - Wykwalifikowanych tłumaczy języka migowego - Informacje na piśmie w różnych formatach (duży druk, audio, dostępne formaty elektroniczne, inne formaty) - Zapewnia bezpłatne usługi językowe dla osób, dla których angielski nie jest pierwszym językiem, na przykład: - Wykwalifikowanych tłumaczy - Informacje na piśmie w innych językach Jeżeli chcesz skorzystać z tych usług, skontaktuj się z HHS pod numerem 1-877-696-6775.",1
"Jeżeli uważasz, że HHS nie świadczy tych usług lub w inny sposób dopuszcza się dyskryminacji ze względu na rasę, koloru skóry, pochodzenie, wiek, niepełnosprawność bądź płeć, możesz złożyć skargę do: U.S. Department of Health and Human Services, Office for Civil Rights (Biuro Praw Obywatelskich), drogą elektroniczną za pośrednictwem Office for Civil Rights Complaint Portal na stronie pocztą tradycyjną lub dzwoniąc pod numer telefonu: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Português (Portuguese) O U.S. Department of Health and Human Services (HHS, Departamento de Saúde e dos Serviços Humanos dos Estados Unidos da América) cumpre as leis de direitos civis federais aplicáveis e não exerce discriminação com base na raça, cor, nacionalidade, idade, deficiência ou sexo. HHS não exclui ou trata de forma diferente devido à raça, cor, nacionalidade, idade, deficiência ou sexo.",1
"HHS: - Faculta ajuda e serviços gratuitos a pessoas com dificuldades de comunicar de forma eficaz connosco, tais como: - Intérpretes de língua gestual qualificados - Informação escrita noutros formatos (impressão maior, áudio, formatos electrónicos acessíveis, outros formatos) - Faculta serviços linguísticas grátis a pessoas cuja língua principal não é inglês, tais como: - Intérpretes qualificados - Informação escrita noutros idiomas Se necessita destes serviços, contacte HHS através do número 1-877-696-6775. Se considera que a HHS não cumpriu estes serviços ou exerceu discriminação de outra forma com base na raça, cor, nacionalidade, idade, deficiência ou sexo, pode apresentar uma reclamação junto de: U.S. Department of Health and Human Services, Office for Civil Rights (Gabinete de Direitos Civis), por via electrónica através do Office for Civil Rights Complaint Portal, disponível em ou por correio ou telefone: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Italiano (Italian) ATTENZIONE: In caso la lingua parlata sia l’italiano, sono disponibili servizi di assistenza linguistica gratuiti. Chiamare il numero 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Dipartimento statunitense per la salute e i servizi umani) è conforme a tutte le leggi federali vigenti in materia di diritti civili e non pone in essere discriminazioni sulla base di razza, colore, origine nazionale, età, disabilità o sesso. HHS non esclude le persone o le tratta diversamente a causa di razza, colore, origine nazionale, età, disabilità o sesso. HHS: - Offre sostegni e servizi gratuiti alle persone affette da disabilità per comunicare con noi in modo efficace, quali: - Interpreti qualificati nella lingua dei segni - Informazioni scritte in altri formati (stampe a grandi caratteri, audio, formati elettronici accessibili, altri formati) - Offre servizi linguistici gratuiti alle persone la cui lingua primaria non è l’inglese, quali: - Interpreti qualificati - Informazioni scritte in altre lingue In caso si necessiti di tali servizi, contattare HHS al numero 1-877-696-6775.",1
"In caso si ritenga che HHS non abbia offerto tali servizi o abbia posto in essere discriminazioni in altri modi sulla base di razza, colore, origine nazionale, età, disabilità o sesso, è possibile presentare una vertenza a: U.S. Department of Health and Human, Office for Civil Rights (Ufficio per i diritti civili), elettronicamente mediante l’Office for Civil Rights Complaint Portal, disponibile all’indirizzo oppure a mezzo posta o telefono all’attenzione di: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Deutsch (German) ACHTUNG: Wenn Sie Deutsch sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen zur Verfügung. Rufnummer: 1-877-696-6775. Das Department of Health and Human Services (HHS, U.S.-Gesundheitsministerium) erfüllt geltenden bundesstaatliche Menschenrechtsgesetze und lehnt jegliche Diskriminierung aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. lehnt den Ausschluss oder die unterschiedliche Behandlung von Menschen aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. HHS: - Bietet kostenlose Hilfe und Dienstleistungen für Menschen mit Behinderung zur effektiven Kommunikation, wie z.",1
"B.: - Qualifizierte Gebärdensprachen-Dolmetscher - Schriftliche Informationen in anderen Formaten (große Ausdrucke, Audio, zugängliche elektronische Formate, sonstige Formate) - Bietet kostenlose Sprachdienste für Menschen, deren Hauptsprache nicht Englisch ist, wie z. B.: - Qualifizierte Dolmetscher - Schriftliche Informationen in anderen Sprachen Sollten Sie diese Dienstleistungen benötigen, so wenden Sie sich an das HHS unter 1-877-696-6775.",1
"Sollten Sie der Ansicht sein, dass HHS es versäumte, diese Dienstleistungen anzubieten, oder auf sonstige Weise aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht diskriminierte, so können Sie eine Beschwerde einreichen bei: Department of Health and Human Services, Office for Civil Rights (Amt für Bürgerrechte), elektronisch über das Office for Civil Rights Complaint Portal, zugänglich über oder per Post oder telefonisch an: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 日本語 (Japanese) 注意事項：日本語を話される場合、無料の言語支援をご利用いただけます。1-877-696-6775 まで、お電話にてご連絡ください。 U.S. Department of Health and Human Services（HHS、保健社会福祉省）は適用される連邦公民権法を遵守し、人種、肌の色、出身国、年齢、障害、または性別に基づく差別をいたしません。HHS は人種、肌の色、出身国、年齢、障害、または性別を理由として人を排除したり、異なる扱いをいたしません。 HHS: - 効果的にコミュニケーションを図るため、障害のある人に以下の支援やサポートを無料で提供いたします。 - 資格ある手話通訳者 - その他形式の文字情報（大きな活字、音声信号、手軽な電子形式、その他） - 英語を母語としない人へ以下の言語サービスを無料で提供いたします。 - 資格ある通訳者 - 英語以外の言語で書かれた情報 これらのサービスを必要とされる場合は、HHS（1-877-696-6775）までご連絡ください。 HHS がこれらのサービスの提供を怠ったり、人種、肌の色、出身国、年齢、障害、または性別に基づいた何らかの方法で差別したと思われる場合、こちらまで苦情を申し立てることができます。また、公民権に関する苦情は、U.S.",1
"Department of Health and Human ServicesのOffice for Civil Rights（公民権局）へ、Office for Civil Rights Complaint Portal から電子申請するか、以下へ郵便または電話で申し立てることもできます： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) فارسی (Farsi) توجه: اگر به زبان فارسی گفتگو می کنید، تسهیلات زبانی بصورت رایگان برای شما فراهم می باشد. با .1-877-696-6775 تماس بگیرید HHS) U.S. Department of Health and Human Services, وزارت بهداشت و خدمات انسانی آمریکا) از قوانین حقوق مدنی فدرال مربوطه تبعیت می کند و هیچگونه تبعیضی بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد قایل نمی شود. HHS بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد ایشان را از خدمات محروم نمی کند و با آنها برخورد متفاوتی ندارد.",1
":HHS - برای افرادی که ناتوانی دارند، برای برقرار کردن ارتباط موثر، کمک هایی بطور رایگان فراهم می کند، مانند: - مترجمین واجد شرایط زبان اشاره - اطلاعات نوشتاری به فرمت های دیگر (چاپ با حروف درشت، صوتی، فرمت های الکترونیک قابل دسترسی ساده، و فرمت های دیگر) - برای افرادی که زبان اولیه شان انگلیسی نیست خدمات زبانی رایگان ارایه می کند، مانند: - مترجمین شفاهی واجد شرایط - اطلاعات نوشتاری به زبانهای دیگر اگر به چنین خدماتی نیاز دارید، با HHS به 1-877-696-6775 تماس بگیرید اگر معتقدید که HHS چنین خدماتی را به شما ارایه نداده و یا اینکه به شکلی دیگر به دلیل نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت درمورد شما تبعیض قایل شده می توانید شکواییه ای به این آدرس ثبت کنید: اگر احساس می کنید که HHS این خدمات را به شما ارایه نکرده و یا به هر شکلی بدلیل نژاد، رنگ پوست، اصلیت ملی، سن، معلولیت یا جنسیت شما را مورد تبعیض قرار داده، می توانید نزد U.S. Department of Health and Human Services، Office for Civil Rights (اداره حمایت از حقوق مدنی)، شکواییه خود را ثبت نمایید. دسترسی الکترونیکی به این اداره از طریق Office for Civil Rights Complaint Portal به آدرس یا تماس از طریق ایمیل یا تلفن با آدرس زیر میسر است: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) English ATTENTION: If you do not speak English, language assistance services are available to you free of charge.",1
"Call 1-800-232-4636 Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The CDC nondiscrimination notice lists the services available to you and how to file a complaint if you feel that CDC has failed to provide these services or discriminated in another way.",1
"Language Assistance Services – CDC In November of 2023, the U.S. Department of Health and Human Services (HHS) updated its 2013 Language Access Plan in an effort to “ensure greater access to the life-saving services that HHS provides for people with Limited English Proficiency (LEP) and people with disabilities.” Consistent with the updated HHS plan, CDC launched a 2024 plan which outlines the action steps the agency will take to meet the language access needs of the public while continuing to support communities that may be underserved and improving access to information for people with LEP and people with disabilities. The strategic actions within the CDC plan prioritize efforts that will advance language accessibility to public health information and the agency’s communication with the public. The plan can be found online here: Español (Spanish) ATENCIÓN: Si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-800-232-4636. Los Centros para el Control y la Prevención de Enfermedades (CDC) de los EE. UU. cumplen con las leyes federales de derechos civiles aplicables y no discriminan por motivos de raza, color, nacionalidad, edad, discapacidad o sexo. Los CDC no excluyen a las personas ni las trata de forma diferente debido a su origen étnico, color, nacionalidad, edad, discapacidad o sexo.",1
"Los CDC: - Proporcionan asistencia y servicios gratuitos a las personas con discapacidades para que se comuniquen de manera eficaz con nosotros; algunos de esos servicios son: - Intérpretes de lenguaje de señas capacitados. - Información escrita en otros formatos (letra grande, audio, formatos electrónicos accesibles, otros formatos). - Proporcionan servicios lingüísticos gratuitos a las personas cuyo idioma materno no es el inglés; algunos de esos servicios son: - Intérpretes capacitados. - Información escrita en otros idiomas. Si necesita recibir estos servicios, comuníquese con los CDC al 1-800-232-4636. Si considera que el Departamento de Salud y Servicios Humanos (HHS) no le proporcionó estos servicios o lo discriminó de otra manera por motivos de origen étnico, color, nacionalidad, edad, discapacidad o sexo, puede presentar un reclamo a la Oficina de Derechos Civiles (Office for Civil Rights) del Departamento de Salud y Servicios Humanos de los EE. UU.",1
"de manera electrónica a través del portal de “Office for Civil Rights Complaint”, disponible en o bien, por correo postal a la siguiente dirección o por teléfono a los números que figuran a continuación: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 繁體中文 (Chinese) 注意：如果您使用繁體中文，您可以免費獲得語言援助服務。請致電 1-877-696-6775。 U.S. Department of Health and Human Services（HHS、美國衛生及公共服務部）遵守適用的聯邦民權法律規定、不因種族、膚色、民族血統、年齡、殘障或性別而歧視任何人。HHS 不因種族、膚色、民族血統、年齡、殘障或性別而排斥任何人或以不同的方式對待他們。 HHS - 向殘障人士免費提供各種援助和服務、以幫助他們與我們進行有效溝通、如： - 合格的手語翻譯員 - 以其他格式提供的書面資訊（大號字體、音訊、無障礙電子格式、其他格式） - 向母語非英語的人員免費提供各種語言服務，如： - 合格的翻譯員 - 以其他語言書寫的資訊 如果您需要此類服務、請聯絡 HHS 撥打 1-877-696-6775 如果您認為 HHS 未能提供此類服務或者因種族、膚色、民族血統、年齡、殘障或性別而透過其他方式歧視您、您可以向U.S. Department of Health and Human Services的 Office for Civil Rights（民權辦公室）提交民權投訴、透過 Office for Civil Rights Complaint Portal 以電子方式投訴： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019、800-537-7697 (TDD)（聾人用電信設備） Tiếng Việt (Vietnamese) CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-877-696-6775. U.S. Department of Health and Human Services (HHS, Bộ Y Tế và Dịch Vụ Nhân Sinh Hoa Kỳ) tuân thủ luật dân quyền hiện hành của Liên bang và không phân biệt đối xử dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính.",1
"HHS không loại trừ mọi người hoặc đối xử với họ khác biệt vì chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính. HHS: - Cung cấp dịch vụ hỗ trợ miễn phí cho những người khuyết tật để giao tiếp với chúng tôi có hiệu quả, như: - Thông dịch viên ngôn ngữ ký hiệu đủ năng lực - Thông tin bằng văn bản ở các định dạng khác (chữ in lớn, âm thanh, định dạng điện tử có thể tiếp cận, các định dạng khác) - Cung cấp miễn phí các dịch vụ ngôn ngữ cho những người có ngôn ngữ chính không phải là tiếng Anh, như: - Thông dịch viên đủ năng lực - Thông tin được trình bày bằng ngôn ngữ khác Nếu bạn cần những dịch vụ này, hãy liên hệ HHS theo số 1-877-696-6775. Nếu bạn tin rằng HHS không cung cấp những dịch vụ này hoặc phân biệt đối xử theo cách khác dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính, bạn có thể nộp đơn khiếu nại với U.S. Department of Health and Human Services, Office for Civil Rights (Văn Phòng Dân Quyền) bằng hình thức điện tử qua Office for Civil Rights Complaint Portal, có trên trang hoặc qua đường bưu điện hoặc bằng điện thoại tại: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 한국어 (Korean) 주의: 한국어를 사용하시는 경우, 언어 지원 서비스를 무료로 이용하실 수 있습니다. 1-877-696-6775 번으로 전화해 주십시오. Department of Health and Human Services (HHS, 보건복지부)은(는) 관련 연방 공민권법을 준수하며 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 차별하지 않습니다.",1
"HHS은(는) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 누군가를 배제하거나 다른 방식으로 대우하지 않습니다. HHS: - 장애인들이 저희와 효과적으로 의사소통할 수 있도록 다음과 같은 무료 지원과 서비스를 제공합니다. - 자격있는 수화 통역자 - 다른 형식의 서면 정보(큰 활자, 음성, 사용 가능한 전자 형식, 기타 형식) - 주로 사용하는 언어가 영어가 아닌 이들에게는 다음과 같은 무료 언어 서비스를 제공합니다. - 자격있는 통역자 - 다른 언어로 작성된 서면 정보 이러한 서비스가 필요하시면 HHS에 -877-696-6775번으로 연락하십시오. HHS 이(가) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 이러한 서비스를 제공하지 않거나 다른 방식으로 차별했다고 생각하시는 경우, 를 통한 전자 방식 또는 우편이나 전화로 Department of Health and Human Services, Office for Civil Rights (시민권 사무국)에 민원을 제출할 수 있습니다. 주소 및 연락처는 다음과 같습니다. U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Tagalog PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa 1-877-696-6775. Sumusunod ang U.S. Department of Health and Human Services (HHS, Kagawaran ng Mga Serbisyong Pangkalusugan at Pantao ng U.S.) sa mga naaangkop na Pampederal na batas sa karapatang sibil at hindi nandidiskrimina batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian. Ang HHS ay hindi nagtatangi ng mga tao o hindi nagpapakita ng ibang pakikitungo dahil sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian.",1
"Ang HHS ay: - Nagbibigay ng mga libreng tulong at serbisyo sa mga taong may kapansanan upang mahusay silang makipag-ugnayan sa amin, gaya ng: - Mga kwalipikadong interpreter ng sign language - Nakasulat na impormasyon sa iba pang mga format (malaking print, audio, mga naa-access na electronic na format, iba pang mga format) - Nagbibigay ng mga libreng serbisyo sa wika sa mga taong hindi Ingles ang pangunahing wika, gaya ng: - Mga kwalipikadong interpreter - Impormasyong nakasulat sa iba pang mga wika Kung kailangan mo ang mga serbisyong ito, makipag-ugnayan kay HHS sa 1-877-696-6775. Kung naniniwala kang hindi naibigay ng HHS ang mga serbisyong ito o nandiskrimina ito sa ibang paraan batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian, maaari kang maghain ng karaingan sa U.S. Department of Health and Human Services, Office for Civil Rights (Tanggapan para sa Mga Karapatang Sibil), sa electronic na paraan sa Office for Civil Rights Complaint Portal, na makikita sa o sa pamamagitan ng koreo o telepono sa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Русский (Russian) ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Министерство здравоохранения и социальных служб США) соблюдает применимое федеральное законодательство в области гражданских прав и не допускает дискриминации по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS не исключает людей и не относится к ним по-разному из-за расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS: - Для эффективного взаимодействия предоставляет безвозмездную помощь и оказывает услуги людям с ограниченными возможностями, а именно: - услуги квалифицированных сурдопереводчиков; - письменную информацию в других форматах (крупный шрифт, аудио формат, доступные электронные форматы, прочие форматы). - Предоставляет бесплатные услуги перевода людям, для которых английский не является основным языком, а именно: - услуги квалифицированных переводчиков; - письменную информацию на других языках. Если вы нуждаетесь в таких услугах, обратитесь к HHS по телефону 1-877-696-6775.",1
"Если вы считаете, что в HHS вам не предоставили указанных услуг или иным образом дискриминировали вас по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола, вы можете подать жалобу в U.S. Department of Health and Human Services, Office for Civil Rights (Управление по гражданским правам), в электронном виде через Office for Civil Rights Complaint Portal, доступный по ссылке: по почте или по телефону: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) العربية (Arabic) ملحوظة: إذا كنت تتحدث اذكر اللغة، فإن خدمات المساعدة اللغوية تتوافر لك بالمجان. اتصل برقم .1-877-696-6775 تلتزم HHS) Department of Health and Human Services, وزارة الخدمات الصحية والبشرية) بقوانين الحقوق المدنية الفدرالية المعمول بها ولا تميز على أساس العرق أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.",1
"لا تستبعد HHS الأشخاص أو تعاملهم على نحو مختلف بسبب النوع أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.. :HHS - توفر مساعدات وخدمات مجانية للأشخاص من ذوي الإعاقات للتواصل بصورة فعالة معنا، مثل: - مترجمي لغة إشارة مؤهلين - معلومات كتابية بتنسيقات أخرى (مطبوعة بأحرف كبيرة، مواد صوتية، تنسيقات إلكترونية متيسرة، وغير ذلك من التنسيقات) - توفر خدمات لغوية مجانية للأشخاص الذين لغتهم الأساسية ليست الإنجليزية، مثل: - مترجمين مؤهلين - معلومات مكتوبة بلغات أخرى إذا كنت بحاجة لهذه الخدمات، اتصل بـ HHS على الرقم .1-877-696-6775 إذا كنت تعتقد أن HHS قد أخفقت في توفير تلك الخدمات أو أنها قد ميزت بطريقة أخرى على أساس العرق أو اللون أو الأصل Department of Health and Human Services، مكتب Office for Civil Rights (مكتب الحقوق المدنية)، من خلال مكتب Office for Civil Rights Complaint Portal، المتوفر على الرابط أو بالبريد أو الهاتف على: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (رقم هاتف الصم والبكم) Kreyòl Ayisyen (Haitian Creole) ATANSYON: Si w pale Kreyòl Ayisyen, gen sèvis èd pou lang ki disponib gratis pou ou. Rele 1-877-696-6775. U.S. Department of Health and Human Services, (HHS, Ministè Sèvis Sante ak Imen Ameriken) konfòm ak lwa sou dwa sivil Federal ki aplikab yo e li pa fè diskriminasyon sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks. HHS pa ekskli moun oswa trete yo nan fason ki diferan akoz ras, koulè, peyi orijin, laj, enfimite oswa sèks yo.",1
"HHS: - Bay èd ak sèvis gratis pou moun ki andikape pou yo kominike avèk nou nan fason ki efikas, tankou: - Enèprèt langaj siy ki kalifye - Enfòmasyon ekri nan lòt fòma (gwo lèt, odyo, fòma elektwonik ki aksesib, lòt fòma) - Bay sèvis lang gratis a moun lang prensipal yo pa Anglè, tankou: - Enèprèt kalifye - Enfòmasyon ki ekri nan lòt lang Si w bezwen sèvis sa yo, kontakte HHS nan 1-877-696-6775. Si w kwè HHS pa t bay sèvis sa yo oswa te fè diskriminasyon nan yon lòt fason sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks, ou ka depoze yon plent nan: U.S. Department of Health and Human Services, Office for Civil Rights (Biwo Dwa Sivil) atravè Office for Civil Rights Portal, pa mwayen elektwonik ki disponib nan oswa pa lapòs oswa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Français (French) ATTENTION: Si vous parlez français, des services d’aide linguistique vous sont proposés gratuitement. Appelez le 1-877-696-6775. L’U.S. Department of Health and Human Services (HHS, Département de la Santé et des Services Sociaux des États-Unis) respecte les lois fédérales en vigueur relatives aux droits civiques et ne pratique aucune discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou un handicap.",1
"HHS n’exclut et ne traite aucune personne différemment en raison de sa race, sa couleur de peau, son origine nationale, son âge, son sexe ou son handicap. HHS: - Fournit gratuitement des aides et services aux personnes handicapées afin de permettre une communication efficace avec nous, par exemple: - Interprètes qualifiés en langue des signes - Informations écrites dans d’autres formats (gros caractères, audio, formats électroniques accessibles, autres formats) - Fournit gratuitement des services linguistiques aux personnes dont la langue principale n’est pas l’anglais, par exemple: - Interprètes qualifiés - Informations écrites dans d’autres langues Si vous avez besoin de ces services, contactez HHS au 1-877-696-6775. Si vous pensez que HHS n’a pas fourni ces services ou a fait preuve d’une autre forme de discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou le handicap, vous pouvez déposer une réclamation auprès de l’U.S. Department of Health and Human Services, l’Office for Civil Rights (Bureau des Droits Civiques), par voie électronique via l’Office for Civil Rights Complaint Portal, disponible à l’adresse par courrier ou par téléphone à: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Polski (Polish) UWAGA: Jeżeli mówisz po polsku, możesz skorzystać z bezpłatnej pomocy językowej. Zadzwoń pod numer 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Departament Zdrowia i Opieki Społecznej Stanów Zjednoczonych) postępuje zgodnie z obowiązującymi federalnymi prawami obywatelskimi i nie dopuszcza się dyskryminacji ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS nie wyklucza żadnych osób i nie stosuje różnego traktowania ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS: - Zapewnia bezpłatną pomoc i usługi osobom niepełnosprawnym w celu umożliwienia skutecznej komunikacji, na przykład: - Wykwalifikowanych tłumaczy języka migowego - Informacje na piśmie w różnych formatach (duży druk, audio, dostępne formaty elektroniczne, inne formaty) - Zapewnia bezpłatne usługi językowe dla osób, dla których angielski nie jest pierwszym językiem, na przykład: - Wykwalifikowanych tłumaczy - Informacje na piśmie w innych językach Jeżeli chcesz skorzystać z tych usług, skontaktuj się z HHS pod numerem 1-877-696-6775.",1
"Jeżeli uważasz, że HHS nie świadczy tych usług lub w inny sposób dopuszcza się dyskryminacji ze względu na rasę, koloru skóry, pochodzenie, wiek, niepełnosprawność bądź płeć, możesz złożyć skargę do: U.S. Department of Health and Human Services, Office for Civil Rights (Biuro Praw Obywatelskich), drogą elektroniczną za pośrednictwem Office for Civil Rights Complaint Portal na stronie pocztą tradycyjną lub dzwoniąc pod numer telefonu: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Português (Portuguese) O U.S. Department of Health and Human Services (HHS, Departamento de Saúde e dos Serviços Humanos dos Estados Unidos da América) cumpre as leis de direitos civis federais aplicáveis e não exerce discriminação com base na raça, cor, nacionalidade, idade, deficiência ou sexo. HHS não exclui ou trata de forma diferente devido à raça, cor, nacionalidade, idade, deficiência ou sexo.",1
"HHS: - Faculta ajuda e serviços gratuitos a pessoas com dificuldades de comunicar de forma eficaz connosco, tais como: - Intérpretes de língua gestual qualificados - Informação escrita noutros formatos (impressão maior, áudio, formatos electrónicos acessíveis, outros formatos) - Faculta serviços linguísticas grátis a pessoas cuja língua principal não é inglês, tais como: - Intérpretes qualificados - Informação escrita noutros idiomas Se necessita destes serviços, contacte HHS através do número 1-877-696-6775. Se considera que a HHS não cumpriu estes serviços ou exerceu discriminação de outra forma com base na raça, cor, nacionalidade, idade, deficiência ou sexo, pode apresentar uma reclamação junto de: U.S. Department of Health and Human Services, Office for Civil Rights (Gabinete de Direitos Civis), por via electrónica através do Office for Civil Rights Complaint Portal, disponível em ou por correio ou telefone: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Italiano (Italian) ATTENZIONE: In caso la lingua parlata sia l’italiano, sono disponibili servizi di assistenza linguistica gratuiti. Chiamare il numero 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Dipartimento statunitense per la salute e i servizi umani) è conforme a tutte le leggi federali vigenti in materia di diritti civili e non pone in essere discriminazioni sulla base di razza, colore, origine nazionale, età, disabilità o sesso. HHS non esclude le persone o le tratta diversamente a causa di razza, colore, origine nazionale, età, disabilità o sesso. HHS: - Offre sostegni e servizi gratuiti alle persone affette da disabilità per comunicare con noi in modo efficace, quali: - Interpreti qualificati nella lingua dei segni - Informazioni scritte in altri formati (stampe a grandi caratteri, audio, formati elettronici accessibili, altri formati) - Offre servizi linguistici gratuiti alle persone la cui lingua primaria non è l’inglese, quali: - Interpreti qualificati - Informazioni scritte in altre lingue In caso si necessiti di tali servizi, contattare HHS al numero 1-877-696-6775.",1
"In caso si ritenga che HHS non abbia offerto tali servizi o abbia posto in essere discriminazioni in altri modi sulla base di razza, colore, origine nazionale, età, disabilità o sesso, è possibile presentare una vertenza a: U.S. Department of Health and Human, Office for Civil Rights (Ufficio per i diritti civili), elettronicamente mediante l’Office for Civil Rights Complaint Portal, disponibile all’indirizzo oppure a mezzo posta o telefono all’attenzione di: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Deutsch (German) ACHTUNG: Wenn Sie Deutsch sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen zur Verfügung. Rufnummer: 1-877-696-6775. Das Department of Health and Human Services (HHS, U.S.-Gesundheitsministerium) erfüllt geltenden bundesstaatliche Menschenrechtsgesetze und lehnt jegliche Diskriminierung aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. lehnt den Ausschluss oder die unterschiedliche Behandlung von Menschen aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. HHS: - Bietet kostenlose Hilfe und Dienstleistungen für Menschen mit Behinderung zur effektiven Kommunikation, wie z.",1
"B.: - Qualifizierte Gebärdensprachen-Dolmetscher - Schriftliche Informationen in anderen Formaten (große Ausdrucke, Audio, zugängliche elektronische Formate, sonstige Formate) - Bietet kostenlose Sprachdienste für Menschen, deren Hauptsprache nicht Englisch ist, wie z. B.: - Qualifizierte Dolmetscher - Schriftliche Informationen in anderen Sprachen Sollten Sie diese Dienstleistungen benötigen, so wenden Sie sich an das HHS unter 1-877-696-6775.",1
"Sollten Sie der Ansicht sein, dass HHS es versäumte, diese Dienstleistungen anzubieten, oder auf sonstige Weise aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht diskriminierte, so können Sie eine Beschwerde einreichen bei: Department of Health and Human Services, Office for Civil Rights (Amt für Bürgerrechte), elektronisch über das Office for Civil Rights Complaint Portal, zugänglich über oder per Post oder telefonisch an: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 日本語 (Japanese) 注意事項：日本語を話される場合、無料の言語支援をご利用いただけます。1-877-696-6775 まで、お電話にてご連絡ください。 U.S. Department of Health and Human Services（HHS、保健社会福祉省）は適用される連邦公民権法を遵守し、人種、肌の色、出身国、年齢、障害、または性別に基づく差別をいたしません。HHS は人種、肌の色、出身国、年齢、障害、または性別を理由として人を排除したり、異なる扱いをいたしません。 HHS: - 効果的にコミュニケーションを図るため、障害のある人に以下の支援やサポートを無料で提供いたします。 - 資格ある手話通訳者 - その他形式の文字情報（大きな活字、音声信号、手軽な電子形式、その他） - 英語を母語としない人へ以下の言語サービスを無料で提供いたします。 - 資格ある通訳者 - 英語以外の言語で書かれた情報 これらのサービスを必要とされる場合は、HHS（1-877-696-6775）までご連絡ください。 HHS がこれらのサービスの提供を怠ったり、人種、肌の色、出身国、年齢、障害、または性別に基づいた何らかの方法で差別したと思われる場合、こちらまで苦情を申し立てることができます。また、公民権に関する苦情は、U.S.",1
"Department of Health and Human ServicesのOffice for Civil Rights（公民権局）へ、Office for Civil Rights Complaint Portal から電子申請するか、以下へ郵便または電話で申し立てることもできます： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) فارسی (Farsi) توجه: اگر به زبان فارسی گفتگو می کنید، تسهیلات زبانی بصورت رایگان برای شما فراهم می باشد. با .1-877-696-6775 تماس بگیرید HHS) U.S. Department of Health and Human Services, وزارت بهداشت و خدمات انسانی آمریکا) از قوانین حقوق مدنی فدرال مربوطه تبعیت می کند و هیچگونه تبعیضی بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد قایل نمی شود. HHS بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد ایشان را از خدمات محروم نمی کند و با آنها برخورد متفاوتی ندارد.",1
":HHS - برای افرادی که ناتوانی دارند، برای برقرار کردن ارتباط موثر، کمک هایی بطور رایگان فراهم می کند، مانند: - مترجمین واجد شرایط زبان اشاره - اطلاعات نوشتاری به فرمت های دیگر (چاپ با حروف درشت، صوتی، فرمت های الکترونیک قابل دسترسی ساده، و فرمت های دیگر) - برای افرادی که زبان اولیه شان انگلیسی نیست خدمات زبانی رایگان ارایه می کند، مانند: - مترجمین شفاهی واجد شرایط - اطلاعات نوشتاری به زبانهای دیگر اگر به چنین خدماتی نیاز دارید، با HHS به 1-877-696-6775 تماس بگیرید اگر معتقدید که HHS چنین خدماتی را به شما ارایه نداده و یا اینکه به شکلی دیگر به دلیل نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت درمورد شما تبعیض قایل شده می توانید شکواییه ای به این آدرس ثبت کنید: اگر احساس می کنید که HHS این خدمات را به شما ارایه نکرده و یا به هر شکلی بدلیل نژاد، رنگ پوست، اصلیت ملی، سن، معلولیت یا جنسیت شما را مورد تبعیض قرار داده، می توانید نزد U.S. Department of Health and Human Services، Office for Civil Rights (اداره حمایت از حقوق مدنی)، شکواییه خود را ثبت نمایید. دسترسی الکترونیکی به این اداره از طریق Office for Civil Rights Complaint Portal به آدرس یا تماس از طریق ایمیل یا تلفن با آدرس زیر میسر است: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) English ATTENTION: If you do not speak English, language assistance services are available to you free of charge.",1
"Call 1-800-232-4636 Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The CDC nondiscrimination notice lists the services available to you and how to file a complaint if you feel that CDC has failed to provide these services or discriminated in another way.",1
"Key points - High blood pressure (hypertension) is consistently at or above 130/80 mm Hg. - High blood pressure typically has no signs or symptoms but can cause problems for your heart, brain, kidneys, and eyes. - No matter your age, you can take steps each day to keep your blood pressure in a healthy range. - Some people may be able to control their blood pressure by making lifestyle changes or taking blood pressure medicines. Definition of high blood pressure Blood pressure is the pressure that occurs when blood pushes against the walls of your arteries. Arteries carry blood from your heart to other parts of your body. Normal blood pressure is less than 120/80 mm Hg.1 High blood pressure, also called hypertension, is blood pressure that is higher than normal. High blood pressure is consistently at or above 130/80 mm Hg.1 Your blood pressure changes throughout the day based on your activities. Having blood pressure consistently above normal may result in a diagnosis of high blood pressure. The higher your blood pressure levels, the more risk you have for other health problems, such as heart disease, heart attack, and stroke. Learn about how you can prevent and treat high blood pressure during pregnancy, which can put you and your baby at risk for health problems. Diagnosis Your health care team can diagnose high blood pressure.",1
"They can also make treatment decisions by reviewing your systolic (first number) and diastolic (second number) blood pressure levels and comparing them to guidelines. Most health care professionals will use these guidelines from the ACC and AHA to diagnose high blood pressure:1 If a health care professional diagnoses you with high blood pressure, talk with your health care team about your blood pressure levels and how they affect your treatment plan. Learn how and where to measure your blood pressure and why it's important to know your numbers. Signs and symptoms High blood pressure usually has no warning signs or symptoms, and many people do not know they have it. Measuring your blood pressure is the only way to know whether you have high blood pressure. Causes There are several causes of and risk factors for high blood pressure. Fortunately, you can control many of them. High blood pressure usually develops over time. It can occur because of unhealthy lifestyle choices, such as not getting enough regular physical activity. Certain health conditions, such as diabetes and obesity, can also increase the risk for developing high blood pressure. And high blood pressure can occur during pregnancy. People who have depression, anxiety, stress, or post-traumatic stress disorder over a long period of time may develop other health problems, including an increased heart rate and high blood pressure.",1
"Other risk factors, such as family history and the environment, can also increase a person's risk for high blood pressure. Potential problems having high blood pressure could cause High blood pressure can damage your health in many ways. It can seriously hurt important organs like your heart, brain, kidneys, and eyes. The good news is that, in most cases, you can manage your blood pressure to lower your risk for serious health problems. - High blood pressure (hypertension) complications can damage your health in many ways, including harming organs such as your heart, brain, and kidneys. Heart attack and heart disease High blood pressure can damage your arteries by making them less elastic. This decreases the flow of blood and oxygen to your heart and leads to heart disease. In addition, decreased blood flow to the heart can cause: - Chest pain, also called angina. - Heart attack, which happens when the blood supply to your heart is blocked and heart muscle begins to die without enough oxygen. The longer the blood flow is blocked, the greater the damage to the heart. - Heart failure, a condition that means your heart can't pump enough blood and oxygen to your other organs. Stroke and brain problems High blood pressure can cause the arteries that supply blood and oxygen to the brain to burst or be blocked, causing a stroke. Brain cells die during a stroke because they do not get enough oxygen. Stroke can cause serious disabilities in speech, movement, and other basic activities.",1
"A stroke can cause death. Having high blood pressure, especially in midlife, is linked to having poorer cognitive function and dementia later in life. Learn more about the link between high blood pressure and dementia from the National Institutes of Health's Mind Your Risks® campaign. Heart valve disease High blood pressure can cause heart valve disease, which is when any valve in the heart is damaged or diseased. Kidney disease Adults with diabetes, high blood pressure, or both have a higher risk of developing chronic kidney disease than those without these conditions. Prevention No matter your age, you can take steps each day to keep your blood pressure in a healthy range. Many people with high blood pressure can lower their blood pressure into a healthy range or keep their numbers in a healthy range by making lifestyle changes. Talk with your health care team about: - Physical activity each week (about 30 minutes a day, 5 days a week) - Not smoking - Eating a healthy diet, including limiting sodium (salt) and alcohol - Keeping a healthy weight - Managing stress In addition to making positive lifestyle changes, some people with high blood pressure need to take medicine to manage their blood pressure. Talk with your health care team right away if: - You think you have high blood pressure. - If you've been told you have high blood pressure but do not have it under control.",1
"By taking action to lower your blood pressure, you can help protect yourself against heart disease and stroke, also called cardiovascular disease (CVD). - Whelton PK, Carey RM, Aronow, WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248.",1
"Language Assistance Services – CDC In November of 2023, the U.S. Department of Health and Human Services (HHS) updated its 2013 Language Access Plan in an effort to “ensure greater access to the life-saving services that HHS provides for people with Limited English Proficiency (LEP) and people with disabilities.” Consistent with the updated HHS plan, CDC launched a 2024 plan which outlines the action steps the agency will take to meet the language access needs of the public while continuing to support communities that may be underserved and improving access to information for people with LEP and people with disabilities. The strategic actions within the CDC plan prioritize efforts that will advance language accessibility to public health information and the agency’s communication with the public. The plan can be found online here: Español (Spanish) ATENCIÓN: Si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-800-232-4636. Los Centros para el Control y la Prevención de Enfermedades (CDC) de los EE. UU. cumplen con las leyes federales de derechos civiles aplicables y no discriminan por motivos de raza, color, nacionalidad, edad, discapacidad o sexo. Los CDC no excluyen a las personas ni las trata de forma diferente debido a su origen étnico, color, nacionalidad, edad, discapacidad o sexo.",1
"Los CDC: - Proporcionan asistencia y servicios gratuitos a las personas con discapacidades para que se comuniquen de manera eficaz con nosotros; algunos de esos servicios son: - Intérpretes de lenguaje de señas capacitados. - Información escrita en otros formatos (letra grande, audio, formatos electrónicos accesibles, otros formatos). - Proporcionan servicios lingüísticos gratuitos a las personas cuyo idioma materno no es el inglés; algunos de esos servicios son: - Intérpretes capacitados. - Información escrita en otros idiomas. Si necesita recibir estos servicios, comuníquese con los CDC al 1-800-232-4636. Si considera que el Departamento de Salud y Servicios Humanos (HHS) no le proporcionó estos servicios o lo discriminó de otra manera por motivos de origen étnico, color, nacionalidad, edad, discapacidad o sexo, puede presentar un reclamo a la Oficina de Derechos Civiles (Office for Civil Rights) del Departamento de Salud y Servicios Humanos de los EE. UU.",1
"de manera electrónica a través del portal de “Office for Civil Rights Complaint”, disponible en o bien, por correo postal a la siguiente dirección o por teléfono a los números que figuran a continuación: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 繁體中文 (Chinese) 注意：如果您使用繁體中文，您可以免費獲得語言援助服務。請致電 1-877-696-6775。 U.S. Department of Health and Human Services（HHS、美國衛生及公共服務部）遵守適用的聯邦民權法律規定、不因種族、膚色、民族血統、年齡、殘障或性別而歧視任何人。HHS 不因種族、膚色、民族血統、年齡、殘障或性別而排斥任何人或以不同的方式對待他們。 HHS - 向殘障人士免費提供各種援助和服務、以幫助他們與我們進行有效溝通、如： - 合格的手語翻譯員 - 以其他格式提供的書面資訊（大號字體、音訊、無障礙電子格式、其他格式） - 向母語非英語的人員免費提供各種語言服務，如： - 合格的翻譯員 - 以其他語言書寫的資訊 如果您需要此類服務、請聯絡 HHS 撥打 1-877-696-6775 如果您認為 HHS 未能提供此類服務或者因種族、膚色、民族血統、年齡、殘障或性別而透過其他方式歧視您、您可以向U.S. Department of Health and Human Services的 Office for Civil Rights（民權辦公室）提交民權投訴、透過 Office for Civil Rights Complaint Portal 以電子方式投訴： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019、800-537-7697 (TDD)（聾人用電信設備） Tiếng Việt (Vietnamese) CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-877-696-6775. U.S. Department of Health and Human Services (HHS, Bộ Y Tế và Dịch Vụ Nhân Sinh Hoa Kỳ) tuân thủ luật dân quyền hiện hành của Liên bang và không phân biệt đối xử dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính.",1
"HHS không loại trừ mọi người hoặc đối xử với họ khác biệt vì chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính. HHS: - Cung cấp dịch vụ hỗ trợ miễn phí cho những người khuyết tật để giao tiếp với chúng tôi có hiệu quả, như: - Thông dịch viên ngôn ngữ ký hiệu đủ năng lực - Thông tin bằng văn bản ở các định dạng khác (chữ in lớn, âm thanh, định dạng điện tử có thể tiếp cận, các định dạng khác) - Cung cấp miễn phí các dịch vụ ngôn ngữ cho những người có ngôn ngữ chính không phải là tiếng Anh, như: - Thông dịch viên đủ năng lực - Thông tin được trình bày bằng ngôn ngữ khác Nếu bạn cần những dịch vụ này, hãy liên hệ HHS theo số 1-877-696-6775. Nếu bạn tin rằng HHS không cung cấp những dịch vụ này hoặc phân biệt đối xử theo cách khác dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính, bạn có thể nộp đơn khiếu nại với U.S. Department of Health and Human Services, Office for Civil Rights (Văn Phòng Dân Quyền) bằng hình thức điện tử qua Office for Civil Rights Complaint Portal, có trên trang hoặc qua đường bưu điện hoặc bằng điện thoại tại: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 한국어 (Korean) 주의: 한국어를 사용하시는 경우, 언어 지원 서비스를 무료로 이용하실 수 있습니다. 1-877-696-6775 번으로 전화해 주십시오. Department of Health and Human Services (HHS, 보건복지부)은(는) 관련 연방 공민권법을 준수하며 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 차별하지 않습니다.",1
"HHS은(는) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 누군가를 배제하거나 다른 방식으로 대우하지 않습니다. HHS: - 장애인들이 저희와 효과적으로 의사소통할 수 있도록 다음과 같은 무료 지원과 서비스를 제공합니다. - 자격있는 수화 통역자 - 다른 형식의 서면 정보(큰 활자, 음성, 사용 가능한 전자 형식, 기타 형식) - 주로 사용하는 언어가 영어가 아닌 이들에게는 다음과 같은 무료 언어 서비스를 제공합니다. - 자격있는 통역자 - 다른 언어로 작성된 서면 정보 이러한 서비스가 필요하시면 HHS에 -877-696-6775번으로 연락하십시오. HHS 이(가) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 이러한 서비스를 제공하지 않거나 다른 방식으로 차별했다고 생각하시는 경우, 를 통한 전자 방식 또는 우편이나 전화로 Department of Health and Human Services, Office for Civil Rights (시민권 사무국)에 민원을 제출할 수 있습니다. 주소 및 연락처는 다음과 같습니다. U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Tagalog PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa 1-877-696-6775. Sumusunod ang U.S. Department of Health and Human Services (HHS, Kagawaran ng Mga Serbisyong Pangkalusugan at Pantao ng U.S.) sa mga naaangkop na Pampederal na batas sa karapatang sibil at hindi nandidiskrimina batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian. Ang HHS ay hindi nagtatangi ng mga tao o hindi nagpapakita ng ibang pakikitungo dahil sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian.",1
"Ang HHS ay: - Nagbibigay ng mga libreng tulong at serbisyo sa mga taong may kapansanan upang mahusay silang makipag-ugnayan sa amin, gaya ng: - Mga kwalipikadong interpreter ng sign language - Nakasulat na impormasyon sa iba pang mga format (malaking print, audio, mga naa-access na electronic na format, iba pang mga format) - Nagbibigay ng mga libreng serbisyo sa wika sa mga taong hindi Ingles ang pangunahing wika, gaya ng: - Mga kwalipikadong interpreter - Impormasyong nakasulat sa iba pang mga wika Kung kailangan mo ang mga serbisyong ito, makipag-ugnayan kay HHS sa 1-877-696-6775. Kung naniniwala kang hindi naibigay ng HHS ang mga serbisyong ito o nandiskrimina ito sa ibang paraan batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian, maaari kang maghain ng karaingan sa U.S. Department of Health and Human Services, Office for Civil Rights (Tanggapan para sa Mga Karapatang Sibil), sa electronic na paraan sa Office for Civil Rights Complaint Portal, na makikita sa o sa pamamagitan ng koreo o telepono sa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Русский (Russian) ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Министерство здравоохранения и социальных служб США) соблюдает применимое федеральное законодательство в области гражданских прав и не допускает дискриминации по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS не исключает людей и не относится к ним по-разному из-за расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS: - Для эффективного взаимодействия предоставляет безвозмездную помощь и оказывает услуги людям с ограниченными возможностями, а именно: - услуги квалифицированных сурдопереводчиков; - письменную информацию в других форматах (крупный шрифт, аудио формат, доступные электронные форматы, прочие форматы). - Предоставляет бесплатные услуги перевода людям, для которых английский не является основным языком, а именно: - услуги квалифицированных переводчиков; - письменную информацию на других языках. Если вы нуждаетесь в таких услугах, обратитесь к HHS по телефону 1-877-696-6775.",1
"Если вы считаете, что в HHS вам не предоставили указанных услуг или иным образом дискриминировали вас по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола, вы можете подать жалобу в U.S. Department of Health and Human Services, Office for Civil Rights (Управление по гражданским правам), в электронном виде через Office for Civil Rights Complaint Portal, доступный по ссылке: по почте или по телефону: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) العربية (Arabic) ملحوظة: إذا كنت تتحدث اذكر اللغة، فإن خدمات المساعدة اللغوية تتوافر لك بالمجان. اتصل برقم .1-877-696-6775 تلتزم HHS) Department of Health and Human Services, وزارة الخدمات الصحية والبشرية) بقوانين الحقوق المدنية الفدرالية المعمول بها ولا تميز على أساس العرق أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.",1
"لا تستبعد HHS الأشخاص أو تعاملهم على نحو مختلف بسبب النوع أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.. :HHS - توفر مساعدات وخدمات مجانية للأشخاص من ذوي الإعاقات للتواصل بصورة فعالة معنا، مثل: - مترجمي لغة إشارة مؤهلين - معلومات كتابية بتنسيقات أخرى (مطبوعة بأحرف كبيرة، مواد صوتية، تنسيقات إلكترونية متيسرة، وغير ذلك من التنسيقات) - توفر خدمات لغوية مجانية للأشخاص الذين لغتهم الأساسية ليست الإنجليزية، مثل: - مترجمين مؤهلين - معلومات مكتوبة بلغات أخرى إذا كنت بحاجة لهذه الخدمات، اتصل بـ HHS على الرقم .1-877-696-6775 إذا كنت تعتقد أن HHS قد أخفقت في توفير تلك الخدمات أو أنها قد ميزت بطريقة أخرى على أساس العرق أو اللون أو الأصل Department of Health and Human Services، مكتب Office for Civil Rights (مكتب الحقوق المدنية)، من خلال مكتب Office for Civil Rights Complaint Portal، المتوفر على الرابط أو بالبريد أو الهاتف على: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (رقم هاتف الصم والبكم) Kreyòl Ayisyen (Haitian Creole) ATANSYON: Si w pale Kreyòl Ayisyen, gen sèvis èd pou lang ki disponib gratis pou ou. Rele 1-877-696-6775. U.S. Department of Health and Human Services, (HHS, Ministè Sèvis Sante ak Imen Ameriken) konfòm ak lwa sou dwa sivil Federal ki aplikab yo e li pa fè diskriminasyon sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks. HHS pa ekskli moun oswa trete yo nan fason ki diferan akoz ras, koulè, peyi orijin, laj, enfimite oswa sèks yo.",1
"HHS: - Bay èd ak sèvis gratis pou moun ki andikape pou yo kominike avèk nou nan fason ki efikas, tankou: - Enèprèt langaj siy ki kalifye - Enfòmasyon ekri nan lòt fòma (gwo lèt, odyo, fòma elektwonik ki aksesib, lòt fòma) - Bay sèvis lang gratis a moun lang prensipal yo pa Anglè, tankou: - Enèprèt kalifye - Enfòmasyon ki ekri nan lòt lang Si w bezwen sèvis sa yo, kontakte HHS nan 1-877-696-6775. Si w kwè HHS pa t bay sèvis sa yo oswa te fè diskriminasyon nan yon lòt fason sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks, ou ka depoze yon plent nan: U.S. Department of Health and Human Services, Office for Civil Rights (Biwo Dwa Sivil) atravè Office for Civil Rights Portal, pa mwayen elektwonik ki disponib nan oswa pa lapòs oswa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Français (French) ATTENTION: Si vous parlez français, des services d’aide linguistique vous sont proposés gratuitement. Appelez le 1-877-696-6775. L’U.S. Department of Health and Human Services (HHS, Département de la Santé et des Services Sociaux des États-Unis) respecte les lois fédérales en vigueur relatives aux droits civiques et ne pratique aucune discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou un handicap.",1
"HHS n’exclut et ne traite aucune personne différemment en raison de sa race, sa couleur de peau, son origine nationale, son âge, son sexe ou son handicap. HHS: - Fournit gratuitement des aides et services aux personnes handicapées afin de permettre une communication efficace avec nous, par exemple: - Interprètes qualifiés en langue des signes - Informations écrites dans d’autres formats (gros caractères, audio, formats électroniques accessibles, autres formats) - Fournit gratuitement des services linguistiques aux personnes dont la langue principale n’est pas l’anglais, par exemple: - Interprètes qualifiés - Informations écrites dans d’autres langues Si vous avez besoin de ces services, contactez HHS au 1-877-696-6775. Si vous pensez que HHS n’a pas fourni ces services ou a fait preuve d’une autre forme de discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou le handicap, vous pouvez déposer une réclamation auprès de l’U.S. Department of Health and Human Services, l’Office for Civil Rights (Bureau des Droits Civiques), par voie électronique via l’Office for Civil Rights Complaint Portal, disponible à l’adresse par courrier ou par téléphone à: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Polski (Polish) UWAGA: Jeżeli mówisz po polsku, możesz skorzystać z bezpłatnej pomocy językowej. Zadzwoń pod numer 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Departament Zdrowia i Opieki Społecznej Stanów Zjednoczonych) postępuje zgodnie z obowiązującymi federalnymi prawami obywatelskimi i nie dopuszcza się dyskryminacji ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS nie wyklucza żadnych osób i nie stosuje różnego traktowania ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS: - Zapewnia bezpłatną pomoc i usługi osobom niepełnosprawnym w celu umożliwienia skutecznej komunikacji, na przykład: - Wykwalifikowanych tłumaczy języka migowego - Informacje na piśmie w różnych formatach (duży druk, audio, dostępne formaty elektroniczne, inne formaty) - Zapewnia bezpłatne usługi językowe dla osób, dla których angielski nie jest pierwszym językiem, na przykład: - Wykwalifikowanych tłumaczy - Informacje na piśmie w innych językach Jeżeli chcesz skorzystać z tych usług, skontaktuj się z HHS pod numerem 1-877-696-6775.",1
"Jeżeli uważasz, że HHS nie świadczy tych usług lub w inny sposób dopuszcza się dyskryminacji ze względu na rasę, koloru skóry, pochodzenie, wiek, niepełnosprawność bądź płeć, możesz złożyć skargę do: U.S. Department of Health and Human Services, Office for Civil Rights (Biuro Praw Obywatelskich), drogą elektroniczną za pośrednictwem Office for Civil Rights Complaint Portal na stronie pocztą tradycyjną lub dzwoniąc pod numer telefonu: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Português (Portuguese) O U.S. Department of Health and Human Services (HHS, Departamento de Saúde e dos Serviços Humanos dos Estados Unidos da América) cumpre as leis de direitos civis federais aplicáveis e não exerce discriminação com base na raça, cor, nacionalidade, idade, deficiência ou sexo. HHS não exclui ou trata de forma diferente devido à raça, cor, nacionalidade, idade, deficiência ou sexo.",1
"HHS: - Faculta ajuda e serviços gratuitos a pessoas com dificuldades de comunicar de forma eficaz connosco, tais como: - Intérpretes de língua gestual qualificados - Informação escrita noutros formatos (impressão maior, áudio, formatos electrónicos acessíveis, outros formatos) - Faculta serviços linguísticas grátis a pessoas cuja língua principal não é inglês, tais como: - Intérpretes qualificados - Informação escrita noutros idiomas Se necessita destes serviços, contacte HHS através do número 1-877-696-6775. Se considera que a HHS não cumpriu estes serviços ou exerceu discriminação de outra forma com base na raça, cor, nacionalidade, idade, deficiência ou sexo, pode apresentar uma reclamação junto de: U.S. Department of Health and Human Services, Office for Civil Rights (Gabinete de Direitos Civis), por via electrónica através do Office for Civil Rights Complaint Portal, disponível em ou por correio ou telefone: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Italiano (Italian) ATTENZIONE: In caso la lingua parlata sia l’italiano, sono disponibili servizi di assistenza linguistica gratuiti. Chiamare il numero 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Dipartimento statunitense per la salute e i servizi umani) è conforme a tutte le leggi federali vigenti in materia di diritti civili e non pone in essere discriminazioni sulla base di razza, colore, origine nazionale, età, disabilità o sesso. HHS non esclude le persone o le tratta diversamente a causa di razza, colore, origine nazionale, età, disabilità o sesso. HHS: - Offre sostegni e servizi gratuiti alle persone affette da disabilità per comunicare con noi in modo efficace, quali: - Interpreti qualificati nella lingua dei segni - Informazioni scritte in altri formati (stampe a grandi caratteri, audio, formati elettronici accessibili, altri formati) - Offre servizi linguistici gratuiti alle persone la cui lingua primaria non è l’inglese, quali: - Interpreti qualificati - Informazioni scritte in altre lingue In caso si necessiti di tali servizi, contattare HHS al numero 1-877-696-6775.",1
"In caso si ritenga che HHS non abbia offerto tali servizi o abbia posto in essere discriminazioni in altri modi sulla base di razza, colore, origine nazionale, età, disabilità o sesso, è possibile presentare una vertenza a: U.S. Department of Health and Human, Office for Civil Rights (Ufficio per i diritti civili), elettronicamente mediante l’Office for Civil Rights Complaint Portal, disponibile all’indirizzo oppure a mezzo posta o telefono all’attenzione di: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Deutsch (German) ACHTUNG: Wenn Sie Deutsch sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen zur Verfügung. Rufnummer: 1-877-696-6775. Das Department of Health and Human Services (HHS, U.S.-Gesundheitsministerium) erfüllt geltenden bundesstaatliche Menschenrechtsgesetze und lehnt jegliche Diskriminierung aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. lehnt den Ausschluss oder die unterschiedliche Behandlung von Menschen aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. HHS: - Bietet kostenlose Hilfe und Dienstleistungen für Menschen mit Behinderung zur effektiven Kommunikation, wie z.",1
"B.: - Qualifizierte Gebärdensprachen-Dolmetscher - Schriftliche Informationen in anderen Formaten (große Ausdrucke, Audio, zugängliche elektronische Formate, sonstige Formate) - Bietet kostenlose Sprachdienste für Menschen, deren Hauptsprache nicht Englisch ist, wie z. B.: - Qualifizierte Dolmetscher - Schriftliche Informationen in anderen Sprachen Sollten Sie diese Dienstleistungen benötigen, so wenden Sie sich an das HHS unter 1-877-696-6775.",1
"Sollten Sie der Ansicht sein, dass HHS es versäumte, diese Dienstleistungen anzubieten, oder auf sonstige Weise aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht diskriminierte, so können Sie eine Beschwerde einreichen bei: Department of Health and Human Services, Office for Civil Rights (Amt für Bürgerrechte), elektronisch über das Office for Civil Rights Complaint Portal, zugänglich über oder per Post oder telefonisch an: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 日本語 (Japanese) 注意事項：日本語を話される場合、無料の言語支援をご利用いただけます。1-877-696-6775 まで、お電話にてご連絡ください。 U.S. Department of Health and Human Services（HHS、保健社会福祉省）は適用される連邦公民権法を遵守し、人種、肌の色、出身国、年齢、障害、または性別に基づく差別をいたしません。HHS は人種、肌の色、出身国、年齢、障害、または性別を理由として人を排除したり、異なる扱いをいたしません。 HHS: - 効果的にコミュニケーションを図るため、障害のある人に以下の支援やサポートを無料で提供いたします。 - 資格ある手話通訳者 - その他形式の文字情報（大きな活字、音声信号、手軽な電子形式、その他） - 英語を母語としない人へ以下の言語サービスを無料で提供いたします。 - 資格ある通訳者 - 英語以外の言語で書かれた情報 これらのサービスを必要とされる場合は、HHS（1-877-696-6775）までご連絡ください。 HHS がこれらのサービスの提供を怠ったり、人種、肌の色、出身国、年齢、障害、または性別に基づいた何らかの方法で差別したと思われる場合、こちらまで苦情を申し立てることができます。また、公民権に関する苦情は、U.S.",1
"Department of Health and Human ServicesのOffice for Civil Rights（公民権局）へ、Office for Civil Rights Complaint Portal から電子申請するか、以下へ郵便または電話で申し立てることもできます： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) فارسی (Farsi) توجه: اگر به زبان فارسی گفتگو می کنید، تسهیلات زبانی بصورت رایگان برای شما فراهم می باشد. با .1-877-696-6775 تماس بگیرید HHS) U.S. Department of Health and Human Services, وزارت بهداشت و خدمات انسانی آمریکا) از قوانین حقوق مدنی فدرال مربوطه تبعیت می کند و هیچگونه تبعیضی بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد قایل نمی شود. HHS بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد ایشان را از خدمات محروم نمی کند و با آنها برخورد متفاوتی ندارد.",1
":HHS - برای افرادی که ناتوانی دارند، برای برقرار کردن ارتباط موثر، کمک هایی بطور رایگان فراهم می کند، مانند: - مترجمین واجد شرایط زبان اشاره - اطلاعات نوشتاری به فرمت های دیگر (چاپ با حروف درشت، صوتی، فرمت های الکترونیک قابل دسترسی ساده، و فرمت های دیگر) - برای افرادی که زبان اولیه شان انگلیسی نیست خدمات زبانی رایگان ارایه می کند، مانند: - مترجمین شفاهی واجد شرایط - اطلاعات نوشتاری به زبانهای دیگر اگر به چنین خدماتی نیاز دارید، با HHS به 1-877-696-6775 تماس بگیرید اگر معتقدید که HHS چنین خدماتی را به شما ارایه نداده و یا اینکه به شکلی دیگر به دلیل نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت درمورد شما تبعیض قایل شده می توانید شکواییه ای به این آدرس ثبت کنید: اگر احساس می کنید که HHS این خدمات را به شما ارایه نکرده و یا به هر شکلی بدلیل نژاد، رنگ پوست، اصلیت ملی، سن، معلولیت یا جنسیت شما را مورد تبعیض قرار داده، می توانید نزد U.S. Department of Health and Human Services، Office for Civil Rights (اداره حمایت از حقوق مدنی)، شکواییه خود را ثبت نمایید. دسترسی الکترونیکی به این اداره از طریق Office for Civil Rights Complaint Portal به آدرس یا تماس از طریق ایمیل یا تلفن با آدرس زیر میسر است: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) English ATTENTION: If you do not speak English, language assistance services are available to you free of charge.",1
"Call 1-800-232-4636 Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The CDC nondiscrimination notice lists the services available to you and how to file a complaint if you feel that CDC has failed to provide these services or discriminated in another way.",1
"Language Assistance Services – CDC In November of 2023, the U.S. Department of Health and Human Services (HHS) updated its 2013 Language Access Plan in an effort to “ensure greater access to the life-saving services that HHS provides for people with Limited English Proficiency (LEP) and people with disabilities.” Consistent with the updated HHS plan, CDC launched a 2024 plan which outlines the action steps the agency will take to meet the language access needs of the public while continuing to support communities that may be underserved and improving access to information for people with LEP and people with disabilities. The strategic actions within the CDC plan prioritize efforts that will advance language accessibility to public health information and the agency’s communication with the public. The plan can be found online here: Español (Spanish) ATENCIÓN: Si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-800-232-4636. Los Centros para el Control y la Prevención de Enfermedades (CDC) de los EE. UU. cumplen con las leyes federales de derechos civiles aplicables y no discriminan por motivos de raza, color, nacionalidad, edad, discapacidad o sexo. Los CDC no excluyen a las personas ni las trata de forma diferente debido a su origen étnico, color, nacionalidad, edad, discapacidad o sexo.",1
"Los CDC: - Proporcionan asistencia y servicios gratuitos a las personas con discapacidades para que se comuniquen de manera eficaz con nosotros; algunos de esos servicios son: - Intérpretes de lenguaje de señas capacitados. - Información escrita en otros formatos (letra grande, audio, formatos electrónicos accesibles, otros formatos). - Proporcionan servicios lingüísticos gratuitos a las personas cuyo idioma materno no es el inglés; algunos de esos servicios son: - Intérpretes capacitados. - Información escrita en otros idiomas. Si necesita recibir estos servicios, comuníquese con los CDC al 1-800-232-4636. Si considera que el Departamento de Salud y Servicios Humanos (HHS) no le proporcionó estos servicios o lo discriminó de otra manera por motivos de origen étnico, color, nacionalidad, edad, discapacidad o sexo, puede presentar un reclamo a la Oficina de Derechos Civiles (Office for Civil Rights) del Departamento de Salud y Servicios Humanos de los EE. UU.",1
"de manera electrónica a través del portal de “Office for Civil Rights Complaint”, disponible en o bien, por correo postal a la siguiente dirección o por teléfono a los números que figuran a continuación: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 繁體中文 (Chinese) 注意：如果您使用繁體中文，您可以免費獲得語言援助服務。請致電 1-877-696-6775。 U.S. Department of Health and Human Services（HHS、美國衛生及公共服務部）遵守適用的聯邦民權法律規定、不因種族、膚色、民族血統、年齡、殘障或性別而歧視任何人。HHS 不因種族、膚色、民族血統、年齡、殘障或性別而排斥任何人或以不同的方式對待他們。 HHS - 向殘障人士免費提供各種援助和服務、以幫助他們與我們進行有效溝通、如： - 合格的手語翻譯員 - 以其他格式提供的書面資訊（大號字體、音訊、無障礙電子格式、其他格式） - 向母語非英語的人員免費提供各種語言服務，如： - 合格的翻譯員 - 以其他語言書寫的資訊 如果您需要此類服務、請聯絡 HHS 撥打 1-877-696-6775 如果您認為 HHS 未能提供此類服務或者因種族、膚色、民族血統、年齡、殘障或性別而透過其他方式歧視您、您可以向U.S. Department of Health and Human Services的 Office for Civil Rights（民權辦公室）提交民權投訴、透過 Office for Civil Rights Complaint Portal 以電子方式投訴： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019、800-537-7697 (TDD)（聾人用電信設備） Tiếng Việt (Vietnamese) CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-877-696-6775. U.S. Department of Health and Human Services (HHS, Bộ Y Tế và Dịch Vụ Nhân Sinh Hoa Kỳ) tuân thủ luật dân quyền hiện hành của Liên bang và không phân biệt đối xử dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính.",1
"HHS không loại trừ mọi người hoặc đối xử với họ khác biệt vì chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính. HHS: - Cung cấp dịch vụ hỗ trợ miễn phí cho những người khuyết tật để giao tiếp với chúng tôi có hiệu quả, như: - Thông dịch viên ngôn ngữ ký hiệu đủ năng lực - Thông tin bằng văn bản ở các định dạng khác (chữ in lớn, âm thanh, định dạng điện tử có thể tiếp cận, các định dạng khác) - Cung cấp miễn phí các dịch vụ ngôn ngữ cho những người có ngôn ngữ chính không phải là tiếng Anh, như: - Thông dịch viên đủ năng lực - Thông tin được trình bày bằng ngôn ngữ khác Nếu bạn cần những dịch vụ này, hãy liên hệ HHS theo số 1-877-696-6775. Nếu bạn tin rằng HHS không cung cấp những dịch vụ này hoặc phân biệt đối xử theo cách khác dựa trên chủng tộc, màu da, nguồn gốc quốc gia, độ tuổi, khuyết tật, hoặc giới tính, bạn có thể nộp đơn khiếu nại với U.S. Department of Health and Human Services, Office for Civil Rights (Văn Phòng Dân Quyền) bằng hình thức điện tử qua Office for Civil Rights Complaint Portal, có trên trang hoặc qua đường bưu điện hoặc bằng điện thoại tại: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 한국어 (Korean) 주의: 한국어를 사용하시는 경우, 언어 지원 서비스를 무료로 이용하실 수 있습니다. 1-877-696-6775 번으로 전화해 주십시오. Department of Health and Human Services (HHS, 보건복지부)은(는) 관련 연방 공민권법을 준수하며 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 차별하지 않습니다.",1
"HHS은(는) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 누군가를 배제하거나 다른 방식으로 대우하지 않습니다. HHS: - 장애인들이 저희와 효과적으로 의사소통할 수 있도록 다음과 같은 무료 지원과 서비스를 제공합니다. - 자격있는 수화 통역자 - 다른 형식의 서면 정보(큰 활자, 음성, 사용 가능한 전자 형식, 기타 형식) - 주로 사용하는 언어가 영어가 아닌 이들에게는 다음과 같은 무료 언어 서비스를 제공합니다. - 자격있는 통역자 - 다른 언어로 작성된 서면 정보 이러한 서비스가 필요하시면 HHS에 -877-696-6775번으로 연락하십시오. HHS 이(가) 인종, 피부색, 출신 국가, 연령, 장애 또는 성별을 이유로 이러한 서비스를 제공하지 않거나 다른 방식으로 차별했다고 생각하시는 경우, 를 통한 전자 방식 또는 우편이나 전화로 Department of Health and Human Services, Office for Civil Rights (시민권 사무국)에 민원을 제출할 수 있습니다. 주소 및 연락처는 다음과 같습니다. U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Tagalog PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa 1-877-696-6775. Sumusunod ang U.S. Department of Health and Human Services (HHS, Kagawaran ng Mga Serbisyong Pangkalusugan at Pantao ng U.S.) sa mga naaangkop na Pampederal na batas sa karapatang sibil at hindi nandidiskrimina batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian. Ang HHS ay hindi nagtatangi ng mga tao o hindi nagpapakita ng ibang pakikitungo dahil sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian.",1
"Ang HHS ay: - Nagbibigay ng mga libreng tulong at serbisyo sa mga taong may kapansanan upang mahusay silang makipag-ugnayan sa amin, gaya ng: - Mga kwalipikadong interpreter ng sign language - Nakasulat na impormasyon sa iba pang mga format (malaking print, audio, mga naa-access na electronic na format, iba pang mga format) - Nagbibigay ng mga libreng serbisyo sa wika sa mga taong hindi Ingles ang pangunahing wika, gaya ng: - Mga kwalipikadong interpreter - Impormasyong nakasulat sa iba pang mga wika Kung kailangan mo ang mga serbisyong ito, makipag-ugnayan kay HHS sa 1-877-696-6775. Kung naniniwala kang hindi naibigay ng HHS ang mga serbisyong ito o nandiskrimina ito sa ibang paraan batay sa lahi, kulay, bansang pinagmulan, edad, kapansanan o kasarian, maaari kang maghain ng karaingan sa U.S. Department of Health and Human Services, Office for Civil Rights (Tanggapan para sa Mga Karapatang Sibil), sa electronic na paraan sa Office for Civil Rights Complaint Portal, na makikita sa o sa pamamagitan ng koreo o telepono sa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Русский (Russian) ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Министерство здравоохранения и социальных служб США) соблюдает применимое федеральное законодательство в области гражданских прав и не допускает дискриминации по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS не исключает людей и не относится к ним по-разному из-за расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола. HHS: - Для эффективного взаимодействия предоставляет безвозмездную помощь и оказывает услуги людям с ограниченными возможностями, а именно: - услуги квалифицированных сурдопереводчиков; - письменную информацию в других форматах (крупный шрифт, аудио формат, доступные электронные форматы, прочие форматы). - Предоставляет бесплатные услуги перевода людям, для которых английский не является основным языком, а именно: - услуги квалифицированных переводчиков; - письменную информацию на других языках. Если вы нуждаетесь в таких услугах, обратитесь к HHS по телефону 1-877-696-6775.",1
"Если вы считаете, что в HHS вам не предоставили указанных услуг или иным образом дискриминировали вас по признакам расы, цвета кожи, национальной принадлежности, возраста, инвалидности или пола, вы можете подать жалобу в U.S. Department of Health and Human Services, Office for Civil Rights (Управление по гражданским правам), в электронном виде через Office for Civil Rights Complaint Portal, доступный по ссылке: по почте или по телефону: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) العربية (Arabic) ملحوظة: إذا كنت تتحدث اذكر اللغة، فإن خدمات المساعدة اللغوية تتوافر لك بالمجان. اتصل برقم .1-877-696-6775 تلتزم HHS) Department of Health and Human Services, وزارة الخدمات الصحية والبشرية) بقوانين الحقوق المدنية الفدرالية المعمول بها ولا تميز على أساس العرق أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.",1
"لا تستبعد HHS الأشخاص أو تعاملهم على نحو مختلف بسبب النوع أو اللون أو الأصل الوطني أو السن أو الإعاقة أو نوع الجنس.. :HHS - توفر مساعدات وخدمات مجانية للأشخاص من ذوي الإعاقات للتواصل بصورة فعالة معنا، مثل: - مترجمي لغة إشارة مؤهلين - معلومات كتابية بتنسيقات أخرى (مطبوعة بأحرف كبيرة، مواد صوتية، تنسيقات إلكترونية متيسرة، وغير ذلك من التنسيقات) - توفر خدمات لغوية مجانية للأشخاص الذين لغتهم الأساسية ليست الإنجليزية، مثل: - مترجمين مؤهلين - معلومات مكتوبة بلغات أخرى إذا كنت بحاجة لهذه الخدمات، اتصل بـ HHS على الرقم .1-877-696-6775 إذا كنت تعتقد أن HHS قد أخفقت في توفير تلك الخدمات أو أنها قد ميزت بطريقة أخرى على أساس العرق أو اللون أو الأصل Department of Health and Human Services، مكتب Office for Civil Rights (مكتب الحقوق المدنية)، من خلال مكتب Office for Civil Rights Complaint Portal، المتوفر على الرابط أو بالبريد أو الهاتف على: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (رقم هاتف الصم والبكم) Kreyòl Ayisyen (Haitian Creole) ATANSYON: Si w pale Kreyòl Ayisyen, gen sèvis èd pou lang ki disponib gratis pou ou. Rele 1-877-696-6775. U.S. Department of Health and Human Services, (HHS, Ministè Sèvis Sante ak Imen Ameriken) konfòm ak lwa sou dwa sivil Federal ki aplikab yo e li pa fè diskriminasyon sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks. HHS pa ekskli moun oswa trete yo nan fason ki diferan akoz ras, koulè, peyi orijin, laj, enfimite oswa sèks yo.",1
"HHS: - Bay èd ak sèvis gratis pou moun ki andikape pou yo kominike avèk nou nan fason ki efikas, tankou: - Enèprèt langaj siy ki kalifye - Enfòmasyon ekri nan lòt fòma (gwo lèt, odyo, fòma elektwonik ki aksesib, lòt fòma) - Bay sèvis lang gratis a moun lang prensipal yo pa Anglè, tankou: - Enèprèt kalifye - Enfòmasyon ki ekri nan lòt lang Si w bezwen sèvis sa yo, kontakte HHS nan 1-877-696-6775. Si w kwè HHS pa t bay sèvis sa yo oswa te fè diskriminasyon nan yon lòt fason sou baz ras, koulè, peyi orijin, laj, enfimite oswa sèks, ou ka depoze yon plent nan: U.S. Department of Health and Human Services, Office for Civil Rights (Biwo Dwa Sivil) atravè Office for Civil Rights Portal, pa mwayen elektwonik ki disponib nan oswa pa lapòs oswa: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Français (French) ATTENTION: Si vous parlez français, des services d’aide linguistique vous sont proposés gratuitement. Appelez le 1-877-696-6775. L’U.S. Department of Health and Human Services (HHS, Département de la Santé et des Services Sociaux des États-Unis) respecte les lois fédérales en vigueur relatives aux droits civiques et ne pratique aucune discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou un handicap.",1
"HHS n’exclut et ne traite aucune personne différemment en raison de sa race, sa couleur de peau, son origine nationale, son âge, son sexe ou son handicap. HHS: - Fournit gratuitement des aides et services aux personnes handicapées afin de permettre une communication efficace avec nous, par exemple: - Interprètes qualifiés en langue des signes - Informations écrites dans d’autres formats (gros caractères, audio, formats électroniques accessibles, autres formats) - Fournit gratuitement des services linguistiques aux personnes dont la langue principale n’est pas l’anglais, par exemple: - Interprètes qualifiés - Informations écrites dans d’autres langues Si vous avez besoin de ces services, contactez HHS au 1-877-696-6775. Si vous pensez que HHS n’a pas fourni ces services ou a fait preuve d’une autre forme de discrimination basée sur la race, la couleur de peau, l’origine nationale, l’âge, le sexe ou le handicap, vous pouvez déposer une réclamation auprès de l’U.S. Department of Health and Human Services, l’Office for Civil Rights (Bureau des Droits Civiques), par voie électronique via l’Office for Civil Rights Complaint Portal, disponible à l’adresse par courrier ou par téléphone à: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Polski (Polish) UWAGA: Jeżeli mówisz po polsku, możesz skorzystać z bezpłatnej pomocy językowej. Zadzwoń pod numer 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Departament Zdrowia i Opieki Społecznej Stanów Zjednoczonych) postępuje zgodnie z obowiązującymi federalnymi prawami obywatelskimi i nie dopuszcza się dyskryminacji ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS nie wyklucza żadnych osób i nie stosuje różnego traktowania ze względu na rasę, kolor skóry, pochodzenie, wiek, niepełnosprawność bądź płeć. HHS: - Zapewnia bezpłatną pomoc i usługi osobom niepełnosprawnym w celu umożliwienia skutecznej komunikacji, na przykład: - Wykwalifikowanych tłumaczy języka migowego - Informacje na piśmie w różnych formatach (duży druk, audio, dostępne formaty elektroniczne, inne formaty) - Zapewnia bezpłatne usługi językowe dla osób, dla których angielski nie jest pierwszym językiem, na przykład: - Wykwalifikowanych tłumaczy - Informacje na piśmie w innych językach Jeżeli chcesz skorzystać z tych usług, skontaktuj się z HHS pod numerem 1-877-696-6775.",1
"Jeżeli uważasz, że HHS nie świadczy tych usług lub w inny sposób dopuszcza się dyskryminacji ze względu na rasę, koloru skóry, pochodzenie, wiek, niepełnosprawność bądź płeć, możesz złożyć skargę do: U.S. Department of Health and Human Services, Office for Civil Rights (Biuro Praw Obywatelskich), drogą elektroniczną za pośrednictwem Office for Civil Rights Complaint Portal na stronie pocztą tradycyjną lub dzwoniąc pod numer telefonu: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Português (Portuguese) O U.S. Department of Health and Human Services (HHS, Departamento de Saúde e dos Serviços Humanos dos Estados Unidos da América) cumpre as leis de direitos civis federais aplicáveis e não exerce discriminação com base na raça, cor, nacionalidade, idade, deficiência ou sexo. HHS não exclui ou trata de forma diferente devido à raça, cor, nacionalidade, idade, deficiência ou sexo.",1
"HHS: - Faculta ajuda e serviços gratuitos a pessoas com dificuldades de comunicar de forma eficaz connosco, tais como: - Intérpretes de língua gestual qualificados - Informação escrita noutros formatos (impressão maior, áudio, formatos electrónicos acessíveis, outros formatos) - Faculta serviços linguísticas grátis a pessoas cuja língua principal não é inglês, tais como: - Intérpretes qualificados - Informação escrita noutros idiomas Se necessita destes serviços, contacte HHS através do número 1-877-696-6775. Se considera que a HHS não cumpriu estes serviços ou exerceu discriminação de outra forma com base na raça, cor, nacionalidade, idade, deficiência ou sexo, pode apresentar uma reclamação junto de: U.S. Department of Health and Human Services, Office for Civil Rights (Gabinete de Direitos Civis), por via electrónica através do Office for Civil Rights Complaint Portal, disponível em ou por correio ou telefone: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Italiano (Italian) ATTENZIONE: In caso la lingua parlata sia l’italiano, sono disponibili servizi di assistenza linguistica gratuiti. Chiamare il numero 1-877-696-6775.",1
"U.S. Department of Health and Human Services (HHS, Dipartimento statunitense per la salute e i servizi umani) è conforme a tutte le leggi federali vigenti in materia di diritti civili e non pone in essere discriminazioni sulla base di razza, colore, origine nazionale, età, disabilità o sesso. HHS non esclude le persone o le tratta diversamente a causa di razza, colore, origine nazionale, età, disabilità o sesso. HHS: - Offre sostegni e servizi gratuiti alle persone affette da disabilità per comunicare con noi in modo efficace, quali: - Interpreti qualificati nella lingua dei segni - Informazioni scritte in altri formati (stampe a grandi caratteri, audio, formati elettronici accessibili, altri formati) - Offre servizi linguistici gratuiti alle persone la cui lingua primaria non è l’inglese, quali: - Interpreti qualificati - Informazioni scritte in altre lingue In caso si necessiti di tali servizi, contattare HHS al numero 1-877-696-6775.",1
"In caso si ritenga che HHS non abbia offerto tali servizi o abbia posto in essere discriminazioni in altri modi sulla base di razza, colore, origine nazionale, età, disabilità o sesso, è possibile presentare una vertenza a: U.S. Department of Health and Human, Office for Civil Rights (Ufficio per i diritti civili), elettronicamente mediante l’Office for Civil Rights Complaint Portal, disponibile all’indirizzo oppure a mezzo posta o telefono all’attenzione di: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Deutsch (German) ACHTUNG: Wenn Sie Deutsch sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen zur Verfügung. Rufnummer: 1-877-696-6775. Das Department of Health and Human Services (HHS, U.S.-Gesundheitsministerium) erfüllt geltenden bundesstaatliche Menschenrechtsgesetze und lehnt jegliche Diskriminierung aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. lehnt den Ausschluss oder die unterschiedliche Behandlung von Menschen aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht ab. HHS: - Bietet kostenlose Hilfe und Dienstleistungen für Menschen mit Behinderung zur effektiven Kommunikation, wie z.",1
"B.: - Qualifizierte Gebärdensprachen-Dolmetscher - Schriftliche Informationen in anderen Formaten (große Ausdrucke, Audio, zugängliche elektronische Formate, sonstige Formate) - Bietet kostenlose Sprachdienste für Menschen, deren Hauptsprache nicht Englisch ist, wie z. B.: - Qualifizierte Dolmetscher - Schriftliche Informationen in anderen Sprachen Sollten Sie diese Dienstleistungen benötigen, so wenden Sie sich an das HHS unter 1-877-696-6775.",1
"Sollten Sie der Ansicht sein, dass HHS es versäumte, diese Dienstleistungen anzubieten, oder auf sonstige Weise aufgrund von Rasse, Hautfarbe, Herkunft, Alter, Behinderung oder Geschlecht diskriminierte, so können Sie eine Beschwerde einreichen bei: Department of Health and Human Services, Office for Civil Rights (Amt für Bürgerrechte), elektronisch über das Office for Civil Rights Complaint Portal, zugänglich über oder per Post oder telefonisch an: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) 日本語 (Japanese) 注意事項：日本語を話される場合、無料の言語支援をご利用いただけます。1-877-696-6775 まで、お電話にてご連絡ください。 U.S. Department of Health and Human Services（HHS、保健社会福祉省）は適用される連邦公民権法を遵守し、人種、肌の色、出身国、年齢、障害、または性別に基づく差別をいたしません。HHS は人種、肌の色、出身国、年齢、障害、または性別を理由として人を排除したり、異なる扱いをいたしません。 HHS: - 効果的にコミュニケーションを図るため、障害のある人に以下の支援やサポートを無料で提供いたします。 - 資格ある手話通訳者 - その他形式の文字情報（大きな活字、音声信号、手軽な電子形式、その他） - 英語を母語としない人へ以下の言語サービスを無料で提供いたします。 - 資格ある通訳者 - 英語以外の言語で書かれた情報 これらのサービスを必要とされる場合は、HHS（1-877-696-6775）までご連絡ください。 HHS がこれらのサービスの提供を怠ったり、人種、肌の色、出身国、年齢、障害、または性別に基づいた何らかの方法で差別したと思われる場合、こちらまで苦情を申し立てることができます。また、公民権に関する苦情は、U.S.",1
"Department of Health and Human ServicesのOffice for Civil Rights（公民権局）へ、Office for Civil Rights Complaint Portal から電子申請するか、以下へ郵便または電話で申し立てることもできます： U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) فارسی (Farsi) توجه: اگر به زبان فارسی گفتگو می کنید، تسهیلات زبانی بصورت رایگان برای شما فراهم می باشد. با .1-877-696-6775 تماس بگیرید HHS) U.S. Department of Health and Human Services, وزارت بهداشت و خدمات انسانی آمریکا) از قوانین حقوق مدنی فدرال مربوطه تبعیت می کند و هیچگونه تبعیضی بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد قایل نمی شود. HHS بر اساس نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت افراد ایشان را از خدمات محروم نمی کند و با آنها برخورد متفاوتی ندارد.",1
":HHS - برای افرادی که ناتوانی دارند، برای برقرار کردن ارتباط موثر، کمک هایی بطور رایگان فراهم می کند، مانند: - مترجمین واجد شرایط زبان اشاره - اطلاعات نوشتاری به فرمت های دیگر (چاپ با حروف درشت، صوتی، فرمت های الکترونیک قابل دسترسی ساده، و فرمت های دیگر) - برای افرادی که زبان اولیه شان انگلیسی نیست خدمات زبانی رایگان ارایه می کند، مانند: - مترجمین شفاهی واجد شرایط - اطلاعات نوشتاری به زبانهای دیگر اگر به چنین خدماتی نیاز دارید، با HHS به 1-877-696-6775 تماس بگیرید اگر معتقدید که HHS چنین خدماتی را به شما ارایه نداده و یا اینکه به شکلی دیگر به دلیل نژاد، رنگ پوست، اصلیت ملیتی، سن، ناتوانی یا جنسیت درمورد شما تبعیض قایل شده می توانید شکواییه ای به این آدرس ثبت کنید: اگر احساس می کنید که HHS این خدمات را به شما ارایه نکرده و یا به هر شکلی بدلیل نژاد، رنگ پوست، اصلیت ملی، سن، معلولیت یا جنسیت شما را مورد تبعیض قرار داده، می توانید نزد U.S. Department of Health and Human Services، Office for Civil Rights (اداره حمایت از حقوق مدنی)، شکواییه خود را ثبت نمایید. دسترسی الکترونیکی به این اداره از طریق Office for Civil Rights Complaint Portal به آدرس یا تماس از طریق ایمیل یا تلفن با آدرس زیر میسر است: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) English ATTENTION: If you do not speak English, language assistance services are available to you free of charge.",1
"Call 1-800-232-4636 Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The CDC nondiscrimination notice lists the services available to you and how to file a complaint if you feel that CDC has failed to provide these services or discriminated in another way.",1
"What to know The Office of Equal Employment Opportunity (OEEO) is closed as part of HHS’s Reduction in Force, in accordance with President Donald Trump’s Executive Order 14210, dated February 11, 2025, and the Department of Health and Human Services’ (HHS) broader reorganization strategy to improve its efficiency and effectiveness to make America healthier. For additional information on the Federal sector EEO process, please visit the U.S. Equal Employment Opportunity Commission (EEOC) website at www.eeoc.gov. Our mission OEEO's mission is to end employment discrimination and promote equal employment opportunity in the workplace. Vision To be a model EEO program that protects rights and serves all CDC staff. Values CDC/Agency for Toxic Substances and Disease Registry (ATSDR) are committed to a policy of nondiscrimination in all personnel practices. This ensures equal opportunity for employment, promotion, and training for all segments of the workforce. Priorities OEEO is committed to protecting the rights and providing applicants, employees, and the agency with essential information under Equal Employment Opportunity (EEO) federal statutes, policies, regulations, and guidance. Goals OEEO is a critical partner in achieving CDC and ATSDR’s public health goals.",1
"Federal law protects you from being discriminated on the following bases: - Race or color - Religion - Sex and pregnancy - Age (40 or older) - Disability - National origin - Retaliation - Genetics Our office supports the agency’s responsibility of maintaining a model Equal Employment Opportunity (EEO) program. Equal Employment Opportunity Commission (EEOC) guidelines states that model EEO programs address concerns under Title VII and Section 501 of the Rehabilitation Act. The six essential elements for a model EEO program, as outlined in the EEO Management Directive 715 are as follows: - Demonstrated commitment from agency leadership - Integration of EEO into the agency’s strategic mission - Management and program accountability - Proactive prevention of unlawful discrimination - Efficiency - Responsiveness and legal compliance If you have any questions, please contact us at 770-488-3210. Our work OEEO leads efforts to track and report on objectives, strategies, and actions aligned with U.S. EEOC mandates. This ensures the agency's progress toward establishing a model EEO program. The Affirmative Employment Program (AEP) Team supports CDC/ATSDR's goal of maintaining a workforce that represents the communities that we serve. The AEP is an integral part of CDC's EEO program. The Alternative Dispute Resolution (ADR) Team is committed to preventing and managing disruptive workplace conflict. They provide efficient and effective services to CDC/ATADR employees.",1
"The EEO Complaints and Adjudication Team strives to handle all allegations of discrimination with great care. CDC recognizes and values our employees and staff and takes pride in being a safe and healthy place to work. The Reasonable Accommodation (RA) Team at CDC is committed to accommodating and ensuring the safety of persons with disabilities as mandated by the Rehabilition Act of 1973 and The Americans with Disabilities Act of 1990, As Amended.",1
"Featured Topics H5 Bird Flu: Current Situation Hand Hygiene as a Family Activity Living with Diabetes How to Prevent Norovirus About Dementia Risk Factors for PneumoniaA to Z News All News - OCT 31Salmonella outbreak linked to moringa leaf, an ingredient in powdered supplements - OCT 30CDC continues to note illnesses despite product recalls and asks consumers to check for recalled foods in Listeria outbreak linked to prepared meals - OCT 06CDC Immunization Schedule Adopts Individual-Based Decision-Making for COVID-19 and Standalone Vaccination for Chickenpox in Toddlers - SEP 30Statement from Laura Chanchien Parajón, MD, MPH, Director (Acting), CDC's National Center for Chronic Disease Prevention and Health Promotion, on the passing of Suzy Ellis, Tips From Former Smokers® participant - SEP 26Listeria Outbreak to include more Prepared Foods Scientific Journals Science at CDC To make science and data easier for broad audiences to interpret, CDC is translating science into practical, easy to understand policy by clarifying and presenting scientific language so that anyone can understand it and standardizing guideline development across the agency.",1
"Measles deaths down 88% since 2000, but cases surge WHO issues first global guideline on infertility Lifetime toll: 840 million women faced partner or sexual violence More countries report rising levels of drug-resistant gonorrhoea, warns WHO World AIDS Day 2025 – Overcoming disruption, transforming the AIDS response 7th Meeting of the Montreux Collaborative on fiscal space, public financial management and health financing Fourth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement WHO EPI-WIN webinar: UNiTE to end digital violence: why digital safety is a gender and public health imperative in emergencies World AIDS Day 2025: Geneva commemoration event",1
"An official website of the United States government Here’s how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock () or means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Know Your Blood Pressure Numbers High blood pressure is a risk for heart disease. Knowing your numbers is the first step to controlling it. The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives. Featured Resources & Initiatives Image Explore NIH’s groundbreaking initiatives and programs that are advancing biomedical research, accelerating scientific discovery, and improving health for all Americans.",1
"Transforming your care Healing starts here The right answers the first time Effective treatment depends on getting the right diagnosis. Our experts diagnose and treat the toughest medical challenges. The world's best hospital Mayo Clinic is the No. 1 hospital in the world according to Newsweek. Learn more about our top-ranked specialties. World-class care for global patients We make it easy for patients around the world to get care from Mayo Clinic. Locations Learn more about Mayo Clinic locations or choose a specific location. Phoenix & Scottsdale Jacksonville Rochester Iowa, Minnesota, Wisconsin London, United Kingdom Featured care areas We solve the world's most serious and complex medical challenges.",1
"Their Future, in Our Hands The latest edition of Hopkins Bloomberg Public Health features a special section on child health, examining urgent problems that threaten children’s well-being, and public health approaches and research that can help kids make their way toward a healthy adulthood. Our Academic Program Offerings Our programs welcome those from within and outside the traditional boundaries of public health. Whether you're a future college graduate, a midcareer public health leader, or someone looking to make a career change, we have a program for you. Master of Public Health (MPH) The Master of Public Health (MPH) is our most flexible degree. With 12 concentrations to choose from, students can tailor their degree to their unique goals while completing classes at their own pace on campus, fully online, or a mix of the two. Master of Science in Public Health (MSPH) The Master of Science in Public Health (MSPH) is a professional degree alternative to the Master of Public Health (MPH) degree for students who want more focused skills in a specific field of public health or who lack two years of health-related work experience to begin or advance a career as a public health professional. MSPH programs generally require one academic year of coursework, followed by a field placement. The field placement duration and location vary by department/concentration.",1
"Register Today for the Winter Institute Designed for busy working professionals and students, the Johns Hopkins Bloomberg School of Public Health Winter Institute allows you to complete credit or non-credit courses in a short period of time. JHU employees may benefit from tuition remission. Headlines Why Experts Have Concluded That Vaccines Do Not Cause Autism How a retracted study from the 1990s led to a persistent myth about vaccines. What Is SNAP? And Why Does It Matter? The Supplemental Nutrition Assistance Program, also known as food stamps, is the United States’ largest anti-hunger program and helps an average of 41.7 million Americans per month. Most of the Foods We Eat Are Ultra-Processed. Are They All Unhealthy? Ultra-processed foods are associated with a long, ever-expanding list of adverse health outcomes. But what exactly classifies as an ultra-processed food—and are they all unhealthy? How Public Health Can Thrive in a Hard Season The years ahead will test our mettle, but we will deliver for public health. Understanding the Evidence on Pregnancy, Tylenol, and Autism The research so far—including one of the largest studies yet on the topic—suggests that Tylenol use during pregnancy does not cause autism. For Better Health, Drink Less Alcohol Although alcohol use is declining in the U.S., drinking still poses an enormous threat to public health. For more on measles, check out these regularly updated resources from our Centers: U.S.",1
"Measles Tracker from the International Vaccine Access Center Measles Outbreak Response Strategies from the Center for Outbreak Response Innovation Their Future, in Our Hands A healthy childhood is essential for lifelong well-being, but urgent problems, like chronic absenteeism, the impact of digital devices on mental health, and exposures to environmental toxins, are threatening U.S. kids’ ability to thrive and flourish into adulthood. How public health approaches and research can help prevent, minimize, and solve these issues is the focus of the special section of the 2025 Fall/Winter issue of Hopkins Bloomberg Public Health, available online now. Research Saves Lives Without research—at Johns Hopkins and at thousands of other universities, medical schools, and research institutions across the nation—scientific breakthroughs suffer, and the lifesaving treatments of tomorrow are at risk. Subscribe to Stay Informed Meet Our Faculty Our faculty are world-renowned experts, and trusted advisers to our students, public health leaders, and the public. Randy Bryant, PhD, studied mechanistic enzymology and now trains future scientists and public health leaders in the classroom, teaching biochemistry, and mentoring students. Jaiprasath Sachithanandham, PhD, is a virologist who studies respiratory viruses like SARS-CoV-2 and H5N1, focusing on virus evolution and immune responses.",1
"Karen Shen, PhD, conducts health economics research on healthcare labor markets and financing policies impacting aging populations and people with mental health and substance use disorders. Roland J. Thorpe, Jr., PhD, MS, is a gerontologist and social epidemiologist with nationally-recognized expertise in minority aging, men’s health, and place-based disparities. Join Us in Baltimore Pursue a degree at the #1 school of public health in one of America's best cities. With 50+ museums, a bustling restaurant scene, gorgeous parks, and more, Baltimore is a great place to study and live. Why Choose the Johns Hopkins Bloomberg School of Public Health? #1 Ranked by U.S. News & World Report since 1994 1st and Largest School of Public Health 1,800+ Courses Offered 80+ Research Centers and Institutes 29K+ Alumni Living in over 115 Countries 90+ Degree Programs 46 Certificate Programs 3:1 Student-to-Primary-Faculty Ratio Support Our Work Our work is made possible in part by contributions from Bloomberg School donors.",1
"Faculty Directory Our faculty are world-renowned experts, and trusted advisers to our students, public health leaders, and the public. Meet Our Faculty We take pride in celebrating the richness of our diverse faculty community, recognizing that it enriches our academic environment and enhances our collective experiences. | Name | Title | Department | Overview | |---|---|---|---| | Mia Aassar | Research Associate | Health Policy and Management | - | | Rachy Abraham | Assistant Scientist | Biochemistry and Molecular Biology | - | | Rachel Adkinson | Research Associate | International Health | - | | Smisha Agarwal | Associate Professor | International Health | Smisha Agarwal, PhD, MPH ’09, MBA, studies how to improve maternal and newborn health in low-income settings by strengthening health systems and using technological solutions. | | Jacqueline Agnew | Professor - Emeritus | Environmental Health and Engineering | Jacqueline Agnew, PhD '92, seeks to better understand the relationship between workplace exposures, worker characteristics, and musculoskeletal disorders. | | Peter Agre | Professor | Molecular Microbiology and Immunology | Peter Agre, MD '74, emeritus leader of the Johns Hopkins Malaria Research Institute, is the 2003 Nobel Laureate in Chemistry for his discovery of aquaporin proteins.",1
"| | Rexford Ahima | Professor | Epidemiology | - | | Saifuddin Ahmed | Professor | Population, Family and Reproductive Health | Saifuddin Ahmed, MBBS, PhD ‘96, his research includes reproductive epidemiology, particularly maternal mortality estimation; program evaluation for family planning and MCH care. | | Jim Aizire | Associate Research Professor | Epidemiology | - | | Ellesse-Roselee Akré | Assistant Professor | Health Policy and Management | - | | Nadia Akseer | Associate Scientist | International Health | - | | Aveika Akum | Senior Research Associate | International Health | - | | Sandra Albornoz Marin | Research Associate | Environmental Health and Engineering | - | | Tanya Alderete | Associate Professor | Environmental Health and Engineering | Tanya L. Alderete, PhD, investigates the effects of environmental exposures on human health throughout the life course. Her work integrates clinical, epidemiological, and multiomics research. | | Caleb Alexander | Professor | Epidemiology | G. Caleb Alexander, MD, MS, is a practicing internist and epidemiologist focused on maximizing the use, safety, and effectiveness of prescription medicines.",1
"| | Tesfa Alexander | Associate Practice Professor | Health Policy and Management | - | | Daniel Ali | Assistant Scientist | International Health | - | | Joseph Ali | Associate Professor | International Health | Joseph Ali, JD, studies how to conduct global public health research and practice that maximally respects ethical values in an increasingly interconnected digital world. | | Dana Alkhoury | Research Associate | Health Policy and Management | Dana Alkhoury, MPH ‘11, is dedicated to advancing medical knowledge and improving health outcomes through rigorous research and effective implementation strategies. | | Lauren Allen | Assistant Scientist | Health Policy and Management | Lauren Allen, DrPH ’21, specializes in clinical research administration in the domains of policy setting and implementation, management of multi-institutional research, and knowledge dissemination. |",1
"Master's Degrees A master's degree from the Bloomberg School catalyzes the powers of education, science, partnerships, people, and advocacy. We offer nine different master’s degree programs to train you to become the next public health leader. Master of Public Health (MPH) The Master of Public Health is a flexible school-wide degree program offering full-time and part-time options, in-person or online. The rigorous curriculum prepares students to become leading public health professionals capable of addressing current global health problems with multidisciplinary, evidence-based approaches. Master of Science in Public Health (MSPH) The Master of Science in Public Health (MSPH) is a professional degree alternative to the Master of Public Health (MPH) degree for students who want more focused skills in a specific field of public health or who lack two years of health related work experience in order to begin or advance a career as a public health professional. Master of Applied Science (MAS) The Master of Applied Science programs are fully online, part-time degrees that will prepare public health practitioners, researchers, and policymakers to address complex public health challenges. The hands on training in these online degree programs are valuable to both an established career and to those who have recently entered the workforce.",1
"- Patient Safety and Healthcare Quality - Population Health Management - Spatial Analysis for Public Health Master of Health Science (MHS) The Bloomberg School offers the Master of Health Science (MHS) degree program in every department. Through in-depth study and research in a particular public health discipline, the MHS prepares students for further graduate work or research careers. At a minimum, the MHS degree programs require four terms of full-time coursework, a written culmination such as a thesis, essay or other written exercise, and an oral presentation. Master of Science (ScM) Master of Science (ScM) students at the Bloomberg School are generally interested in hands-on experiences leading to prominent careers in public health research. At a minimum, the ScM degree programs require four terms of full-time coursework, a written culmination such as a thesis, essay or other written exercise, and an oral presentation. Master of Arts in Public Health Biology (MAPHB) The Master of Arts is a fully online, part-time degree program. This innovative, interdisciplinary program focuses on biological tenets and research methods that are relevant to current issues in public health. The MA degree integrates major strengths of the School, providing unmatched opportunities for advanced training to prepare students to observe, understand and address public health problems from a multidisciplinary perspective.",1
"Master of Bioethics (MBE) The Master of Bioethics degree is a collaborative program of the Johns Hopkins Berman Institute of Bioethics and the Johns Hopkins Bloomberg School of Public Health. The goal of the MBE program is to prepare students from diverse individual and professional backgrounds for the bioethics challenges of professional and civic life. Master of Health Administration (MHA) This accelerated program is ranked in the top ten of graduate programs in health administration by U.S. News and World Report and provides a rigorous and comprehensive academic experience with a career-building residency. The curriculum includes a wide variety of courses and opportunities to study current economic, social, technical and marketplace issues that are directly influencing the health sector today. Master of Science in Toxicology for Human Risk Assessment (MS) The Master of Science (MS) in Toxicology for Human Risk Assessment is the only program of its kind in the United States. Our innovative masters program equips graduates with the knowledge and skills needed to begin or advance their career as professionals in the evolving field of human health and environmental risk assessment.",1
"Population, Family and Reproductive Health Our mission is to optimize the health and well-being of individuals, families, and populations across the life course through public health science, teaching and practice locally, nationally, and globally. Population, Family and Reproductive Health Headlines Student Spotlight: Pratik Prashant Neve Volunteering as a data collector for a serological survey during the COVID-19 pandemic ignited Pratik's passion for public health. What Is SNAP? And Why Does It Matter? The Supplemental Nutrition Assistance Program, also known as food stamps, is the United States’ largest anti-hunger program and helps an average of 41.7 million Americans per month. For Adult Well-Being, Address Childhood Trauma Helping children and adolescents cope with adverse experiences can prevent them from defining the future. Research Saves Lives Population, Family, and Reproductive Health plays a vital role in safeguarding the well-being of individuals, families and communities. Faculty, staff and trainees at the Bloomberg School and at research institutions across the U.S. identify the root causes of maternal and infant mortality, improve access to family planning, and enhance systems of care. Our efforts contribute to safer pregnancies, healthier families, and stronger communities, where informed healthcare strategies can mean the difference between life and death. What’s Next for Family Planning?",1
"Reeling from aid cuts, the sexual and reproductive health community comes together to make its way forward. Frontline Research, Real Progress From job sites to city streets, courtrooms to EHRs, five stories show public health’s reach and impact. Research Helps Survivors of Intimate Partner Violence Get Support They Need Backed by federal funding, public health researcher Michele Decker, ScD, MPH, works to understand the scope and impact of gender-based violence and to determine how to prevent it. What We Do in the Department of Population, Family and Reproductive Health The Department of Population, Family and Reproductive Health is dedicated to improving health throughout the life course worldwide. We train research scientists, public health leaders, and health professionals to excel in careers related to a broad spectrum of population, family, and reproductive health issues.",1
"Population, Family and Reproductive Health Highlights Alumni Network 1,000+ alumni living in 50+ countries Research and Practice 11 centers and initiatives enhance your education MCH Center of Excellence Recipient of Maternal and Child Health grants from HHS/HRSA for 70 years Unique Field Opportunities Students have recently worked with UNICEF, the Bureau of Maternal and Child Health, International Health Research Institute, and WIC Population, Family and Reproductive Health Programs Master of Science in Public Health (MSPH) The MSPH enables students to integrate coursework in the life course framework, PFRH areas of interest, policy, program management, and leadership with practical knowledge and skills. Master of Health Science (MHS) The MHS provides training in the life course framework, PFRH areas of interest statistics, and research and evaluation methods. Bachelor's / Master of Science in Public Health (MSPH) The Bachelor's/MSPH is designed exclusively for undergraduate students currently enrolled at Johns Hopkins University (JHU). Doctor of Philosophy (PhD) The emphasis of the PhD program is to apply coursework in life course theory, population, and core PFRH areas of interest through mentored, original, investigator-initiated research. Centers and Institutes in the Department of Population, Family and Reproductive Health PFRH is home to eleven research centers and initiatives that provide unrivaled hands-on experience with industry leaders domestically and globally.",1
"Center for Adolescent Health Center on the Early Life Origins of Disease Center of Excellence in Maternal and Child Health Johns Hopkins Center for Global Women’s Health and Gender Equity Child and Adolescent Health Measurement Initiative (CAHMI) Early Childhood Services Research Program William H. Gates Sr. Institute for Population and Reproductive Health Global Early Adolescent Study Hopkins Population Center STRONG Research Program Women, Infants and Children Program (WIC) Kay O'Neill, MSPH Kay O'Neill, MSPH ’11, translates research findings into program practice, strengthening outcomes of programs that support vulnerable families. Support Our Department This work is made possible in part by contributions to from generous donors.",1
"Inclusion, Diversity, Anti-Racism, and Equity (IDARE) The School’s Strategic Plan prioritizes the cultivation of a diverse, inclusive, and nurturing environment for students, faculty, staff, and the community. This means striving to be an institution where all people, including those who are historically marginalized, disenfranchised, or excluded, can thrive. But meaningful change and impact necessitates bold action and investments. Our schoolwide Inclusion, Diversity, Anti-Racism, and Equity Action Plan identifies strategies for creating an anti-racist environment where we fuel our creativity and excellence by cultivating a more equitable, inclusive, and socially just community. This strategy acknowledges the importance of: - Being a model for IDARE among schools of public health; - Committing ALL of us to actively work towards IDARE and not solely relying on members of our Black community, Indigenous Peoples, and people of color; - Ensuring adequate resources for advancing IDARE; - Integrating IDARE as a fundamental thread throughout the work of our School. These priorities are only the beginning of our journey to advance systemic, structural, and cultural change. We ask every member of our community to embrace these priorities and contribute to our efforts in support of IDARE.",1
"The Office of IDARE The Office of Inclusion, Diversity, Anti-Racism, and Equity (IDARE) supports efforts to dismantle structural oppression and racist policies and practices within the Bloomberg School, our community, and public health. Visit the IDARE Office to find additional information such as: - Our School's land acknowledgement - Recent IDARE messages - IDARE-related resources - Ongoing IDARE initiatives - Contact information Department-Specific Efforts Our academic departments conduct a variety of IDARE-related activities. Visit the departments to learn more.",1
"Why Experts Have Concluded That Vaccines Do Not Cause Autism How a retracted study from the 1990s undermined trust in vaccines and led to a persistent myth. In 1971, the FDA approved the measles-mumps-rubella (MMR) vaccine, which combined three vaccines that had been approved previously—in 1963, 1967, and 1969, respectively. The vaccine has proven safe and effective and has been widely administered around the world for decades. But in 1998, a paper describing 12 children who received the MMR and later developed autism or other disorders planted seeds of doubt about the vaccine’s safety. The paper was later retracted, and several large studies have since shown no association between vaccines and autism, but the idea persists among some groups that vaccines cause autism. In the March 14 episode of Public Health On Call, vaccinologist Daniel Salmon, PhD ’03, MPH, director of the Johns Hopkins Institute for Vaccine Safety, spoke with Josh Sharfstein, MD, about how this idea took hold and why it’s been so hard to dispel. This Q&A is adapted from that conversation. When did you start seeing concerns about vaccines and autism as a side effect of vaccines? The issue was first raised by an article published by Andrew Wakefield in 1998. He was a GI doctor at the Royal Free Hospital in London, a very well-known hospital, and he published a paper in The Lancet, a prestigious journal.",1
"He looked at 12 children, eight of whom the parents reported developing autism after getting the MMR vaccine. The study was described as a consecutive case series—but it wasn’t even really that, because there was no control group or control period. But even a case series can’t tell you whether one thing causes another thing. It is simply a description. But once that paper was published, Wakefield got a lot of press and told people that he had shown vaccines had caused autism, which again, that study couldn’t even do. The paper was ultimately retracted. Within a short amount of time, several of the authors pulled their names. There were lots of problems later found with what was published. For example, the cases were not consecutive [i.e., they did not include all of the children studied]. They were cherry-picked cases. And we know that, given that the age when children receive the MMR is also the age when some children regress into autism, there will be a temporal relationship; by chance alone, some children would develop autism after vaccination. So, from a scientific perspective, the paper didn’t show much. But you had a very well-credentialed, very charismatic person coming from an outstanding institution publishing this paper in a very prestigious journal, and he really ran with it. Do you think it was just Dr. Wakefield himself that made people think vaccines cause autism, or were there other factors?",1
"I think autism was ripe for vaccine safety controversies for a few reasons: It becomes apparent to the parent early in childhood, around when we give a lot of vaccines. Autism seems to be increasing in incidence or prevalence, so there’s more of it out there. And we don’t fully understand what causes it. So, you have a lot of parents who are watching their children develop normally and then regress into autism. And they want to know why. In addition, you had autism advocacy groups, where parents came together looking for answers and looking for support for their children. So, you have parents thinking, what happened? What caused this? And then they think, my child had just gotten vaccinated. And then they talk with other parents of autistic children who say, wow, my child just got vaccinated, too. Parents are looking for answers, understandably. And so the issue was very ripe for it to be associated with vaccines—not by cause and effect, but by timing and temporality. What research was done to look into this perceived link? The attention this question got led to a number of large epidemiological studies that looked at kids who were vaccinated with the MMR vaccine and those who weren’t, so there were control groups. And those studies found no association between the MMR vaccine and autism.",1
"Once it started to become clear that the MMR vaccine was not associated with autism, the hypothesis shifted from the MMR vaccine [as a cause of autism] to thimerosal, which at the time was used as a preservative in some childhood vaccines. Thimerosal was never used in the MMR vaccine, but it was used as a preservative in multidose vials of other vaccines. That led to a number of large studies looking at thimerosal in vaccines and autism, and those studies also found no relationship. Then the hypothesis shifted again to the number of vaccines given at one time, so there were studies of that, which also found no relationship between vaccines and autism. At this point, we have 16 well-conducted, large population-based studies, carefully designed, done by different investigators in different countries, using different but strong methods. And all have found no relationship between MMR vaccine, thimerosal in vaccines, or the number of vaccines given and autism. The evidence is compelling. Why do you think this theory has persisted despite the research showing there is no relationship between vaccines and autism? It’s a complicated question. There’s not a single, simple answer to that. I’m not an autism researcher, but my understanding is that we’ve identified some causes for autism, but there are still a lot of causes we haven’t identified. So the question of what causes autism spectrum disorder is still out there.",1
"Another part of the answer is that it took some time for those studies to be done—more than a year for the first study after the MMR vaccine hypothesis, and years in the case of the thimerosal hypothesis. It created a void, a vacuum of information in a time when about a quarter of the parents had already made up their minds that vaccines cause autism. I think if the science had been done sooner—understanding that good science takes time and effort—that would have helped. I also think if there’d been more trust in public health authorities and in those doing the science, it may have been received in a more impactful way. To be clear, when you say good science versus bad science, you’re talking about how the study is done. Correct. I’m talking about the rigor of the methods used in a study. Can you give an example of rigorous study versus a non-rigorous study? Something we often hear from people worried about vaccines is that we need to do a vaccinated/unvaccinated study. And intuitively, that makes a lot of sense. It seems rather straightforward. But in fact, it’s more complicated than that. Consider the example of what causes lung cancer. If you looked at lung cancer rates among people who drink alcohol, you would find that the rate is higher than it is for nondrinkers, and somebody might conclude that drinking alcohol causes lung cancer. But that’s not the case. The issue is that people who drink are more likely to smoke, and smoking causes lung cancer.",1
"So drinking would be a confounder, something that’s associated with the exposure and the outcome, but not a part of the causal pathway. And in the case of looking at vaccinated versus unvaccinated children, only about 2% of American children are completely unvaccinated. And that 2% is very, very different from the 98%. I received an email last week that said, why can’t you just look at Amish children [based on the misperception that Amish children are not vaccinated], and we can figure out whether vaccines cause autism and other health outcomes? Amish children are very, very different from other populations of children—in their lifestyle, in all sorts of environmental exposures, in what they eat, and, importantly, in terms of how they access and use medicine and health care. I’ve never studied autism among Amish children, but my guess is that even if autism rates were about the same, they’re probably much less likely to get diagnosed. Earlier I brought up the issue of confounding. You really have to adjust for confounding when you look at vaccine safety. These studies can be done, and they have been done. They’re just not easy to do. And sometimes it’s not intuitive. What do you think about the idea of doing more research on whether vaccines are linked to autism? I’m a scientist and I believe in the value of science. The science that has been done has shown that vaccines are very safe. They’re not perfectly safe; they do sometimes, very rarely cause adverse reactions.",1
"But when it comes to autism, the science has already largely been done. If you gave me a pot of money and said, let’s do more vaccine safety research, autism would not be high up on this list because the existing science is already quite compelling. More from the Bloomberg School - See latest headlines - Learn more about our departments:",1
"Departments The largest institution of its kind in the world, the Bloomberg School is home to 10 departments that offer faculty and students the flexibility to focus on a variety of public health disciplines. Biochemistry and Molecular Biology A founding department of the Bloomberg School, faculty and students conduct research to discover and characterize fundamental biological processes relevant to health and disease. Biostatistics The first academic department of statistical science in the world, faculty prepare students to be on the cutting edge of data analysis and evidence-based decision-making. Environmental Health and Engineering Faculty and students discover and apply new knowledge critical to understanding and mitigating the impact of the natural, built, and social environments on human health. Epidemiology The oldest department of epidemiology in the world, students gain proficiency in study design, measurement, and inference to prevent and control disease in human populations. Health, Behavior and Society Faculty and students study the optimal ways to change human behavior to impact public health—from social policy and social environment to individual behavior change. Health Policy and Management Faculty empower tomorrow’s public health leaders, inspiring them to embrace today’s challenges to create change in fields like government and health care management.",1
"International Health As global leaders in health research and program implementation, faculty and students focus on saving lives in the most underserved populations around the world. Mental Health In the only department dedicated to mental health in a school of public health, faculty and students advance understanding and prevention of mental and behavioral disorders. Molecular Microbiology and Immunology Faculty and students focus on understanding basic biological processes underlying the major infectious diseases affecting public health, including malaria, tuberculosis, and AIDS. Population, Family and Reproductive Health Grounded in a life course framework, faculty and students develop skills in areas like population sciences, biologic markers and behavioral science, program evaluation, and advocacy.",1
"Departmental Affiliations Randy Bryant, PhD, studied mechanistic enzymology and now trains future scientists and public health leaders in the classroom, teaching biochemistry, and mentoring students. Contact Info Research Interests Mechanistic enzymology Experiences & Accomplishments BS in Chemistry - University of Virginia PhD in Organic Chemistry - Penn State University Postdoctoral research - Department of Biochemistry, Stanford University Select Publications Grove, D.E., Anne, G., Hedayati, M.A., and Bryant, F.R. (2012) ""Stimulation of the Streptococcus pneumoniae RecA protein-promoted three-strand exchange reaction by the competence-specific SsbB protein"" Biochem. Biophys. Res. Comm. 424:40-44. Steffen, S.E. and Bryant, F.R. (2012) ""Altered nucleotide cofactor-dependent properties of the mutant [S240K]RecA protein"" Biochem. Biophys. Res. Comm. 421:527-531. Salerno, B., Anne, G., and Bryant, F.R. (2011) ""DNA binding compatibility of the Streptococcus pneumoniae SsbA and SsbB proteins"" PLoS ONE 6(9):e24305. Grove, D.E., and Bryant, F.R. (2006) ""Effect of Mg(2+) on the DNA binding modes of the Streptococcus pneumoniae SsbA and SsbB Proteins"" J. Biol.Chem.281:2087-2094. Grove, D.E., Willcox, S., Griffith, J.D., and Bryant, F.R. (2005) ""Differential single-stranded DNA binding properties of the paralogous SsbA and SsbB proteins from Streptococcus pneumoniae"" J. Biol. Chem. 280:11067-11073.",1
"For Better Health, Drink Less Alcohol Although alcohol use is declining in the U.S., drinking still poses an enormous threat to public health. Reducing cancer incidence, mortality, and morbidity; and identifying inequities in cancer burdens across populations Explore the latest public health research and insights about cancer. Although alcohol use is declining in the U.S., drinking still poses an enormous threat to public health. Looking for prominent public health experts in the field of cancer? They’re here at the Bloomberg School of Public Health. Ashi Weeraratna, PhD, studies how cancer cells move to distant sites and how changes in the normal cells around a tumor contribute to their movement, especially as we age. Elizabeth A. Platz, ScD, MPH, uses molecular epidemiology to understand the mechanisms of cancer incidence and progression to identify prevention and treatment strategies. Gypsyamber D’Souza, PhD '07, MS, MPH, researches infectious diseases and cancer prevention, focusing on translational epidemiology to answer patient and policy questions.",1
"Student Life Student life at the Bloomberg School is everything from working in a lab on top-notch research to enjoying the cultural diversity of Baltimore. Students enjoy a collegial environment both within and outside the walls of the school – taking advantage of both the expertise of the faculty and also the rich life experiences of their classmates. On a given day, students are taking classes, attending seminars, publishing papers, working in labs, participating in field work, volunteering with local nonprofits and enjoying the city of Baltimore. International Students The Bloomberg School welcomes its international students with open arms and takes pride in the diversity of the entire student body. The largest school of public health in the world, the Bloomberg School is currently home to more than 2,900 students from more than 80 countries who meet here in Baltimore to pursue their public health careers. Because there is such a strong international presence among students, the environment automatically fosters a sense of open learning, mutual respect and friendly collaboration. By joining culturally-themed student groups and other organizations outside the school, international students also tend to take full advantage of living in Baltimore. If you are an international student interested in applying to the Bloomberg School, be sure to review the information listed on the Admissions Office’s international students page.",1
"The Office of International Services also provides many resources – including visa information – for international students, faculty and staff at the Bloomberg School, the School of Nursing and the Johns Hopkins Hospital. Current and past students agree—life at the Bloomberg School is always exciting. Our building includes on campus dining, a private fitness center, a rooftop terrace, and expansive views of Baltimore. Learn about our housing, dining, transportation and fitness offerings.",1
"Careers The Bloomberg School offers industry-leading opportunities for rewarding careers in public health with the opportunity to contribute to protecting health and saving lives—millions at a time. Career Opportunities We invite you to browse our faculty and staff openings for opportunities across our School, as well as our Centers and Institutes. Resources for Current Students, Faculty, Staff, and Alumni Handshake is the university-wide service for students and alumni to access job and internship postings from tens of thousands of employers, connect with career services, and learn about recruiting events and job fairs. SMILE is the University platform for faculty and staff from all JHU schools and divisions to post paid campus internships as well as traditional student employment opportunities.",1
"About At the #1 ranked Johns Hopkins Bloomberg School of Public Health, we’re protecting health and saving lives—millions at a time. As the largest school of public health in the world, we offer unrivaled breadth and depth. The Bloomberg School works to keep millions around the world safe from illness and injury by pioneering new research, deploying knowledge in the field, and educating tomorrow’s public health leaders. Our 10 academic departments, 1,800+ faculty, and 80+ research centers provide a public health education like no other. As the first institution of its kind worldwide, we’re building on a rich history. Since 1916, our people have eradicated smallpox, made water safe to drink, uncovered the dangers of tobacco, and contained the spread of HIV. Epidemics, health equity, gun violence, and mental health are just some of the topics we’re tackling. As the recipient of more research grants than any other school of public health, we’re hard at work around the globe on the biggest public health challenges of our time. Meet Dean Pollack Porter Keshia M. Pollack Porter, PhD ’06, MPH, an internationally recognized health policy scholar, dynamic leader, and unwavering advocate for public health, became the 12th dean of the Bloomberg School on August 1, 2025. Our University and community offer rich opportunities for collaboration and impact. We’re one of nine divisions at Johns Hopkins.",1
"We share a campus and countless collaborations with the School of Medicine and School of Nursing—both leaders in their fields. Together, we’re deeply engaged with our home city of Baltimore. We believe strongly in our collective responsibility to meet the holistic health needs of all peoples and all communities. We are taking purposeful actions to ensure that the Bloomberg School is an organization that embodies its values and realizes the power of its people, creating an environment where we fuel our creativity and ensure excellence by cultivating a diverse, inclusive, and nurturing environment for students, faculty, and staff.",1
"ACADEMICS Academic Program Finder - Academic Program Finder - Master's Degrees - MSPH in Population, Family and Reproductive Health - Master of Applied Science (MAS) in Patient Safety and Healthcare Quality - Master of Applied Science (MAS) in Population Health Management - Master of Applied Science (MAS) in Spatial Analysis for Public Health - Master of Arts and Master of Science in Public Health (MA/MSPH) - Master of Arts in Public Health Biology (MAPHB) - Master of Bioethics (MBE) - Master of Health Administration (MHA) - Master of Health Science (MHS) - Department of Biochemistry and Molecular Biology - Master of Health Science (MHS) - Department of Epidemiology - Master of Health Science (MHS) - Department of Mental Health - Master of Health Science (MHS) - Department of Molecular Microbiology and Immunology - Master of Health Science (MHS) in Health Economics and Outcomes Research - Master of Health Science (MHS) in Health, Behavior and Society - Master of Health Science (MHS) - Master of Health Science - Department of Biostatistics - Master of Health Science - Department of Population, Family and Reproductive Health - Master of Health Science in Global Health Economics - Master of Public Health (MPH) - Master of Science (ScM) - Department of Biochemistry and Molecular Biology - Master of Science (ScM) - Department of Biostatistics - Master of Science (ScM) - Department of Epidemiology - Master of Science (ScM) - Department of Molecular Microbiology and Immunology - Master of Science (ScM) in Genetic Counseling - Master of Science in Public Health (MSPH) in Health Education and Health Communication - Master of Science in Public Health (MSPH) in Health Policy - Master of Science in Public Health - Department of International Health - Master of Science in Public Health (MSPH) in Global Disease Epidemiology and Control - Master of Science in Public Health (MSPH) in Health Systems - Master of Science in Public Health (MSPH) in Human Nutrition - Master of Science In Public Health (MSPH) In Human Nutrition – Dietitian - Master of Science in Public Health (MSPH) in Social and Behavioral Interventions - Doctoral Degrees - Doctor of Philosophy (PhD) - Department of Biochemistry and Molecular Biology - Doctor of Philosophy (PhD) - Department of Biostatistics - Doctor of Philosophy (PhD) - Department of Epidemiology - Doctor of Philosophy (PhD) - Department of Mental Health - Doctor of Philosophy (PhD) - Department of Molecular Microbiology and Immunology - Doctor of Philosophy (PhD) - Department of Population, Family and Reproductive Health - Doctor of Philosophy (PhD) in Clinical Investigation - Doctor of Philosophy (PhD) in Health Policy and Management - Doctor of Philosophy (PhD) in Social and Behavioral Sciences - Doctor of Philosophy - Department of International Health - JHU-Tsinghua Doctor of Public Health - Doctor of Public Health (DrPH) - Combined / Dual Degrees - Certificate Programs - Adolescent Health Certificate Program - Bioethics Certificate Program - Clinical Trials Certificate Program - Community- Based Public Health Certificate Program - Demographic Methods Certificate Program - Epidemiology for Public Health Professionals Certificate Program - Evaluation: International Health Programs Certificate Program - Frequently Asked Questions for Certificate Programs - Gender and Health Certificate Program - Gerontology Certificate Program - Global Digital Health Certificate Program - Global Health Certificate Program - Global Health Practice Certificate Program - Health Communication Certificate Program - Health Disparities and Health Inequality Certificate Program - Health Education Certificate Program - Health Finance and Management Certificate Program - Healthcare Epidemiology and Infection Prevention and Control Certificate Program - Humanitarian Health Certificate Program - Implementation Science and Research Practice Certificate Program - Injury and Violence Prevention Certificate Program - Leadership for Public Health and Healthcare Certificate Program - Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) Public Health Certificate Program - Maternal and Child Health Certificate Program - Mental Health Policy, Economics and Services Certificate Program - Non-Degree Students General Admissions Info - Pharmacoepidemiology and Drug Safety Certificate Program - Population Health Management Certificate Program - Population and Health Certificate Program - Public Health Advocacy Certificate Program - Public Health Economics Certificate Program - Public Health Informatics Certificate Program - Public Health Training Certificate for American Indian Health Professionals - Public Health, Human Rights, and the Law Certificate Program - Public Mental Health Research Certificate Program - Quality, Patient Safety and Outcomes Research Certificate Program - Requirements for Successful Completion of a Certificate Program - Rigor, Reproducibility, and Responsibility in Scientific Practice Certificate Program - Risk Sciences and Public Policy Certificate Program - Social Epidemiology Certificate Program - Spatial Analysis for Public Health Certificate Program - Training Certificate in Public Health - Tropical Medicine Certificate Program - Tuition for Certificate Programs - Vaccine Science and Policy Certificate Program - Online Programs - Accelerated Learning Institutes - Postdoctoral Programs - Residency Programs - Graduate Training Programs in Clinical Investigation - For Working Professionals - Training Grants - Mixed Methods Research Training Program for the Health Sciences - About the Program - Announcements - Application Process - Contact Us - Current Scholars - 2015 Scholars - Jennifer I Manuel, PhD, MSW - Joke Bradt, PhD - Josiemer Mattei, PhD, MPH - Justin Sanders, MD, MSc - Linda Charmaran, PhD - Nao Hagiwara, PhD - Nynikka R. A. Palmer, DrPH, MPH - Olayinka O. Shiyanbola, BPharm, PhD - Sarah Ronis, MD, MPH - Susan D. Brown, PhD - Tara Lagu, MD, MPH - Theresa Hoft, PhD - Wynne E. Norton, PhD - Yvonne Mensa-Wilmot, PhD, MPH - 2016 Scholars - A. Susana Ramírez, PhD, MPH - Animesh Sabnis, MD, MSHS - Autumn Kieber-Emmons, MD, MPH - Benjamin Han, MD, MPH - Brooke A. Levandowski, PhD, MPA - Camille R. Quinn, PhD, AM, LCSW - Justine Wu, MD, MPH - Kelly Aschbrenner, PhD - Kim N. Danforth, ScD, MPH - Loreto Leiva, PhD - Marie Brault, PhD - Mary E. Cooley, PhD, RN, FAAN - Meganne K. Masko, PhD, MT-BC/L - PhuongThao D. Le, PhD, MPH - Rebecca Lobb, ScD, MPH - 2017 Scholars - Allegra R. Gordon, ScD MPH - Anita Misra-Hebert, MD MPH FACP - Arden M. Morris, MD, MPH - Caroline Silva, PhD - Danielle Davidov, PhD - Hans Oh, PhD - J. Nicholas Dionne-Odom, PhD RN ACHPN - Jacqueline Mogle, PhD - Jammie Hopkins, DrPH, MS - Joe Glass, PhD MSW - Karen Whiteman, PhD MSW - Katie Schultz, PhD MSW - Rose Molina, MD - Uriyoán Colón-Ramos, ScD MPA - 2018 Scholars - Andrew Riley, PhD - Byron J. Powell, PhD, LCSW - Carrie Nieman MD, MPH - Charles R. Rogers, PhD, MPH, MS, CHES® - Emily E. Haroz, PhD - Jennifer Tsui, Ph.D., M.P.H.",1
"- Jessica Magidson, PhD - Katherine Sanchez, PhD, LCSW - Kelly Doran, MD, MHS - Kiara Alvarez, PhD - LaPrincess C. Brewer, MD, MPH - Melissa Radey, PhD, MA, MSSW - Sophia L. Johnson, PharmD, MPH, PhD - Supriya Gupta Mohile, MD, MS - Virginia McKay, PhD - 2019 Scholars - Andrew Cohen, MD, PhD - Angela Chen, PhD, PMHNP-BC, RN - Christopher Salas-Wright, PhD, MSW - Eliza Park MD, MS - Jaime M. Hughes, PhD, MPH, MSW - Johanne Eliacin, PhD, HSPP - Lingrui Liu ScD MS - Meaghan Kennedy, MD - Nicole Stadnick, PhD, MPH - Paula Aristizabal, MD - Radhika Sundararajan, MD - Sara Mamo, AuD, PhD - Tullika Garg, MD MPH FACS - 2020 Scholars - Allison Magnuson, DO - Ariel Williamson PhD, DBSM - Benita Bamgbade, PharmD, PhD - Christopher Woodrell MD - Hung-Jui (Ray) Tan, MD, MSHPM - Jasmine Abrams, PhD - Jose Alejandro Rauh-Hain, MD - Karen Flórez, DrPH, MPH - Lavanya Vasudevan, PhD, MPH, CPH - Maria Garcia, MD, MPH - Robert Brady, PhD - Saria Hassan, MD - Scherezade Mama, DrPH - Yuan Lu, ScD - 2021 Scholars - 2015 Scholars - Resources - Sign Up for Our Email List - Mixed Methods Research Training Program for the Health Sciences - Master's Degrees - Course Directory - Academic Calendar - Hybrid Campus - Convocation - Lecture Series",1
"Contact Us Departments - Biochemistry and Molecular Biology - Contact E-mail [email protected] | Visit Department Website Location: Building Wolfe Street Building, E3132 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - Biostatistics - Visit Department Website Contact Phone 410-955-3067 (Phone) | 410-955-0958 (Fax) Location: Building Wolfe Street Building, E3527 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - Environmental Health and Engineering - Contact E-mail [email protected] | Visit Department Website Contact Phone 667-306-9570 Location: Building Wolfe Street Building, E7527 Hours: Hours 8:30 a.m. to 5:00 p.m., Monday through Friday - Epidemiology - Contact E-mail [email protected] | Visit Department Website Location: Building Wolfe Street Building, W6041 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - Health Policy and Management - Contact E-mail [email protected] | Visit Department Website Location: 750 E. Pratt Street, Baltimore, MD 21202 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - Health, Behavior and Society - Contact E-mail [email protected] | Visit Department Website Location: 621 N. Washington Street, Baltimore, MD 21205 Hours: Hours From 8:00 a.m. to 4:00 p.m., Monday through Friday - International Health - Visit Department Website Contact Phone 410-955-3934 (Phone) | 410-955-7159 (Fax) Location: Building Wolfe Street Building, E8527 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - MAS Office - Visit Department Website Hours: Hours From 8 a.m. to 5:30 p.m., Monday through Friday - Mental Health - Contact E-mail [email protected] | Visit Department Website Contact Phone (410) 955-3910 Location: Building Wolfe Street Building, Suite W1100 Hours: Hours M-F, 8:30am-5pm - Molecular Microbiology and Immunology - Contact E-mail [email protected] | Visit Department Website Contact Phone 410-614-4232 Location: Building Wolfe Street Building, E5008 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - Population, Family and Reproductive Health - Visit Department Website Contact Phone 410-955-3384 (Phone) Location: Building Wolfe Street Building, E4527 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - School of Nursing - Visit Department Website Hours: Hours From 8 a.m. to 5:30 p.m., Monday through Friday Dining - Daily Grind - Contact Phone 410-502-0833 Location: Building Wolfe Street Building, 2nd floor Hours: Hours From 7:30 a.m. to 3:00 p.m., Monday through Friday - Garden Plate - Contact Phone 410-955-3002 Location: Building Wolfe Street Building, 9th floor Hours: Hours From 10:00 a.m. to 3:00 p.m., Monday through Friday Notes For dining, additional locations are available on the Dining page.",1
"Offices - Admissions Services - Contact E-mail [email protected] | Homepage Link Visit Website Contact Phone 410-955-3543 (Phone) | 410-955-0464 (Fax) Location: Building Wolfe Street Building, E1002 Hours: Hours From 8:30 a.m. to 4:00 p.m., Monday through Friday - Communications and Marketing - Contact E-mail [email protected] | Homepage Link Visit Website Location: 750 E Pratt St 14th Fl, Baltimore, MD 21202 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - Continuing Education - Contact E-mail [email protected] | Homepage Link Visit Website Contact Phone 410-955-5995 Location: Building Wolfe Street Building, W1513 Hours: Hours From 8:00 a.m. to 3:00 p.m., Monday through Friday - Development - Homepage Link Visit Website Contact Phone 410-955-5194 (Phone) | 410-614-2405 (Fax) Location: 750 E Pratt St 14th Fl, Baltimore, MD 21202 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - Faculty, Office of - Contact E-mail [email protected] | Homepage Link Visit Website Location: Building Wolfe Street Building, W1033 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - Financial Aid - Homepage Link Visit Website Contact Phone 410-955-3004 (Phone) | 410-955-0464 (Fax) Location: Building Wolfe Street Building, E1002 Hours: Hours From 8:00 a.m. to 4:00 p.m., Monday through Friday NotesRequest support through the SEAM Form.",1
"- Human Resources - Contact E-mail [email protected] Location: 750 E Pratt St., 14th Floor NotesBSPH Users: Visit internal HR Website | General Public: Visit JHU HR Website - Inclusion, Diversity, Anti-Racism, and Equity (IDARE) - Contact E-mail [email protected] | Homepage Link Visit Website Contact Phone 410-955-3034 (Phone) | 410-502-9809 (Fax) Location: Building Wolfe Street Building, W1600 NotesJoel I. Bolling, MA Assistant Dean for IDARE [email protected]Mahnoor K. Ahmed, MS IDARE Director for Student Recruitment and Engagement [email protected]Audrey Ndaba, MS Student Disability Services Coordinator [email protected] - Information Technology Administrative Office - Contact Phone 410-955-3566 Location: 621 N. Washington Street Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - Information Technology Client Services - Homepage Link Visit Website Contact Phone 410-955-3781 (Phone) | 410-614-6160 (Fax) Location: Building Wolfe Street Building, W3014 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - Multimedia - Homepage Link Visit Website Contact Phone 410-955-3066 Location: Building Wolfe Street Building, WB501 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday - Residency Programs Office - Contact E-mail [email protected] Contact Phone 410-955-3630 Location: Building Wolfe Street Building, WB602 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday NotesFor more information, visit the respective websites of: - Security - Notes Escort Services On the Web: Escort Services Phone: 410-955-5585General Calls for Assistance On the Web: Contact a Security Office Phone: 410-955-5585 - Student Accounts - Homepage Link Visit Website Contact Phone 410-955-5725 (Phone) | 410-614-8633 (Fax) Location: Building Wolfe Street Building, W1101 Hours: Hours From 8:30 a.m. to 4:00 p.m., Monday through Friday NotesRequest support through the SEAM Form.",1
"- Student Affairs - Homepage Link Visit Website Contact Phone 443-287-7277 (Phone) | 410-955-0464 (Fax) Location: Building Wolfe Street Building, E1002 Hours: Hours From 8:00 a.m. to 4:00 p.m., Monday through Friday NotesFor additional information, visit the respective websites of: Programs - Graduate Training Programs in Clinical Investigation - Contact E-mail [email protected] | Homepage Link Visit Website Contact Phone 410-502-9734 Location: E. Monument St, suite 1-500 L Room: 2024 - Master of Bioethics - Contact E-mail [email protected] | Homepage Link Visit Website Contact Phone 410-614-5550 Location: Ashland Avenue Room: 1809 Hours: Hours From 9:00 a.m. to 5:00 p.m., Monday through Friday - Master of Public Health Program - Contact E-mail [email protected] | Homepage Link Visit Website Contact Phone 410-955-1291 Location: Building Wolfe Street Building, W1015 Hours: Hours From 8:30 a.m. to 5:00 p.m., Monday through Friday",1
"Understanding the Evidence on Pregnancy, Tylenol, and Autism Establishing cause and effect is more complicated than the headlines suggest. The research so far—including one of the largest studies yet on the topic—suggests that Tylenol use during pregnancy does not cause autism. But conflicting study results and recent rhetoric discouraging Tylenol use during pregnancy have sown confusion and highlighted the challenges of establishing a definitive cause-and-effect relationship between the drug and neurodevelopmental outcomes. Our understanding of the issue hinges on an evolving body of research, and on the design and quality of those studies—namely, how well researchers have accounted for all the relevant factors that could influence their results. Challenges of Studying Tylenol Use During Pregnancy Studies that establish causal relationships between medications and adverse effects often involve randomized controlled trials. In this case, that might mean one group of pregnant women being assigned to take Tylenol for fevers that might arise, and the other not, and then comparing the results in their children up to 10 years later. Such a study, however, would be challenging to design and conduct in an ethical and feasible way.",1
"Observational studies, however, involve “simply watching people and seeing what happens to the children of mothers who do take acetaminophen and comparing that against children who are born to mothers who don’t use acetaminophen,” says Brian Lee, PhD ’09, MHS ’08, an epidemiology professor at Drexel University. Lee, using health records from Sweden’s national health system, conducted one of the largest studies to assess whether acetaminophen use might be associated with autism and other neurodevelopmental outcomes. Obstacles to Understanding Cause and Effect The challenge of understanding cause and effect is that there may be other factors at play that influence both the exposure of interest (in this case, taking Tylenol) and the outcome (in this case, autism). Ice cream offers a helpful analogy for understanding these confounding factors. Looking at data alone, there’s a statistical association between eating ice cream and drowning, says Lee. “But of course, it's not a causal one. The confounder here is hot weather, which increases both your ice cream consumption and your propensity to go swimming—hence drowning.” To account for the weather factor, you might look only at data from hot days—“and that association between ice cream eating and drowning completely goes away,” Lee explains.",1
"When it comes to studying Tylenol and autism, one confounding factor is that women may take the painkiller during pregnancy to address another health condition that may be linked to autism, such as infection or fever. “It might look like there's an association with acetaminophen, but really the association could just be reflecting the underlying infection that the person has,” Lee said in the September 29 episode of Public Health On Call. And then there’s another major consideration: Genetics, “that big elephant in the room that causes a large portion of autism,” says Lee. “So then the question is, how well does the study really adjust for those differences … so that we can try to separate the effect we care about from all these other relationships?” Elizabeth Stuart, PhD, AM, chair of Biostatistics, told the podcast. A Major Study on Tylenol and Autism Lee’s study, conducted in Sweden, did not have access to genetic data. But it did have a massive trove of health records of nearly 2.5 million children born in Sweden between 1995 and 2019, as well as the health records of entire families. As a result, it was able to account for genetics by comparing siblings, who have significant genetic similarities—something that previous studies linking Tylenol and autism did not. Like studies that preceded it, Lee’s research initially found a small association between Tylenol use and autism when they compared members of the general population.",1
"But when looking at siblings within the same family where the mom took acetaminophen for one pregnancy and not another, that increased risk “completely disappeared,” says Lee. “There was no evidence to say that there was any effect whatsoever.” The sibling comparison was a major advantage to the design of this study. But,, like all studies, there were limitations, says Stuart. For example, mothers may not accurately report their Tylenol use. And “we don't necessarily have direct measures and certainty around what the women were taking”—such as how much Tylenol they took and how often, Stuart notes. To account for inevitable limitations, researchers like Lee also try to anticipate potential issues with their data and assess how much impact they may have. Making Sense of Conflicting Findings On the podcast, Lee addressed why many studies may have found an association between autism and acetaminophen use during pregnancy. In his view, it’s because those studies did not utilize a sibling control to account for familial factors. Recently, a Japanese study of some 200,000 pregnancies came to the same conclusion as the Swedish study: It suggested a slight increased risk of autism from acetaminophen use during pregnancy, but when they analyzed siblings with comparable genetic makeup, there was no link. Lee noted that early studies linking coffee intake with increased risk of cancer did not account for the fact that many coffee drinkers were also smokers.",1
"“And in the later studies that did, these associations went away. And I think the science here for acetaminophen and autism is headed in that direction,” says Lee. Building a Body of Evidence on Tylenol and Autism Lee and Stuart both said that no one study on Tylenol and autism can establish cause and effect. “It's really about building a body of evidence and being transparent about the strengths and weaknesses of any individual study,” says Stuart. “Usually for epidemiology, we never get a 100% definitive case closed on any topic,” says Lee. Rather, as more and more studies are done, “there's an evidence needle pointing in a certain direction that is shifting toward, this causes this, or this doesn’t.” Right now, in his view, “the needle is pointing strongly toward there being no causal effect of acetaminophen use during pregnancy on autism.” The Next Step Toward Understanding the Tylenol-Autism Issue It’s essential to be clear and transparent about where the evidence stands, Stuart says. To help achieve that, one next step might be for a government agency, a nonprofit, or academic or professional organization to bring together people with different types of expertise on the topic and study design to assess and communicate where the evidence stands—and helping the general public process that uncertainty, says Stuart. “Sometimes science communication makes it seem more certain than it is.",1
"In these sorts of questions, we just don't have that certainty.” As people navigate questions around Tylenol and autism, it’s key to give people “a little bit more understanding of why we don't have certainty in these questions, and a little bit more comfort with that.” Even if the research is not fully settled, the practical recommendations about how to use Tylenol during pregnancy remain unchanged, says Lee: “Even if you don't have any reason to believe that a medication is harmful, you probably shouldn't be taking it … at levels that exceed the levels recommended by a physician.”",1
"Strategy and Development We help faculty create the foundation for successful research. With experts in so many diverse topics, The Bloomberg School seeks to enhance our faculty's ability to identify potential collaborators and navigate access to data, sample, and participant research resources. Team science is encouraged, and interdisciplinary approaches predominate our research teams. Our faculty are highly successful in obtaining funding for their research activities. We support them by regularly providing information on potential funding opportunities, both internal and external, and guidance on how to navigate the application process of our main funders like the National Institutes of Health. Increasingly, successful grant applications involve pre-review by mentors and peers and sharing of best practices and grant templates.",1
"Implementation and Impact The School is focused on ensuring that all steps in the research process can be facilitated, starting with building and communicating with research teams. Implementing complex research studies around the world is an extremely challenging task. Research teams at the Bloomberg School often recruit study participants in difficult to reach places and from underrepresented and challenging life situations. Our faculty lead cohorts of well-characterized study participants linked to highly informative biorepositories which allows investigation of pathways and biomarkers of health outcomes. Our faculty are able to recruit great staff, students and postdocs to contribute to our research success. We advocate for procedures to make certain that data collection, management and analyses are high quality, as well as to ensure the integrity and security of data. Opportunities abound for participation in writing accountability groups and sharing one's research in progress. Our communications teams help with broader dissemination of important research findings and ensure impact beyond the academic literature.",1
"Information Sessions and Events We have created virtual and in-person ways for prospective students to get to know the dynamic community of researchers and students working together at the Bloomberg School. Admissions Virtual Chats Chat with Admissions Services to learn more about our School and programs. Virtual Info Sessions Sessions will cover various topics about the School and specific programs. Information Fairs Connect with Admissions Services at events globally and online. Campus Tours Visit Baltimore and explore the Bloomberg School through an On-Campus Tour. Ready to Apply? Seeking more information regarding the application process? Check out our How to Apply page here! Virtual Chats and Info Sessions Virtual chats and info sessions offer interested students an informal opportunity to learn about life at the Bloomberg School. Chats are held select Thursdays from 12 p.m. to 1 p.m. EST, or you can access previously recorded sessions below. Previously Recorded Chats Virtual chats and info sessions offer interested students a chance to view live or previously recorded webinars about what life is like here at the Bloomberg School. | Thursday, October 16, 2025 | Recording of Session | Upcoming Virtual Chat Sessions Admissions offers virtual chat sessions on select Thursdays from 12 p.m. to 1 p.m. (Eastern Time). Chat sessions are a great way to get questions answered about the School, programs, or life in Baltimore.",1
"| Thursday, December 4, 2025, 12 p.m. | Register for Session | | Thursday, December 18, 2025, 12 p.m. | Register for Session | | Thursday, January 15, 2026, 12 p.m. | Register for Session | | Thursday, January 29, 2026, 12 p.m. | Register for Session | | Thursday, February 5, 2026, 12 p.m. | Register for Session | | Thursday, February 19, 2026, 12 p.m. | Register for Session | | Thursday, March 19, 2026, 12 p.m. | Register for Session | | Thursday, April 23, 2026, 12 p.m. | Register for Session | | Thursday, May 7, 2026, 12 p.m. | Register for Session | | Thursday, May 14, 2026, 12 p.m. | Register for Session | Can't chat on the date listed? Email us at [email protected] and we'll find a time that works for you! School-Wide Virtual Info Sessions Throughout the fall Departments and Programs at the Bloomberg School of Public Health will offer information sessions to learn more about the particular programs, requirements and unique opportunities they offer. Previous recordings are provided below. A schedule of events will be provided in the fall. Cultivating Community & Belonging as First Generation and URG Students Our School recognizes the unique lived experiences of our students and aims to create space and opportunities for all members of our community to feel valued and supported.",1
"The Office of Inclusion, Diversity, Anti-Racism, and Equity (IDARE) invites you to join us to learn more about our efforts to cultivate a diverse and inclusive environment on campus and in our community. Each session will provide participants an opportunity to learn more about the initiatives and resources offered by the IDARE office, as well as insights into the experiences of current students and recent alums who identify as first-generation and/or members of underrepresented or underserved groups (URGs). All are welcome. Ins and Outs of Public Health Hear from the Admissions about the exciting opportunities awaiting you here as well as the ins and outs of applying to public health graduate programs. You will also receive information about popular career options in the field and how our alumni network can help you in your decision. The Bloomberg School has a large number of academic offerings and we understand you may have questions regarding which direction to take or which program is right for you. If so, then this session is for you. We hope you’ll join us! | September 12, 2025, 12 p.m. to 1 p.m. (Eastern Time) | Recording of Session | Master's Program Information Session You've probably noticed that we offer nine—yes nine!—master's degrees in public health. And you may have wondered how they differ from one another and which one is right for you. This virtual session will explain the differences between our nine master's degrees.",1
"From duration of program, to program components, to special application requirements, we will cover it all. We understand how overwhelming it can be to research graduate school programs so we want to help you decide which Bloomberg School master's degree program is the best fit for you. Hope to ""see"" you there! | September 16, 2025, 12 p.m. to 1 p.m. (Eastern Time) | Recording of Session | Careers in Public Health See where the Bloomberg School can take you. Learn from our Career Services Office about the programs and events sponsored by the office, career outcomes of graduates and how to make the most out of our public health degree programs. We hope you can participate! | October 3, 2025, 12 p.m. to 1 p.m. (Eastern Time) | Recording of Session | Population & Family Health, Mental Health, Education, and Bioethics Students can explore opportunities in community and mental health, education and bioethics. Learn more about these opportunities among our departments of Health, Behavior and Society, Population, Family and Reproductive Health, Master of Bioethics, and Mental Health. Fall session (s) will be posted at a later date. Public Health Practice: What Does the Internship Experience Look Like? On the ground experience is an invaluable part of the professional master's programs at the Bloomberg School. Join the Public Health Practice Office for an engaging conversation with current students about the internship and field placement opportunities.",1
"We look forward to your participation! | November 11, 2025, 12 p.m. to 1 p.m. ( Eastern Time) | Recording of Session | Public Health Programs to Prepare for Medical School & Lab Science Opportunities Join the Departments of Environmental Health and Engineering, Molecular Microbiology and Immunology, and Biochemistry and Molecular Biology to learn more about how students training at our School can study in public health to further their skill sets to apply to medical school. Departments will also highlight lab opportunities available for students. | Fall date to be announced soon. | The Research Experience & Centers to Explore The Bloomberg School has over 80 research institutes and centers. During a panel discussion learn from faculty, center staff and current students about the research opportunities master's and doctoral students get involved with and projects associated with the centers and institutes. We hope to ""see"" you there! | October 29, 2025 12 p.m. to 1 p.m. (Eastern Time) | Recording of Session | Department & Program-Specific Virtual Info Sessions Throughout the fall Departments and Programs at the Bloomberg School of Public Health will offer information sessions to learn more about the particular programs, requirements and unique opportunities they offer. A schedule of events will be added throughout the fall. Biochemistry and Microbiology | October 24, 2025, 11:30 a.m. (Virtual Open House) | Recording of Session (Passcode: !=?%y1!!)",1
"| Biostatistics | Fall Session To Be Announced | DrPH Information Session | September 24, 2025 12 p.m. | Recording of Session | | October 24, 2025, 11:30 a.m. (Virtual Open House) | Recording of Session | | November 6, 2025 12 p.m. | Recording of Session | Environmental Health and Engineering Information Session | October 24, 2025, 11:30 a.m. (Virtual Open House) | Recording of Session (Passcode: PrSS&K0G) | Epidemiology | September 18, 2025 10 a.m. (MHS and ScM Program highlights) | Recording of Session | | September 25, 2025 9 a.m. (PhD) | Recording of Session | | October 16, 2025 10 a.m. (Application Workshop) | Recording of Session | | October 24, 2025 11:30 a.m. (Virtual Open House) | Recording of Session | | November 13, 2025 10 a.m. (MHS and ScM Program highlights) | Recording of Session | | December 2, 2025, 12:15 p.m. (Alumni Panel) | Register for Session | Health, Behavior and Society Information Sessions | November 17, 2025, 10 a.m. (MSPH and MHS) | Register for Session | Health Policy and Management (HPM) Information Sessions | October 21, 2025, 2 p.m. (PhD Only) | Slides from Session | | October 24, 2025, 11:30 a.m. (MHA Virtual Open House Session) | Slides from Session | | December 1, 2025, 10 a.m. (MHS in Health Economics and Outcomes Research) | Register for Session | | December 1, 2025, 12 p.m. (MSPH in Health Policy) | Register for Session | International Health | October 3, 2025, 10 a.m. (PhD) | Recording of Session | | October 8, 2025, 12 p.m. (MSPH in Human Nutrition-Dietitian) | Recording of Session (Passcode: MRe*a2*K) | | October 24, 2025, 11:30 a.m. (Virtual Open House) | Recording of Session | | October 28, 2025, 8 a.m. (MSPH in Human Nutrition-Dietitian) | Recording of Session (Passcode: D1xn^Z%g) | | November 7, 2025, 12 p.m. (MSPH) | Recording of Session | | November 19, 2025, 6 p.m. (BA/Master's) | Recording of Session | | November 20, 2025, 10 a.m. (Health Systems Programs) | Recording of Session | | December 11, 2025, 8 a.m. (MSPH and MHS-except Dietitian) | Register for Session | | March 2, 2026, 10 a.m. MHS in Global Health Economics | Register for Session | | April 22, 2026, 6 p.m. (BA/Master's) | Register for Session | Master of Bioethics (MBE) Information Session | December 3, 2025, 12 p.m. | Register for Session | Master of Applied Science (MAS) Information Sessions | October 20, 2025, 6:30 p.m. (Patient Safety and Healthcare Quality) | Recording of Session | | October 22, 2025, 12 p.m. (Spatial Analysis) | Recording of Session | | November 3, 2025, 12 p.m. (Population Health Management) | Recording of Session | Master of Public Health (MPH) Information Sessions- | October 9, 2025, 12 p.m. (MPH/MBA Program) | Recording of Session (Passcode: dFK27%Z8) | | October 24, 2025, 11:30 a.m. (Virtual Open House) | Recording of Session | Mental Health | October 24, 2025, 11:30 a.m. (Virtual Open House) | Recording of Session | Molecular Microbiology and Immunology | Session To Be Announced | Population, Family and Reproductive Health | October 24, 2025, 11:30 a.m. (Virtual Open House) | Recording of Session (Passcode: wNX^j*75) | | November 11, 2025, 12 p.m. (Spotlight on Community Engagement in Public Health) | Recording of Session | Fall Open Houses On-Campus Open House October 10, 2025 The day included: - Connecting with faculty, students and staff while on campus in Baltimore - A welcome from the Dean and introduction to the Bloomberg School - Cultivating Community Session - Program and Student Affairs Fair to learn about our departments and programs - Department and Program breakout sessions Virtual Open House October 24, 2025 Virtual Open House included: - A welcome from school leadership and introduction to the Bloomberg School - Zoom breakout sessions with departments and programs - Chat with representatives from all our academic departments and degree programs.",1
"Learn more about our academic offerings, including master's and doctoral degrees, online learning opportunities, certificate programs, and much more. - A virtual meet and greet with representatives from Career Services; Office of Inclusion, Diversity, Anti-Racism and Equity (IDARE); Financial Aid; Student Assembly and other groups. Check out the recording from Open House 2025. Recordings of department and program sessions will be added in the program sections above. Want to host a recruiting event? Admissions Services staff are happy to present virtually to interested universities and organizations about our School and programs. Email [email protected] to get started.",1
"Faculty Directory Our faculty are world-renowned experts, and trusted advisers to our students, public health leaders, and the public. Meet Our Faculty We take pride in celebrating the richness of our diverse faculty community, recognizing that it enriches our academic environment and enhances our collective experiences. | Name | Title | Department | Overview | |---|---|---|---| | Mia Aassar | Research Associate | Health Policy and Management | - | | Rachy Abraham | Assistant Scientist | Biochemistry and Molecular Biology | - | | Rachel Adkinson | Research Associate | International Health | - | | Smisha Agarwal | Associate Professor | International Health | Smisha Agarwal, PhD, MPH ’09, MBA, studies how to improve maternal and newborn health in low-income settings by strengthening health systems and using technological solutions. | | Jacqueline Agnew | Professor - Emeritus | Environmental Health and Engineering | Jacqueline Agnew, PhD '92, seeks to better understand the relationship between workplace exposures, worker characteristics, and musculoskeletal disorders. | | Peter Agre | Professor | Molecular Microbiology and Immunology | Peter Agre, MD '74, emeritus leader of the Johns Hopkins Malaria Research Institute, is the 2003 Nobel Laureate in Chemistry for his discovery of aquaporin proteins.",1
"| | Rexford Ahima | Professor | Epidemiology | - | | Saifuddin Ahmed | Professor | Population, Family and Reproductive Health | Saifuddin Ahmed, MBBS, PhD ‘96, his research includes reproductive epidemiology, particularly maternal mortality estimation; program evaluation for family planning and MCH care. | | Jim Aizire | Associate Research Professor | Epidemiology | - | | Ellesse-Roselee Akré | Assistant Professor | Health Policy and Management | - | | Nadia Akseer | Associate Scientist | International Health | - | | Aveika Akum | Senior Research Associate | International Health | - | | Sandra Albornoz Marin | Research Associate | Environmental Health and Engineering | - | | Tanya Alderete | Associate Professor | Environmental Health and Engineering | Tanya L. Alderete, PhD, investigates the effects of environmental exposures on human health throughout the life course. Her work integrates clinical, epidemiological, and multiomics research. | | Caleb Alexander | Professor | Epidemiology | G. Caleb Alexander, MD, MS, is a practicing internist and epidemiologist focused on maximizing the use, safety, and effectiveness of prescription medicines.",1
"| | Tesfa Alexander | Associate Practice Professor | Health Policy and Management | - | | Daniel Ali | Assistant Scientist | International Health | - | | Joseph Ali | Associate Professor | International Health | Joseph Ali, JD, studies how to conduct global public health research and practice that maximally respects ethical values in an increasingly interconnected digital world. | | Dana Alkhoury | Research Associate | Health Policy and Management | Dana Alkhoury, MPH ‘11, is dedicated to advancing medical knowledge and improving health outcomes through rigorous research and effective implementation strategies. | | Lauren Allen | Assistant Scientist | Health Policy and Management | Lauren Allen, DrPH ’21, specializes in clinical research administration in the domains of policy setting and implementation, management of multi-institutional research, and knowledge dissemination. |",1
"Student Spotlight: Pratik Prashant Neve Volunteering as a data collector for a serological survey during the COVID-19 pandemic ignited Pratik's passion for public health. The use of metrics, statistics, data science, and more to frame and inform issues, and to monitor and evaluate programs Explore the latest public health research and insights about Data. Volunteering as a data collector for a serological survey during the COVID-19 pandemic ignited Pratik's passion for public health. Add subtext below TOPIC Faculty: Looking for prominent public health experts in the field of data? They’re here at the Bloomberg School of Public Health. Karen Bandeen-Roche, PhD, MS, creates statistical reasoning needed to learn how we can lengthen healthy life and increase independence for older adults. Brian Caffo, PhD, MS, is a biostatistician who studies big, complex data in the neurosciences. Nilanjan Chatterjee, PhD, MS, models disease risk associated with genetic, lifestyle, biomarkers. and other factors, with the goal of improving disease prevention.",1
"Most of the Foods We Eat Are Ultra-Processed. Are They All Unhealthy? More than half of the calories that the average American adult consumes are from ultra-processed foods. Two people are standing in line at the grocery store. One has a cart full of instant ramen, hot dogs, ice cream, and soda, and the other has a cart full of whole grain bread, breakfast cereal, peanut butter, and strawberry yogurt. Which one is buying ultra-processed foods (UPFs)? It’s a trick question. The answer is: both. UPFs have become a popular topic of conversation, and a growing concern in public health. These foods are associated with worse diet quality and a long, ever-expanding list of adverse health outcomes. But what classifies as an ultra-processed food? The majority of the foods that we eat in the United States, says Julia Wolfson, PhD ’16, MPP, an associate professor in International Health. “They dominate our food systems. If you imagine a typical grocery store, most of the foods and beverages lining the shelves are ultra-processed.” In fact, nearly 75% of the U.S. food supply is estimated to be ultra-processed. More than half of the calories that the average American adult consumes come from UPFs; in children, that number is more than 60%. But not all ultra-processed foods are equally concerning. Teasing out what UPFs fall under the moniker of “junk food,” is more nuanced. And finding ways to reduce consumption is even more complicated.",1
"What Makes a Food “Ultra-Processed” “Food processing has existed in some form throughout most of human history,” Wolfson says. One of the earliest examples is cooking with fire, and later, preservation methods like drying, smoking, curing, pickling, canning, and salting became commonplace. Traditionally processed foods include items like homemade breads, cheese, and canned fish, which are altered from their natural state by adding salt, fat, sugar, or oil. UPFs, however, are substantively different. The term “ultra-processed foods” originated from the Nova food classification system, which defines food in four categories, ranging from least to most processed: - Unprocessed or minimally processed foods like fruit, vegetables, milk, or fish. - Processed culinary ingredients like salt, sugar, olive oil, and butter. - Processed foods, such as jam, pickles, or canned fruit. - Ultra-processed foods, like energy drinks, instant oatmeal, sliced bread, or hot dogs. Ultra-processed foods have one or more ingredient that wouldn’t be found in a kitchen, like chemical-based preservatives, emulsifiers like hydrogenated oils, sweeteners like high fructose corn syrup, and artificial colors and flavors. UPFs undergo processing techniques like pre-frying, molding, extrusion, fractioning, and other chemical alterations that leave the final products bearing almost no resemblance to the original ingredients.",1
"UPFs Are Ubiquitous and Appealing Examples of ultra-processed foods that might instantly spring to mind include sodas, prepackaged snacks such as chips, cookies, and crackers, candy, boxed macaroni and cheese, frozen and ready-to-eat meals, lunch meats, jerky, and hotdogs. The processes and ingredients used to create UPFs often make these foods hyperpalatable, Wolfson says, meaning they are designed to be exceptionally appealing to the human palate—and can be addictive. Ultra-processed foods typically contain a combination of ingredients like sugar, fat, and salt that stimulate the brain's reward system, making it hard to stop eating them. UPFs also reduce satiety, because industrial processing alters their structure, making them softer and easier to eat and digest. This leads to a faster rate of consumption, which can override natural fullness signals and cause people to overeat. Additionally, UPFs often contain additives and have lower levels of fiber, leading to less sustained fullness. Because ultra-processed foods are typically high in saturated fat, sodium, and sugar, and lower in water and fiber content, they are also more calorie-dense per gram (approximately 378 calories per 100 grams) compared to whole foods like fruits and vegetables (around 68 calories per 100 grams). “Many of these ultra-processed foods are intentionally designed by the food industry to be irresistible to consumers, and they’re heavily marketed with the goal of maximizing profits,” says Wolfson.",1
"“It might not be something to worry about if they comprised just a small proportion of the foods that we eat, but that’s not the case.” Some UPFs Are Less Unhealthy Than Others Not all ultra-processed foods are equally concerning for health. “Many ultra-processed foods are junk foods, but many others are products that we use all the time to feed our families, and we incorporate them into the meals that we cook every day,” Wolfson says. Prepackaged whole grain breads, many yogurts, instant oatmeal, and jarred pasta sauces are all ultra-processed foods, but have lower levels of saturated fats and added sugars while still containing a plethora of nutrients that help reduce disease risk. Baked beans, which contain protein, fiber, and minerals like iron and potassium, are ultra-processed, but consumption of beans has been shown to support heart health by lowering cholesterol, improve digestive health through fiber, and help stabilize blood sugar. “Dairy alternatives like soy milk and or meat alternatives—these are ultra-processed and can be beneficial,” Wolfson says. “It's a balancing act. It's important to identify foods that are of most concern for health … I would like to see the Dietary Guidelines for Americans strike that balance in clear recommendations while not treating all ultra-processed foods with the same broad brush.” What Makes UPFs Unhealthy Ultra-processed foods are associated with worse diet quality and a long and growing list of adverse health outcomes.",1
"A 2024 umbrella review of 45 meta-analyses of studies including almost 10 million people found that diets high in UPFs are linked to 32 health conditions, including obesity, type 2 diabetes, cardiometabolic diseases, many cancers, gastrointestinal disorders, asthma, anxiety, depression, cardiovascular events, and all-cause mortality. Ultra-processed meats (any meat that has been processed to change its shape, flavor, and freshness), for example, have been classified by the WHO as a Group 1 carcinogen—a categorization shared by tobacco and asbestos—for their link to colorectal cancer. A study published in JAMA Oncology in November found that, compared with women with healthier diets, women who eat a lot of UPFs are 1.5 times more likely to develop pre-cancerous polyps before the age of 50. Sodas have some of the strongest evidence for health harms, says Wolfson. Heavily manufactured with additives, high levels of sugar or artificial sweeteners, and lacking essential nutrients, these beverages appeal to us on a biological level: For early humans, sugar was a rare and valuable source of calories, and the ability to detect and desire it helped ensure they got enough energy to survive. But today’s sodas deliver large amounts of pure sugar or high-fructose corn syrup in a way that our ancestors never encountered and lead to potential health issues like obesity, heart disease, type 2 diabetes, and others.",1
"The disassembling and reassembling of chemical and physical structures caused by processing affects how our bodies metabolize these foods, making them ""pre-digested."" This leads to rapid absorption of sugar and fat and rapid spikes in blood glucose. It also bypasses the need for the body to break down food, which can lead to a disrupted gut microbiome because of low fiber content and potential harm from additives like emulsifiers. Over time, this can increase the risk of inflammatory bowel diseases, insulin resistance, and other health issues. Some research has shown that our bodies absorb more calories from UPFs than foods that have been minimally processed. Reducing UPF Consumption Ultra-processed foods have been a major talking point among top U.S. health officials this year, mostly notably Health and Human Services Secretary Robert F. Kennedy Jr., who called them “poison” and has vowed to remove them from programs like SNAP. When it comes to realistic solutions to reducing ultra-processed food consumption, “a lot of options are on the table,” Wolfson says. For example, educating the public about ultra-processed foods through improved front-of-package food labels. This “could help consumers make different choices and also prompt the food industry to reformulate some products so that they wouldn't get that label.” Taxes and policy changes are viable options. Many countries, and some U.S. communities, now have soda taxes that decrease intake, for example.",1
"In June, California voted to enact the first U.S. law to define and ban unhealthy ultra-processed foods from an estimated over 1 billion meals served to California schoolchildren in the 2025–2026 school year. But recognizing that these foods are widely used—and why—would be crucial. UPFs are shelf stable, unlike fresh produce. They save time, effort, and mental energy while cooking. Most importantly, they are more affordable. UPFs cost 55 cents per 100 calories, compared with $1.45 for unprocessed foods. “Time consideration, accessibility, and affordability—these are really big barriers to being able to consume less ultra-processed foods,” says Wolfson. “We are balancing work and childcare and other responsibilities as well as our household budgets and needing to get food on the table every single day. Ultra-processed foods are so widely consumed because they fill a need.” If policy changes, taxes, labeling, or other messaging around the dangers of ultra-processing are put into action, “we need to help people afford the alternative,” Wolfson says, pointing to expansion of healthy food incentive programs, more sufficient SNAP benefits, and advocating for equitable minimum wage laws that allow people to afford a diet that is more minimally processed. On an individual level, reducing or eliminating UPF intake can be a gradual process. If at all possible, you should: - Keep lots of healthy foods at home and try not to purchase UPFs when at the grocery store.",1
"- Try preparing meals at home in advance that use less processed foods. - Read the nutrition labels and ingredient lists on products before you buy them, looking for foods that have only a few pronounceable, recognizable ingredients. - Try replacing an ultra-processed food with fruit or vegetables. Use minimally processed frozen or canned options if fresh fruit or vegetables aren’t available. - Replace sugary beverages with water. - Choose whole grains, like whole wheat bread, over processed grains like white bread. - Make a homemade version of a processed food, like sweet potato chips, healthy muffins, bread, or salad dressings. - Choose healthier menu options when eating out, like salmon with steamed vegetables instead of a hamburger. More from the Bloomberg School - See latest headlines - Learn more about our departments:",1
"Resources for Practitioners We are pleased to offer the following resources to support practitioners in their public health work. Investigating Epidemics like COVID-19: An Analyst's Guide Those curious about outbreaks and analysis and/or interested in a career detecting, investigating and/or analyzing data from outbreaks could benefit from this free, virtual course. The course uses audio, audiovisual, text, scenarios, and guided analytic practice to teach public health surveillance, outbreak response, and analysis of outbreak data. Responsible Reporting on Suicide Suicide is a leading cause of death worldwide. Public health organizations have identified training journalists to responsibly report on the topic as a key priority for prevention. The Bloomberg School is pleased to launch a free, online course designed to give journalists the concrete tools they need to meet that goal. How to Deliver Effective Testimony: Tips from Public Health Experts Delivering effective testimony is an essential advocacy skill for moving public health issues forward. The tips is this video, from the Lerner Center for Public Health Advocacy, can guide your approach to providing testimony that will lead to lasting change.",1
"Adapting Public Health Messages for Social Media: Tips You Can Use With Your Communities This half-hour recorded training offers strategies and tips on how to create engaging and informative public health content for social media, based on practices that the Johns Hopkins Bloomberg School of Public Health's award-winning social media team used to engage hundreds of millions of people during the pandemic. This training was produced by our Center for Teaching and Learning with support from Bloomberg Philanthropies. COVID-19 Public Health Workforce Training Initiatives Public health workers and community members across the globe can access Bloomberg School online courses and tailored training certificates and programs on contact tracing and related topics. Over 500,000 people have enrolled in the COVID-19 contact tracing course developed by a team of faculty, staff, and students in partnership with Bloomberg Philanthropies and local public health departments and made available for free on the Coursera platform, along with additional JHU Coursera offerings. This much-needed contact tracing course has helped scale up the public health workforce in real time in response to the COVID-19 pandemic. Resources for Reducing Harm from Overdose and Addiction Nearly 841,000 Americans have died from overdoses since 1999, according to the Centers for Disease Control and Prevention.",1
"While opioids account for a majority of deaths, as many as one-third of overdose deaths are attributable to other drugs, including amphetamines and cocaine. Public health experts agree on many approaches to reduce harm from addiction and overdose—stigma reduction, overdose prevention, and mental health support. The Bloomberg School is taking a leading role in advancing these approaches through public policy, community involvement, and education. Free Coursera offerings and MOOCs Practitioners can also access dozens of courses from Bloomberg School faculty on Coursera. Practice-focused offerings include courses on topics such as gun violence, food systems, health equity, and epidemiology, among others. Topical and Skills-based Training Opportunities Public health practitioners looking to obtain training in on-demand public health topics and skills in areas such as communications, data analytics, resource management, and disease prevention and control can access free trainings through the Mid-Atlantic Regional Public Health Training Center (MAR-PHTC).",1
"SBC Learning Central The Johns Hopkins Center for Communication Programs has developed 20 free online courses and counting for French- and English-speaking social and behavior change communication practitioners and stakeholders working across key public health topics (e.g., sexual and reproductive health, malaria, nutrition, and emergency outbreaks).The goal of this practical resource is to help institutionalize social and behavior change approaches and create a critical mass of skilled practitioners and supportive decision makers worldwide. Inspiring healthy behaviors can improve the lives of individuals and their families. TRUST in Public Health The Center for Health Security has launched a new website—Tackling Rumors and Understanding and Strengthening Trust—to support public health professionals in addressing misinformation and building trust in public health. The TRUST website provides tools, resources, and guidance, informed by the experiences of more than 100 front-line workers. Professional Trainings for Organizations The Office of Continuing and Executive Education offers professional development opportunities to empower your employees and organization.",1
"ABOUT Leadership - At a Glance - Leadership - Dean Pollack Porter - Deans - Chairs - Faculty Senate - Student Assembly - Staff Assembly - Health Advisory Board - Board Members - Alfred Sommer, MD, MHS '73 - Andrea D. Willis, MD, MPH '99, FAAP - Ashok Agarwal, MPH '84 - Brian D. Crawford, PhD '82 - Caroline Popper, MD, MPH '90 - Catharine C. Dorrier - Chereé M. Haswell Johnson, JD - Christopher Anzalone - Christopher I.M. Jones - Colleen Cutcliffe, PhD - Constance R. Caplan, MA '78 - Dave Hickey - Dean Goodermote - Deborah Levy, PhD '97, MPH - Douglass B.",1
"Given, MD - Edward J. Ludwig, MBA - Faith Thomas, JD - George L. Bunting, Jr. - Hsien-Hsien Lei, PhD '98 - Ira M. Rutkow, MD, PhD '81, MPH '78 - Irene C. Frary, MBA - Joseph A. Boystak, MPH '77 - Karl P. Ronn - Kathleen Ludwig - Kelvin A. Baggett, MD, MPH '05 - Manfred Eggersdorfer, PhD - Margaret Conn Himelfarb, MPH '04 - Marion Bergman, MD - Michael J. Klag, MD, MPH '87 - Michael Kullman - Nikos Pavlidis, MSc - Pamela Hoehn-Saric - Randolph ""Randy"" Gordon, MD, MPH '88 - Ravi Kavasery, MD - Robert Carr, MD, MPH '86, FACPM - Robert J. Abernethy, '62 - Roberta L. Schwartz, PhD, MHS '94 - Rodrigo A. Sierra, MBA - Roger C. Lipitz - Shale D. Stiller, MLS '77 - Sister Charlotte Kerr, RN, BSN, MPH - Stephen G. Moore, MD, MPH '93 - Suprotik Basu, MHS `02 - Thomas McCann - William C. Clarke III - William Flumenbaum - Membership Committee - Philanthropic Impact - Board Members - Student Life - Campus - Baltimore - Strategic Priorities - Inclusion, Diversity, Anti-Racism, and Equity (IDARE) - History - What is Public Health? The Bloomberg School's leadership team includes Dean Pollack Porter, her office of vice, associate, and assistant deans, and the chairs of the 10 academic departments and the MPH and DrPH programs. They are advised by the Faculty Senate, Student Assembly, Staff Assembly, and Health Advisory Board as they consider the priorities, procedures, and future planning of the School.",1
"Together, these leaders bring a well-rounded lens to management and oversight of the School's academic, research, and practice activities.",1
"Departmental Affiliations Primary Krieger School of Arts and Sciences Joint School of Medicine Joint Joint Roland J. Thorpe, Jr., PhD, MS, is a gerontologist and social epidemiologist with nationally-recognized expertise in minority aging, men’s health, and place-based disparities. Contact Info 624 N. Broadway, Hampton House 708 Baltimore Maryland 21205 US 410-955-7241 Research Interests Health Disparities; Race;SES; Poverty Status; Functional Decline; Functional Status; Lower Extremity Functioning; Hypertension, Mobility Limitation; Older Adults; Life Course; Men's Health Disparities Across the Life Course; Men's Health Experiences & Accomplishments Education PhD Purdue University 2004 MS Purdue University 1997 BS Florida A&M University 1995 Projects Environmental Exposures and Cognitive Decline, Dementia, and Alzheimer's Disease Among Middle to Old Age Black Men in the United States Investigation of environmental justice in a diverse longitudinal sample of older adults in the United States Leadership and Education in Academic Research and Networking for Enhancing Retention and Success (LEARNERS) Investigating the role of neighborhood disadvantage in opioid use disparities among women at the intersections of race and sexual orientation How Income Inequality Has Influenced Health Outcomes in US Counties: Longitudinal Analytics (1999-2018) Assessing the Impact of the Racial Composition of Police Departments and Neighbourhoods on Violence in the U.S",1
"Winter Institute Courses - Academic Program Finder - Master's Degrees - MSPH in Population, Family and Reproductive Health - Master of Applied Science (MAS) in Patient Safety and Healthcare Quality - Master of Applied Science (MAS) in Population Health Management - Master of Applied Science (MAS) in Spatial Analysis for Public Health - Master of Arts and Master of Science in Public Health (MA/MSPH) - Master of Arts in Public Health Biology (MAPHB) - Master of Bioethics (MBE) - Master of Health Administration (MHA) - Master of Health Science (MHS) - Department of Biochemistry and Molecular Biology - Master of Health Science (MHS) - Department of Epidemiology - Master of Health Science (MHS) - Department of Mental Health - Master of Health Science (MHS) - Department of Molecular Microbiology and Immunology - Master of Health Science (MHS) in Health Economics and Outcomes Research - Master of Health Science (MHS) in Health, Behavior and Society - Master of Health Science (MHS) - Master of Health Science - Department of Biostatistics - Master of Health Science - Department of Population, Family and Reproductive Health - Master of Health Science in Global Health Economics - Master of Public Health (MPH) - Master of Science (ScM) - Department of Biochemistry and Molecular Biology - Master of Science (ScM) - Department of Biostatistics - Master of Science (ScM) - Department of Epidemiology - Master of Science (ScM) - Department of Molecular Microbiology and Immunology - Master of Science (ScM) in Genetic Counseling - Master of Science in Public Health (MSPH) in Health Education and Health Communication - Master of Science in Public Health (MSPH) in Health Policy - Master of Science in Public Health - Department of International Health - Master of Science in Public Health (MSPH) in Global Disease Epidemiology and Control - Master of Science in Public Health (MSPH) in Health Systems - Master of Science in Public Health (MSPH) in Human Nutrition - Master of Science In Public Health (MSPH) In Human Nutrition – Dietitian - Master of Science in Public Health (MSPH) in Social and Behavioral Interventions - Doctoral Degrees - Doctor of Philosophy (PhD) - Department of Biochemistry and Molecular Biology - Doctor of Philosophy (PhD) - Department of Biostatistics - Doctor of Philosophy (PhD) - Department of Epidemiology - Doctor of Philosophy (PhD) - Department of Mental Health - Doctor of Philosophy (PhD) - Department of Molecular Microbiology and Immunology - Doctor of Philosophy (PhD) - Department of Population, Family and Reproductive Health - Doctor of Philosophy (PhD) in Clinical Investigation - Doctor of Philosophy (PhD) in Health Policy and Management - Doctor of Philosophy (PhD) in Social and Behavioral Sciences - Doctor of Philosophy - Department of International Health - JHU-Tsinghua Doctor of Public Health - Doctor of Public Health (DrPH) - Combined / Dual Degrees - Certificate Programs - Adolescent Health Certificate Program - Bioethics Certificate Program - Clinical Trials Certificate Program - Community- Based Public Health Certificate Program - Demographic Methods Certificate Program - Epidemiology for Public Health Professionals Certificate Program - Evaluation: International Health Programs Certificate Program - Frequently Asked Questions for Certificate Programs - Gender and Health Certificate Program - Gerontology Certificate Program - Global Digital Health Certificate Program - Global Health Certificate Program - Global Health Practice Certificate Program - Health Communication Certificate Program - Health Disparities and Health Inequality Certificate Program - Health Education Certificate Program - Health Finance and Management Certificate Program - Healthcare Epidemiology and Infection Prevention and Control Certificate Program - Humanitarian Health Certificate Program - Implementation Science and Research Practice Certificate Program - Injury and Violence Prevention Certificate Program - Leadership for Public Health and Healthcare Certificate Program - Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) Public Health Certificate Program - Maternal and Child Health Certificate Program - Mental Health Policy, Economics and Services Certificate Program - Non-Degree Students General Admissions Info - Pharmacoepidemiology and Drug Safety Certificate Program - Population Health Management Certificate Program - Population and Health Certificate Program - Public Health Advocacy Certificate Program - Public Health Economics Certificate Program - Public Health Informatics Certificate Program - Public Health Training Certificate for American Indian Health Professionals - Public Health, Human Rights, and the Law Certificate Program - Public Mental Health Research Certificate Program - Quality, Patient Safety and Outcomes Research Certificate Program - Requirements for Successful Completion of a Certificate Program - Rigor, Reproducibility, and Responsibility in Scientific Practice Certificate Program - Risk Sciences and Public Policy Certificate Program - Social Epidemiology Certificate Program - Spatial Analysis for Public Health Certificate Program - Training Certificate in Public Health - Tropical Medicine Certificate Program - Tuition for Certificate Programs - Vaccine Science and Policy Certificate Program - Online Programs - Accelerated Learning Institutes - Postdoctoral Programs - Residency Programs - Graduate Training Programs in Clinical Investigation - For Working Professionals - Training Grants - Mixed Methods Research Training Program for the Health Sciences - About the Program - Announcements - Application Process - Contact Us - Current Scholars - 2015 Scholars - Jennifer I Manuel, PhD, MSW - Joke Bradt, PhD - Josiemer Mattei, PhD, MPH - Justin Sanders, MD, MSc - Linda Charmaran, PhD - Nao Hagiwara, PhD - Nynikka R. A. Palmer, DrPH, MPH - Olayinka O. Shiyanbola, BPharm, PhD - Sarah Ronis, MD, MPH - Susan D. Brown, PhD - Tara Lagu, MD, MPH - Theresa Hoft, PhD - Wynne E. Norton, PhD - Yvonne Mensa-Wilmot, PhD, MPH - 2016 Scholars - A. Susana Ramírez, PhD, MPH - Animesh Sabnis, MD, MSHS - Autumn Kieber-Emmons, MD, MPH - Benjamin Han, MD, MPH - Brooke A. Levandowski, PhD, MPA - Camille R. Quinn, PhD, AM, LCSW - Justine Wu, MD, MPH - Kelly Aschbrenner, PhD - Kim N. Danforth, ScD, MPH - Loreto Leiva, PhD - Marie Brault, PhD - Mary E. Cooley, PhD, RN, FAAN - Meganne K. Masko, PhD, MT-BC/L - PhuongThao D. Le, PhD, MPH - Rebecca Lobb, ScD, MPH - 2017 Scholars - Allegra R. Gordon, ScD MPH - Anita Misra-Hebert, MD MPH FACP - Arden M. Morris, MD, MPH - Caroline Silva, PhD - Danielle Davidov, PhD - Hans Oh, PhD - J. Nicholas Dionne-Odom, PhD RN ACHPN - Jacqueline Mogle, PhD - Jammie Hopkins, DrPH, MS - Joe Glass, PhD MSW - Karen Whiteman, PhD MSW - Katie Schultz, PhD MSW - Rose Molina, MD - Uriyoán Colón-Ramos, ScD MPA - 2018 Scholars - Andrew Riley, PhD - Byron J. Powell, PhD, LCSW - Carrie Nieman MD, MPH - Charles R. Rogers, PhD, MPH, MS, CHES® - Emily E. Haroz, PhD - Jennifer Tsui, Ph.D., M.P.H.",1
"- Jessica Magidson, PhD - Katherine Sanchez, PhD, LCSW - Kelly Doran, MD, MHS - Kiara Alvarez, PhD - LaPrincess C. Brewer, MD, MPH - Melissa Radey, PhD, MA, MSSW - Sophia L. Johnson, PharmD, MPH, PhD - Supriya Gupta Mohile, MD, MS - Virginia McKay, PhD - 2019 Scholars - Andrew Cohen, MD, PhD - Angela Chen, PhD, PMHNP-BC, RN - Christopher Salas-Wright, PhD, MSW - Eliza Park MD, MS - Jaime M. Hughes, PhD, MPH, MSW - Johanne Eliacin, PhD, HSPP - Lingrui Liu ScD MS - Meaghan Kennedy, MD - Nicole Stadnick, PhD, MPH - Paula Aristizabal, MD - Radhika Sundararajan, MD - Sara Mamo, AuD, PhD - Tullika Garg, MD MPH FACS - 2020 Scholars - Allison Magnuson, DO - Ariel Williamson PhD, DBSM - Benita Bamgbade, PharmD, PhD - Christopher Woodrell MD - Hung-Jui (Ray) Tan, MD, MSHPM - Jasmine Abrams, PhD - Jose Alejandro Rauh-Hain, MD - Karen Flórez, DrPH, MPH - Lavanya Vasudevan, PhD, MPH, CPH - Maria Garcia, MD, MPH - Robert Brady, PhD - Saria Hassan, MD - Scherezade Mama, DrPH - Yuan Lu, ScD - 2021 Scholars - 2015 Scholars - Resources - Sign Up for Our Email List - Mixed Methods Research Training Program for the Health Sciences - Master's Degrees - Course Directory - Academic Calendar - Hybrid Campus - Convocation - Lecture Series Below you will find information on the courses offered as part of the Winter Institute. The courses listed below are offered in different formats, and you can get a sense of the instructional delivery method by looking at the last two digits of the course number.",1
"Course numbers ending in .83 will be offered asynchronously online; course numbers ending in .73 will be taught synchronously online over Zoom; course numbers ending in .13 will be taught onsite at our Baltimore campus, and course numbers ending in .43 will be the virtual, synchronous sections of hybrid courses; all .43 virtual sections will be combined with .13 onsite sections to make one hybrid course with two different types of students participating together. Courses with a .51 suffix are taught onsite in Washington, DC.",1
"In the School Applied learning is at the core of our educational mission. Practicums and field placements We engage students in activities that align with their career goals and apply public health concepts and critical thinking relevant to the student’s area of interest. Practicums and field placements further develop their skill sets and add new tools to their professional toolkit. Upon completion of their degree program, students have practical experiences and skills to share with potential employers. All professional degree students (MPH, MSPH, DrPH, MHA) complete a practicum experience to comply with accreditation requirements. Conversations and Connections Ongoing conversations hosted by the Office of Public Health Practice bring faculty, staff, students, and alumni together to explore important tools and topics for advancing public health, equity, and social justice in Baltimore, across the nation, and around the world. Our conversations emphasize the knowledge, skills, and tools needed to advance public health and to help students navigate their own career transitions and trajectories. These conversations engage the School community around topics such as response to COVID-19 and other pressing public health problems, racism and health equity, local and global advocacy, and public health communications in times of crisis. Students play a leading role in these conversation events by suggesting topics, moderating sessions, and organizing student-driven discussions.",1
"Practice-Focused Student Activities Events offered by the Student Assembly and various Bloomberg School student groups provide students the chance to explore new topics, learn about different cultures, and gain new skills. Student-driven events include professional development and advocacy-oriented field trips, policy hackathons, special events to celebrate Public Health Practice Week, and seminars featuring public health practitioners and leaders working on the front lines in key current-day issues such as the opioid crisis, health equity, gun violence, e-cigarettes, and more.",1
"Get Inspired Get Inspired by the Power of Public Health! Your gift can help drive the Bloomberg School's mission by supporting our research, practice, and educational initiatives that save lives by the millions. Donors like you help us train tomorrow's public health leaders, enable faculty to make new ideas a reality, and energize research centers working to solve the toughest causes of death, injury, and disease. Below are some of the ways a gift to the Bloomberg School can help. If you would like to designate your gift to a specific campaign, please learn more about designating your gift. People, Education, and Training An endowed scholarship honors a lifelong love affair with statistics. From sharecropper’s daughter to biostatistician, Gertrude Huster, MHS ’84, seeks to honor those who helped her dream big—at a time when few women pursued STEM careers. More People, Education, and Training Stories Science, Innovation, and Evidence Eliasberg Family Foundation Funding Helps Track Avian Flu H5N1 Mutations Private foundation philanthropy provides critical seed funding for research and strengthens case for federal funding. More Science, Innovation, and Evidence Stories Advocacy, Community, and Practice Supporting Public Health Leaders Who Make Good Things Happen Longtime Bloomberg School donors Kathy and Ed Ludwig create impact by supporting public health leadership.",1
"More Advocacy, Community, and Practice Stories Health Equity Scholars By empowering them with funding, our HES students seek to address the root causes of health inequity. Health Equity Scholars From across the School's ten departments, these junior scientists, research trainees, and promising policy advocates and practitioners are using a social justice and health equity lens to dismantle racist structures that affect health outcomes. Join Us! Your gift ensures the strength of our research, the impact of our practice work, and the reach of our world-class educational enterprise.",1
"Academics We offer accredited graduate degrees, as well as non-degree opportunities, with different formats and approaches to meet a variety of interests and career goals.",1
"- Academic Program Finder - Master's Degrees - MSPH in Population, Family and Reproductive Health - Master of Applied Science (MAS) in Patient Safety and Healthcare Quality - Master of Applied Science (MAS) in Population Health Management - Master of Applied Science (MAS) in Spatial Analysis for Public Health - Master of Arts and Master of Science in Public Health (MA/MSPH) - Master of Arts in Public Health Biology (MAPHB) - Master of Bioethics (MBE) - Master of Health Administration (MHA) - Master of Health Science (MHS) - Department of Biochemistry and Molecular Biology - Master of Health Science (MHS) - Department of Epidemiology - Master of Health Science (MHS) - Department of Mental Health - Master of Health Science (MHS) - Department of Molecular Microbiology and Immunology - Master of Health Science (MHS) in Health Economics and Outcomes Research - Master of Health Science (MHS) in Health, Behavior and Society - Master of Health Science (MHS) - Master of Health Science - Department of Biostatistics - Master of Health Science - Department of Population, Family and Reproductive Health - Master of Health Science in Global Health Economics - Master of Public Health (MPH) - Master of Science (ScM) - Department of Biochemistry and Molecular Biology - Master of Science (ScM) - Department of Biostatistics - Master of Science (ScM) - Department of Epidemiology - Master of Science (ScM) - Department of Molecular Microbiology and Immunology - Master of Science (ScM) in Genetic Counseling - Master of Science in Public Health (MSPH) in Health Education and Health Communication - Master of Science in Public Health (MSPH) in Health Policy - Master of Science in Public Health - Department of International Health - Master of Science in Public Health (MSPH) in Global Disease Epidemiology and Control - Master of Science in Public Health (MSPH) in Health Systems - Master of Science in Public Health (MSPH) in Human Nutrition - Master of Science In Public Health (MSPH) In Human Nutrition – Dietitian - Master of Science in Public Health (MSPH) in Social and Behavioral Interventions - Doctoral Degrees - Doctor of Philosophy (PhD) - Department of Biochemistry and Molecular Biology - Doctor of Philosophy (PhD) - Department of Biostatistics - Doctor of Philosophy (PhD) - Department of Epidemiology - Doctor of Philosophy (PhD) - Department of Mental Health - Doctor of Philosophy (PhD) - Department of Molecular Microbiology and Immunology - Doctor of Philosophy (PhD) - Department of Population, Family and Reproductive Health - Doctor of Philosophy (PhD) in Clinical Investigation - Doctor of Philosophy (PhD) in Health Policy and Management - Doctor of Philosophy (PhD) in Social and Behavioral Sciences - Doctor of Philosophy - Department of International Health - JHU-Tsinghua Doctor of Public Health - Doctor of Public Health (DrPH) - Combined / Dual Degrees - Certificate Programs - Adolescent Health Certificate Program - Bioethics Certificate Program - Clinical Trials Certificate Program - Community- Based Public Health Certificate Program - Demographic Methods Certificate Program - Epidemiology for Public Health Professionals Certificate Program - Evaluation: International Health Programs Certificate Program - Frequently Asked Questions for Certificate Programs - Gender and Health Certificate Program - Gerontology Certificate Program - Global Digital Health Certificate Program - Global Health Certificate Program - Global Health Practice Certificate Program - Health Communication Certificate Program - Health Disparities and Health Inequality Certificate Program - Health Education Certificate Program - Health Finance and Management Certificate Program - Healthcare Epidemiology and Infection Prevention and Control Certificate Program - Humanitarian Health Certificate Program - Implementation Science and Research Practice Certificate Program - Injury and Violence Prevention Certificate Program - Leadership for Public Health and Healthcare Certificate Program - Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) Public Health Certificate Program - Maternal and Child Health Certificate Program - Mental Health Policy, Economics and Services Certificate Program - Non-Degree Students General Admissions Info - Pharmacoepidemiology and Drug Safety Certificate Program - Population Health Management Certificate Program - Population and Health Certificate Program - Public Health Advocacy Certificate Program - Public Health Economics Certificate Program - Public Health Informatics Certificate Program - Public Health Training Certificate for American Indian Health Professionals - Public Health, Human Rights, and the Law Certificate Program - Public Mental Health Research Certificate Program - Quality, Patient Safety and Outcomes Research Certificate Program - Requirements for Successful Completion of a Certificate Program - Rigor, Reproducibility, and Responsibility in Scientific Practice Certificate Program - Risk Sciences and Public Policy Certificate Program - Social Epidemiology Certificate Program - Spatial Analysis for Public Health Certificate Program - Training Certificate in Public Health - Tropical Medicine Certificate Program - Tuition for Certificate Programs - Vaccine Science and Policy Certificate Program - Online Programs - Accelerated Learning Institutes - Postdoctoral Programs - Residency Programs - Graduate Training Programs in Clinical Investigation - For Working Professionals - Training Grants - Mixed Methods Research Training Program for the Health Sciences - About the Program - Announcements - Application Process - Contact Us - Current Scholars - 2015 Scholars - Jennifer I Manuel, PhD, MSW - Joke Bradt, PhD - Josiemer Mattei, PhD, MPH - Justin Sanders, MD, MSc - Linda Charmaran, PhD - Nao Hagiwara, PhD - Nynikka R. A. Palmer, DrPH, MPH - Olayinka O. Shiyanbola, BPharm, PhD - Sarah Ronis, MD, MPH - Susan D. Brown, PhD - Tara Lagu, MD, MPH - Theresa Hoft, PhD - Wynne E. Norton, PhD - Yvonne Mensa-Wilmot, PhD, MPH - 2016 Scholars - A. Susana Ramírez, PhD, MPH - Animesh Sabnis, MD, MSHS - Autumn Kieber-Emmons, MD, MPH - Benjamin Han, MD, MPH - Brooke A. Levandowski, PhD, MPA - Camille R. Quinn, PhD, AM, LCSW - Justine Wu, MD, MPH - Kelly Aschbrenner, PhD - Kim N. Danforth, ScD, MPH - Loreto Leiva, PhD - Marie Brault, PhD - Mary E. Cooley, PhD, RN, FAAN - Meganne K. Masko, PhD, MT-BC/L - PhuongThao D. Le, PhD, MPH - Rebecca Lobb, ScD, MPH - 2017 Scholars - Allegra R. Gordon, ScD MPH - Anita Misra-Hebert, MD MPH FACP - Arden M. Morris, MD, MPH - Caroline Silva, PhD - Danielle Davidov, PhD - Hans Oh, PhD - J. Nicholas Dionne-Odom, PhD RN ACHPN - Jacqueline Mogle, PhD - Jammie Hopkins, DrPH, MS - Joe Glass, PhD MSW - Karen Whiteman, PhD MSW - Katie Schultz, PhD MSW - Rose Molina, MD - Uriyoán Colón-Ramos, ScD MPA - 2018 Scholars - Andrew Riley, PhD - Byron J. Powell, PhD, LCSW - Carrie Nieman MD, MPH - Charles R. Rogers, PhD, MPH, MS, CHES® - Emily E. Haroz, PhD - Jennifer Tsui, Ph.D., M.P.H.",1
"- Jessica Magidson, PhD - Katherine Sanchez, PhD, LCSW - Kelly Doran, MD, MHS - Kiara Alvarez, PhD - LaPrincess C. Brewer, MD, MPH - Melissa Radey, PhD, MA, MSSW - Sophia L. Johnson, PharmD, MPH, PhD - Supriya Gupta Mohile, MD, MS - Virginia McKay, PhD - 2019 Scholars - Andrew Cohen, MD, PhD - Angela Chen, PhD, PMHNP-BC, RN - Christopher Salas-Wright, PhD, MSW - Eliza Park MD, MS - Jaime M. Hughes, PhD, MPH, MSW - Johanne Eliacin, PhD, HSPP - Lingrui Liu ScD MS - Meaghan Kennedy, MD - Nicole Stadnick, PhD, MPH - Paula Aristizabal, MD - Radhika Sundararajan, MD - Sara Mamo, AuD, PhD - Tullika Garg, MD MPH FACS - 2020 Scholars - Allison Magnuson, DO - Ariel Williamson PhD, DBSM - Benita Bamgbade, PharmD, PhD - Christopher Woodrell MD - Hung-Jui (Ray) Tan, MD, MSHPM - Jasmine Abrams, PhD - Jose Alejandro Rauh-Hain, MD - Karen Flórez, DrPH, MPH - Lavanya Vasudevan, PhD, MPH, CPH - Maria Garcia, MD, MPH - Robert Brady, PhD - Saria Hassan, MD - Scherezade Mama, DrPH - Yuan Lu, ScD - 2021 Scholars - 2015 Scholars - Resources - Sign Up for Our Email List - Mixed Methods Research Training Program for the Health Sciences - Master's Degrees - Course Directory - Academic Calendar - Hybrid Campus - Convocation - Lecture Series Our Academic Program Offerings Our programs welcome those from within and outside the traditional boundaries of public health.",1
"Whether you're a future college graduate, a midcareer public health leader, or someone looking to make a career change, we have a program for you. FIND THE RIGHT PROGRAM FOR YOU Information Sessions and How to Apply The Office of Admissions Services is the go-to resource for students who are interested in exploring a public health education at the Johns Hopkins Bloomberg School of Public Health. Nine Master's Degrees The Bloomberg School offers nine different master’s degree programs to train you to become the next public health leader. Two Doctoral Degrees The Bloomberg School’s doctoral degree programs target students with specific career goals in public health research, teaching or leadership, and typically require a longer time commitment. We offer the Doctor of Public Health (DrPH) and the Doctor of Philosophy (PhD). Continuing and Executive Education The Bloomberg School also offers the following programs to meet the needs of lifelong learners at any stage of their public health careers: Accelerated Path to a Master's Degree for Goucher College Students The Bloomberg School's partnership with Goucher College offers their students an accelerated path to a master’s degree, where they can earn their undergraduate degree at Goucher while pursuing a Master of Health Science (MHS) from the Department of Health, Behavior and Society or a Master of Bioethics (MBE) from the Bloomberg School.",1
"The Writing Center works with all students enrolled in degree programs at the Bloomberg School. The Bloomberg School Writing Center offers degree-seeking students free, individual conferences with experienced tutors, all of whom are careful and perceptive readers of all types of writing done at the School. Our online students enjoy a complete Bloomberg School experience. We offer best-in-class online teaching, delivered via our proprietary CoursePlus learning platform. We also offer remote students the full array of opportunities outside the classroom. As a premier public health institution, we believe it is part of our mission to share knowledge freely and openly. We make many free offerings available via Coursera. We also make many events and publications open to the public to enable broader understanding and application of public health expertise.",1
"Two New RSV Products to Protect Infants A new vaccine for pregnant people and an antibody treatment for babies could substantially lower the rates of severe RSV infections among children. The unique health needs of children and adolescents in life’s first two decades including development, illness, and injury Explore the latest public health research and insights about Child and Adolescent Health. A new vaccine for pregnant people and an antibody treatment for babies could substantially lower the rates of severe RSV infections among children. Looking for prominent public health experts in the field of Child and Adolescent Health? They’re here at the Bloomberg School of Public Health. Tamar Mendelson, PhD, studies the development, evaluation, and dissemination of strategies to promote mental health among adolescents in under-resourced urban communities. Kristin Mmari, DrPH, MA, assesses contextual factors and interventions influencing adolescent health in vulnerable adolescent populations, domestically and internationally. Julie Denison, PhD '06, MHS '99, develops interventions for youth living with HIV, with a focus on the role of family and environmental and structural determinants of health. Robert Blum, MD, PhD, MPH, studies adolescent health worldwide, with a focus on gender socialization in early adolescence and how it shapes health and wellness.",1
"Academic Calendar - Academic Program Finder - Master's Degrees - MSPH in Population, Family and Reproductive Health - Master of Applied Science (MAS) in Patient Safety and Healthcare Quality - Master of Applied Science (MAS) in Population Health Management - Master of Applied Science (MAS) in Spatial Analysis for Public Health - Master of Arts and Master of Science in Public Health (MA/MSPH) - Master of Arts in Public Health Biology (MAPHB) - Master of Bioethics (MBE) - Master of Health Administration (MHA) - Master of Health Science (MHS) - Department of Biochemistry and Molecular Biology - Master of Health Science (MHS) - Department of Epidemiology - Master of Health Science (MHS) - Department of Mental Health - Master of Health Science (MHS) - Department of Molecular Microbiology and Immunology - Master of Health Science (MHS) in Health Economics and Outcomes Research - Master of Health Science (MHS) in Health, Behavior and Society - Master of Health Science (MHS) - Master of Health Science - Department of Biostatistics - Master of Health Science - Department of Population, Family and Reproductive Health - Master of Health Science in Global Health Economics - Master of Public Health (MPH) - Master of Science (ScM) - Department of Biochemistry and Molecular Biology - Master of Science (ScM) - Department of Biostatistics - Master of Science (ScM) - Department of Epidemiology - Master of Science (ScM) - Department of Molecular Microbiology and Immunology - Master of Science (ScM) in Genetic Counseling - Master of Science in Public Health (MSPH) in Health Education and Health Communication - Master of Science in Public Health (MSPH) in Health Policy - Master of Science in Public Health - Department of International Health - Master of Science in Public Health (MSPH) in Global Disease Epidemiology and Control - Master of Science in Public Health (MSPH) in Health Systems - Master of Science in Public Health (MSPH) in Human Nutrition - Master of Science In Public Health (MSPH) In Human Nutrition – Dietitian - Master of Science in Public Health (MSPH) in Social and Behavioral Interventions - Doctoral Degrees - Doctor of Philosophy (PhD) - Department of Biochemistry and Molecular Biology - Doctor of Philosophy (PhD) - Department of Biostatistics - Doctor of Philosophy (PhD) - Department of Epidemiology - Doctor of Philosophy (PhD) - Department of Mental Health - Doctor of Philosophy (PhD) - Department of Molecular Microbiology and Immunology - Doctor of Philosophy (PhD) - Department of Population, Family and Reproductive Health - Doctor of Philosophy (PhD) in Clinical Investigation - Doctor of Philosophy (PhD) in Health Policy and Management - Doctor of Philosophy (PhD) in Social and Behavioral Sciences - Doctor of Philosophy - Department of International Health - JHU-Tsinghua Doctor of Public Health - Doctor of Public Health (DrPH) - Combined / Dual Degrees - Certificate Programs - Adolescent Health Certificate Program - Bioethics Certificate Program - Clinical Trials Certificate Program - Community- Based Public Health Certificate Program - Demographic Methods Certificate Program - Epidemiology for Public Health Professionals Certificate Program - Evaluation: International Health Programs Certificate Program - Frequently Asked Questions for Certificate Programs - Gender and Health Certificate Program - Gerontology Certificate Program - Global Digital Health Certificate Program - Global Health Certificate Program - Global Health Practice Certificate Program - Health Communication Certificate Program - Health Disparities and Health Inequality Certificate Program - Health Education Certificate Program - Health Finance and Management Certificate Program - Healthcare Epidemiology and Infection Prevention and Control Certificate Program - Humanitarian Health Certificate Program - Implementation Science and Research Practice Certificate Program - Injury and Violence Prevention Certificate Program - Leadership for Public Health and Healthcare Certificate Program - Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) Public Health Certificate Program - Maternal and Child Health Certificate Program - Mental Health Policy, Economics and Services Certificate Program - Non-Degree Students General Admissions Info - Pharmacoepidemiology and Drug Safety Certificate Program - Population Health Management Certificate Program - Population and Health Certificate Program - Public Health Advocacy Certificate Program - Public Health Economics Certificate Program - Public Health Informatics Certificate Program - Public Health Training Certificate for American Indian Health Professionals - Public Health, Human Rights, and the Law Certificate Program - Public Mental Health Research Certificate Program - Quality, Patient Safety and Outcomes Research Certificate Program - Requirements for Successful Completion of a Certificate Program - Rigor, Reproducibility, and Responsibility in Scientific Practice Certificate Program - Risk Sciences and Public Policy Certificate Program - Social Epidemiology Certificate Program - Spatial Analysis for Public Health Certificate Program - Training Certificate in Public Health - Tropical Medicine Certificate Program - Tuition for Certificate Programs - Vaccine Science and Policy Certificate Program - Online Programs - Accelerated Learning Institutes - Postdoctoral Programs - Residency Programs - Graduate Training Programs in Clinical Investigation - For Working Professionals - Training Grants - Mixed Methods Research Training Program for the Health Sciences - About the Program - Announcements - Application Process - Contact Us - Current Scholars - 2015 Scholars - Jennifer I Manuel, PhD, MSW - Joke Bradt, PhD - Josiemer Mattei, PhD, MPH - Justin Sanders, MD, MSc - Linda Charmaran, PhD - Nao Hagiwara, PhD - Nynikka R. A. Palmer, DrPH, MPH - Olayinka O. Shiyanbola, BPharm, PhD - Sarah Ronis, MD, MPH - Susan D. Brown, PhD - Tara Lagu, MD, MPH - Theresa Hoft, PhD - Wynne E. Norton, PhD - Yvonne Mensa-Wilmot, PhD, MPH - 2016 Scholars - A. Susana Ramírez, PhD, MPH - Animesh Sabnis, MD, MSHS - Autumn Kieber-Emmons, MD, MPH - Benjamin Han, MD, MPH - Brooke A. Levandowski, PhD, MPA - Camille R. Quinn, PhD, AM, LCSW - Justine Wu, MD, MPH - Kelly Aschbrenner, PhD - Kim N. Danforth, ScD, MPH - Loreto Leiva, PhD - Marie Brault, PhD - Mary E. Cooley, PhD, RN, FAAN - Meganne K. Masko, PhD, MT-BC/L - PhuongThao D. Le, PhD, MPH - Rebecca Lobb, ScD, MPH - 2017 Scholars - Allegra R. Gordon, ScD MPH - Anita Misra-Hebert, MD MPH FACP - Arden M. Morris, MD, MPH - Caroline Silva, PhD - Danielle Davidov, PhD - Hans Oh, PhD - J. Nicholas Dionne-Odom, PhD RN ACHPN - Jacqueline Mogle, PhD - Jammie Hopkins, DrPH, MS - Joe Glass, PhD MSW - Karen Whiteman, PhD MSW - Katie Schultz, PhD MSW - Rose Molina, MD - Uriyoán Colón-Ramos, ScD MPA - 2018 Scholars - Andrew Riley, PhD - Byron J. Powell, PhD, LCSW - Carrie Nieman MD, MPH - Charles R. Rogers, PhD, MPH, MS, CHES® - Emily E. Haroz, PhD - Jennifer Tsui, Ph.D., M.P.H.",1
"- Jessica Magidson, PhD - Katherine Sanchez, PhD, LCSW - Kelly Doran, MD, MHS - Kiara Alvarez, PhD - LaPrincess C. Brewer, MD, MPH - Melissa Radey, PhD, MA, MSSW - Sophia L. Johnson, PharmD, MPH, PhD - Supriya Gupta Mohile, MD, MS - Virginia McKay, PhD - 2019 Scholars - Andrew Cohen, MD, PhD - Angela Chen, PhD, PMHNP-BC, RN - Christopher Salas-Wright, PhD, MSW - Eliza Park MD, MS - Jaime M. Hughes, PhD, MPH, MSW - Johanne Eliacin, PhD, HSPP - Lingrui Liu ScD MS - Meaghan Kennedy, MD - Nicole Stadnick, PhD, MPH - Paula Aristizabal, MD - Radhika Sundararajan, MD - Sara Mamo, AuD, PhD - Tullika Garg, MD MPH FACS - 2020 Scholars - Allison Magnuson, DO - Ariel Williamson PhD, DBSM - Benita Bamgbade, PharmD, PhD - Christopher Woodrell MD - Hung-Jui (Ray) Tan, MD, MSHPM - Jasmine Abrams, PhD - Jose Alejandro Rauh-Hain, MD - Karen Flórez, DrPH, MPH - Lavanya Vasudevan, PhD, MPH, CPH - Maria Garcia, MD, MPH - Robert Brady, PhD - Saria Hassan, MD - Scherezade Mama, DrPH - Yuan Lu, ScD - 2021 Scholars - 2015 Scholars - Resources - Sign Up for Our Email List - Mixed Methods Research Training Program for the Health Sciences - Master's Degrees - Course Directory - Academic Calendar - Hybrid Campus - Convocation - Lecture Series The current academic calendar is below. You can also view the 2026-27 academic calendar. 2025-2026 The Johns Hopkins Bloomberg School of Public Health academic calendar includes five 8-week regular terms, a Summer Institute, and Winter Intersession.",1
The Bloomberg School must follow the University’s academic calendar and comply with the University's credit hour policy. Health Insurance Requirements Deadlines Tuition Payment Due Dates BSPH USERS: Download the academic calendar. Download religious and spiritual observances.,1
"Summer Institutes | Begin Tuesday, May 27, 2025 | Registration Begins for Summer Institute Term Memorial Day Holiday Recess Registration Ends for Summer Institute Term Add/Drop Begins for Summer Institute Term Add/Drop and Last Day to Make Schedule Changes for Summer Institute Term Part-time/Online MPH New Student Orientation Juneteenth Holiday Incomplete Contract Period | 2nd Term | Wednesday, October 22 to Friday, December 19, 2025 | Registration Begins for 2nd Term 2nd Term Registration Ends Instruction Begins for 2nd Term Add Period Drop Period Thanksgiving Recess Last Day to Make Schedule Changes for 2nd Term (course withdrawal deadline) Incomplete Contract Period Last Day of 2nd Term Grades Due for 2nd Term **Grades for graduating students are due by Friday, December 19 Registration Begins for Winter Intersession Registration Ends for Winter Intersession Part-time/Online MPH New Student Orientation Add/Drop and Last Day to Make Schedule Changes for Winter Intersession Term Incomplete Contract Period Martin Luther King Jr. Day Holiday Grades Due for Winter | 3rd Term | Tuesday, January 20 to Monday, March 16, 2026 | Registration Begins for 3rd Term 3rd Term Registration Ends Instruction Begins for 3rd Term Add Period Drop Period Last Day to Make Schedule Changes for 3rd Term (course withdrawal deadline) Incomplete Contract Period Make-up day for 3rd term onsite classes (if needed) Last Day of 3rd Term Spring Recess Grades Due for 3rd Term | 4th Term | Monday, March 23 to Friday, May 15, 2026 | Registration Begins for 4th Term 4th Term Registration Ends Instruction Begins for 4th Term Add Period Drop Period Last Day to Make Schedule Changes for 4th Term (course withdrawal deadline) Incomplete Contract Period Last Day of Class for 4th Term Bloomberg School Convocation Ceremony Universitywide Commencement Ceremony Grades Due for 4th Term **Grades for graduating students are due by Friday, May 15 Residency Program Ends |",1
"Health Policy and Management We advance evidence-informed solutions to systemic public health challenges and train tomorrow’s leading health administrators, advocates, policymakers, and researchers. Health Policy & Management Headlines Nearly 1 in 10 Adults in the U.S. Experienced a Mental Health Crisis Last Year A new study shows significant disparities in mental health among groups. Federal Housing Assistance Linked to Earlier Cancer Diagnosis in Older Adults Medicare patients receiving federal housing assistance were less likely to be diagnosed with distant-stage breast, colorectal, and non-small cell lung cancers. From Dissertation Seminars to the Editor’s Desk: Denys Lau’s Journey Through Public Health Denys Lau, PhD ’02, helms one of the most influential public health journals as the 15th editor-in-chief of the American Journal of Public Health (AJPH). What We Do in the Department of Health Policy and Management Our faculty, staff and students are committed to solving the most entrenched public health challenges in the world through evidence-based policy change. 2023 - 2024 Year in Review Every day, the Department of Health Policy & Management advances evidence-informed solutions to public health challenges and trains the next generation of leading health administrators, advocates, policymakers and researchers. Learn more about HPM's impact in the 2023 - 2024 academic year.",1
"Health Policy and Management Highlights #1 Health Policy & Management Department in the 2024 - 2025 U.S. News & World Report 350+ students and 2,000+ alumni 100+ full-time faculty 18 research centers Health Policy and Management Programs As one of the largest health policy and management programs in the country, we are dedicated to advancing local, national, and global health policy to make a difference. Within four degree programs (three master’s and the PhD), students have opportunities to engage directly with faculty, study internationally, and complete practicums in the field, contributing directly to global policy. Our students graduate with marketable skills and real-world experience, ready to make an impact, from the #1 school of public health. Doctor of Philosophy (PhD) in Health Policy and Management Our PhD program trains students to conduct original investigator-initiated research through a combination of coursework and research mentoring. Master of Science in Public Health (MSPH) in Health Policy MSPH students evaluate health care and work with decision makers to identify relevant regulatory policies, strategies, and interventions. This program also prepares students for further doctoral training in economics and health policy. Master of Health Administration (MHA) The Master of Health Administration (MHA) program is uniquely designed for future health care executives early in their careers.",1
"The two-year accelerated curriculum includes one year of full-time academic coursework followed by a full-time, 11-month compensated administrative residency in one of many Hopkins affiliates and partner institutions across the country. Master of Health Science (MHS) in Health Economics and Outcomes Research The MHS in Health Economics and Outcomes Research is a professionally-oriented degree program designed for individuals seeking specialized academic training to establish or expand their careers as health policy analysts. Chair of Health Policy and Management named next Dean of the Bloomberg School of Public Health In February 2022, Keshia M. Pollack Porter, PhD, MPH, an expert in advancing health equity and policy change that promotes safe and healthy environments, became chair of the Department of Health Policy and Management (HPM) at the Johns Hopkins Bloomberg School of Public Health. As of August 2025, she will assume a new role as dean of the Bloomberg School. HPM's faculty, staff, students, and alumni are grateful for her visionary leadership over the past 3 years and excited to see where she leads the School as dean! Centers and Institutes in the Department of Health Policy and Management We are home to 17 research and practice-based centers and institutes that focus on a range of public health issues.",1
"We also co-direct the Johns Hopkins-Pompeu Fabra University Public Policy Center, a collaboration between Johns Hopkins University, the Bloomberg School and the Universitat Pompeu Fabra in Barcelona, Spain. Johns Hopkins Center for Gun Violence Solutions Johns Hopkins Center for Health Disparities Solutions Center for Health Services and Outcomes Research (CHSOR) Johns Hopkins Center for Injury Research and Policy Center for Law and the Public's Health Center for Mental Health and Addiction Policy Center for Population Health Information Technology (CPHIT) Johns Hopkins Evidence-Based Practice Center Institute for Health and Social Policy (IHSP) Johns Hopkins Primary Care Policy Center The Risk Sciences and Public Policy Institute at the Bloomberg School The Roger and Flo Lipitz Center to Advance Policy in Aging and Disability Johns Hopkins Berman Institute of Bioethics Hopkins’ Economics of Alzheimer’s Disease & Services Center Lerner Center for Public Health Advocacy Hopkins Business of Health Initiative Johns Hopkins Drug Access and Affordability Initiative About the Department's Commitment to IDARE The Department of Health Policy and Management is committed to building a diverse, inclusive, nurturing environment where all students, faculty and staff can thrive. Our department's work often focuses on the intersection of racism and other forms of discrimination, health disparities and inequities, which impact policies that are at the forefront of national discussions.",1
"Our goal is for everyone in the department to understand the wide spectrum of human diversity and be the adequately equipped to advocate for policies and practices that advance equity, and inclusion. We are strengthened by our diverse community and understand the critical need for different perspectives and a genuine understanding of our many differences across race, ethnicity, gender, age, socio-economic status, national origin, sexual orientation, disability status, and religion, among others. Mariana Socal, MD, PhD, MPP, MSc is a health economist who studies ways to make the U.S. pharmaceutical market more competitive, reducing costs and ensuring a stable, high-quality prescription drug supply for the American people. Meet Our Job-Seeking PhD Candidates Our PhD candidates are seeking solutions to major health policy challenges. Read about their work and where they are headed with their careers. Support Our Department A gift to our department can help to provide student scholarships and internships, attract and retain faculty, and support innovation.",1
"Giving to Mayo Clinic Help transform the future of healthcare Philanthropy at Mayo Clinic Mayo Clinic has the vision and values to forever alter the trajectory of healthcare, ensuring high-quality, personalized care is accessible to everyone, everywhere. In this defining moment for healthcare, philanthropy at Mayo Clinic drives innovation to impact, faster. We invite you to join us today. Ways to give As a nonprofit, Mayo Clinic engages generous, compassionate people and organizations to support our mission. Gifts of all sizes make a difference. Discover multiple ways you can give to Mayo Clinic today and in the future. Honoring philanthropy We are proud to honor the many people and organizations who, like our founders, recognize the transformative power their gift holds. Mayo Clinic Magazine Your impact goes beyond the walls of Mayo Clinic and brings hope to patients and their families. Discover how philanthropy drives life-changing advances in patient care, research and education by reading stories from Mayo Clinic Magazine.",1
"For 160 years, Mayo Clinic has never wavered from our leadership role in medicine. We earned our reputation through the most cutting-edge research combined with dedicated, compassionate physicians and healthcare teams. As a nonprofit organization, Mayo Clinic reinvests all earnings into giving patients high-quality care, finding answers to the most complex medical questions, and training the next generation of doctors and researchers. Because Mayo Clinic is on the forefront of healthcare, we see our supporters as co-visionaries who imagine the unimaginable. See Mayo Clinic facts and statistics. Your gift holds great power to help Mayo Clinic continue to transform medicine and expand its unparalleled patient experience to people everywhere. Learn more about funding opportunities and ways to give by exploring this site.",1
"Patient & Visitor Guide Your guide to getting care at Mayo Clinic Everything you need to know before requesting an appointment We prioritize patient centered care, making sure you get the personalized attention and expert care you need. Find everything you need to know before requesting your appointment with Mayo Clinic. Planning your trip to Mayo Clinic & after you arrive Getting here, getting around, campus maps, where to stay and eat, patient support, and more. Mayo Clinic in ArizonaScottsdale & Phoenix Mayo Clinic in FloridaJacksonville Mayo Clinic in MinnesotaRochester Additional help to make the most of your visit Your travel experience should be as comfortable as possible. We’re here to help. Online access, support groups, and patient stories Create your online profile and connect with other Mayo Clinic patients and care teams for resources and support. Confidentiality, civil rights & service terms We are dedicated to protecting your confidentiality and privacy",1
"Updated April 12, 2024 Welcome Welcome to the Mayo Clinic website and related sites and digital and online services (“Mayo Clinic Site” or the “Site”), an online e-commerce, information, and communications service provided by Mayo Clinic and all affiliates (“Mayo Clinic” or “We” or “Us”). These Terms of Use cover the uses for all of this Site, although additional conditions, restrictions, and policies, including the Notice of Privacy Practices (NPP) and the Privacy Policy, posted or referenced on the Site may also apply. NOT MEDICAL ADVICE The content, products, and services offered herein are here to educate consumers on health care and medical issues that may affect their daily lives. Nothing in the content, products or services should be considered, or used as a substitute for, medical advice, diagnosis, or treatment. This Site and its services do not constitute the practice of any medical, nursing, or other professional health care advice, diagnosis, or treatment. You should always talk to your health care provider for diagnosis and treatment, including your specific medical needs. None of the products or services offered through this Site represents or warrants that any particular service or product is safe, appropriate, or effective for you. We advise users to always seek the advice of a physician or other qualified health care provider with any questions regarding personal health or medical conditions.",1
"IF YOU HAVE OR SUSPECT THAT YOU HAVE A MEDICAL PROBLEM OR CONDITION, PLEASE CONTACT A QUALIFIED HEALTH CARE PROFESSIONAL IMMEDIATELY. IF YOU ARE IN THE UNITED STATES AND ARE EXPERIENCING A MEDICAL EMERGENCY, PLEASE CALL 911 OR CALL FOR EMERGENCY MEDICAL HELP ON THE NEAREST TELEPHONE. Mayo Clinic may modify these terms and conditions at any time, and such modifications shall be effective immediately upon posting the modified terms and conditions on Mayo Clinic's Site. You agree to review the agreement periodically to be aware of such modifications, and your accessing or using the service constitutes your acceptance of the agreement as it appears at the time of your access or use. From time to time, Mayo Clinic may offer Site visitors the opportunity to participate in additional features or services through this Site. You may be required to enter into additional agreements or authorizations before you can access such features or services. Intended for users 18 and older Other than our Patient Portal, the Site is intended for use by individuals 18 years of age or older. This Site is not directed for use by children under the age of 18. Users under the age of 18 should get the assistance of a parent or guardian to use this Site. Our Patient Portal is available to patients 18 years of age and older. It is also available to patients who are between the ages of 13 years old and 17 years old with the permission of their parents or legal guardians.",1
"Acceptable use You agree that you will not: - Use this website for any purpose in violation of local, state, national, or international laws. - Use this Site as a means to distribute advertising or other unsolicited material to any third party. - Use this website to post or transmit material that is unlawful, obscene, defamatory, threatening, harassing, abusive, slanderous, hateful, or embarrassing to any other person or entity. - Attempt to disable, “hack,” or otherwise interfere with the proper functioning of this website. - Violate or attempt to violate the security of the Site, including, without limitation: - accessing data not intended for Site users or logging onto a server or an account which Site users are not authorized to access; - attempting to probe, scan or test the vulnerability of a system or network or to breach security or authentication measures without proper authorization; or - accessing or using the Site or any portion thereof without authorization, in violation of these Terms of Use or in violation of applicable law. - Use any scraper, crawler, spider, robot, or other automated means of any kind to access or copy data on the Site, deep-link to any feature or content on the Site, or bypass our robot exclusion headers or other measures we may use to prevent or restrict access to the Site.",1
"- Use any device, software, routine, or any other means to interfere or attempt to interfere with the proper working of this Site or any activity being conducted on this Site. Violations of system or network security may result in civil or criminal liability. Mayo Clinic will investigate occurrences that may involve such violations and may involve, and cooperate with, law enforcement authorities in prosecuting users who are involved in such violations. In the event access to the Site or a portion thereof is limited by requiring a user ID and password (“Protected Areas”), you agree to access Protected Areas using only your user ID and password as provided to you by Mayo Clinic. You agree to protect the confidentiality of your user ID and password and not to share or disclose your user ID or password to any third party. You agree that you are fully responsible for all activity occurring under your user ID. Your access to the Site may be revoked by Mayo Clinic at any time with or without cause. Account set-up You agree to the following: - You agree to provide true, accurate, current, and complete information when registering to use the Site and establishing an account (“Registration Information”). - You agree to maintain and promptly update the Registration Information to keep it true, accurate, current, and complete.",1
"If you provide any information that is untrue, inaccurate, not current, or incomplete, or Mayo Clinic has reasonable grounds to suspect that such information is untrue, inaccurate, not current, or incomplete, Mayo Clinic may suspend or terminate your account. - You agree that you are entirely responsible for maintaining the confidentiality of any passwords and any usage and activities that occur in connection with your account. - You agree not to allow others to access your account or utilize your password. Doing so will compromise the security of your account. Order limitations We reserve the right to reject any order you place with us from the Mayo Clinic Store and Mayo Clinic Marketplace, or to limit quantities on any order, without giving any reason. If we reject your order, we will generally attempt to notify you using the email address you gave us when you placed the order. Mayo Clinic reserves the right, at our sole discretion, to limit the quantity of items purchased per person, per household, or per order. These restrictions may be applicable to orders placed by the same account, the same credit card, and also to orders that use the same billing and/or shipping address. We will provide notification to the customer should such limits be applied. Please note that certain orders constitute improper use of the Site or purchase of products. We reserve the right, at our sole discretion, to refuse or cancel any order for any reason.",1
"Your account may also be restricted or terminated for any reason, at our sole discretion. Mayo Clinic also reserves the right, at our sole discretion, to prohibit sales to dealers or resellers. For purposes of these Terms of Use, reselling shall be defined as purchasing or intending to purchase any product(s) from Mayo Clinic for the purpose of engaging in a commercial sale of that same product(s) with a third party. Termination of use Mayo Clinic may, in its sole discretion, terminate your account or your use of the Site at any time. You are personally liable for any orders that you place or charges that you incur prior to termination. Mayo Clinic reserves the right to change, suspend, or discontinue all or any aspects of the Site at any time without prior notice. User-Generated Content, Reviews, Feedback, and other Postings to the Site If you submit, upload, or post any comments, ideas, suggestions, information, files, videos, images, or other materials to us or our Site (“User-Generated Content”), you agree not to provide any User-Generated Content that (1) is defamatory, abusive, libelous, unlawful, obscene, threatening, harassing, fraudulent, pornographic, or harmful, or that could encourage criminal or unethical behavior, (2) violates or infringes the privacy, copyright, trademark, trade dress, trade secrets, or intellectual property rights of any person or entity, or (3) contains or transmits a virus or any other harmful component.",1
"You agree not to contact other users of the Site through unsolicited e-mail, telephone calls, mailings, or any other method of communication. You represent and warrant to Mayo Clinic that you have the legal right and authorization to provide all User-Generated Content to Mayo Clinic for the purposes and Mayo Clinic's use as set forth herein. Mayo Clinic shall have a royalty-free, irrevocable, transferable right and license to use the User-Generated Content in whatever manner Mayo Clinic desires, including, without limitation, to copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from, and/or sell and/or distribute such User-Generated Content and/or incorporate such User-Generated Content into any form, medium, or technology throughout the world. Mayo Clinic is and shall be under no obligation (1) to maintain any User-Generated Content in confidence; (2) to pay to you any compensation for any User-Generated Content; or (3) to respond to any User-Generated Content. Mayo Clinic does not regularly review posted User-Generated Content but does reserve the right (but not the obligation) to monitor and edit or remove any User-Generated Content submitted to the Site. You grant Mayo Clinic the right to use the name that you submit in connection with any User-Generated Content. You agree not to use a false email address, impersonate any person or entity, or otherwise mislead as to the origin of any User-Generated Content.",1
"You are and shall remain solely responsible for the content of any User-Generated Content you make. Mayo Clinic and its affiliates take no responsibility and assume no liability for any User-Generated Content submitted by you or any third party. E-Commerce Payment. A valid credit card number, expiration date, and card security code is required for all purchases on the Mayo Clinic Store and Mayo Clinic Marketplace. If we are unable to charge the full cost of your purchase to the credit card you provide, we may cancel your order or request an alternate form of payment. Mayo Clinic's designated credit card processor will collect your credit card information and related personal information for its use in processing your payment for the products or services ordered by you. Any complaints or grievances regarding the processing of your payment should be addressed to Mayo Clinic at mayoclinicsupport@mayoclinic.com. You understand that the prices for products and services may be changed from time to time. If you enroll to make recurring payments automatically, all charges and fees will be billed to the credit card you designate during the setup process. If you want to designate a different credit card or if there is a change in your credit card, you must change your information online. This may temporarily delay your ability to make online payments while we verify your new payment information.",1
"You represent and warrant that if you are making online payments that (i) any credit card, debit card, or bank account information you supply is true, correct, and complete, (ii) charges incurred by you will be honored by your credit/debit card company or bank, (iii) you will pay the charges incurred by you in the amounts posted, including any applicable taxes, (iv) you are the person in whose name the card was issued, and (v) you are authorized to make a purchase or other transaction with the relevant credit card and credit card information. Prescriptions. Some products available through the Mayo Clinic Store site may require a valid prescription by a licensed healthcare provider (“Provider”). Mayo Clinic does not endorse any specific device, durable medical equipment, medication, pharmacy, or pharmacologic product (collectively “Prescription Product”). If a Provider prescribes a Prescription Product, he/she will limit supply based upon state regulations and will only prescribe a Prescription Product as determined in his/her own discretion and professional judgment. There is no guarantee a prescription will be written. You agree that any prescriptions that you acquire from a Provider will be solely for your personal use. You agree to fully and carefully read all provided product information and labels and to contact a physician or pharmacist if you have any questions regarding the prescription.",1
"Mayo Clinic fully honors patient freedom of choice and, if you receive a prescription for a Prescription Product from Mayo Clinic or a Mayo Provider, you always have the option to instruct Mayo Clinic to transmit that prescription to the pharmacy of your choice. Any questions about prescriptions for Mayo Clinic Store purchases should be directed to accounts@store.mayoclinic.com. Responsibility for charges and fees; Insurance. You are solely responsible for all charges and applicable fees (including delivery charges, taxes and any fees assessed by your bank) associated with your order from the Mayo Clinic Store. Some products or charges may be eligible for payment or reimbursement by Medicare, Medicaid, private insurance, out-of-state workers' compensation payer, or other insurance plan. Regardless of insurance coverage and reimbursement amounts, you will be responsible for the purchase price and all charges associated with your order and product purchase. Any questions about insurance coverage for Mayo Clinic Store purchases should be directed to accounts@store.mayoclinic.com.",1
"Indemnification You agree that you will defend, indemnify, and hold harmless Mayo Clinic from and against any damages, losses, liabilities, judgments, costs, or expenses (including reasonable attorneys' fees and costs) against or incurred by Mayo Clinic arising out of a claim by a third party relating to your breach of these Terms of Use or applicable law, User-Generated Content and any other materials you post or allow to be posted to the Site, your use or access of the Site, access of this Site by anyone using your user ID and password, or any other actions taken by you on the Site. Intellectual property The marks “Mayo,” “Mayo Clinic,” “Mayo Clinic Health System,” and the triple-shield Mayo logo are trademarks and/or service marks of the Mayo Foundation for Medical Education and Research. The content and design of this Site is protected by U.S. and international copyright laws. You may not copy, reproduce, republish, upload, post, display, transmit, or frame any of these materials without prior written consent from the copyright owners, except that you may view, download, display, and print a single copy of these materials on a single computer for personal, noncommercial use only, so long as: you do not alter or modify the materials in any way; you include all applicable notices and disclaimers (including copyright notices); and you do not use the materials in a way that suggests an association with Mayo Clinic or an affiliated Mayo entity.",1
"You understand and agree that title to these materials shall not pass to you or any other user. Disclaimers YOU UNDERSTAND AND AGREE THAT MAYO CLINIC SITE AND ANY SERVICES, CONTENT, OR INFORMATION CONTAINED ON OR PROVIDED BY MAYO CLINIC SITE IS PROVIDED ON AN “AS IS” BASIS. MAYO CLINIC DOES NOT MAKE ANY EXPRESS OR IMPLIED WARRANTIES, REPRESENTATIONS, OR ENDORSEMENTS WHATSOEVER (INCLUDING WITHOUT LIMITATION WARRANTIES OF TITLE OR NONINFRINGEMENT OR THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE) WITH REGARD TO THE SERVICE OR ANY MERCHANDISE, INFORMATION, OR SERVICE PROVIDED THROUGH THE SERVICE. IN ADDITION, MAYO CLINIC DOES NOT GUARANTEE THAT USE OF MAYO CLINIC SITE WILL BE FREE FROM TECHNOLOGICAL DIFFICULTIES INCLUDING, BUT NOT LIMITED TO, UNAVAILABILITY OF INFORMATION, DOWNTIME, SERVICE DISRUPTIONS, VIRUSES, OR WORMS. YOU UNDERSTAND THAT YOU ARE RESPONSIBLE FOR IMPLEMENTING SUFFICIENT PROCEDURES AND CHECKPOINTS TO SATISFY YOUR PARTICULAR REQUIREMENTS FOR ACCURACY OF DATA INPUT AND OUTPUT. Errors on Mayo Clinic Site Content, prices, and availability of products and services are subject to change without notice. Errors will be corrected where discovered, and Mayo Clinic reserves the right to revoke any stated offer and to correct any errors, inaccuracies, or omissions, including after an order has been submitted and whether or not the order has been confirmed and your credit card charged.",1
"In the event a product or service is listed at an incorrect price due to typographical error or error in pricing information received from our suppliers, we shall have the right to refuse or cancel any orders placed for product / service listed at the incorrect price. We shall have the right to refuse or cancel any such orders whether or not the order has been confirmed and your credit or debit card charged. If your credit or debit card has already been charged for the purchase and your order is canceled, we shall promptly issue a credit to your credit or debit card account in the amount of the incorrect price. Individual bank policies will dictate when this amount is credited to your account. If you are not fully satisfied with your purchase, you may return it in accordance with the Site's return policy. Accuracy and integrity of information Although Mayo Clinic attempts to ensure the integrity and accuracy of the Site, it makes no representations, warranties, or guarantees whatsoever as to the correctness or accuracy of the Site and content thereon. It is possible that the Site could include typographical errors, inaccuracies, or other errors and that unauthorized additions, deletions, and alterations could be made to the Site by third parties. In the event that an inaccuracy arises, please inform Mayo Clinic so that it can be corrected. Mayo Clinic reserves the right to unilaterally correct any inaccuracies on the Site without notice.",1
"Information contained on the Site may be changed or updated without notice. Additionally, Mayo Clinic shall have no responsibility or liability for information or content posted to the Site from any non-Mayo Clinic affiliated third party. Limitations of liability THE USE OF THE SITE IS ENTIRELY AT YOUR OWN RISK, AND IN NO EVENT SHALL MAYO CLINIC BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY, PUNITIVE, OR ANY OTHER MONETARY OR OTHER DAMAGES, FEES, FINES, PENALTIES, OR LIABILITIES ARISING OUT OF OR RELATING IN ANY WAY TO THIS SERVICE, OR SITES ACCESSED THROUGH THIS SERVICE, AND/OR CONTENT OR INFORMATION PROVIDED HEREIN. ANY CLAIMS AGAINST MAYO CLINIC AND MAYO CLINIC'S LIABILITY RELATING TO A PRODUCT OR SERVICE PURCHASED ON OUR SITE IS LIMITED TO THE AMOUNT YOU PAID FOR THE PRODUCT OR SERVICE. YOUR SOLE AND EXCLUSIVE REMEDY FOR DISSATISFACTION WITH THE SITE OR SERVICE IS TO STOP USING THE SERVICE. USER HEREBY ACKNOWLEDGES THAT THIS PARAGRAPH SHALL APPLY TO ALL CONTENT, MERCHANDISE, AND SERVICES AVAILABLE THROUGH THE SITE. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL DAMAGES, SO THE ABOVE LIMITATION OR EXCLUSION MAY NOT APPLY TO YOU. Links to third party websites The Site contains links to other sites operated by third parties, including but not limited to third party sites that may display the Mayo Clinic trademarks (“Third Party Sites”).",1
"These links are available for your convenience and are intended only to enable access to these Third Party Sites and for no other purpose. Mayo Clinic does not warrant or make any representation about the substance, quality, functionality, accuracy, fitness for a particular purpose, merchantability or any other representation about any Third Party Site or its content. A link to a Third Party Site on the Mayo Clinic Site does not constitute sponsorship, endorsement, approval, or responsibility for any Third Party Site. Mayo Clinic makes no representation or warranty as to any products or services offered on any Third Party Site. The conditions of use and privacy policy of any Third Party Site may differ substantially from the conditions of use and legal notices that apply to your use of the Site. Please review the conditions of use for all Third Party Sites for more information about the terms and conditions that apply to your use of Third Party Sites. Jurisdiction You agree that any dispute or claim (including personal injury claims) related to your use of the Mayo Clinic Site shall be governed by the laws of the State of Minnesota. The exclusive forum for actions between the parties is the District Court of Minnesota sitting in Olmsted County, Minnesota. These Terms of Use also apply to anyone claiming on your behalf. Contact information If you have any questions about the service, please contact us at mayoclinicsupport@mayoclinic.com.",1
"This is where the unbelievable happens. At Mayo Clinic, we are doing what’s never been done. From groundbreaking treatments to personalized care enhanced through innovations like AI and 3D printing, we have the skills, the people, and the ideas to transform medicine. Health care will never be the same. Watch our documentary: Get a closer look at how 3D printing is transforming surgery and saving lives. Stay connected. Sign up for videos, articles, and insights from Mayo Clinic physicians and teams. Find out more: How our physicians and teams are pushing the boundaries of possible. Curing the uncurable: Maggie’s story. An experimental drug helps treat one girl’s rare disease. Read more about Maggie’s story Seeing the unseeable: Chris’s story. A bone marrow transplant that offered a veteran more hope. Read more about Chris’s story Treating the untreatable: Danielle’s story. The complex procedure that healed a dancer. Read more about Danielle's story Solving the unsolvable: Maria’s story. A surgery to end the pain from trigeminal neuralgia. Read more about Maria's story Predicting the unpredictable: Tygh’s story. A proactive approach to manage Krabbe disease. Read more about Tygh's story Detecting the undetectable: Alejandro’s story. Early colon cancer detection saves a life. Read more about Alejandro’s story See if our team of experts can help you. Play Video Play Video Play Video Find out more:How diseases are becoming more curable through the power of data.",1
"Find out more:How making details more seeable bring a better diagnosis. Find out more: How complex surgeries are made more predictable through technology. 1 & only. Mayo Clinic is proud to be ranked No. 1 in Minnesota and Arizona, as well as the top hospital in the Jacksonville metro area, with more specialties ranked in the top three than any other hospital in the nation, according to U.S. News & World Report. Cure, Connect, and Transform. These three words are the foundation of our Bold. Forward. strategy—the driving force behind our transformation and delivery of healthcare. We are changing everything and creating new possibilities for patients by providing unparalleled team-based expertise for patients with complex or serious conditions, leveraging cutting-edge technology to connect with patients no matter where they are, and developing an innovative new digital data platform to deliver new knowledge and insights. The future of healthcare is here. Why choose Mayo Clinic More experience The million patients we treat each year prepares us to treat the one who matters most — you. The right answers Count on our experts to deliver an accurate diagnosis and the right plan for you the first time. You come first Treatment at Mayo Clinic is a truly human experience. You’re cared for as a person first. Innovation with impact All of our patient care, education and research are driven to make discoveries that can help heal you. Multiple locations.",1
One vision to change medicine as we know it. Scottsdale & Phoenix Mayo Clinic in Arizona Jacksonville Mayo Clinic in Florida Rochester Mayo Clinic in Minnesota,1
"Pa PAES SeePain, back SeePain, breast SeePain, chest SeePain, knee SeePain, neck SeePain, wrist SeePainful bladder syndrome SeePainful periods SeePalsy, Bell's SeePalsy, cerebral SeePalsy, facial SeePancreas inflammation SeeParaneoplastic neurological disorder SeeParaneoplastic neurological syndrome SeePartial anomalous pulmonary venous connection SeePathological gambling SeePathological laughter and crying SeePathological stealing See Pb PBA See Pc PCOS See Pd Pe Pediculosis capitis SeePelvic pain, chronic SeePelvic support problems, uterine prolapse SeePerforated eardrum SeePericardial inflammation SeePeriodontal disease, gingivitis SeePeriodontal disease, periodontitis SeePeripheral neurofibromatosis SeePeripheral vascular disease SeePernicious anemia SeePernio SeePeroneal muscular atrophy SeePersonality disorder, antisocial SeePersonality disorder, borderline SeePersonality disorder, narcissistic SeePersonality disorder, schizoid SeePersonality disorder, schizotypal SeePertussis SeePes planus SeePetit mal seizure See Ph Pharyngitis SeePhlebitis SeePhobia, social See Pi Pick's disease SeePiles SeePilonidal dimple SeePimples SeePituitary adenoma SeePituitary insufficiency SeePityriasis versicolor See Pk PKD SeePKU See Pl Plantar neuroma SeePleuritis See Pn PN SeePNF See Po Polyps, colon SeePolyps, endometrial SeePolyps, nasal SeePolyps, stomach SeePolyps, uterine SeePompholyx SeePoor color vision SeePopliteal cyst SeePost-cardiac injury syndrome SeePost-chemotherapy cognitive impairment SeePost-concussion syndrome SeePosterior prolapse SeePostmyocardial infarction syndrome SeePostural hypotension See Pr Prader-Labhart-Willi syndrome SeePreexcitation syndrome SeePregnancy-related hypertension SeePremature ovarian failure SeePremature ovarian insufficiency SeePremature puberty SeePremenstrual syndrome SeePresbycusis SeePressure sore SeePressure ulcer SeePrickly heat SeePrimary adrenal insufficiency SeePrimary biliary cirrhosis SeePrimary polycythemia SeeProlapse, mitral valve SeeProlapsed bladder SeeProlapsed uterus SeeProstate gland enlargement SeePruritis ani SeePruritus See Ps Pt Pu Puffy eyes See Pv PVPS See Py Pyelonephritis See Mayo Clinic does not endorse companies or products.",1
Advertising revenue supports our non-profit mission.,1
"Specialty rankings Mayo Clinic is top-ranked in more specialties than any other hospital and has been recognized as an Honor Roll member according to U.S. News & World Report’s 2025-2026 “Best Hospitals” rankings. U.S. News & World Report 2025-2026 “Best Hospitals” Rankings Rochester, Minnesota Breakthroughs don’t happen unless you make them We are changing the very definition of possible, and we’re doing it right here, right now. Meet the physicians and teams united by an unrelenting purpose to change the future of healthcare, forever. From research to reality, faster Mayo Clinic patients are often the first to benefit from our research. Right now, our doctors are working on more than 12,000 clinical studies, researching new treatments and therapies for the world’s most challenging and complex medical issues. “Mayo Clinic is once again honored to lead the “Best Hospitals” rankings. This recognition affirms our commitment to healthcare excellence as we continue to transform healthcare for people everywhere.” Gianrico Farrugia, M.D. Mayo Clinic's president and CEO Contact us Phoenix/Scottsdale, Arizona Mayo Clinic in Arizona is the No. 1 hospital in Arizona for the 13th consecutive year. Jacksonville, Florida Most top-ranked specialties in Florida. Rochester, Minnesota Mayo Clinic in Rochester is the No. 1 hospital in the world and top-ranked in 13 specialties nationally.",1
"Foresight from Unparalleled Insight Drone footage sweeping over Mayo Clinic’s downtown Rochester campus during sunrise, emphasizing the size and modern architecture of the facility. Your Trusted Partner in Health Mayo Clinic’s Executive Health Program leverages the full breadth and depth of its nationally recognized expertise to help busy CEOs, business leaders, and executives protect and optimize their health and performance - combining world-class physicians, advanced diagnostics and therapeutics, and expert interpretation and insight to help executives thrive at work and in life. Access to the Top-Ranked, World’s Best Care Mayo Clinic is top-ranked in more specialties than any other hospital in the nation and has been named Newsweek’s “World’s Best Hospital”. In our Executive Health Program we combine expert physicians with state-of-the-art technology including artificial intelligence, digital imaging, and telemedicine to proactively address your health needs. Customized Itinerary. Comprehensive Care. Our Executive Health Program maximizes your visit through a comprehensive and personalized 1-to-3-day itinerary of preventive health exams, tests, and consults tailored to your medical assessment and what matters most to you. If needed we can leverage the full breadth, depth and medical rigor of Mayo Clinic for our Executive Health patients. Rochester,Minnesota Scottsdale,Arizona Jacksonville,Florida London,United Kingdom",1
"What it is, how it's done, how to prepare, risks and results. Mayo Clinic accepts appointments in Arizona, Florida and Minnesota and at Mayo Clinic Health System sites. Mayo Clinic conducts thousands of clinical trials and research studies each year. Mayo Clinic cancer specialists use innovative therapies to treat even the rarest of cancers while helping you maintain your quality of life. Mayo Clinic heart specialists have extensive experience in treating heart disease, and perform more than 10,000 cardiac procedures and 4,000 surgeries each year, including complex and minimally invasive surgical procedures. Mayo Clinic's departments of Neurology and Neurosurgery are highly rated for their patient outcomes and research achievements. Mayo Clinic is the largest integrated transplant provider in the United States, performing all solid organ and bone marrow transplants. Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission. Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press. Your GivingTuesday gift can go 2X as far.",1
"Mayo Clinic in Rochester, Minnesota World-class care, focused on you Welcome to Mayo Clinic in Rochester, Minnesota, the original and largest Mayo Clinic campus. Located in the heart of Rochester, Minnesota — a dynamic city just 90 minutes south of the Twin Cities of Minneapolis and St. Paul — Mayo Clinic has been safely caring for patients from around the world for more than 100 years. Mayo Clinic will always be your safe care destination. Planning your trip here Additional help to make the most of your visit Learn about Rochester, Minnesota Discover more about this Midwest destination. Wellness services to enhance your onsite experience We offer a variety of wellness services including spa services, healthy living classes, and more to help make your stay both comfortable and enjoyable. Be a blood donor Each whole blood donation can help save lives.",1
"To request an appointment at Mayo Clinic, patients living in the U.S. can call during local business hours to speak with an appointment coordinator. Because hold times vary, you can also use our online request above to tell us when to call you. If this is an emergency, call 911 or your local emergency services. Rochester, Minnesota Central Appointment Office 507-538-3270 7 a.m. to 6 p.m. Central time Monday through Friday Children's Center 855-629-6543 7 a.m. to 6 p.m. Central time Monday through Friday Phoenix/Scottsdale, Arizona Central Appointment Office 480-301-8484 8 a.m. to 5 p.m. Mountain time Monday through Friday Jacksonville, Florida Central Appointment Office 904-953-0853 8 a.m. to 5 p.m. Eastern time Monday through Friday Mayo Clinic Health System Our regional network of care providers serving communities in Iowa, Minnesota and Wisconsin. Find phone numbers for a location near you",1
"Mayo Clinic's mission is to provide the best care to every patient through integrated clinical practice, education and research. Mayo Clinic strives to benefit humanity through work in these three areas while supporting the communities in which people live and work. Mayo Clinic appropriately serves patients in difficult financial circumstances and offers financial assistance to those who have an established need to receive medically necessary services and meet criteria for assistance. Mayo Clinic seeks to provide support for those unable to pay for medically necessary care. This includes: - Using fair and consistent billing and collection practices, including charitable care and financial assistance policies and a standard application process - Providing extended payment plan options and medically necessary services at reduced rates or at no cost for patients eligible for financial assistance - Providing emergency care, regardless of ability to pay Mayo Clinic determines the need for financial assistance by reviewing the medically necessary services requested by the referring provider; any care previously provided; available insurance coverage or other sources of payment; and an applicant's financial profile. This method allows for a fair and accurate way to assist patients who are experiencing financial hardship.",1
"Required financial information may include annual household income, applicable assets, household size and confirmation of application for all sources of coverage, including Medicaid, if eligible. International patients are not generally eligible for financial assistance. If you're experiencing financial hardship, please contact Patient Account Services to discuss options such as a payment plan or financial assistance. You may visit Registration and Business Services offices in any of the following locations: Mayo Clinic in Arizona - Mayo Clinic Building, Scottsdale campus - Mayo Clinic Specialty Building, Phoenix campus - Mayo Clinic Hospital, Phoenix campus You may also call Patient Account Services at 844-217-9591 (toll-free), Monday through Friday, 8 a.m. to 5 p.m. Mountain time. Mayo Clinic in Florida - Davis Building - Mayo Clinic Hospital - Mayo Building You may also call Patient Account Services at 844-217-9591 (toll-free), Monday through Friday, 8 a.m. to 5 p.m. Eastern time. Mayo Clinic in Minnesota - Mayo Clinic — Gonda Building, Lobby Level East - Mayo Clinic Hospital, Methodist Campus — Eisenberg Building, Lobby Level - Mayo Clinic Hospital, Saint Marys Campus — Mary Brigh Building, Main Floor You may also call Patient Account Services at 844-217-9591 (toll-free), Monday through Friday, 8 a.m. to 5 p.m. Central time. You may also contact us by phone. Call Patient Account Services at 844-217-9591 (toll-free), Monday through Friday.",1
"All Mayo locations Monday through Thursday 7:00 a.m. to 7:00 p.m. Central time (during daylight saving time) 7:00 a.m. to 6:00 p.m. Central time (during standard time) Friday 7:00 a.m. to 4:00 p.m. (year round) Collaborating to Help You Mayo Clinic collaborates with Elevate Patient Financial Solutions (ElevatePFS) to provide free financial advocacy for patients who do not have medical insurance. ElevatePFS will work with patients to identify what assistance they may qualify for. Special programs are available to those who meet certain eligibility requirements such as: - Eligibility-Medicaid, Medicare, COBRA - Disability (SSDI/SSI) You may be referred to ElevatePFS if you received care from Mayo Clinic without insurance or if a financial counselor identified that you might need or qualify for more insurance coverage. You may reach ElevatePFS directly: Rochester: 1-715-318-0498 Arizona: 1-623-254-7152 Florida: 1-904-862-2069 How do I apply? The most convenient option for most people is to submit a financial assistance application through their Patient Online Services accounts. - Applying through Patient Online Services lets you submit all documentation online. - Please note that you must have a patient account already established with Mayo Clinic to use this option. - Log in or create your patient account now.",1
"Alternatively: Please note that if you choose either alternative option, you must mail or fax your supporting documentation and/or PDF application, whereas applying via Patient Online Services lets you submit the supporting documentation online. Please return the completed application (if in PDF form) and all other required supporting documentation (unstapled, unclipped, and unaltered) to Patient Account Services: By mail: Mayo Clinic PO Box 860910 Minneapolis, MN 55486-0910 Or by fax: 507-284-3445 Additional documents Related information",1
Skip to content Care at Mayo Clinic Patient-Centered Care About Mayo Clinic Request Appointment Find a Doctor Locations Clinical Trials Connect to Support Groups Patient & Visitor Guide Billing & Insurance Departments & Centers International Services Contact Us Patient & Visitor Guide Health Library Diseases & Conditions Symptoms Tests & Procedures Drugs & Supplements Healthy Lifestyle Mayo Clinic Health Letter & Books Mayo Clinic Health Letter & Books For Medical Professionals Medical Professional Resources Refer a Patient Continuing Medical Education Mayo Clinic Laboratories Video Center Journals & Publications Mayo Clinic Alumni Association Continuing Medical Education Research & Education at Mayo Clinic Research Research at Mayo Clinic Research Faculty Laboratories Core Facilities Centers & Programs Departments & Divisions Clinical Trials Institutional Review Board Postdoctoral Fellowships Training Grant Programs Education Mayo Clinic College of Medicine and Science Mayo Clinic Graduate School of Biomedical Sciences Mayo Clinic Alix School of Medicine Mayo Clinic School of Graduate Medical Education Mayo Clinic School of Health Sciences Mayo Clinic School of Continuous Professional Development Mayo Clinic College of Medicine and Science Giving to Mayo Clinic Give Now Giving to Mayo Clinic Frequently Asked Questions Contact Us to Give Make a Donation Request appointment Log in Search Menu Request appointment Donate Diseases & conditions Find a doctor Care at Mayo Clinic Patient-Centered Care About Mayo Clinic Request Appointment Find a Doctor Locations Clinical Trials Connect to Support Groups Patient & Visitor Guide Billing & Insurance Departments & Centers International Services Contact Us Patient & Visitor Guide Health Library Diseases & Conditions Symptoms Tests & Procedures Drugs & Supplements Healthy Lifestyle Mayo Clinic Health Letter & Books Mayo Clinic Health Letter & Books For Medical Professionals Medical Professional Resources Refer a Patient Continuing Medical Education Mayo Clinic Laboratories Video Center Journals & Publications Mayo Clinic Alumni Association Continuing Medical Education Research & Education at Mayo Clinic Research Research at Mayo Clinic Research Faculty Laboratories Core Facilities Centers & Programs Departments & Divisions Clinical Trials Institutional Review Board Postdoctoral Fellowships Training Grant Programs Education Mayo Clinic College of Medicine and Science Mayo Clinic Graduate School of Biomedical Sciences Mayo Clinic Alix School of Medicine Mayo Clinic School of Graduate Medical Education Mayo Clinic School of Health Sciences Mayo Clinic School of Continuous Professional Development Mayo Clinic College of Medicine and Science Giving to Mayo Clinic Give Now Giving to Mayo Clinic Frequently Asked Questions Contact Us to Give Make a Donation Home Home Billing and Insurance Financial assistance Financial Assistance Documents — Arizona campus Billing and Insurance Overview Before arriving Overview Patient checklist Registration International patients Pre-service deposits Frequently asked questions Insurance Overview Insurance types accepted at Mayo Clinic Overview Contracted insurance plans Medicare Medicaid TRICARE HMOs Other insurance types Uninsured patients Insurance approvals Prescription prior authorizations Post-service denials Out-of-network patient information Frequently asked questions Bills and payments Overview Billing process Understanding your statements Payment options Frequently asked questions Frequently asked questions about messaging fees Financial assistance Overview Financial Assistance Documents — Arizona campus Financial Assistance Documents — Florida campus Financial Assistance Documents — Minnesota campus Copay and Grant Assistance Program Overview Frequently asked questions Price estimates Overview CMS price transparency Arizona price transparency Florida price transparency Minnesota price transparency No Surprises Act Contact us Glossary of billing and insurance terms Home Home Billing and Insurance Financial assistance Financial Assistance Documents — Arizona campus Double your impact!,1
Give Now! Your GivingTuesday gift can go 2X as far. Give Now!,1
Skip to content Care at Mayo Clinic Patient-Centered Care About Mayo Clinic Request Appointment Find a Doctor Locations Clinical Trials Connect to Support Groups Patient & Visitor Guide Billing & Insurance Departments & Centers International Services Contact Us Patient & Visitor Guide Health Library Diseases & Conditions Symptoms Tests & Procedures Drugs & Supplements Healthy Lifestyle Mayo Clinic Health Letter & Books Mayo Clinic Health Letter & Books For Medical Professionals Medical Professional Resources Refer a Patient Continuing Medical Education Mayo Clinic Laboratories Video Center Journals & Publications Mayo Clinic Alumni Association Continuing Medical Education Research & Education at Mayo Clinic Research Research at Mayo Clinic Research Faculty Laboratories Core Facilities Centers & Programs Departments & Divisions Clinical Trials Institutional Review Board Postdoctoral Fellowships Training Grant Programs Education Mayo Clinic College of Medicine and Science Mayo Clinic Graduate School of Biomedical Sciences Mayo Clinic Alix School of Medicine Mayo Clinic School of Graduate Medical Education Mayo Clinic School of Health Sciences Mayo Clinic School of Continuous Professional Development Mayo Clinic College of Medicine and Science Giving to Mayo Clinic Give Now Giving to Mayo Clinic Frequently Asked Questions Contact Us to Give Make a Donation Request appointment Log in Search Menu Request appointment Donate Diseases & conditions Find a doctor Care at Mayo Clinic Patient-Centered Care About Mayo Clinic Request Appointment Find a Doctor Locations Clinical Trials Connect to Support Groups Patient & Visitor Guide Billing & Insurance Departments & Centers International Services Contact Us Patient & Visitor Guide Health Library Diseases & Conditions Symptoms Tests & Procedures Drugs & Supplements Healthy Lifestyle Mayo Clinic Health Letter & Books Mayo Clinic Health Letter & Books For Medical Professionals Medical Professional Resources Refer a Patient Continuing Medical Education Mayo Clinic Laboratories Video Center Journals & Publications Mayo Clinic Alumni Association Continuing Medical Education Research & Education at Mayo Clinic Research Research at Mayo Clinic Research Faculty Laboratories Core Facilities Centers & Programs Departments & Divisions Clinical Trials Institutional Review Board Postdoctoral Fellowships Training Grant Programs Education Mayo Clinic College of Medicine and Science Mayo Clinic Graduate School of Biomedical Sciences Mayo Clinic Alix School of Medicine Mayo Clinic School of Graduate Medical Education Mayo Clinic School of Health Sciences Mayo Clinic School of Continuous Professional Development Mayo Clinic College of Medicine and Science Giving to Mayo Clinic Give Now Giving to Mayo Clinic Frequently Asked Questions Contact Us to Give Make a Donation Home Home Giving to Mayo Clinic Contact us Giving to Mayo Clinic Overview Our priorities Overview Artificial intelligence Bold.,1
Forward. Unbound. Cancer Clinical trials Mayo Clinic Alix School of Medicine Mayo Clinic Platform Novel therapeutics and advanced diagnostics President's Strategic Initiative Fund Ways to give Overview Alumni giving Annual giving Corporate and foundation giving Overview Corporate matching gift programs Employee and retiree giving International giving Gift planning Honoring philanthropy Contact us Overview Frequently asked questions Home Home Giving to Mayo Clinic Contact us Double your impact! Give Now! Your GivingTuesday gift can go 2X as far. Give Now!,1
"Ba Baldness SeeBarber's itch SeeBarlow's syndrome SeeBarotitis media SeeBarotrauma SeeBasal joint arthritis See Bb BBS See B Bd BDD See Be Behcet syndrome SeeBenign migratory glossitis SeeBenign paroxysmal positional vertigo SeeBerger's disease See Bi Bile duct cancer SeeBinge drinking See Bl Blackheads SeeBladder calculi SeeBladder control, loss of SeeBladder infection SeeBladder inflammation SeeBladder prolapse SeeBlastocystosis SeeBlocked ureter See Bm BMS See Bo Body odor and sweating SeeBone infection SeeBowel incontinence SeeBowel obstruction See Bp Br Bradycardia-tachycardia syndrome SeeBrain arteriovenous malformation SeeBrain tumor, child SeeBreast cancer, inflammatory SeeBreast cancer, male SeeBreast infection SeeBroken blood vessel in eye SeeBroken hip See Bu Bunyaviruses SeeBurkitt's tumor SeeBurn injury SeeBurning thigh pain SeeBursitis of the knee See Mayo Clinic does not endorse companies or products. Advertising revenue supports our non-profit mission.",1
"Mayo Clinic's approach Living-donor transplant consultation at Mayo Clinic Start your donor evaluation Begin the process of becoming a living kidney or liver donor by clicking here to complete a health history questionnaire. Living-Donor Toolkit Learn what transplant recipients and living donors can expect: tests, screening, the procedures, risks, recovery, financial information and more. Mayo Clinic has one of the largest transplant practices in the United States. Our transplant doctors, surgeons and other transplant staff members at the Mayo Clinic campuses in Arizona, Florida and Minnesota have extensive experience with living-donor kidney and liver transplantation. The living-donor process at Mayo Clinic starts with completing a health history questionnaire. Care team roles Health care professionals trained in many medical specialties work together as a team to ensure favorable outcomes for living donors. - Team approach. Mayo Clinic's integrated teams of surgeons, doctors, transplant nurses, pharmacists and others work together to provide your care, from your evaluation through post-surgery care. The transplant team will evaluate you to determine if you can donate a kidney or part of your liver. You'll have blood tests as well as a thorough physical examination and psychological evaluation. Several other tests, including detailed imaging of your liver or kidneys, will be performed to ensure that you're in good health and you meet donation criteria.",1
"After you donate an organ, living-donor coordinators and other transplant staff members will offer you support and follow-up care for several months after your surgery. - Coordinated care. Having all of this subspecialized expertise in a single place, focused on you, means that you're not just getting one opinion — your care is discussed among the team, your test results are available quickly, appointments are scheduled in coordination, and your transplant care team works together to determine what may be most appropriate for you. - Surgical expertise. Mayo Clinic surgeons perform living-donor transplant surgery for liver transplant and kidney transplant. Surgeons perform minimally invasive surgery to remove a living donor's kidney (laparoscopic donor nephrectomy) for a kidney transplant, which is less painful and has a shorter recovery time for the donor compared with open surgery. - Research. Mayo Clinic researchers actively study the health of donors after transplant surgery to improve results. At Mayo Clinic, you may have access to ongoing clinical trials, research and new treatments as part of your living-donor transplantation experience. The Mayo Clinic experience and patient stories Our patients tell us that the quality of their interactions, our attention to detail and the efficiency of their visits mean health care like they've never experienced. See the stories of satisfied Mayo Clinic patients.",1
"Expertise and rankings Living-donor transplant team at Mayo Clinic Experience Mayo Clinic surgeons have extensive experience performing living-donor transplant surgery for liver transplant and kidney transplant. Transplant leader Mayo Clinic has one of the largest living-donor kidney and liver transplant programs in the United States. Across its three sites, Mayo Clinic surgeons have performed more than 17,500 kidney transplants. They currently perform about 1,000 kidney transplants each year, including many from living kidney donors. Mayo Clinic surgeons perform more than 500 liver transplants each year among its three campuses, including many from living liver donors. Advanced treatment and technology Mayo Clinic surgeons have extensive expertise with all types of living-donor transplant surgeries, including minimally invasive procedures, HIV-positive organ donation, paired-organ donation and other complex procedures. Innovation and research Mayo Clinic transplant researchers take a leading role in efforts to find new, improved ways to conduct all aspects of transplantation, improve the experience of donation, reduce risks and improve the outcomes of transplantation. The Mayo Clinic Transplant Center supports many studies for living-donor transplant research. Nationally recognized expertise Mayo Clinic in Rochester, Minnesota, ranks No. 1 for diabetes and endocrinology in the U.S. News & World Report Best Hospitals rankings.",1
"Mayo Clinic in Phoenix/Scottsdale, Arizona, and Mayo Clinic in Jacksonville, Florida, are ranked among the Best Hospitals for diabetes and endocrinology by U.S. News & World Report. Mayo Clinic in Rochester, Minnesota, ranks No. 1 for digestive disorders in the U.S. News & World Report Best Hospitals rankings. Mayo Clinic in Phoenix/Scottsdale, Arizona, and Mayo Clinic in Jacksonville, Florida, are ranked among the Best Hospitals for digestive disorders by U.S. News & World Report. Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and Wisconsin, according to U.S. News & World Report's 2025–2026 ""Best Children's Hospitals"" rankings. Locations, travel and lodging Mayo Clinic has major campuses in Phoenix and Scottsdale, Arizona; Jacksonville, Florida; and Rochester, Minnesota. The Mayo Clinic Health System has dozens of locations in several states. For more information on visiting Mayo Clinic, choose your location below: Costs and insurance Living-donor frequently asked costs and insurance questions Learn more Mayo Clinic has dedicated transplant financial services representatives and social workers who can assist you with insurance and financial questions regarding your living organ donation. Mayo Clinic works with hundreds of insurance companies and is an in-network provider for millions of people. In most cases, Mayo Clinic doesn't require a physician referral.",1
"Some insurers require referrals or may have additional requirements for certain medical care. Many insurance companies require you to get preapproval authorization prior to transplant services. For international patients Mayo Clinic has dedicated international patient account representatives who can assist you with questions regarding your costs and insurance. Read more about international financial services. Case managers Mayo Clinic financial staff will work closely with your case managers from your insurance company. Your case manager, who is assigned to you, is available to answer questions and calls related to your insurance costs. Clinical trials Explore Mayo Clinic studies of tests and procedures to help prevent, detect, treat or manage conditions. Jan. 31, 2025",1
"Heart arrhythmia care at Mayo Clinic Mayo Clinic doctors trained in heart and blood vessel conditions (cardiologists), heart rhythm conditions (electrophysiologists), heart and blood vessel surgery (cardiovascular surgeons), and other areas collaborate as a multidisciplinary team to provide the most appropriate care for people with arrhythmia and other heart conditions. - One-stop care. A detailed itinerary for appointments, tests and procedures lets you make the most of your time at Mayo Clinic. All tests and labs are done at Mayo, which means tests taken in the morning can often be reviewed the same afternoon. This collaborative approach means your care team often can evaluate you and develop a treatment plan within 2 to 3 days. - Advanced diagnosis and treatment. Researchers in Mayo Clinic's Cardiovascular Research Center focus on developing diagnostic tests and innovative treatments for people with cardiovascular disease. - Innovative research. Professionals in the Heart Rhythm Clinic actively research the genetics, causes, diagnostic tests and treatments for arrhythmia and conduct clinical trials. Expertise and rankings Mayo Clinic doctors have extensive experience and expertise in diagnosing and treating people with all types of arrhythmia. Mayo doctors evaluate and treat more than 53,000 people with arrhythmia each year.",1
"Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Phoenix/Scottsdale, Arizona, and Mayo Clinic in Jacksonville, Florida, are ranked among the Best Hospitals for heart and heart surgery by U.S. News & World Report. Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and Wisconsin, according to U.S. News & World Report's 2025-2026 ""Best Children's Hospitals"" rankings. Mayo Clinic Children's Highly skilled pediatric experts diagnose and treat all types of conditions in children. As a team, we work together to find answers, set goals and develop a treatment plan tailored to your child's needs. Learn more about Mayo Clinic Children's. Locations, travel and lodging Mayo Clinic has major campuses in Phoenix and Scottsdale, Arizona; Jacksonville, Florida; and Rochester, Minnesota. The Mayo Clinic Health System has dozens of locations in several states. For more information on visiting Mayo Clinic, choose your location below: Costs and insurance Mayo Clinic works with hundreds of insurance companies and is an in-network provider for millions of people. In most cases, Mayo Clinic doesn't require a physician referral. Some insurers require referrals or may have additional requirements for certain medical care. All appointments are prioritized on the basis of medical need. Learn more about appointments at Mayo Clinic.",1
"Please contact your insurance company to verify medical coverage and to obtain any needed authorization prior to your visit. Often, your insurer's customer service number is printed on the back of your insurance card. Mayo Clinic Heart Rhythm Program Arizona Florida Minnesota Oct. 13, 2023",1
"Mayo Clinic has a diverse inventory of facilities and real estate. The inventory includes clinics, hospitals, research facilities, educational facilities, administrative, power plants, parking ramps, healthy living, senior housing and warehousing. These facilities are managed locally within coordinated Mayo Clinic expectations. Local management is focused on hub locations that include the following: - Mayo Clinic's campuses in Arizona (Phoenix and Scottsdale) - Mayo Clinic's campus in Florida (Jacksonville) - Mayo Clinic's campus in Minnesota (Rochester) - Mayo Clinic Health System — Northwest Wisconsin (Barron, Bloomer, Eau Claire, Menomonie and Osseo) - Mayo Clinic Health System — Southwest Wisconsin (La Crosse and Sparta) - Mayo Clinic Health System — Southeast Minnesota (Albert Lea, Austin, Cannon Falls, Lake City, Owatonna and Red Wing) - Mayo Clinic Health System — Southwest Minnesota (Fairmont, Mankato, New Prague, St. James, Springfield and Waseca) Facilities-related procurement recognizes the benefits of local suppliers and professionals for most facilities work. Specialized projects will generate the review of national resources. Ultimate selection and accountability lies with the project team or local leadership. Facilities construction-related and maintenance contracting philosophy Mayo Clinic has developed design, construction, and service contract forms and agreements.",1
"The majority of routine work is accomplished through contract amendments to master agreements with established designers and contractors. Limited new relationships are pursued, due to the investment Mayo Clinic makes in developing external ""team members"" to its specific environment. Supplies procurement philosophy To reduce overall nonconstruction supply expenses, Mayo Clinic actively leverages its purchasing volume by seeking agreements with suppliers in certain product and service categories to serve all Mayo Clinic facilities. Working with a group-purchasing organization, Mayo Clinic pursues national contracting opportunities that offer value to health care facilities in its system. This procurement is coordinated by Mayo Clinic Supply Chain Management. New relationships In compliance with expectations of the U.S. government, Mayo Clinic verifies service and product vendors to ensure they are legitimate companies. Verification utilizes an authentication process provided by PRGX Global Inc., which charges an authentication fee. This process allows a new contracted relationship to be established in our invoicing system and must be completed prior to submitting an invoice.",1
"Authentication is important because it: - Is necessary to perform services at Mayo Clinic - Ensures appropriate 1099 reporting - Ensures appropriate tracking and use of minority suppliers - Limits access to your competitors that do not comply with requirements Companies need an invitation email or letter containing the PRGX website address and a unique identification code, both of which are needed to begin the authentication process. Mayo Clinic staff will send you this invitation if services from your firm are requested. Once logged in to the PRGX website, you will be asked to: - Complete a company profile, which includes entering your Taxpayer Identification Number (TIN) or federal Employer Identification Number (EIN) - Identify your company's principal party or owner - Upload documents, which vary depending on your business but may include Internal Revenue Service forms W-8 and W-9, your business license, and your minority-owned-business certificate - Pay an authentication fee by credit card",1
"Heart valve disease care at Mayo Clinic Mayo Clinic team discussion A team of doctors collaborate and discuss heart valve disease. Your Mayo Clinic care team At Mayo Clinic, doctors trained in heart disease (cardiologists), doctors trained in heart surgery (cardiovascular surgeons) and other heart valve disease specialists work together to provide you with coordinated, comprehensive care. This collaborative approach means your care team can often evaluate you and develop a treatment plan within 2 to 3 days. Advanced diagnosis and treatment Mayo Clinic offers many diagnostic tests and treatment options for heart valve disease, including aortic valve disease, mitral valve disease, pulmonary valve disease and tricuspid valve disease. Your Mayo Clinic care team uses advanced imaging techniques to accurately diagnose heart valve disease and other heart conditions. These techniques include echocardiography, 3D echocardiography and transesophageal echocardiography. Imaging discussion Mayo Clinic doctors collaborate and discuss a 3D echocardiogram. Research and technology at Mayo Clinic Mayo Clinic doctors discuss research and technology, such as the 3D printing of models of the heart. Innovative heart valve surgery Mayo Clinic heart surgeons have experience and training in innovative techniques used to perform heart valve surgery. When possible, surgeons repair heart valves instead of replacing them.",1
"Robot-assisted heart surgery at Mayo Clinic A Mayo Clinic surgeon sits at a remote computer station and uses finger tools to control the arms of a robot to do robot-assisted heart surgery. A surgical team assists at the operating table. Mayo surgeons may perform minimally invasive heart surgery, which involves the use of smaller incisions than those used in open-heart surgery. Sometimes, doctors perform robot-assisted heart surgery to repair heart valves. Mayo doctors may do less invasive heart procedures using long, thin tubes called catheters to repair or replace some heart valves. Sometimes clips or plugs are used to make the repairs. Expertise and rankings Mayo Clinic cardiologists, cardiovascular surgeons and other care professionals have experience diagnosing and treating all types of heart valve disease. Each year, Mayo doctors evaluate or treat about 37,000 people with heart valve disease. Pediatric expertise Doctors at Mayo Clinic's campus in Minnesota have treated children with congenital heart disease for many years. Pediatric cardiologists and pediatric cardiovascular surgeons at Mayo Clinic's campus in Minnesota have extensive experience evaluating and treating children with heart disease, including congenital heart disease.",1
"Nationally recognized expertise Mayo Clinic campuses are nationally recognized for expertise in cardiology and cardiovascular surgery: - The Adult Congenital Heart Disease Association (ACHA) has designated the Adult Congenital Heart Disease (ACHD) Clinic at Mayo Clinic's campus in Rochester, Minnesota, as an ACHA/ACHD Accredited Comprehensive Care Center. This accreditation was achieved because the ACHD Clinic meets personnel requirements, offers specific medical services, and uses policies and procedures that help ensure the highest level of care for adults with congenital heart disease. This accreditation also signifies that Mayo Clinic has doctors with special expertise in diagnosing and treating congenital heart disease. - Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Phoenix/Scottsdale, Arizona, and Mayo Clinic in Jacksonville, Florida, are ranked among the Best Hospitals for heart and heart surgery by U.S. News & World Report. - Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and Wisconsin, according to U.S. News & World Report's 2025-2026 ""Best Children's Hospitals"" rankings. Learn more about Mayo Clinic's cardiovascular surgery and cardiovascular medicine departments' expertise and rankings. Mayo Clinic Children's Highly skilled pediatric experts diagnose and treat all types of conditions in children.",1
"As a team, we work together to find answers, set goals and develop a treatment plan tailored to your child's needs. Learn more about Mayo Clinic Children's. Locations, travel and lodging Mayo Clinic has major campuses in Phoenix and Scottsdale, Arizona; Jacksonville, Florida; and Rochester, Minnesota. The Mayo Clinic Health System has dozens of locations in several states. For more information on visiting Mayo Clinic, choose your location below: Costs and insurance Mayo Clinic works with hundreds of insurance companies and is an in-network provider for millions of people. In most cases, Mayo Clinic doesn't require a physician referral. Some insurers require referrals or may have additional requirements for certain medical care. All appointments are prioritized on the basis of medical need. Learn more about appointments at Mayo Clinic. Please contact your insurance company to verify medical coverage and to obtain any needed authorization prior to your visit. Often, your insurer's customer service number is printed on the back of your insurance card. Nov. 22, 2023",1
"Sarcoma care at Mayo Clinic The doctors at Mayo Clinic Comprehensive Cancer Center are respected for their expertise in diagnosing and treating sarcoma. At Mayo Clinic, you can expect compassionate, comprehensive care that's focused on your individual needs. Your Mayo Clinic Care team At Mayo Clinic, specialists in sarcoma include adult and pediatric medical oncologists, radiation oncologists, orthopedic and general surgeons, and pathologists. They work as a multidisciplinary team to care for people with sarcoma. Other healthcare professionals are included as needed, such as specialists in physical medicine and rehabilitation. A full range of treatment options Mayo Clinic doctors will work with you to review all your treatment options and choose the treatment that best suits your needs and goals. The range of treatments offered to people with sarcoma includes: - Surgery, including innovations designed to preserve function as much as possible, such as rotationplasty and prosthetics. - Systemic therapies, including chemotherapy, targeted therapy and immunotherapy medicines. - Radiation therapy, including innovative treatments such as intraoperative radiation therapy (IORT) and proton therapy. - Clinical trials. Expertise and rankings Mayo Clinic experts have extensive experience diagnosing and treating sarcoma. When you seek care here, you can expect: - Personalized care.",1
"At Mayo Clinic, adult and pediatric medical oncologists, radiation oncologists, orthopedic surgeons that specialize in sarcoma treatment, pathologists, and specialists in physical medicine and rehabilitation work as a multidisciplinary team to create a care plan that takes all your needs into consideration. Other healthcare professionals are included as needed. - Experience you can trust. Mayo Clinic experts have experience diagnosing and treating all types of sarcomas, including very rare types. - Nationally recognized expertise. Mayo Clinic Comprehensive Cancer Center meets the strict standards for a National Cancer Institute Comprehensive Cancer Center. These standards recognize scientific excellence and a multispecialty approach focused on cancer prevention, diagnosis and treatment. Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Jacksonville, Florida, and Mayo Clinic in Phoenix/Scottsdale, Arizona, are ranked among the Best Hospitals for cancer by U.S. News & World Report. Mayo Clinic Children's Highly skilled pediatric experts diagnose and treat all types of conditions in children. As a team, we work together to find answers, set goals and develop a treatment plan tailored to your child's needs. Learn more about Mayo Clinic Children's. Locations, travel and lodging Mayo Clinic has major campuses in Phoenix and Scottsdale, Arizona; Jacksonville, Florida; and Rochester, Minnesota. The Mayo Clinic Health System has dozens of locations in several states.",1
"For more information on visiting Mayo Clinic, choose your location below: Costs and insurance Mayo Clinic works with hundreds of insurance companies and is an in-network provider for millions of people. In most cases, Mayo Clinic doesn't require a physician referral. Some insurers require referrals or may have additional requirements for certain medical care. All appointments are prioritized on the basis of medical need. Learn more about appointments at Mayo Clinic. Please contact your insurance company to verify medical coverage and to obtain any needed authorization prior to your visit. Often, your insurer's customer service number is printed on the back of your insurance card. Jan. 22, 2025",1
"About Mayo ClinicSolving the world's toughest medical problems — one person at a time Who we areTransforming health care Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world. We're building the future, one where the best possible care is available to everyone — and more people can heal at home. Our relentless research turns into earlier diagnoses and new cures. That's how we inspire hope in those who need it most. Innovating for new solutions At Mayo Clinic, experts work together to solve the most challenging unmet needs of patients. Our history of innovation dates back almost 150 years, when brothers Will and Charlie Mayo pioneered an integrated, team-based approach to medicine. Today, that trailblazing spirit drives innovations like Mayo Clinic Platform — which powers new technologies to change how care is delivered to all. Top rankings for quality care Our unwavering drive to create better medical care has earned Mayo Clinic more top rankings for high-quality patient care than any other health care organization. In fact, Mayo Clinic has more specialties ranked in the top three than any other hospital in the nation. Our impactBuilding a healthier world We think big and act boldly to improve the health of communities and accelerate equality and diversity in health care. We share our knowledge globally, impact policy, and partner with others to create lasting — and much-needed — change for a healthier world.",1
"Improving health equity We partner with community organizations to end health disparities through education programs, personalized health care, and community-engaged research. We're accelerating recruitment of diverse investigators and clinical trial participants to eliminate bias in medicine and science and ensure more cures for all. We're strengthening our diversity and inclusion pipelines for health care professionals and leadership development. We're also using our platform to make innovative care accessible for all. And we're just getting started. Belonging $100 million to eliminate racism and advance empowered belonging within Mayo Clinic — and to improve health equity. Greenhouse gas reduction 50% reduction in greenhouse gas emissions and 20% reduction in energy within 10 years as part of our commitment to the Better Climate Challenge. People and culturePeople who make the difference Everyone at Mayo Clinic is on a mission to provide compassionate, world-class care to each person, in every connection. That includes 1.3 million patients from over 130 countries who visit Mayo Clinic campuses each year. We also train future health leaders who share our drive to transform health care. Mayo Clinic is a nonprofit organization committed to clinical practice, education, and research, providing whole-person care to everyone who needs healing. Here, experts solve the biggest health care challenges together.",1
"Behind our top rankings, you'll find a diverse, inclusive culture of teamwork, excellence, mutual respect, and dedication to putting patients first. We are undaunted by the unknown and walk alongside patients on their journeys to find answers and solutions. “A diverse staff makes every single aspect of our organization better. At Mayo Clinic, we work to create the right environment for our staff to thrive, feel valued, enjoy their work, and provide an unparalleled patient experience.” Gianrico Farrugia, M.D. President & CEO, Mayo Clinic ResourcesDiscover more about Mayo Clinic Campuses in Minnesota, Arizona, and Florida, a network of regional clinics and hospitals, and international locations Overseeing our charitable, clinical, scientific, and educational mission Public reporting information for our participation as a Medicare ACO Helping us provide the best care to every patient Expertise and resources for member medical organizations Mayo Clinic is committed to providing whole-person care to everyone who needs healing.",1
"Why choose Mayo Clinic for care? Leading expertiseA team of experts will design your treatment plan Your Mayo Clinic care team includes the best specialists in every medical field you need, focused on you. No matter what serious or complex health challenge you're facing, you can be confident that you're receiving the most advanced care at Mayo Clinic. The right answers, the first timeProviding peace of mind and hope Getting your diagnosis right the first time means you can start on the most effective treatment plan. We are continuously developing better tools for diagnosis and treatment, so you get answers, options, and hope where none may have existed before. A compassionate, human experienceFocused on creating a plan that works for you A team of specialists will thoroughly and carefully evaluate your condition and work together to create a customized plan to meet your goals. Our team approach makes your experience less complicated, so you can focus on getting better. Innovation to impact, fasterTurning scientific discoveries into patient care Mayo Clinic patients are often the first to benefit from our research. Right now, our doctors are working on more than 12,000 clinical studies, researching new treatments and therapies for the world's most challenging and complex medical issues. ResourcesThings you can do next Start an appointment request with Mayo Clinic. Find out more about your insurance coverage. What you need to know about appointments and referrals.",1
"Ib IBS See Id Idiopathic intracranial hypertension SeeIdiopathic myelofibrosis SeeIdiopathic thrombocytopenic purpura SeeIdiopathic toe walking See Ig IgA vasculitis See Ii Il Im Immune thrombocytopenic purpura SeeImpaired glucose tolerance SeeImpotence See In Inborn error of metabolism SeeIncontinence, bowel SeeIncontinence, fecal SeeIncontinence, urinary SeeInfantile hemangioma SeeInfectious arthritis SeeInfertility, female SeeInfertility, male SeeInflamed gallbladder SeeInflamed pancreas SeeInflamed pericardium SeeInfluenza, avian SeeInfluenza, H1N1 SeeInfluenza, swine flu SeeInsulin resistance syndrome SeeInterdigital neuroma SeeIntermittent claudication SeeIntestinal lipodystrophy SeeIntracranial aneurysm SeeIntraductal carcinoma SeeIntrahepatic cholestasis of pregnancy See Ir Iron overload See Is Ischemia, intestinal SeeIschemic bone necrosis SeeIschemic priapism SeeIslet cell cancer See It Mayo Clinic does not endorse companies or products. Advertising revenue supports our non-profit mission.",1
"Ra RA SeeRapid eye movement sleep behavior disorder SeeRapid gastric emptying SeeRapid heartbeat SeeRash, poison ivy See Re Reading disability, specific SeeRebound headache SeeRectal inflammation SeeRectal itching SeeRectal ulcer SeeRectocele SeeRecurrent oral ulcers SeeRecurrent prostate cancer SeeReflux, bile SeeReflux, vesicoureteral SeeRegurgitation, aortic valve SeeRegurgitation, mitral valve SeeReiter's syndrome SeeRenal artery disease SeeRenal cancer SeeRenal lithiasis SeeRenal vascular disease SeeRetinopathy, diabetic See Rh Rhinitis, allergic SeeRhinitis, nonallergic SeeRhinitis, vasomotor See Ri Rib fracture SeeRift Valley fever SeeRinging in the ear SeeRingworm of the foot See Rl RLS See Ro Road rage SeeRound back See Rs Ru Rubeola SeeRunner's knee SeeRuptured disk See Mayo Clinic does not endorse companies or products. Advertising revenue supports our non-profit mission.",1
"Mayo Clinic is the first and largest integrated group practice in the world. Its mission is to inspire hope and contribute to health and well-being by providing the best care to every patient through integrated clinical practice, education and research. Mayo Clinic Supply Chain Management supports this mission through the provision of products and information that directly support patient care. Each year, Mayo Clinic facilities in four states purchase more than $4.9 billion in supplies, medical equipment and services. To reduce overall expenses, Mayo Clinic actively leverages its purchasing volume by seeking agreements with suppliers in certain product and service categories to serve all Mayo Clinic facilities. Working with a group-purchasing organization, Mayo Clinic pursues national contracting opportunities that offer value to all health care facilities in its system. Current suppliers To continue as suppliers, companies currently doing business with Mayo Clinic must complete a vendor onboarding process. This onboarding process determines whether your company meets standards put in place due to increased regulatory requirements. For more information, see Mayo Clinic Supplier Guidelines. Product recall notifications In the event of a product issue or recall, suppliers should email all notifications to: scmrecalls@mayo.edu. The U.S. Food and Drug Administration (FDA) allows recall notices to be sent by email. Paper is no longer required.",1
"See FDA Guidance (2006): Using Electronic Means to Distribute Certain Product Information. End of vendor support and end of manufacture Healthcare Technology Management at Mayo Clinic monitors equipment support for all medical equipment (including lab and research equipment). Vendors are required to promptly notify Mayo Clinic of any updates regarding end of vendor support and end of manufacture for their products. Please send all correspondence to HTMVendorInfor@mayo.edu. Your cooperation is greatly appreciated. Potential suppliers For your company to be eligible to submit bids or sell products and services to Mayo Clinic, you need to complete a vendor onboarding process. A Mayo Clinic department that has an existing or new business relationship with your company will submit the vendor and contact information to initiate the vendor onboarding process. Vendors may receive correspondences with questions when verifying company information prior to completing the onboarding requirement. Completing the onboarding process does not guarantee your company the opportunity to conduct business with Mayo Clinic. If you have questions about the vendor onboarding processes, please contact: Mayo Clinic Supply Chain Management Customer Support Phone: 507-266-5551",1
"La Lactase deficiency SeeLactation mastitis SeeLassa fever SeeLateral elbow tendinopathy SeeLateral epicondylitis SeeLateral epicondylosis See Lc LCIS See Le Leg fracture SeeLegionellosis SeeLentigines, solar SeeLeukemia, acute lymphocytic SeeLeukemia, acute myelogenous SeeLeukemia, chronic lymphocytic SeeLeukemia, chronic myelogenous SeeLeukemia, general SeeLeukemia, hairy cell See Li Lice, body SeeLichen planus, oral SeeLichen simplex chronicus SeeLipodystrophy, intestinal SeeListeriosis SeeLiver failure, acute SeeLiver spots SeeLiver, enlarged See Lo Localized scleroderma SeeLockjaw SeeLoss of bladder control SeeLou Gehrig's disease SeeLow blood sugar SeeLow body temperature SeeLow platelet count SeeLow testosterone SeeLow-flow priapism See Lu Lung collapse SeeLung collapse SeeLung disease, interstitial See Ly Lymph nodes, swollen SeeLymphadenitis SeeLymphadenitis, mesenteric SeeLymphoma, Hodgkin SeeLymphoma, non-Hodgkin SeeLymphoplasmacytic lymphoma See Mayo Clinic does not endorse companies or products. Advertising revenue supports our non-profit mission.",1
"Print Adult congenital heart disease care at Mayo ClinicYour Mayo Clinic care teamMayo Clinic doctors trained in heart disease (cardiologists) and heart surgery (cardiovascular surgeons) have experience evaluating and treating adults with congenital heart disease and all types of heart conditions. Collaborative care. Mayo cardiologists, cardiovascular surgeons and other health professionals work together to provide coordinated, comprehensive care. This collaborative approach means that they can often evaluate you and develop a treatment plan within 2 to 3 days. Mayo Clinic provides care for you as a whole person. We take the time to get to know you and work with you to provide exactly the care you need. Advanced diagnosis and treatment. When possible, cardiovascular surgeons use minimally invasive heart surgery to treat adults with congenital heart disease. The Mayo Clinic experience and patient stories Our patients tell us that the quality of their interactions, our attention to detail and the efficiency of their visits mean health care like they've never experienced. See the stories of satisfied Mayo Clinic patients. (VIDEO) Hockey exec wins faceoff against heart issueDr. Jason Anderson discussing the new valve with Kyle Davidson A general manager of a professional sports team is a job that inherently comes with a high amount of stress, difficulty and demand — making important decisions that affect the future of a franchise.",1
"But recently at Mayo Clinic, Chicago Blackhawks GM Kyle Davidson made a crucial choice about his personal health that affects his own future — undergo another open-heart surgery or have a… Britiny's teamBritiny Schultz Britiny Schultz can't wait for fall. A huge football fan, she's looking forward to cheering on her favorite teams. It's something many fans take for granted — not Britiny. She's able to keep cheering, thanks to her doctors at Mayo Clinic and the incredible gift of life from not just one, but two organ donors. Britiny and her nieces and nephews The South Dakota native says she closely follows two teams: ""The Bison… Expertise and rankingsMayo Clinic doctors have extensive experience in treating people with congenital heart disease. Each year, Mayo Clinic health professionals evaluate and treat nearly 14,000 adults with congenital heart disease. Each Mayo Clinic location offers treatment for adults with congenital heart disease in the Adult Congenital Heart Disease Clinic. Healthcare professionals in the Center for Congenital Heart Disease at Mayo Clinic's campus in Minnesota treats adults with congenital heart disease and children with congenital heart defects.",1
"Nationally recognized expertise Mayo Clinic campuses are nationally recognized for expertise in cardiology and cardiovascular surgery: The Adult Congenital Heart Disease Association (ACHA) has designated the Adult Congenital Heart Disease (ACHD) Clinic at Mayo Clinic's campus in Rochester, Minnesota, as an ACHA/ACHD Accredited Comprehensive Care Center. This accreditation was achieved because the ACHD Clinic meets personnel requirements, offers specific medical services, and uses policies and procedures that help ensure the highest level of care for adults with congenital heart disease. This accreditation also signifies that Mayo Clinic has doctors with special expertise in diagnosing and treating congenital heart disease. Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Phoenix/Scottsdale, Arizona, and Mayo Clinic in Jacksonville, Florida, are ranked among the Best Hospitals for heart and heart surgery by U.S. News & World Report. Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and Wisconsin, according to U.S. News & World Report's 2025-2026 ""Best Children's Hospitals"" rankings. With Mayo Clinic's emphasis on collaborative care, specialists at each of the campuses — Minnesota, Arizona and Florida — interact very closely with colleagues at the other campuses and the Mayo Clinic Health System.",1
"Learn more about Mayo Clinic's cardiovascular medicine and cardiovascular surgery departments' expertise and rankings. Locations, travel and lodgingMayo Clinic has major campuses in Phoenix and Scottsdale, Arizona; Jacksonville, Florida; and Rochester, Minnesota. The Mayo Clinic Health System has dozens of locations in several states. For more information on visiting Mayo Clinic, choose your location below: Mayo Clinic's campus in Arizona Mayo Clinic's campus in Florida Mayo Clinic's campus in Minnesota Mayo Clinic Health System Mayo Clinic Healthcare, located in London Costs and insuranceMayo Clinic works with hundreds of insurance companies and is an in-network provider for millions of people. In most cases, Mayo Clinic doesn't require a physician referral. Some insurers require referrals or may have additional requirements for certain medical care. All appointments are prioritized on the basis of medical need. Learn more about appointments at Mayo Clinic. Please contact your insurance company to verify medical coverage and to obtain any needed authorization prior to your visit. Often, your insurer's customer service number is printed on the back of your insurance card. More information about billing and insurance: Mayo Clinic in Arizona, Florida and Minnesota Mayo Clinic Health System ContactArizona Mayo Clinic Adult Congenital Heart Disease 13400 E. Shea Blvd.",1
"Scottsdale, AZ 85259 Phone: 480-301-8484 Florida Mayo Clinic Adult Congenital Heart Disease 4500 San Pablo Road Jacksonville, FL 32224 Phone: 904-953-0859 Minnesota Mayo Clinic Adult Congenital Heart Disease 200 First St. SW Rochester, MN 55905 Phone: 507-738-4002 By Mayo Clinic Staff Request an appointment Doctors & departments April 06, 2024 Print Living with congenital heart disease in adults? Connect with others like you for support and answers to your questions in the Transplants support group on Mayo Clinic Connect, a patient community. Transplants Discussions How long does it take to recover from donating a kidney? 9 Replies Sat, Nov 15, 2025 chevron-right Any pointers, we meet with pulmonologist regarding lung transplant? 5 Replies Sun, Nov 09, 2025 chevron-right Snapshots of hope: Life on the other side of transplant. 110 Replies Sun, Nov 09, 2025 chevron-right See more discussions Related Kinser's story Robotic or minimally invasive cardiac surgery for adult-adolescent congenital heart disease Associated Procedures Aortic valve repair and aortic valve replacement Cardiac catheterization Chest X-rays Echocardiogram Electrocardiogram (ECG or EKG) Heart transplant Implantable cardioverter-defibrillators (ICDs) Pacemaker Stress test Show more associated procedures News from Mayo Clinic How can adults with congenital heart disease reduce risks?",1
Study finds lifetime cardiology monitoring is key Products & Services A Book: Mayo Clinic Family Health Book Newsletter: Mayo Clinic Health Letter — Digital Edition Show more products and services from Mayo Clinic Congenital heart disease in adultsSymptoms&causesDiagnosis&treatmentDoctors&departmentsCare atMayoClinic CON-20248753 Diseases & Conditions Congenital heart disease in adults,1
"To further our mission of making reliable health information available to the public, we accept advertising and sponsorship under strict guidelines. We will refuse any advertisement that we believe is incompatible with our mission. The presence of an ad on our site or in one of our newsletters does not imply endorsement of the advertised company or product. Advertisers and sponsors must not make unsubstantiated health claims or suggest that Mayo Clinic has endorsed a product. Advertising may be placed on the site adjacent to content related to advertiser or sponsor interest, and also may be targeted to users by using non-personal data. Our sponsors and advertisers have agreed that they will not collect any personally identifiable information from our site visitors while they are on Mayo Clinic's health information website. Mayo Clinic maintains a distinct separation between advertising content and editorial content. All advertising content on Mayo Clinic's health information website or in one of our newsletters is clearly labeled as an advertisement. Sponsored areas of the site are labeled as such, and the sponsoring organizations are identified. For more detailed information about advertising and sponsorship on Mayo Clinic's health information website, go to:",1
"Ma Macular degeneration, dry SeeMacular degeneration, wet SeeMad cow disease SeeMajor depressive disorder SeeMalignant fibrous histiocytoma SeeMalignant mesothelioma SeeMallet toe and hammertoe SeeManic-depressive illness SeeMASH SeeMASLD SeeMastalgia See Mc Md MD SeeMDS See Me Measles, German SeeMedial epicondylitis SeeMedial tibial stress syndrome SeeMediterranean anemia SeeMegacolon SeeMegaloblastic anemia SeeMelanoma of the eye SeeMeniscus tear SeeMenorrhagia SeeMetabolic dysfunction-associated steatohepatitis SeeMetabolic dysfunction-associated steatotic liver disease SeeMetastatic colorectal cancer SeeMethicillin-resistant staphylococcus aureus infection See Mf MFS See Mg MG See Mi Microscopic hematuria SeeMiliaria SeeMilk intolerance See Mo MOG antibody-associated disorder SeeMono See Mr Ms MS SeeMSA See Mu Mucocutaneous lymph node syndrome SeeMultiple endocrine neoplasia type 1 SeeMunchausen syndrome See My Myelodysplastic neoplasms SeeMyocardial infarction SeeMyopia See Mz MZL See Mayo Clinic does not endorse companies or products. Advertising revenue supports our non-profit mission.",1
"[MUSIC PLAYING] Brain & Central Nervous System Cancers: Personalized care for each patient Jan C. Buckner, M.D., Medical Oncology, Mayo Clinic: Central nervous system tumors are rare in the overall scheme of things. They involve both the brain and spinal cord. Fredric B. Meyer, M.D., Neurosurgery, Mayo Clinic: There are 120 brain tumors that adults and children can suffer from. We have perhaps the largest neurosurgical practice in North America, which means we have great expertise and depth in managing the most complex tumors. Dr. Buckner: And although they may be rare, at Mayo Clinic, they're not rare. Our specialized teams are comfortable seeing these rare types of tumors day in and day out. Dr. Meyer: We have a team of neuroradiologists who have developed leading MRI technology and programming to help us diagnose brain tumors. There's a whole host of range of technologies that have been developed here that are unique and leading the way nationally. Some of those technologies would include MR spectroscopy, MR profusion, MR diffusion -- very multi-dimensional approaches to looking at a patient's problem. Sameer R. Keole, M.D., Radiation Oncology, Mayo Clinic: PET imaging is an incredibly useful tool in cancer care. Different isotopes give different value, but if they have a short half life, the only way you can inject them into a patient is if you have a cyclotron onsite. We have a cyclotron onsite.",1
"Dr. Buckner: One of the problems with imaging and brain tumors is interpretation of the imaging. At Mayo Clinic, we have a more comprehensive way of obtaining the images, getting all of the information we can possibly get from the image in order to know if this is truly recurrent tumor, progressive tumor, or on the other side, is it an artifact of apparent reduced tumor size when it's just the effect of therapies? Dr. Meyer: One of the techniques which we have developed here is using awake brain surgery and very complex mapping of the brain surface in the descending white matter tracks to try to preserve neurological function. It's important to remember that the closer a tumor or an epileptic focus comes to functioning brain tissue, the higher the risk. So when that risk is close, when those anatomies are close, we use awake mapping to try to prevent harm to a patient. Alfredo Quinones-Hinojosa, M.D., Neurosurgery, Mayo Clinic: The image guidance, to a minimally invasive brain surgery, is crucial to be able to not only understand the anatomy of the brain, but to be able to navigate and getting into all those difficult little places where function is extraordinarily important. And a lot of these new software modalities like functional MRI allow us to have a preconceived idea of the dangerous parts of the brain. So when you go in and you want to take a tumor out, for instance, you have an idea as to which areas you should and should not touch.",1
"Those that should not be touched, most likely they need to be left behind so that patients have a much better outcome in the long term. Dr. Meyer: In certain types of brain tumors, especially at the base of the skull, there's anatomy that needs to be protected, like nerves that are responsible for vision, for talking, and so forth. Using a Gamma Knife, for example, allows one to radiate that tumor mass but protect the surrounding brain tissue. Dr. Keole: The key is what's surrounding that target? That's where proton beam excels. The proton beam can spare normal, healthy tissues, including those in the brain, by anywhere from 70% to 99% versus our best X-ray techniques. Dr. Buckner: One of the most exciting developments recently has been improved molecular diagnostics for brain tumor. Mayo Clinic scientists were instrumental in developing a new classification system for gliomas. Dr. Quinones-Hinojosa: We can take the tumors out. We can send them through the laboratory, understand the different molecular pathology and molecular biology of these cancers, but when it comes down to it, what we're trying to do is trying to enhance how we personalize medicine and how is precision medicine better utilized for the care of the patient? Every patient has a different molecular subtype. Our understanding in the lab is allowing us to understand how we can treat every patient individually.",1
"New molecular biology tools have allowed us to nowadays understand how cancer cells migrate, not only in the brain, but in other parts of the body. Dr. Buckner: Not only is each individual tumor unique to that patient but it continues to evolve. It can evolve down different pathways and it is possible to build a mutational tree so that we understand in which direction the tumor is mutating and develop therapies appropriately. Dr. Quinones-Hinojosa: And these molecular agents are extraordinarily important to understand, so that way we can put the brakes on those cancers. In our laboratory with our team, we have patented multiple technologies. Multiple drugs can actually play a role in blocking and stopping the cell migration. Dr. Meyer: We have a broad range of clinical trials to treat patients with brain tumors across Mayo Clinic. Some of them are chemotherapy, some are radiation, but some of them are also viral therapies and immunotherapies. Dr. Quinones-Hinojosa: The Mayo Clinic is at the forefront of utilizing stem cells that we get from either fat from our own body or from our own bone marrow. You can use the stem cells, especially with the way we have used them in our laboratory, as a Trojan horse. We can actually load treatments into these stem cells that we get from our own fat, and we have proven that these are stem cells like little Trojan horses, goes in there, into parts of the brain, localizes a bad cancer cell, and delivers a cargo.",1
"Dr. Keole: I think as we move into new therapies, including immunotherapies or vaccine therapies, then that really allows us to leverage the body's immune system to help us fight the tumor. And so the goal is really going to be to try to treat the tumors, but really leave the patient in even better shape after their fight with the cancer is done. Dr. Quinones-Hinojosa: So not only are we talking about personalized medicine, but more importantly, we're talking about precision medicine because at the end of the day, your body is the best tool that can heal your own body. [MUSIC PLAYING]",1
"Postdoctoral Researcher in Computational Materials Science - Employer - National Institute for Materials Science (NIMS) - Location - Tsukuba, Ibaraki (JP) - Salary - Monthly salary 317,570yen ～410,460yen - Closing date - 26 Feb 2026 - Website - View more categoriesView less categories - Discipline - Physics - Job Type - Postdoctoral - Employment - Hours - Full time - Duration - Fixed term - Qualification - PhD - Sector - Government Job Details Research on magnetic properties and related topics employing statistical physics computational methods. The successful candidate is expected to study the static and dynamical properties of phase transitions involving magnetism, elasticity, dielectricity, etc. by applying and developing computational methods such as classical and quantum Monte Carlo simulations, molecular dynamics, master equation approaches. Research themes may include spin transitions, critical phenomena, ultrafast magnetization reversal, magnetic resonance, coercivity, and thermal conduction. Company Learn more about this company Visit this company’s hub to learn about their values, culture, and latest jobs. Visit employer hubApply for Postdoctoral Researcher in Computational Materials Science Already uploaded your CV? Sign in to apply instantly Fields marked with an asterisk (*) are required Learn more about this company Visit this company’s hub to learn about their values, culture, and latest jobs.",1
Visit employer hubSign in to create job alerts Sign in or create an account to start creating job alerts and receive personalised job recommendations straight to your inbox. Create alert,1
"Academic Positions Available Shenzhen University of Advanced Technology - Employer - Shenzhen University of Advanced Technology - Location - Shenzhen, Guangdong, China - Salary - Competitive - Closing date - 29 Jan 2026 View more categoriesView less categories - Discipline - Applied Science, Biomedicine, Computing, Health Science, Life Science - Job Type - Faculty Member, Postdoctoral, Research Assistant, Researcher - Employment - Hours - Full time - Duration - Permanent - Qualification - PhD - Sector - Academia Job Details Academic Positions Available Shenzhen University of Advanced Technology About SUAT Shenzhen University of Advanced Technology (SUAT) is a newly established and highly rated university in Shenzhen, a city full of charms, energy, vitality and innovation. With the support of the Shenzhen Institute of Advanced Technology as well as it's abundant resources in science, education, and industry, SUAT will build a first-class and new-type research university with ""high starting point, high standard and high quality"". SUAT has already attracted a cohort of outstanding scientists from major research institutes and universities around the world. Bolstered by excellent scientiﬁc, educational, and industrial resources from the Chinese Academy of Sciences, Guangdong Province and Shenzhen City, SUAT fosters interdisciplinary research and training, integrates research and entrepreneurship into education, and aims to be a world-class university of science and technology.",1
"With a trinity of colleges (academic colleges, research institutes, and residential colleges), SUAT nurtures students through a three-track educational system encompassing basic science, engineering, and entrepreneurship. It embraces a philosophy of educating elite undergraduates, tailoring the instruction towards the education of outstanding scientists, exceptional engineers, and innovative entrepreneurs. In 2024, SUAT has enrolled its ﬁrst cohort of 120 undergraduate students in the science, technology, engineering and mathematics track. The 120 strong SUATers were among the highest-ranked high school students from Guangdong Province with the national entrance exam scores ranging from 664 to 624, which exceeded the undergraduate admission line by 182 points.",1
"To meet the challenges of emerging science, technology and industry and to energize the emerging productive forces, SUAT has established seven faculties, namely the Faculty of Life and Health Sciences, the Faculty of Pharmaceutical Sciences, the Faculty of Computer Science and Control Engineering, the Faculty of Synthetic Biology, the Faculty of Materials Science and Energy Engineering, the Faculty of Biomedical Engineering and the Faculty of Computer Science and Microelectronics, in addition to a number of research institutes including the Institute of Cell and Gene Technology, the Institute of Emerging Agricultural Technology and the Institute of Artificial Intelligence Research, and Institute of Advanced Medical Devices and Institute of Higher Education and Future Medical Center .",1
"For more information, please visit the school official website: The following is a list of SUAT’s current faculties and institutes: Faculty | Faculty of Life and Health Sciences Department of Biology Interdisciplinary Center for Bio-Intelligence Department of Neuroscience Department of Mental Health and Public Health | | Faculty of Synthetic Biology Department of Biological Sciences Department of Engineering Biology Frontier Interdisciplinary Center Specialized Teaching Platform | | Faculty of Computer Science and Control Engineering Department of Computer Science and Engineering Department of Intelligent Science and Technology Department of Robotics and Automation Department of Electronic and Electrical Engineering Department of Computational Biology and Medical Big Data | | Faculty of Biomedical Engineering Department of Life Electronics Department of Imaging and Information Department of Biomaterials and Tissue Engineering Department of Neurorehabilitation Engineering | | Faculty of Materials Science and Energy Engineering Department of Electronic Information Materials Department of Smart Energy Materials Department of Biomedical Materials | | Faculty of Pharmaceutical Sciences Department of Medicinal Chemistry and Pharmaceutical Engineering Department of Biopharmaceuticals Department of Pharmacology Department of Pharmaceutical Materials and Translational Medicine Center for Intelligent Pharmacy | | Faculty of Computility Microelectronics Department of Computational Engineering Department of Integrated Circuit Engineering | Institute | Institute of Cell and Gene Technology Center for Cell Proliferation, Differentiation and Fate Regulation Center for Gene Regulation and Editing Center for Green Agriculture Research .......... | | Institute of Emerging Agricultural Technology Center for Next-Generation Germplasm Innovation Center for Plant Proteins Innovation Center for the Innovation of Functional Plants Center for the Study of Plant-Environment Interactions | | Artificial Intelligence Research Institute of SUAT Center for Neurocognition and Social Behavior Large Model Research Center Computer Vision and Recognition Center .......... | | Institute of Advanced Medical Devices Advanced Imaging Laboratory Innovative Diagnostic Laboratory Medical Materials Laboratory .......... | | Institute of Higher Education | | Future Medical Center | | Institute of Intelligent Robotics | | Institute of Scientific Instruments | Available Positions and Requirements Individuals are invited to apply for one of the following positions: 01 Tenured Professor Applicants should have a sustained and high-level academic output with strong academic influence in their respective fields.",1
"Their academic achievements should be widely recognized and respected by the academic community both domestically and internationally. A doctoral degree is required, along with experience in holding a position equivalent to an Associate Professor or above at a renowned overseas university or research institution, demonstrating high research standards and strong innovation capabilities. 02 Associate Professor In principle, excellent young scientists with an age of 40 years old or young are welcome to apply for this position. Generally applicants should have obtained a formal teaching or research position in an overseas university, scientific research institution or enterprise R&D institution, and have ≥36 consecutive months of working experience. For those candidates with an overseas doctoral degree and outstanding academic achievements, the requirement for overseas working experience can be reduced. Outstanding candidates who have been working in China are also encouraged to apply. 03 Tenure-Track Assistant Professor Applicants should hold a doctoral degree in the relevant field, have made important scientific achievements, and show excellent academic potential and teaching ability. 04 Postdoctoral Fellow Applicants should have a doctoral degree within 3 last years and generally be 35 years old or younger (exceptional candidates older than 35 will also be considered), and have strong credentials and excellent scientific research ability.",1
"05 Research Scientist Applicants should hold a doctoral degree, have at least 2years of postgraduate research experience, an excellent independent research ability and teamwork mentality. 06 Research Assistant Applicants should hold a MS degree and demonstrate the ability to assist in project research and the daily management of projects. SUAT provides highly competitive compensation, benefits, and startup packages. Interested individuals should contact the relevant departments listed below: 01 Human Resources Department Contact：Ms. Zhang Email：recruit@suat-sz.edu.cn 02 Faculty Contact Faculty of Life and Health Sciences Contact：Ms. Sun Email：lhs_recruit@suat-sz.edu.cn Faculty of Pharmaceutical Sciences Contact：Mr.Li Email：pharm.hr@suat-sz.edu.cn Faculty of Computer Science and Control Engineering Contact：Ms. Yan Email：yanjingjing@suat-sz.edu.cn Faculty of Synthetic Biology Contact：Ms. Gao Email：synbiofaculty_hr@suat-sz.edu.cn Faculty of Materials Science and Energy Engineering Contact：Ms. Du Email：msee-hr@suat-sz.edu.cn Faculty of Biomedical Engineering Contact：Ms. Lin Email：linshaocong@suat-sz.edu.cn Faculty of Computility Microelectronics Contact：Mr. Huang Email：dh.huang@suat-sz.edu.cn 03 Institute Contact Institute of Cell and Gene Technology Contact：Ms. Liu Email：icgt@suat-sz.edu.cn Institute of Emerging Agricultural Technology Contact：Ms. Sun Email：sunning@suat-sz.edu.cn Institute of Artificial Intelligence Contact：Ms.",1
"Xie Email：xielu@suat-sz.edu.cn Institute of Advanced Medical Devices Contact：Mr.He Email：jy.he@nmed.org.cn Future Medical Center Contact：Ms. Zhu Email：zhulin@suat-sz.edu.cn Company Shenzhen University of Advanced Technology (hereinafter referred to as ""SUAT""), based on the rich academic and scientific resources of the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (hereinafter referred to as ""SIAT""), is a new research-oriented university built with “high starting point, high level, high standards, and high quality.” With the support of the Chinese Academy of Sciences and Guangdong Province, SUAT collaborates with SIAT in scientific and educational cooperation, leveraging complementary advantages for win-win development. After nearly six years of preparation, SUAT has gathered a high-level teaching staff dominated by overseas high-level talents. Relying on the excellent scientific, educational, and industrial resources of first-class scientific research institutions, and drawing on the educational models of world-class universities of science and technology, SUAT integrates industry and education, blends science and education, and fosters interdisciplinary majors. With a trinity of colleges (academic colleges, research institutes, and residential colleges), SUAT nurtures talents through a three-track cultivation system encompassing academics, engineering, and entrepreneurship.",1
"It offers elite undergraduate education, tailoring instruction to cultivate outstanding scientists, exceptional engineers, and innovative entrepreneurs. In 2024, SUAT will enroll its first cohort of undergraduate students, admitting 120 physics majors of Guangdong Province. The highest admission score was 664, while the lowest was 624, exceeding the undergraduate admission line by 182 points. As a representative of new research universities, SUAT has garnered widespread attention and recognition from candidates and parents for its innovative and unique talent cultivation model, as well as its campus culture that promotes the spirit of scientists and the spirit of special economic zones. SUAT and SIAT collaborate in scientific and educational endeavors, mutually empowering each other through dual appointments, resource sharing, and complementary advantages. Together, they serve the construction of a powerful country in education, science and technology, and talent development. Meanwhile, this collaboration provides SUAT with high-level international teaching resources and national-level research platforms, supporting its rapid advancement towards world-class status in emerging and interdisciplinary fields. Apply for Academic Positions Available Shenzhen University of Advanced Technology Already uploaded your CV?",1
Sign in to apply instantly Fields marked with an asterisk (*) are required Sign in to create job alerts Sign in or create an account to start creating job alerts and receive personalised job recommendations straight to your inbox. Create alert,1
"Connecting leading candidates to the world's finest science jobs Browse Jobs - Applied Science 148 - Biomedicine 270 - Chemistry 135 - Clinical 52 - Computing 175 - Earth Science 45 - Engineering 144 - Environmental Science 78 - Health Science 339 - Life Science 376 - Mathematics 74 - Physics 204 - Bioinformatician 23 - Engineer 31 - Faculty Member 279 - Head of Department 30 - Health Professional 72 - Manager 35 - PhD Position 105 - Postdoctoral 299 - Principal Investigator 66 - Professor 140 - Research Assistant 60 - Researcher 200 - United States 410 - Germany 177 - China 83 - Austria 72 - Denmark 68 - Luxembourg 52 - United Kingdom 50 - Asia Pacific 49 - Belgium 26 - Canada 22 - Middle East 21 - United Arab Emirates 17 Job of the week Employers Advertise With Us About us Navigating your scientific career can be demanding whichever field you’re in, wherever you are in the world. That’s why we aim to support and inspire you with all manner of advice for every career stage. Search and apply to jobs from international companies and institutions. Sign up for events to broaden your skills and knowledge. Read more on our services. Career Advice - Nature Career Guides Browse collections of career guides. Learn about the mission and achievements of the world's leading research organisations, find out more about their job roles, courses, and events, alongside independently written editorials that cover advancements and career opportunities in your field.",1
"- Working Scientist Podcast Working Scientist is the Nature Careers podcast, produced by the careers editors at Nature. Working Scientist is a regular free audio show featuring advice and information from global industry experts with a strong focus on supporting early career researchers working in academia and other sectors.",1
"VinUniversity Assistant Professorships (VAP) - Employer - VinUniversity - Location - Vietnam (VN) - Salary - Attractive remuneration - Closing date - 26 Feb 2026 - Website - View more categoriesView less categories - Discipline - Applied Science, Computing, Engineering, Health Science, Mathematics, Physics - Job Type - Faculty Member, Principal Investigator, Professor - Employment - Hours - Full time - Duration - Fixed term - Qualification - PhD - Sector - Academia Job Details ABOUT VINUNIVERSITY VinUniversity (VinUni) is the first private, not-for-profit Vietnamese university established based on international standards. The university integrates the models of excellent international universities with the unique cultural and economic characteristics of Vietnam, to make a breakthrough in Vietnamese higher education and to become a world-class university. The University has built strategic collaborations with Cornell University and the University of Pennsylvania — a choice that speaks to our commitment to excellence, innovation in research and teaching, and to making a difference in the world. VinUni comprises of College of Arts and Sciences; College of Business and Management; College of Engineering and Computer Science; and College of Health Sciences. VinUni’s founding benefactor – Vingroup is one of the biggest private conglomerates in Asia with the largest market capitalization value in Vietnam.",1
"As a multisector corporation, Vingroup focuses on five main areas: Industrials & Technology; Real Estate & Services; Infrastructure; Green Energy; and Social Enterprises. In September 2024, VinUni became the youngest and fastest university in the world to achieve QS 5 stars, earning 5 stars in 9 categories: global engagement, good governance, program strength, academic development, teaching, employability, facilities, arts, and social impact. In October 2024, VinUni was appointed by UNESCO as the first and only UNESCO University Chair, focusing on Environmental Leadership, Cultural Heritage, and Biodiversity. On our journey to become one of the world’s top 100 universities, VinUni is building a dynamic ecosystem of innovation and discovery. Through strategic investments in world-class research centers, state-of-the-art facilities, and transformative technologies, the university empowers collaboration across disciplines, strengthens partnerships with industry and society, and nurtures a thriving global network, who spearheads advancements in AI & Machine Learning, Data Science, Environmental Intelligence, Innovation in Health Sciences, Policy Development and Sustainable Societies. Overview The VinUniversity Assistant Professorships (VAP) is a prestigious early-career award established to attract outstanding young researchers and scholars from around the world to join VinUniversity.",1
"The program aims to nurture a new generation of leading academics whose work will drive high-impact research and strengthen VinUniversity’s position as a world-class university. All candidates undergo a rigorous selection process evaluated by an international panel of distinguished scholars. Who We Are Looking For We welcome applications from early-career researchers who demonstrate exceptional academic potential, creativity, and leadership. Candidates should: - Hold a PhD, MD, or equivalent, obtained in or after 2019. - Have a strong track record of research excellence, demonstrated by high-impact publications, awards, or recognition in their field. - Be able to lead independent and collaborative research of international significance. - Commit to a full-time faculty appointment at VinUniversity. - Clinician scientists engaged in translational or clinical research are strongly encouraged to apply. - Eligibility extends to both new external applicants and VinUni faculty (not holding the rank of Full Professor) who have joined within the last 12 months. Existing VinUni faculty are limited to a single application attempt. What We Offer Successful VAP awardees will receive a competitive package to establish their research program at VinUniversity, including: - Attractive remuneration and faculty appointment, with the potential for long-term contracts and leadership roles.",1
"- Start-up Research Grant: STEM Experimental fields – up to USD 1,000,000 Other fields –up to USD 500,000 - Up to Two (02) PhD full scholarships worth 200,000 USD each. - Dedicated laboratory and office space and access to advanced research infrastructure. - Comprehensive institutional support for grant applications, research administration, and laboratory setup. How to Apply Applicants are required to submit the following supporting documents as part of the online application. It is strongly recommended that all documents are prepared in advance, as incomplete applications will not be considered: - Cover Letter – A statement introducing yourself as a researcher and outlining your vision for contributing to VinUniversity. - Comprehensive Curriculum Vitae (CV) – Including a complete list of academic publications with citation details and impact factors. Please highlight your three most significant publications. - Research Statement – A concise summary of your research accomplishments, current work, and the future direction and potential impact of your research. - Research Project Proposal – A detailed proposal of your planned research project, not exceeding five (5) A4 pages. - Referee Contacts – Contact information for three external referees who can provide an informed assessment of your achievements and potential. We thank all applicants for their interest. Please note that only those candidates selected for interviews will be contacted.",1
Sign in to create job alerts Sign in or create an account to start creating job alerts and receive personalised job recommendations straight to your inbox. Create alert,1
"Connecting leading candidates to the world's finest science jobs Browse Jobs - Applied Science 148 - Biomedicine 270 - Chemistry 135 - Clinical 52 - Computing 175 - Earth Science 45 - Engineering 144 - Environmental Science 78 - Health Science 339 - Life Science 376 - Mathematics 74 - Physics 204 - Bioinformatician 23 - Engineer 31 - Faculty Member 279 - Head of Department 30 - Health Professional 72 - Manager 35 - PhD Position 105 - Postdoctoral 299 - Principal Investigator 66 - Professor 140 - Research Assistant 60 - Researcher 200 - United States 410 - Germany 177 - China 83 - Austria 72 - Denmark 68 - Luxembourg 52 - United Kingdom 50 - Asia Pacific 49 - Belgium 26 - Canada 22 - Middle East 21 - United Arab Emirates 17 Job of the week Employers Advertise With Us About us Navigating your scientific career can be demanding whichever field you’re in, wherever you are in the world. That’s why we aim to support and inspire you with all manner of advice for every career stage. Search and apply to jobs from international companies and institutions. Sign up for events to broaden your skills and knowledge. Read more on our services. Career Advice - Nature Career Guides Browse collections of career guides. Learn about the mission and achievements of the world's leading research organisations, find out more about their job roles, courses, and events, alongside independently written editorials that cover advancements and career opportunities in your field.",1
"- Working Scientist Podcast Working Scientist is the Nature Careers podcast, produced by the careers editors at Nature. Working Scientist is a regular free audio show featuring advice and information from global industry experts with a strong focus on supporting early career researchers working in academia and other sectors.",1
"Tenure-track Positions at The HIT Center for Life Sciences, China - Employer - The HIT Center for Life Sciences (HCLS) - Location - Harbin, Heilongjiang (CN) - Salary - Generously competitive salary - Closing date - 29 Jan 2026 View more categoriesView less categories - Discipline - Applied Science, Biomedicine, Chemistry, Clinical, Computing, Engineering, Health Science, Life Science - Job Type - Faculty Member, Principal Investigator - Employment - Hours - Full time - Duration - Fixed term - Qualification - PhD - Sector - Academia Job Details Harbin Institute of Technology ( which is affiliated with the Ministry of Industry and Information Technology, has three campuses in Harbin, Weihai and Shenzhen. HIT was founded in 1920 and recognized as one of the two model universities in 1951 for studying foreign higher education models. In 1954, it was named one of the six key educational institutions of higher education by the nation. In 1996, it was in the first batch of universities to enter the former Project 211. In 1999, it was identified as one of the 9 universities in the first batch of ""985 Project"". In 2017, it was selected as one of the ""Double First-class"" universities in China. The HIT Center for Life Sciences (HCLS) ( was established in 2016. As the first special zone of HIT, HCLS has relatively independent academic, personnel employment and financial autonomy as well as postgraduate training system.",1
"HCLS has state-of-the-art core facilities including electron microscopy platform, imaging platform, mass spectrometry platform and experimental animal platform. In line with international standards, HCLS runs the Tenure-track system and PI responsibility system and strives to develop into world-class life science research institution in a relatively short period of time. Qualifications Research Directions: neuroscience, microbiology and immunology, biophysical and structural biology (cryo-electron microscopy direction), metabolomics, chemical biology, nano-biomaterials and cellular tissue engineering, proteomics, DNA damage and repair, genome editing, molecular bio-breeding or translational application fields. Required qualifications: The candidate must have a Ph.D. or M.D. with several years of postdoctoral or independent research experience, who has achieved internationally impactful scientific results in recent years and be able to conduct independent and innovative research. The candidate should have the potential to achieve international excellence in his/her discipline in the future. Salary and Benefits Successful candidates are expected to be appointed as independent PI and offered an internationally competitive recruiting package. 1. Generously competitive salary. 2. HCLS will assist with arranging daycare or school for child and job for spouse. 3. Sufficient start-up funds and enough laboratory and office space 4.",1
"Guaranteed graduate student quota: Each PI will allowed to accept up to 1-2 Ph.D students and 2-3 M.S. students per year. Application Excellent candidates with great enthusiasm are encouraged to assemble the application package as following and submitted electronically to zhaoshiyang0502@hit.edu.cn. 1. Cover Letter 2. Curriculum Vitae 3. Publication list of the applicant’s academic achievements 4. Three referees and a statement of future research plans The application will remain open until it is filled. Company Harbin Institute of Technology ( which is affiliated with the Ministry of Industry and Information Technology, has three campuses in Harbin, Weihai and Shenzhen. HIT was founded in 1920 and recognized as one of the two model universities in 1951 for studying foreign higher education models. In 1954, it was named one of the six key educational institutions of higher education by the nation. In 1996, it was in the first batch of universities to enter the former Project 211. In 1999, it was identified as one of the 9 universities in the first batch of ""985 Project"". In 2017, it was selected as one of the ""Double First-class"" universities in China. The HIT Center for Life Sciences (HCLS) ( was established in 2016. As the first special zone of HIT, HCLS has relatively independent academic, personnel employment and financial autonomy as well as postgraduate training system.",1
"HCLS has state-of-the-art core facilities including electron microscopy platform, imaging platform, mass spectrometry platform and experimental animal platform. In line with international standards, HCLS runs the Tenure-track system and PI responsibility system and strives to develop into world-class life science research institution in a relatively short period of time. - Location - Harbin China Apply for Tenure-track Positions at The HIT Center for Life Sciences, China Already uploaded your CV? Sign in to apply instantly Fields marked with an asterisk (*) are required Sign in to create job alerts Sign in or create an account to start creating job alerts and receive personalised job recommendations straight to your inbox. Create alert",1
"Nature subscription Description Nature is the foremost international weekly scientific journal in the world and is the flagship journal for Nature Portfolio. It publishes the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature publishes landmark papers, award winning news, leading comment and expert opinion on important, topical scientific news and events that enable readers to share the latest discoveries in science and evolve the discussion amongst the global scientific community. Nature+ subscription$32.99 / 30 days Learn more - Includes Nature and 55 other Nature journals - Immediate online access to all articles - Content available from 2017 onwards - Flexible monthly subscription For Institutionson demand Are you interested in an institutional license? Learn morePayment methods we accept: All prices are NET prices. VAT will be added later in the checkout. Tax calculation will be finalised during checkout. VAT will be added later in the checkout. Tax calculation will be finalised during checkout.",1
"Nature Nature is the foremost international weekly scientific journal in the world and is the flagship journal for Nature Portfolio. It publishes the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature publishes landmark papers, award winning news, leading comment and expert opinion on important, topical scientific news and events that enable readers to share the latest discoveries in science and evolve the discussion amongst the global scientific community. Nature Publishing Group en © 2025 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. Nature © 2025 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.",1
"permissions@nature.com Nature - Nature, Published online: 28 November 2025; doi:10.1038/s41586-025-09938-4Author Correction: Diversity-oriented synthesis yields novel multistage antimalarial inhibitors]]> Nobutaka KatoEamon ComerTomoyo Sakata-KatoArvind SharmaManmohan SharmaMicah MaetaniJessica BastienNicolas M. BrancucciJoshua A. BittkerVictoria CoreyDavid ClarkeEmily R. DerbyshireGillian L. DornanSandra DuffySean EckleyMaurice A. ItoeKarin M. J. KoolenTimothy A. LewisPing S. LuiAmanda K. LukensEmily LundSandra MarchElamaran MeibalanBennett C. MeierJacob A. McPhailBranko MitasevEli L. MossMorgane SayesYvonne Van GesselMathias J. WawerTakashi YoshinagaAnne-Marie ZeemanVicky M. AverySangeeta N. BhatiaJohn E. BurkeFlaminia CatterucciaJon C. ClardyPaul A. ClemonsKoen J. DecheringJeremy R. DuvallMichael A. FoleyFabian GusovskyClemens H. M. KockenMatthias MartiMarshall L. MorningstarBenito MunozDaniel E. NeafseyAmit SharmaElizabeth A. WinzelerDyann F. WirthChristina A. SchererStuart L. Schreiber doi:10.1038/s41586-025-09938-4 Nature, Published online: 2025-11-28; | doi:10.1038/s41586-025-09938-4 2025-11-28 Nature 10.1038/s41586-025-09938-4 - Nature, Published online: 28 November 2025; doi:10.1038/s41586-025-09952-6Author Correction: Evidence for improved DNA repair in the long-lived bowhead whale]]> Denis FirsanovMax ZacherXiao TianTodd L. SformoYang ZhaoGregory TomblineJ.",1
"Yuyang LuZhizhong ZhengLuigi PerelliEnrico GurreriLi ZhangJing GuoAnatoly KorotkovValentin VolobaevSeyed Ali BiashadZhihui ZhangJohanna HeidAlexander Y. MaslovShixiang SunZhuoer WuJonathan GigasEric C. HillpotJohn C. MartinezMinseon LeeAlyssa WilliamsAbbey GilmanNicholas HamiltonEkaterina StrelkovaEna HaseljicAvnee PatelMaggie E. StraightNalani MillerJulia AblaevaLok Ming TamChloé CoudercMichael R. HoopmannRobert L. MoritzShingo FujiiAmandine PelletierDan J. HaymanHongrui LiuYuxuan CaiAnthony K. L. LeungZhengdong ZhangC. Bradley NelsonLisa M. AbegglenJoshua D. SchiffmanVadim N. GladyshevCarlo C. MaleyMauro ModestiGiannicola GenoveseMirre J. P. SimonsJan VijgAndrei SeluanovVera Gorbunova doi:10.1038/s41586-025-09952-6 Nature, Published online: 2025-11-28; | doi:10.1038/s41586-025-09952-6 2025-11-28 Nature 10.1038/s41586-025-09952-6 - Nature, Published online: 28 November 2025; doi:10.1038/d41586-025-03797-9Researchers have struggled to precisely edit mitochondrial DNA, but new techniques are bringing this ability within reach. ]]> Gemma ConroyBenjamin Thompson doi:10.1038/d41586-025-03797-9 Nature, Published online: 2025-11-28; | doi:10.1038/d41586-025-03797-9 2025-11-28 Nature 10.1038/d41586-025-03797-9 - Nature, Published online: 28 November 2025; doi:10.1038/d41586-025-03877-wStudying trapped antimatter could help to explain why our world is so full of matter.",1
"]]> doi:10.1038/d41586-025-03877-w Nature, Published online: 2025-11-28; | doi:10.1038/d41586-025-03877-w 2025-11-28 Nature 10.1038/d41586-025-03877-w - Nature, Published online: 27 November 2025; doi:10.1038/s41586-025-09953-5Author Correction: Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants]]> Zhiqiang KuXuping XiePaul R. HintonXinli LiuXiaohua YeAntonio E. MuruatoDean C. NgSujit BiswasJing ZouYang LiuDeepal PandyaVineet D. MenacherySachi RahmanYu-An CaoHui DengWei XiongKevin B. CarlinJunquan LiuHang SuElizabeth J. HaanesBruce A. KeytNingyan ZhangStephen F. CarrollPei-Yong ShiZhiqiang An doi:10.1038/s41586-025-09953-5 Nature, Published online: 2025-11-27; | doi:10.1038/s41586-025-09953-5 2025-11-27 Nature 10.1038/s41586-025-09953-5 - Nature, Published online: 27 November 2025; doi:10.1038/s41586-025-09947-3Author Correction: Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver]]> Weiguo FanKolade AdebowaleLóránd VánczaYuan LiMd Foysal RabbiKoshi KunimotoDongning ChenGergely MozesDavid Kung-Chun ChiuYisi LiJunyan TaoYi WeiNia AdenijiRyan L. BrunsingRenumathy DhanasekaranAatur SinghiDavid GellerSu Hao LoLouis HodgsonEdgar G. EnglemanGregory W. CharvilleVivek CharuSatdarshan P. MongaTaeyoon KimRebecca G. WellsOvijit ChaudhuriNatalie J. Török doi:10.1038/s41586-025-09947-3 Nature, Published online: 2025-11-27; | doi:10.1038/s41586-025-09947-3 2025-11-27 Nature 10.1038/s41586-025-09947-3 - Nature, Published online: 27 November 2025; doi:10.1038/s41586-025-09955-3Author Correction: Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury]]> Nobuhiko KayagakiIrma B. StoweKamela AlegreIshan DeshpandeShuang WuZhonghua LinOpher S. KornfeldBettina L. LeeJuan ZhangJohn LiuEric SutoWyne P. LeeKellen SchneiderWeiYu LinDhaya SeshasayeeTushar BhangaleCecile ChalouniMatthew C. JohnsonPrajakta JoshiJan MossemannSarah ZhaoDanish AliNeil M. GoldenbergBlayne A. SayedBenjamin E. SteinbergKim NewtonJoshua D. WebsterRyan L. KellyVishva M. Dixit doi:10.1038/s41586-025-09955-3 Nature, Published online: 2025-11-27; | doi:10.1038/s41586-025-09955-3 2025-11-27 Nature 10.1038/s41586-025-09955-3 - Nature, Published online: 27 November 2025; doi:10.1038/d41586-025-03891-yDespite advances, AI models continue to be geared towards the needs of English-speaking people in high-income countries.",1
"]]> Laura Vargas-Parada doi:10.1038/d41586-025-03891-y Nature, Published online: 2025-11-27; | doi:10.1038/d41586-025-03891-y 2025-11-27 Nature 10.1038/d41586-025-03891-y - Nature, Published online: 27 November 2025; doi:10.1038/d41586-025-03506-6Controversy has erupted after 21% of manuscript reviews for an international AI conference were found to be generated by artificial intelligence. ]]> Miryam Naddaf doi:10.1038/d41586-025-03506-6 Nature, Published online: 2025-11-27; | doi:10.1038/d41586-025-03506-6 2025-11-27 Nature 10.1038/d41586-025-03506-6 - Nature, Published online: 27 November 2025; doi:10.1038/d41586-025-03778-yThe European country has long been recognized as a model of efficiency and innovation — here’s how its research ecosystem is organized.",1
"]]> Katarina Zimmer doi:10.1038/d41586-025-03778-y Nature, Published online: 2025-11-27; | doi:10.1038/d41586-025-03778-y 2025-11-27 Nature 10.1038/d41586-025-03778-y - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09871-6Author Correction: Photocatalytic low-temperature defluorination of PFASs]]> Hao ZhangJin-Xiang ChenJian-Ping QuYan-Biao Kang doi:10.1038/s41586-025-09871-6 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09871-6 2025-11-26 Nature 10.1038/s41586-025-09871-6 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03896-7Distinctive sounds of Martian 'micro-lightning' recorded by NASA’s Perseverance rover for the first time — plus, the final outcomes of the UN’s COP30 climate conference. ]]> Benjamin ThompsonNick Petrić Howe doi:10.1038/d41586-025-03896-7 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03896-7 2025-11-26 Nature 10.1038/d41586-025-03896-7 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03892-xLoops precisely knotted into thread can help novice surgeons to perform perfect sutures. ]]> Elizabeth Gibney doi:10.1038/d41586-025-03892-x Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03892-x 2025-11-26 Nature 10.1038/d41586-025-03892-x - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09774-6The sequential recruitment of a thalamocortical transcriptional cascade enables memory maintenance over long timescales.",1
"]]> Andrea TercerosCeline ChenYujin HaradaTim EilersMillennium GebremedhinPierre-Jacques HamardRichard KocheRoshan SharmaPriya Rajasethupathy doi:10.1038/s41586-025-09774-6 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09774-6 2025-11-26 Nature 10.1038/s41586-025-09774-6 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09727-zInhibition of the histone methyltransferase NSD2 and the androgen receptor in preclinical models can reverse lineage plasticity to suppress tumour growth and promote cell death in multiple subtypes of castration-resistant prostate cancer. ]]> Jia J. LiAlessandro VasciaveoDimitris KaragiannisZhen SunKristjan H. GretarssonXiao ChenOuathek OuerfelliFabio SocciarelliZiv FrankensteinHanyang DongMin ZouWei YuanGuangli YangGabriel M. AizenmanTania PannelliniXinjing XuHimisha BeltranYu ChenKevin GardnerBrian D. RobinsonJohann de BonoOr GozaniCory Abate-ShenMark A. RubinMassimo LodaCharles L. SawyersAndrea CalifanoChao LuMichael M. Shen doi:10.1038/s41586-025-09727-z Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09727-z 2025-11-26 Nature 10.1038/s41586-025-09727-z - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09793-3Ultralow-power ferroelectric field-effect transistors are used to achieve low-power NAND flash memory, overcoming the trade-off between multi-level capability and power efficiency and paving the way for next-generation storage memory.",1
"]]> Sijung YooTaek Jung KimSeung-Geol NamDonghoon KimKihong KimYunseong LeeMoonil JungKwang-Hee LeeSeokhoon ChoiSeung Dam HyunMin-Hyun LeeSeogwoo HongHaesung KimKi Deok BaeHyangsook LeeJung Yeon WonDong-Jin YunByeong Gyu ChaeWook Ghee HahnChang Hyun JooSanghyun JoYoonsang ParkKyung Mee SongKyooho JungSuhwan LimKwangyou SeoKwangsoo KimWanki KimDaewon HaJee-Eun YangSeung-Yeul YangSangwook KimJinseong HeoDuk-Hyun Choe doi:10.1038/s41586-025-09793-3 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09793-3 2025-11-26 Nature 10.1038/s41586-025-09793-3 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09805-2The brain can flexibly perform multiple tasks by compositionally combining task-relevant neural representations. ]]> Sina TafazoliFlora M. BouchacourtAdel ArdalanNikola T. MarkovMotoaki UchimuraMarcelo G. MattarNathaniel D. DawTimothy J. Buschman doi:10.1038/s41586-025-09805-2 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09805-2 2025-11-26 Nature 10.1038/s41586-025-09805-2 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09673-wA mechano-intelligent transmission mechanism based on the slipknot delivers precise force signals for clinical practice and robotic operations such as minimally invasive surgery and tendon-driven robotics.",1
"]]> Yaoting XueJiasheng CaoTao FengKaihang ZhangSiyang LiJiahao HuHaotian GuoJinming ZhangYaoxian SongZhuofan WangLei WangQishan HuangHaofei ZhouFanghao ZhouJiliang ShenYaowei FanZhe WangXinge LiJie-Wei WongZhiwei ChenDongrui RuanZhikun MiaoBin ZhangEnjie ZhouLetian GanXuanqi WangErtai CaoTong ChenWeifeng ZouJunhui ZhangHaojian LuQinghai ZhangSong LiuHuixu DongShiying XiongShuyou PengTuck-Whye WongYuanjie ChenTiefeng LiMingyu ChenXuxu YangWei YangXiujun Cai doi:10.1038/s41586-025-09673-w Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09673-w 2025-11-26 Nature 10.1038/s41586-025-09673-w - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09796-0A mode of brain organization that connects visual and bodily reference frames may translate raw sensory impressions into more abstract formats that are useful for action, social cognition and semantic processing. ]]> Nicholas HedgerThomas NaselarisKendrick KayTomas Knapen doi:10.1038/s41586-025-09796-0 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09796-0 2025-11-26 Nature 10.1038/s41586-025-09796-0 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09760-yControlling pairs of nitrogen vacancy centres enables the measurement of magnetic correlations below the optical diffraction limit, and the use of entangled pairs shows a linear scaling of the measurement sensitivity with readout noise, as opposed to the quadratic scaling that would be obtained with unentangled spins.",1
"]]> Jared RovnyShimon KolkowitzNathalie P. de Leon doi:10.1038/s41586-025-09760-y Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09760-y 2025-11-26 Nature 10.1038/s41586-025-09760-y - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09765-7Soil compaction traps ethylene around roots, which causes transcriptional upregulation of Auxin Response Factor1, resulting in decreased root cortical cell wall thickness and thereby promoting root radial expansion. ]]> Jiao ZhangZengyu LiuEdward J. FarrarMinhao LiHui LuZhuo QuOsvaldo CharaNobutaka MitsudaShingo SakamotoFeiyang XueQiji ShanYa YuJingbin LiXiaobo ZhuMingyuan ZhuJin ShiLucas Peralta OgorekAugusto BorgesMalcolm J. BennettWanqi LiangBipin K. PandeyDabing ZhangStaffan Persson doi:10.1038/s41586-025-09765-7 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09765-7 2025-11-26 Nature 10.1038/s41586-025-09765-7 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09803-4Liver-restricted viral infection in mice results in secondary lymphoid organ dormancy and the compensatory induction of specialized lymphoid tissue in the liver, the structural features and functional outputs of which are closely mirrored in humans.",1
"]]> John GridleyDavid PakAnuradha KumariJacob ShupakBrantley HollandYifeng ShiSheetal TrivediYongtao WangSudhir Pai KasturiAmit KapoorRaymond T. ChungArash Grakoui doi:10.1038/s41586-025-09803-4 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09803-4 2025-11-26 Nature 10.1038/s41586-025-09803-4 - + T cells]]> Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09440-xPD-1 blockade interferes with the selective expansion and maintenance of high-affinity TCR stem-like clones that have a critical role in effective checkpoint blockade therapy. ]]> + T cells]]> Jyh Liang HorEdward C. SchromAbigail Wong-RolleLuke VistainWanjing ShangQiang DongChen ZhaoChengcheng JinRonald N. Germain doi:10.1038/s41586-025-09440-x Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09440-x 2025-11-26 Nature 10.1038/s41586-025-09440-x - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09763-9Inhibitor-induced kinase degradation is a common event that positions supercharging of endogenous degradation circuits as an alternative to classical proximity-inducing degraders.",1
"]]> Natalie S. ScholesMartino BertoniArnau Comajuncosa-CreusKatharina KladnikXuefei GuoFabian FrommeltMatthias HinterndorferHlib RazumkovPolina ProkofevaMartin P. SchwalmFlorian BornSandra RoehmHana ImrichovaBrianda L. SantiniEleonora BaroneCaroline SchätzMiquel Muñoz i OrdoñoSeverin LechnerAndrea RukavinaIciar SerranoMiriam AbeleAnna KorenStefan KubicekStefan KnappNathanael S. GrayGiulio Superti-FurgaBernhard KusterYigong ShiPatrick AloyGeorg E. Winter doi:10.1038/s41586-025-09763-9 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09763-9 2025-11-26 Nature 10.1038/s41586-025-09763-9 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09799-xSequencing of 144 ancient genomes from Shimao city and its satellites presents pedigrees among tomb owners spanning up to four generations showing predominantly patrilineal descent structure across Shimao communities, and possibly sex-specific sacrificial rituals. ]]> Zehui ChenJacob D. GardnerZhouyong SunE.",1
"Andrew BennettQian HanXuesong PeiJing ShaoHan ShiWenjun WangJiayang XueFan BaiXiangming DaiNu HeXiaoning GuoNan DiXiaowei MaoTianxiang LiuPeng CaoFeng LiuQingyan DaiXiaotian FengWanjing PingXiaohong WuLizhao ZhangLiang ChenQiaomei Fu doi:10.1038/s41586-025-09799-x Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09799-x 2025-11-26 Nature 10.1038/s41586-025-09799-x - Australopithecus deyiremeda]]> Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09714-43.4-million-year-old hominin fossils discovered in Ethiopia provide insight into the diet and locomotion of Australopithecus deyiremeda. ]]> Australopithecus deyiremeda]]> Yohannes Haile-SelassieGary T. SchwartzThomas C. PrangBeverly Z. SaylorAlan DeinoLuis GibertAnna RagniNaomi E. Levin doi:10.1038/s41586-025-09714-4 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09714-4 2025-11-26 Nature 10.1038/s41586-025-09714-4 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09766-6Calcium imaging of taste neurons and the ventral brain provides insight into evolutionary divergence of food choice in Drosophila species, supporting a role of sensorimotor processing in addition to peripheral receptor changes.",1
"]]> Enrico BertoliniDaniel MünchJustine PascualNoemi SgammegliaMatteo BruzzoneCarlos RibeiroThomas O. Auer doi:10.1038/s41586-025-09766-6 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09766-6 2025-11-26 Nature 10.1038/s41586-025-09766-6 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09797-zA meta-analysis of 168 studies reveals that economic inequality is not significantly associated with subjective well-being or mental health. ]]> Nicolas SommetAdrien A. FillonOcyna RudmannAlfredo Rossi Saldanha CunhaAnnahita Ehsan doi:10.1038/s41586-025-09797-z Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09797-z 2025-11-26 Nature 10.1038/s41586-025-09797-z - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09788-0Large-scale analyses of bird species traits reveal that land-use change reduces resilience of key ecological functions more than previously thought.",1
"]]> Thomas L. WeeksPatrick A. WalkdenDavid P. EdwardsAlexander C. LeesAlexander L. PigotAndy PurvisJoseph A. Tobias doi:10.1038/s41586-025-09788-0 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09788-0 2025-11-26 Nature 10.1038/s41586-025-09788-0 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09752-yA glasses-free three-dimensional display, which is as large as a conventional desktop screen and has a viewing angle larger than 100°, is achieved by an artificial intelligence-powered optimization algorithm, which adapts the virtual images sent around each eye in real time. ]]> Weijie MaZhangrui ZhaoCanyu ZhaoWanli OuyangHan-Sen Zhong doi:10.1038/s41586-025-09752-y Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09752-y 2025-11-26 Nature 10.1038/s41586-025-09752-y - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09736-yThe SuperCam microphone aboard the Perseverance rover captured 55 triboelectric discharges during dust events on Mars over two Martian years, providing implications for examining the planet’s surface chemistry, habitability and human exploration.",1
"]]> Baptiste ChideRalph D. LorenzFranck MontmessinSylvestre MauriceYann ParotRicardo HuesoGerman MartinezAlvaro Vicente-RetortilloXavier JacobMark LemmonBruno DuboisPierre-Yves MeslinClaire NewmanTanguy BertrandGrégoire DeprezDaniel ToledoAgustin Sánchez-LavegaAgnès CousinRoger C. Wiens doi:10.1038/s41586-025-09736-y Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09736-y 2025-11-26 Nature 10.1038/s41586-025-09736-y - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09779-1Thousands of centromeres were identified and tracked across two major fungal clades, showing that new centromeres spread progressively and that the kinetochore acts as a filter to determine which new centromere variants are tolerated. ]]> Jana HelsenKausthubh RamachandranGavin SherlockGautam Dey doi:10.1038/s41586-025-09779-1 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09779-1 2025-11-26 Nature 10.1038/s41586-025-09779-1 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09790-6An entanglement-enhanced sensing strategy making use of entangled nitrogen–vacancy pairs is described, demonstrating a 3.4-fold improvement in sensitivity and a 1.6-fold improvement in spatial resolution relative to single nitrogen–vacancy centres under ambient conditions.",1
"]]> Xu ZhouMengqi WangXiangyu YeHaoyu SunYuhang GuoShuo HanZihua ChaiWentao JiKangwei XiaFazhan ShiYa WangJiangfeng Du doi:10.1038/s41586-025-09790-6 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09790-6 2025-11-26 Nature 10.1038/s41586-025-09790-6 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09743-zData provided by Amazonian peoples are used to estimate the value of wild animals as a source of food, including its spatial distribution and nutritional value, providing information that will be key for improved management of forest ecosystems in the region.",1
"]]> André Pinassi AntunesPedro de Araujo Lima ConstantinoJulia E. FaDaniel P. MunariThais Q. MorcattyMichelle C. M. JacobBruce W. NelsonMariana Franco CassinoElildo A. R. CarvalhoAmy IckowitzLauren CoadRichard E. BodmerPedro MayorCecile Richard-HansenJoão ValsecchiJoão V. Campos-SilvaJuarez C. B. PezzutiMiguel AparícioEduardo M. von MuhlenMarcela Alvares OliveiraMilton J. de PaulaNatalia C. PimentaMarina A. R. de Mattos VieiraMarcelo A. Santos JuniorAndré V. NunesJean P. BoubliLuan M. G. SuruíEneias C. S. PaumariAbimael V. C. PaumariJosé Lino V. S. PaumariGermano C. PaumariAna Paula L. R. KatukinaDzoodzo BaniwaValencio S. M. BaniwaWalter S. L. BaniwaAbel O. F. BaniwaArmindo B. BaniwaIsaías J. S. BaniwaYaukuma WauraJairo Silvestre ApurinãValdir S. S. ApurinãJosiane O. G. TikunaElias P. A. L. TikunaJosé L. KaxinauáKussugi B. KuikuroJorge T. Penaforth KaixanaGeorge H. RebeloDione TorquatoVanessa S. F. ApurinãMiguel AntúnezPedro E. Perez-PeñaTula G. FangPablo E. PuertasRolando M. AquinoLouise MaranhãoGuillaume LonginCíntia K. M. LopesHani R. El Bizri doi:10.1038/s41586-025-09743-z Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09743-z 2025-11-26 Nature 10.1038/s41586-025-09743-z - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09767-5Parallel operation of two exchange-only qubits consisting of six quantum dots arranged linearly is shown to be achievable and maintains qubit control quality compared with sequential operation, with potential for use in scaled quantum computing.",1
"]]> Mateusz T. MądzikFlorian LuthiGian Giacomo GuerreschiFahd A. MohiyaddinFelix BorjansJason D. ChadwickMatthew J. CurryJoshua ZieglerSarah AtanasovPeter L. BavdazElliot J. ConnorsJ. CorriganH. Ekmel ErcanRobert FloryHubert C. GeorgeBenjamin HarptEric HenryMohammad M. IslamNader KhammassiDaniel KeithLester F. LampertTodor M. MladenovRandy W. MorrisAditi NethwewalaSamuel NeyensRené OttenLinda P. Osuna IbarraBishnu PatraRavi PillarisettyShavindra PremaratneMick RamseyAndrew RisingerJohn D. RooneyRostyslav SavytskyyThomas F. WatsonOtto K. ZietzAnne Y. MatsuuraStefano PelleranoNathaniel C. BishopJeanette RobertsJames S. Clarke doi:10.1038/s41586-025-09767-5 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09767-5 2025-11-26 Nature 10.1038/s41586-025-09767-5 - Nature, Published online: 26 November 2025; doi:10.1038/s41586-025-09786-2Complex prophage integration dynamics, including low-level induction, cross-family host range and transposase-mediated mobilization, challenge existing paradigms and deepen our understanding of phage–bacterial interactions in the human gut microbiome.",1
"]]> Jakob WirbelAngela S. HickeyDaniel ChangNora J. EnrightMai DvorakRachael B. ChaninDanica T. SchmidtkeAmi S. Bhatt doi:10.1038/s41586-025-09786-2 Nature, Published online: 2025-11-26; | doi:10.1038/s41586-025-09786-2 2025-11-26 Nature 10.1038/s41586-025-09786-2 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03811-0Soil produced by the gradual breakdown of rock forms the planet’s thin but crucial ‘skin’. Analyses of a tectonically active landscape along the San Andreas fault aim to address a long-standing question in geomorphology and landscape evolution: what sets the pace at which rock transforms to soil? ]]> doi:10.1038/d41586-025-03811-0 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03811-0 2025-11-26 Nature 10.1038/d41586-025-03811-0 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03745-7Soft fibres that adapt their form and mechanical properties reversibly and rapidly under a magnetic field that is safe for human health have been developed and used to make yarns and fabrics. These programmable fibrous assemblies could be applied in soft robotics and wearable technologies.",1
"]]> doi:10.1038/d41586-025-03745-7 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03745-7 2025-11-26 Nature 10.1038/d41586-025-03745-7 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03649-6The DNA of ancient individuals dating to between 10,000 and 150 years ago reveals the existence of a long-standing, yet previously uncharacterized, lineage in the Southern Cone of South America — a region comprising what is now Argentina, Chile and Uruguay. People with this ancestry produced offspring with other, pre-existing groups in surrounding regions. Genomic data from present-day inhabitants attest to the genetic continuity of the lineage in central Argentina. ]]> doi:10.1038/d41586-025-03649-6 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03649-6 2025-11-26 Nature 10.1038/d41586-025-03649-6 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03816-9Cells have evolved elaborate mechanisms to eliminate unwanted proteins and maintain homeostasis. Inhibitors of a diverse family of enzymes called kinases can co-opt and ‘supercharge’ these protein-degradation mechanisms to prompt kinase degradation.",1
"]]> doi:10.1038/d41586-025-03816-9 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03816-9 2025-11-26 Nature 10.1038/d41586-025-03816-9 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03451-4Fossils newly discovered in Ethiopia indicate that previously unidentified foot bones belong to the ancient human relative Australopithecus deyiremeda. ]]> Fred Spoor doi:10.1038/d41586-025-03451-4 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03451-4 2025-11-26 Nature 10.1038/d41586-025-03451-4 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03885-wEngineered T cells that have been used to treat ulcerative colitis, rheumatoid arthritis and lupus show promising results. ]]> Rachel Fieldhouse doi:10.1038/d41586-025-03885-w Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03885-w 2025-11-26 Nature 10.1038/d41586-025-03885-w - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03786-yHistory repeating. ]]> Monti Sturzaker doi:10.1038/d41586-025-03786-y Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03786-y 2025-11-26 Nature 10.1038/d41586-025-03786-y - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03590-8The Perseverance rover on Mars has serendipitously recorded sounds and electromagnetic signals that are characteristic of lightning in dust storms.",1
"]]> Daniel Mitchard doi:10.1038/d41586-025-03590-8 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03590-8 2025-11-26 Nature 10.1038/d41586-025-03590-8 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03454-1An assessment of the food hunted across the Amazon rainforest reveals its crucial role and how human pressures, particularly deforestation, threaten the resource. ]]> Carla MorselloPatricia Carignano Torres doi:10.1038/d41586-025-03454-1 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03454-1 2025-11-26 Nature 10.1038/d41586-025-03454-1 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03593-5Using genomic data, researchers have uncovered the origins and cultural practices of the people of Shimao, a 4,000-year-old fortified settlement in northern China. ]]> Yu DongRipan S. Malhi doi:10.1038/d41586-025-03593-5 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03593-5 2025-11-26 Nature 10.1038/d41586-025-03593-5 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03855-2More children and adults are being diagnosed with ADHD in some countries. Science is helping to understand why — and how best to provide support.",1
"]]> Helen Pearson doi:10.1038/d41586-025-03855-2 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03855-2 2025-11-26 Nature 10.1038/d41586-025-03855-2 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03452-3Devices made from certain materials can double the frequency of light. Programmable electrodes can tune this response to produce various light spectra. ]]> Kartik Srinivasan doi:10.1038/d41586-025-03452-3 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03452-3 2025-11-26 Nature 10.1038/d41586-025-03452-3 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03890-zNational laboratories have been instructed to broaden access to their data sets to accelerate research as part of the federal government’s AI platform. But who stands to benefit? ]]> Elizabeth GibneyAlexandra WitzeJenna Ahart doi:10.1038/d41586-025-03890-z Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03890-z 2025-11-26 Nature 10.1038/d41586-025-03890-z - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03850-7Germany is one of the most popular destinations for students and scholars worldwide, but those pursuing academic careers face significant hurdles to success.",1
"]]> Diana Kwon doi:10.1038/d41586-025-03850-7 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03850-7 2025-11-26 Nature 10.1038/d41586-025-03850-7 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03853-4The nation’s next generation of scientists and technologists will shape the coming decades. ]]> Kerry Brown doi:10.1038/d41586-025-03853-4 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03853-4 2025-11-26 Nature 10.1038/d41586-025-03853-4 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03886-9Since it was unveiled in 2020, Google DeepMind’s game-changing AI tool has helped researchers all over the world to predict the 3D structures of hundreds of millions of proteins. ]]> Ewen Callaway doi:10.1038/d41586-025-03886-9 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03886-9 2025-11-26 Nature 10.1038/d41586-025-03886-9 - Nature, Published online: 26 November 2025; doi:10.1038/d41586-025-03594-4Alterations in land use are found to leave bird communities with fewer backup species for key ecological roles, making ecosystems vulnerable to further species loss.",1
"]]> Carlos P. Carmona doi:10.1038/d41586-025-03594-4 Nature, Published online: 2025-11-26; | doi:10.1038/d41586-025-03594-4 2025-11-26 Nature 10.1038/d41586-025-03594-4 - Nature, Published online: 25 November 2025; doi:10.1038/s41586-025-09956-2Author Correction: Spatial fibroblast niches define Crohn’s fistulae]]> Colleen McGregorXiao QinMarta JagielowiczTarun GuptaZinan YinVerena LentschDavid Fawkner-CorbettVy Wien LaiPaula Gomez CastroEsther BridgesChloe Hyun-Jung LeeHuei-Wen ChuangLei DengAnna AulicinoRenuka TeagueSorayya MoradiJun Sung ParkJeongmin WooKexin XuRuchi TandonNicole CianciJan BornscheinLing-Pei HoPaulina Siejka-ZielinskaZoe ChristoforidouSarah HillJohannes LehmannRhea KujawaPaola Vargas GutierrezCarol ChengMaria GrecoKatherine BakerMark BignellBruce GeorgeEve FryerMichael ViethAgne AntanaviciuteAlison Simmons doi:10.1038/s41586-025-09956-2 Nature, Published online: 2025-11-25; | doi:10.1038/s41586-025-09956-2 2025-11-25 Nature 10.1038/s41586-025-09956-2 - Nature, Published online: 25 November 2025; doi:10.1038/s41586-025-09930-yPolyclonal origins of human premalignant colorectal lesions]]> Debra Van EgerenRyan O. SchenckAziz KhanAaron M. HorningShanlan MoClemens L. WeißEdward D. EsplinWinston R. BeckerSi WuCasey HansonNasim BarapourLihua JiangKévin ContrepoisHayan LeeStephanie A. NevinsTuhin K. GuhaHao ZhangZhen HeZhicheng MaEmma MonteThomas V. KarathanosRozelle LaquindanumMeredith A. MillsHassan ChaibRoxanne ChiuRuiqi JianJoanne ChanMathew EllenbergerBahareh BahmaniBasil MichaelAnnika K. WeimerD.",1
"Glen EsplinSamuel LancasterJeanne ShenUri LadabaumTeri A. LongacreAnshul KundajeWilliam J. GreenleafZheng HuJames M. FordMichael P. SnyderChristina Curtis doi:10.1038/s41586-025-09930-y Nature, Published online: 2025-11-25; | doi:10.1038/s41586-025-09930-y 2025-11-25 Nature 10.1038/s41586-025-09930-y - Nature, Published online: 25 November 2025; doi:10.1038/s41586-025-09936-6Author Correction: An asymmetric fission island driven by shell effects in light fragments]]> P. MorfouaceJ. TaiebA. ChatillonL. AudouinG. BlanchonR. N. BernardN. DubrayN. PilletD. RegnierH. Alvarez-PolF. AmjadP. AndréG. AutheletL. AtarT. AumannJ. BenlliureK. BoretzkyL. BottT. BreceljC. CaesarP. CarpentierE. CasarejosJ. CederkällA. CorsiD. Cortina-GilA. CvetinovićE. De FilippoT. DickelM. FeijooL. M. FonsecaD. GalavizG. García-JiménezI. GasparicE. I. GeraciR. GernhäuserB. GnoffoK. GöbelA. Graña-GonzálezE. HaettnerA.-L. HartigM. HeilA. HeinzT. HenselM. HollC. HornungA. HorvatA. JedeleD. Jelavic MalenicaT. JeneggerL. JiH. T. JohanssonB. JonsonB. JuradoN. Kalantar-NayestanakiE. KazantsevaA. Kelic-HeilO. A. KiselevP. KlenzeR. KnöbelD. KörperD. KostylevaT. KröllN. KuzminchukB. LaurentI. LihtarYu. A. LitvinovB. LöherN. S. MartoranaB. MaussS. Murillo MoralesD. MücherI. MukhaE. NacherA. ObertelliE. V. PaganoV. PaninJ. ParkS. PaschalisM. PetriS. PietriS. PirroneG. PolitiL. PonnathA. RevelH.-B. RheeJ. L. Rodríguez-SánchezL. RoseD. RossiP. RoyP. RussottoC. ScheidenbergerH. ScheitH. SimonS. Storck-DutineA. StottY.",1
"L. SunC. SürderY. K. TanakaR. TaniuchiO. TengbladI. TismaH. T. TörnqvistM. TrimarchiS. VelarditaJ. VesicB. VossF. WamersH. WeickF. WienholtzJ. ZhaoM. Zhukov doi:10.1038/s41586-025-09936-6 Nature, Published online: 2025-11-25; | doi:10.1038/s41586-025-09936-6 2025-11-25 Nature 10.1038/s41586-025-09936-6 - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03884-xLack of funding is pushing research in Romania to extinction]]> Lucian Pintilie doi:10.1038/d41586-025-03884-x Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03884-x 2025-11-25 Nature 10.1038/d41586-025-03884-x - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03882-zChile must preserve international science in Antarctica]]> Cristóbal Galbán MalagónMarcelo LeppeGustavo ChiangPaulina Bahamonde doi:10.1038/d41586-025-03882-z Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03882-z 2025-11-25 Nature 10.1038/d41586-025-03882-z - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03737-7A survey of people at risk of exposure to natural disasters, and great balls of fire, in our weekly dip into Nature’s archive.",1
"]]> doi:10.1038/d41586-025-03737-7 Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03737-7 2025-11-25 Nature 10.1038/d41586-025-03737-7 - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03883-yUniversities must help students faced with the death of a supervisor]]> Laura Zárraga-Vargas doi:10.1038/d41586-025-03883-y Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03883-y 2025-11-25 Nature 10.1038/d41586-025-03883-y - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03881-0International environmental treaties cannot be reformed through rational design]]> Vito De LuciaJan Solski doi:10.1038/d41586-025-03881-0 Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03881-0 2025-11-25 Nature 10.1038/d41586-025-03881-0 - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03856-1Blending ‘old-fashioned’ logic systems with the neural networks that power large language models is one of the hottest trends in artificial intelligence. ]]> Nicola Jones doi:10.1038/d41586-025-03856-1 Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03856-1 2025-11-25 Nature 10.1038/d41586-025-03856-1 - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03851-6Despite the weak agreement seen at the COP30 climate conference, Brazil was right to prioritize discussing the eventual phase-out of fossil fuels. Others must now help to find a way forward.",1
"]]> doi:10.1038/d41586-025-03851-6 Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03851-6 2025-11-25 Nature 10.1038/d41586-025-03851-6 - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03592-6In 1995, two papers reported long-sought proof of an exotic state of matter — with applications in fields as diverse as quantum computing and cosmology. ]]> Zoran HadzibabicUlrich Schneider doi:10.1038/d41586-025-03592-6 Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03592-6 2025-11-25 Nature 10.1038/d41586-025-03592-6 - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03802-1COP30 negotiated efforts to protect forests and ramp up financial packages for climate action, but with one glaring omission: a road map to cut fossil fuels. ]]> Meghie RodriguesJeff Tollefson doi:10.1038/d41586-025-03802-1 Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03802-1 2025-11-25 Nature 10.1038/d41586-025-03802-1 - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03854-3The world needs a more agile framework for climate action, but that shouldn’t mean abandoning a system that has worked for 30 years.",1
"]]> Kilaparti Ramakrishna doi:10.1038/d41586-025-03854-3 Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03854-3 2025-11-25 Nature 10.1038/d41586-025-03854-3 - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03869-wScientific meetings that support Black, Latino and Indigenous researchers are grappling with funding cuts and other restrictions. ]]> Alexandra Witze doi:10.1038/d41586-025-03869-w Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03869-w 2025-11-25 Nature 10.1038/d41586-025-03869-w - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03768-0Technical advances allow researchers to trace the genetic changes that occur over time. ]]> Heidi Ledford doi:10.1038/d41586-025-03768-0 Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03768-0 2025-11-25 Nature 10.1038/d41586-025-03768-0 - Nature, Published online: 25 November 2025; doi:10.1038/d41586-025-03872-1Bacteria, viruses and fungi that colonize the body — including some that live directly on eye surfaces — can have an important role in eye health.",1
"]]> Roxanne Khamsi doi:10.1038/d41586-025-03872-1 Nature, Published online: 2025-11-25; | doi:10.1038/d41586-025-03872-1 2025-11-25 Nature 10.1038/d41586-025-03872-1 - Nature, Published online: 24 November 2025; doi:10.1038/s41586-025-09916-wMAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance]]> Mark WhiteMegan L. MillsLaura M. MillettKathryn GilroyYourae HongLucas B. ZeigerRosalin J. SimpsonShania M. CorryAmelia LigezaTamsin R. M. LannaganSusanti SusantiRachel A. RidgwayAyse S. YazgiliLucile GrzesiakRaheleh AmirkhahCatriona A. FordNikola VlahovHannah TovellLeah Officer-JonesCatherine FickenRachel PennieArafath K. NajumudeenAlexander RavenNadia NasreddinEkansh ChauhanAndrew S. PapanastasiouColin NixonVivienne MorrisonRene JackstadtJanet S. GrahamCrispin J. MillerSarah J. RossSimon T. BarryValeria PavetRichard H. WilsonJohn Le QuesnePhilip D. DunneSabine TejparSimon LeedhamAndrew D. CampbellOwen J. Sansom doi:10.1038/s41586-025-09916-w Nature, Published online: 2025-11-24; | doi:10.1038/s41586-025-09916-w 2025-11-24 Nature 10.1038/s41586-025-09916-w - Nature, Published online: 24 November 2025; doi:10.1038/d41586-025-03861-4Maria Shrestha works to understand the evolutionary history of crayfish symbionts — and how they might be indicators of trouble.",1
"]]> Stav Dimitropoulos doi:10.1038/d41586-025-03861-4 Nature, Published online: 2025-11-24; | doi:10.1038/d41586-025-03861-4 2025-11-24 Nature 10.1038/d41586-025-03861-4 - Nature, Published online: 24 November 2025; doi:10.1038/d41586-025-03695-0Using hydrogen to power road transportation and heat homes doesn’t save more carbon emissions than direct electrification. ]]> doi:10.1038/d41586-025-03695-0 Nature, Published online: 2025-11-24; | doi:10.1038/d41586-025-03695-0 2025-11-24 Nature 10.1038/d41586-025-03695-0 - Nature, Published online: 24 November 2025; doi:10.1038/d41586-025-03859-yTim Berners-Lee is calling for a return to a decentralized Internet and stronger data privacy, but his arguments could be more inspiring. ]]> Chris Stokel-Walker doi:10.1038/d41586-025-03859-y Nature, Published online: 2025-11-24; | doi:10.1038/d41586-025-03859-y 2025-11-24 Nature 10.1038/d41586-025-03859-y - Nature, Published online: 24 November 2025; doi:10.1038/d41586-025-03857-0The advent of artificial intelligence might be just the latest stage in a guiding biological process that has produced ever more complex, mutually dependent organisms over the history of life.",1
"]]> Blaise Agüera y Arcas doi:10.1038/d41586-025-03857-0 Nature, Published online: 2025-11-24; | doi:10.1038/d41586-025-03857-0 2025-11-24 Nature 10.1038/d41586-025-03857-0 - Nature, Published online: 24 November 2025; doi:10.1038/d41586-025-03858-zEconomists should consider forests and wetlands as well as factories and farms. ]]> Jacob Hochard doi:10.1038/d41586-025-03858-z Nature, Published online: 2025-11-24; | doi:10.1038/d41586-025-03858-z 2025-11-24 Nature 10.1038/d41586-025-03858-z",1
"Connecting leading candidates to the world's finest science jobs Browse Jobs - Applied Science 148 - Biomedicine 270 - Chemistry 135 - Clinical 52 - Computing 175 - Earth Science 45 - Engineering 144 - Environmental Science 78 - Health Science 339 - Life Science 376 - Mathematics 74 - Physics 204 - Bioinformatician 23 - Engineer 31 - Faculty Member 279 - Head of Department 30 - Health Professional 72 - Manager 35 - PhD Position 105 - Postdoctoral 299 - Principal Investigator 66 - Professor 140 - Research Assistant 60 - Researcher 200 - United States 410 - Germany 177 - China 83 - Austria 72 - Denmark 68 - Luxembourg 52 - United Kingdom 50 - Asia Pacific 49 - Belgium 26 - Canada 22 - Middle East 21 - United Arab Emirates 17 Job of the week Employers Advertise With Us About us Navigating your scientific career can be demanding whichever field you’re in, wherever you are in the world. That’s why we aim to support and inspire you with all manner of advice for every career stage. Search and apply to jobs from international companies and institutions. Sign up for events to broaden your skills and knowledge. Read more on our services. Career Advice - Nature Career Guides Browse collections of career guides. Learn about the mission and achievements of the world's leading research organisations, find out more about their job roles, courses, and events, alongside independently written editorials that cover advancements and career opportunities in your field.",1
"- Working Scientist Podcast Working Scientist is the Nature Careers podcast, produced by the careers editors at Nature. Working Scientist is a regular free audio show featuring advice and information from global industry experts with a strong focus on supporting early career researchers working in academia and other sectors.",1
"An official website of the United States government Here’s how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock () or means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Know Your Blood Pressure Numbers High blood pressure is a risk for heart disease. Knowing your numbers is the first step to controlling it. The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives. Featured Resources & Initiatives Image Explore NIH’s groundbreaking initiatives and programs that are advancing biomedical research, accelerating scientific discovery, and improving health for all Americans.",1
"NIH on Social Media NIH on Social Media Primary NIH Accounts Explore other NIH Social Media: NIH Institutes and Centers (ICs) Facebook: National Cancer Institute X: @theNCI X: @NCIDirector Instagram: @nationalcancerinstitute LinkedIn: National Cancer Institute YouTube: National Cancer Institute Facebook: National Eye Institute X: @NEIDirector LinkedIn: National Eye Institute YouTube: National Eye Institute Facebook: National Heart, Lung, and Blood Institute Facebook: National Human Genome Research Institute X: @genome_gov Instagram: @nhgri_nih LinkedIn: National Human Genome Research Institute Facebook: National Institute on Aging X: @NIHAging LinkedIn: National Institute on Aging YouTube National Institute on Aging Facebook: National Institute on Alcohol Abuse and Alcoholism X: @NIAAANews Instagram: @niaaanews LinkedIn: National Institute on Alcohol Abuse and Alcoholism Facebook: National Institute of Allergy and Infectious Diseases X: @NIAIDNews Instagram: @niaid LinkedIn: National Institute of Allergy and Infectious Diseases YouTube: National Institute of Allergy and Infectious Diseases Facebook: Eunice Kennedy Shriver National Institute of Child Health and Human Development X: @NICHD_NIH Instagram: @nichd_nih LinkedIn: Eunice Kennedy Shriver National Institute of Child Health and Human Development YouTube: Eunice Kennedy Shriver National Institute of Child Health and Human Development Facebook: National Institute on Drug Abuse X: @NIDAnews LinkedIn: National Institute on Drug Abuse YouTube: National Institute on Drug Abuse Instagram: @nigms_nih Facebook: National Institute of Mental Health X: @NIMHgov Instagram: @nimhgov LinkedIn: National Institute of Mental Health YouTube: National Institute of Mental Health X: @NINR LinkedIn: National Institute of Nursing Research Facebook: National Library of Medicine X: @NLM_NIH X: @NLMdirector Instagram: @nlm_collections LinkedIn: National Library of Medicine YouTube: National Library of Medicine Facebook: NIH Clinical Center Instagram: @nih_clinicalcenter LinkedIn: NIH Clinical Center YouTube: NIH Clinical Center Facebook: Fogarty International Center X: @fogarty_nih Instagram: @fogary_nih LinkedIn: Fogarty International Center YouTube: Fogarty International Center Facebook: National Center for Complementary and Integrative Health X: @NIH_NCCIH Instagram: @nih_nccih LinkedIn: National Center for Complementary and Integrative Health YouTube: National Center for Complementary and Integrative Health NIH Programs, Initiatives, and Offices Facebook: NIH Intramural Research Program X: @IRPatNIH Instagram: @irpatnih LinkedIn: NIH Intramural Research Program YouTube: NIH Intramural Research Program NIH Comment Guidelines The NIH comment guidelines are designed to encourage respectful and constructive dialogue.",1
"We ask that your comments be respectful and relevant to the specific topic. In submitting comments to an NIH website, you irrevocably grant NIH permission to copy, distribute, make derivatives, display, or perform your work publicly and free-of-charge. Get more information on the NIH Comment Guidelines. This page last reviewed on",1
"Accelerating Medicines Partnership (AMP) Launched in 2014, the Accelerating Medicines Partnership® (AMP®) program is a public-private partnership between the National Institutes of Health (NIH), the U.S. Food and Drug Administration (FDA), multiple biopharmaceutical and life science companies, non-profit and other organizations to transform the current model for developing new diagnostics and treatments. AMP partners share a common goal of increasing the number of new diagnostics and therapies for patients and reduce the time and cost of developing them. The AMP program aims to improve understanding of therapeutically relevant biological pathways and validate information that could be relevant for the development of multiple therapeutics. Through this cross-sector partnership, managed through the Foundation for the NIH (FNIH), NIH and AMP partners are sharing expertise and resources to enable the best-informed contributions to science from all participants. ACCELERATING MEDICINES PARTNERSHIP and AMP are registered service marks of the U.S. Department of Health and Human Services. This page last reviewed on",1
"Impact of NIH Research Spotlight NIH’s ongoing support of high-risk, high-reward research has led to a wide range of innovations that revolutionized science. NIH works to turn scientific discoveries into better health for all. As the largest public funder of biomedical and behavioral research in the world, NIH is the driving force behind decades of advances that improve health, revolutionize science, and serve society more broadly. Evidence of the varied, long-term impacts of NIH activities comes from a variety of sources, ranging from studies on specific health topics, to broader analyses of NIH as a whole. Explore the sections below to discover more about how NIH provides value for the public’s investment. - Improving Health ImageDiscoveries emerging from NIH-supported research have led to new ways to prevent, diagnose, and treat illness, ultimately improving the health of the nation and the world. - Revolutionizing Science ImageNIH fuels the biomedical research enterprise—cultivating world-class scientists and catalyzing new scientific fields, tools, and resources that have changed how science is done. - Serving Society ImageNIH-supported research leads to improvements in health that can bolster the economy, improve productivity, and reduce the costly burden of illness. NIH funding also supports jobs and innovations that advance the biotechnology sector.",1
"Learn More About NIH - Research Matters — weekly update of recent NIH research highlights - NIH RePORT — reports, data, and analyses of NIH research activities - NIH Clinical Trials — overview of NIH-funded clinical trials and how you can participate - Celebration of Science: NIH Highlights — spotlighting remarkable advances from NIH-supported scientists - NIH Home Page — learn how NIH and its 27 institutes and centers work - NIH Catalyst — bimonthly NIH newsletter that showcases the scientific research conducted at the NIH - NIH Record — biweekly NIH newsletter that covers issues of significance to NIH staff, contractors, and trainees - NIH History Office & Stetten Museum — discover the scientific, legislative, and social history of the National Institutes of Health NIH Research News Search Impact of NIH Research This page last reviewed on",1
"Privacy Policy Privacy Policy Protecting your privacy is very important to us. Our Web site links to other National Institutes of Health (NIH) sites, federal agency sites and occasionally, to private organizations. Once you leave the primary NIH.gov site, you are subject to the privacy policy for the site(s) you are visiting. We do not collect any personally identifiable information (PII) about you during your visit to NIH Web sites unless you choose to provide it to us. We do, however, collect some data about your visit to our Web site to help us better understand how the public uses the site and how to make it more helpful. We collect information from visitors who read, browse, and/or download information from our Web site. NIH never collects information for commercial marketing or any purpose unrelated to the NIH mission and goals. When visitors submit questions or comments via the Ask NIH online form, NIH staff responds to the inquiries and files them. Only designated staff members requiring access to the emails to respond, may view, or answer them. When you browse through any Web site, certain information about your visit can be collected.",1
"We automatically collect and temporarily store the following type of information about your visit: - Domain from which you access the Internet; - IP address (an IP address is a number that is automatically assigned to a computer when surfing the Web); - Operating system and information about the browser used when visiting the site; - Date and time of your visit; - Pages you visited; - Address of the Web site that connected you to an NIH Web site (such as google.com or bing.com); and, - Demographic and interest data. We use this information to measure the number of visitors to our site and its various sections and to help make our site more useful to visitors. This information cannot be used to identify you as an individual. NIH.gov uses Google Analytics to collect the information in the bulleted list in the Types of Information Collected section above. Google Analytics gathers information automatically and continuously. No Personally Identifiable Information (PII) is collected. NIH staff conducts analyses and reports on the aggregated data from Google Analytics and those reports are only available to NIH.gov managers, members of the NIH.gov communications and web teams, and other designated staff who require this information to perform their duties. Additionally, NIH.gov participates in the Digital Analytics Program (DAP), in which Google Analytics data is collected from websites across the Federal Government. For more information on DAP, please visit the DigitalGov website.",1
"NIH also uses online surveys to collect opinions and feedback from a random sample of visitors. NIH.gov uses the ForeSee Results’ American Customer Satisfaction Index (ACSI) online survey to obtain feedback and data on visitors’ satisfaction with the NIH.gov website. This survey does not collect PII. Although the survey invitation pops up for a random sample of visitors, it is optional. If you decline the survey, you will still have access to the identical information and resources at the NIH.gov site as those who do not take the survey. The survey reports are available only to NIH.gov managers, members of the NIH.gov Communications and Web Teams, and other designated staff who require this information to perform their duties. NIH retains the data from Google Analytics, and ACSI survey results as long as needed to support the mission of the NIH.gov website. The Office of Management and Budget Memo M-10-22, Guidance for Online Use of Web Measurement and Customization Technologies allows Federal agencies to use session and persistent cookies. When you visit any Web site, its server may generate a piece of text known as a ""cookie"" to place on your computer. The cookie allows the server to ""remember"" specific information about your visit while you are connected. The cookie makes it easier for you to use the dynamic features of Web pages. Cookies from NIH Web pages only collect information about your browser’s visit to the site; they do not collect personal information about you.",1
"There are two types of cookies, single session (temporary), and multi-session (persistent). Session cookies last only as long as your Web browser is open. Once you close your browser, the cookie disappears. Persistent cookies are stored on your computer for longer periods. Session Cookies We use session cookies for technical purposes such as to enable better navigation through our site. These cookies let our server know that you are continuing a visit to our site. The OMB Memo 10-22 Guidance defines our use of session cookies as ""Usage Tier 1 — Single Session.” The policy says, ""This tier encompasses any use of single session web measurement and customization technologies."" Persistent Cookies We use persistent cookies to enable Webtrends and Google Analytics to differentiate between new and returning NIH.gov visitors. Persistent cookies remain on your computer between visits to NIH.gov until they expire. We also use persistent cookies to block repeated invitations to take the ACSI survey. The persistent cookies that block repeated survey invitations expire in 90 days. The OMB Memo 10-22 Guidance defines our use of persistent cookies as ""Usage Tier 2 — Multi-session without Personally Identifiable Information (PII).” The policy says, ""This tier encompasses any use of multi-session Web measurement and customization technologies when no PII is collected."" If you do not wish to have session or persistent cookies placed on your computer, you can disable them using your Web browser.",1
"If you opt out of cookies, you will still have access to all information and resources at NIH.gov. Instructions for disabling or opting out of cookies in the most popular browsers are located at Please note that by following the instructions to opt-out of cookies, you will disable cookies from all sources, not just those from NIH.gov. You do not have to give us personal information to visit the NIH Web sites. However, if you choose to receive alerts or e-newsletters, we collect your email address to complete the subscription process. If you choose to provide us with personally identifiable information, that is, information that is personal in nature and which may be used to identify you, through an e-mail message, request for information, paper or electronic form, questionnaire, customer satisfaction survey, epidemiology research study, etc., we will maintain the information you provide only as long as needed to respond to your question or to fulfill the stated purpose of the communication. If we store your personal information in a record system designed to retrieve information about you by personal identifier (name, personal email address, home mailing address, personal or mobile phone number, etc. ), so that we may contact you, we will safeguard the information you provide to us in accordance with the Privacy Act of 1974, as amended (5 U.S.C. Section 552a).",1
"If NIH operates a record system designed to retrieve information about you in order to accomplish its mission, a Privacy Act Notification Statement should be prominently and conspicuously displayed on the public-facing website or form which asks you to provide personally identifiable information. The notice must address the following five criteria: - NIH legal authorization to collect information about you - Purpose of the information collection - Routine uses for disclosure of information outside of NIH - Whether the request made of you is voluntary or mandatory under law - Effects of non-disclosure if you choose to not provide the requested information For further information about NIH privacy policy, please contact the NIH Senior Official for Privacy at privacy@mail.nih.gov(link sends e-mail); call 301-496-4606 or visit NIH uses web measurement and customization technologies to help our Web sites function better for visitors and to better understand how the public uses the online resources we provide. All uses of web-based technologies comply with existing policies with respect to privacy and data safeguarding standards. Information Technology (IT) systems owned and operated by NIH are assessed using Privacy Impact Assessments (PIAs) posted for public view on the Department of Health and Human Services (DHHS) Web site ( NIH conducts and publishes a PIA for each use of a third-party website and application (TPWA) as they may have a different functionality or practice.",1
"TPWA PIAs are posted for public view on DHHS Web site Groups of records that contain information about an individual and are designed to be retrieved by the individual’s name or other personal identifier linked to the individual are covered by the Privacy Act of 1974, as amended (5 U.S.C. Section 552a). For these records, NIH System of Records Notices are published in the Federal Register and posted on the HHS System of Records Notices Website. When you visit the NIH Institute/Center sites, please look for the Privacy Notice posted on the main pages. When web measurement and customization technologies are used, the Privacy Policy/Notice must provide: - Purpose of the web measurement and/or customization technology; - Usage tier, session type, and technology used; - Nature of the information collected; - Purpose and use of the information; - Whether and to whom the information will be disclosed; - Privacy safeguards applied to the information; - Data retention policy for the information; - Whether the technology is enabled by default or not and why; - How to opt-out of the web measurement/customization technology; - Statement that opting-out still permits users to access comparable information or services; and, - Identities of all third-party vendors involved in the measurement and customization process. NIH will retain data collected using the following technologies long enough to achieve the specified objective for which they were collected.",1
"The data generated from these activities falls under the National Archives and Records Administration (NARA) General Records Schedule (GRS) 20-item IC 'Electronic Records,' and will be handled per the requirements of that schedule ( As part of the OMB Memo M-10-06, Open Government Directive, the NIH uses a variety of new technologies and social media options to communicate and interact with citizens. These sites and applications include popular social networking and media sites, open source software communities and more. TPWAs are Web-based technologies that are not exclusively operated or controlled by NIH, such as applications not hosted on a.gov domain or those that are embedded on NIH Web pages. Users of TPWAs often share information with the general public, user community, and/or the third-party operating the Web site. These actors may use this information in a variety of ways. TPWAs could cause PII to become available or accessible to NIH and the public, regardless of whether the information is explicitly solicited or collected by NIH. The following list includes some of the TPWAs we use and their purpose. NIH sometimes collects and uses PII made available through third-party Web sites. However, we do not share PII made available through third-party Web sites. Your activity on the third-party Web sites we use is governed by the security and privacy policy of those sites, which we have linked below.",1
"You should review the third-party privacy policies before using the sites and ensure that you understand how your information may be used. If you have an account with a third-party Web site, and choose to follow, like, friend, or comment, certain PII associated with your account may be made available to NIH based on the privacy policy of the third-party Web site and your privacy settings within that third-party Web site. Therefore, you should also adjust privacy settings on your account to match your preferences. For any NIH TPWA that collects PII, the list below also includes details on the information NIH collects and how we will protect your private information. Third-Party Web Sites and Applications NIH has three main Facebook pages — National Institutes of Health (NIH), NIH Research Matters, and News in Health. Many other NIH Institutes and Centers (ICs) sponsor their own Facebook pages. IC Facebook Privacy Policies are located on the individual IC web sites, which can found by clicking on the respective IC from the NIH homepage ( NIH Facebook pages are managed by NIH staff members who post news and other items of interest to be consumed by the public. If you have a Facebook account, you can log in to your account to post comments, and 'like' NIH Facebook pages and individual entries. If once you click on an NIH Facebook page, you comment or click on the 'like' button, your PII will be visible to NIH staff and other Facebook site visitors.",1
"The amount of visible personal information displayed will depend on your own Facebook privacy settings. You can completely avoid displaying any PII by not creating a Facebook account, not posting comments, not clicking on the 'like' options, or interacting with NIH Facebook accounts in any way (i.e., private messaging, sharing NIH posts, etc.). NIH staff do not collect, use or disclose any information about visitors who comment or 'like' the NIH Facebook sites. However, as a practice, comment moderator policy requires the removal from NIH Facebook pages of any comments that contain spam or are improper, inflammatory, off-topic or offensive. Repeat offenders may be subject to banning. The information is then saved on a password-protected shared drive accessible to NIH Managers, System Owners, Communications Staff, Web Teams, and other designated staff who require this information to perform their duties. The Facebook Privacy Policy is available at NIH uses Flickr to upload and share photos and images related to the NIH mission and culture. NIH is responsible for the uploaded images on NIH-sponsored Flickr pages and must ensure that the images assigned for posting meet NIH quality standards and comply with all NIH, HHS, and federal policies. Images posted are produced by NIH and its Institutes and Centers (ICs) and may include medical illustrations and other scientific images.",1
"Photos posted may also include pre-approved photos of NIH employees at events or in labs for the purpose of promoting the NIH mission and culture. You do not need to register with Flickr to view the images on NIH Flickr sites, because all NIH images posted on Flickr are visible in the public domain. However, if you choose to register, you will not provide PII directly to NIH. NIH has disabled the commenting feature on its Flickr sites. Therefore, PII cannot be collected or unintentionally received by NIH employees via the Flickr site. The Flickr Privacy Policy is available at NIH uses Google services such as Analytics and reCAPTCHA. Google Analytics information is used to measure the number of visitors to our site and its various sections and to distinguish between new and returning visitors to help make our site more useful to visitors. reCAPTCHA is used to protect our web forms from malicious activity. We do not collect your personally identifiable information (PII) through these services. The Google Privacy Policy is available at NIH utilizes listservs to manage subscriptions and send messages to individuals who opt in to receive specific NIH products. To subscribe, users must provide a valid email address. These listservs are securely managed, and access to subscriber information is strictly limited to NIH personnel — specifically, those responsible for sending communications and staff who monitor email performance.",1
"NIH never shares or grants access to subscriber lists to anyone outside the agency, for any purpose. NIH uses the “groups” feature on LinkedIn to engage with current and past employees and members of the public. In order to join a NIH group on LinkedIn, you must register for a LinkedIn account and provide your first and last name and e-mail address. Upon confirmation of your email address, you must provide LinkedIn with information regarding your employment, country, zip code, job title, etc. The amount of visible personal information will depend on your LinkedIn user privacy settings. You can completely avoid displaying any PII by not creating a LinkedIn account, not joining NIH LinkedIn groups, or not interacting with NIH LinkedIn groups in any way (i.e., private messaging, posting on group pages, etc.). Although NIH staff managing LinkedIn groups may view the information you provide when you submit a request to join NIH LinkedIn groups, NIH staff does not collect, use, or disclose any of this information. The LinkedIn Privacy Policy is available at NIH has one main Pinterest page — National Institutes of Health (NIH).Several other NIH Institutes and Centers (ICs) sponsor their own Pinterest pages. IC Pinterest Privacy Policies are located on the individual IC web sites, which can found by clicking on the respective IC from the NIH homepage ( NIH Pinterest pages are managed by NIH staff members who post news and other items of interest to be consumed by the public.",1
"If you have a Pinterest account, you can log in to your account to post comments, like and ‘repin’ NIH Pinterest postings and individual entries. When you chose to like, comment or ‘repin’ an item from an NIH Pinterest account, your PII will be visible to NIH staff and other Pinterest site visitors. You can completely avoid displaying any PII by not creating a Pinterest account, not posting comments, not clicking on the 'like' options and not sharing items from the NIH Pinterest page or NIH websites. NIH staff do not collect, use or disclose any information about visitors who comment, share, or 'like' the NIH Pinterest sites or posts. However, as a practice, comment moderator policy requires the removal from NIH Pinterest pages of any comments that contain spam or are improper, inflammatory, or offensive. The Pinterest Privacy Policy is available at NIH uses the WordPress.com blog platform to support its NIH Director’s Blog initiative along with others, enabling visitors to interact with staff regarding news and initiatives posted by NIH leaders. As a visitor to an NIH WordPress instance, you can access the NIH.gov home page and post comments. You do not need to register, provide your name, or supply any personal information. The comments are not collected, processed, or reported in any way. However, if you provide your name or other personally identifiable information (PII), the information you provide will appear along with your feedback.",1
"Although WordPress offers some analytics and usage data to NIH, these reports do not include any PII. The reports are password- protected and only available to NIH Managers, System Owners, Communications Staff, Web Teams, and other designated staff that require this information to perform their duties. The WordPress.com Privacy Policy is available at NIH uses X/Twitter to send short messages to share information about NIH with you and respond to your comments and inquiries sent via X/Twitter to NIH. If you want to subscribe to (or follow) NIH X/Twitter feeds, you must create a X/Twitter account at www.x.com. To create an account, you must provide some personal information, such as your name, user name, password and email address. You have the option to provide additional personal information including a short biography, location or a picture. Most information you provide for a X/Twitter account is available to the public, but you can modify how much of your information is visible by changing your privacy settings at the x.com Web site. NIH staff members monitor the number of subscribers and respond to comments and queries via X/Twitter, but the staff never takes possession of the personal information belonging to you as a X/Twitter follower. However, as a practice, comment moderator policy requires the removal from the NIH X/Twitter pages of any comments that contain spam or are improper, inflammatory, or offensive.",1
"The information is then saved on a password-protected shared drive accessible to NIH Managers, System Owners, Communications Staff, Web Teams, and other designated staff who require this information to perform their duties. The Twitter Privacy Policy is available at NIH posts videos on YouTube to make them available to the public. You do not need to register with either YouTube or Google (YouTube Owner) to watch NIH YouTube videos. When you watch videos, YouTube may record non-personally identifiable information about their site usage, such as channels used, videos watched, and data transfer details to improve its services. If you log on to the YouTube site before watching NIH videos, YouTube may associate information about your site usage with your YouTube account. If you log onto YouTube and comment on an NIH video, any personal information you included on your YouTube profile page will be visible to visitors who click on the comment field. If you do not log in before watching NIH videos posted on YouTube, you cannot comment on NIH videos and your site usage will not be associated with you or a YouTube account. The YouTube Privacy Policy is available at NIH conducts and publishes a Privacy Impact Assessment (PIA) for each use of a third-party website as they may have a different functionality or practice.",1
"To learn more, visit the published PIAs at For further information about NIH privacy policy, please contact the NIH Senior Official for Privacy at privacy@mail.nih.gov; call 301-451-3426 or visit This page last reviewed on",1
"NIH Standardized Organoid Modeling (SOM) Center Overview Organoids are small, lab-grown models that mimic the structure and function of human organs and are transforming how researchers study disease and test treatments. Yet most organoid models today are created through trial-and-error, making them difficult to reproduce across labs and slowing their adoption across research and industry. The Standardized Organoid Modeling (SOM) Center will be the nation’s first fully integrated platform dedicated to developing standardized organoid-based New Approach Methodologies (NAMs). The initiative is being launched by the NIH Division of Program Coordination, Planning, and Strategic Initiatives, in collaboration with many other NIH Institutes, Centers, and Offices, including the National Cancer Institute (NCI), the National Institute of Allergy and Infectious Diseases’ (NIAID) Research Technologies Branch and Center for Human Immunology, Infection and Autoimmunity, the National Human Genome Research Institute (NHGRI) the National Center for Advancing Translational Sciences (NCATS), and the Office of Research on Women’s Health, with plans to expand partnerships across many other NIH institutes and centers and the broader scientific community. The SOM Center is supported by special authorities through the Frederick National Laboratory for Cancer Research (FNLCR), the nation’s only Federally Funded Research and Development Center (FFRDC) dedicated exclusively to biomedical research.",1
"Using resources from the FNLCR, NCI will direct the in vitro organoid efforts for the SOM Center, while NIAID’s Division of Intramural Research will drive in silico development through the Research Technologies Office, applying advanced machine learning (ML) and artificial intelligence (AI) tools to enable real-time optimization of organoid protocols. Mission The SOM Center aims to serve as a neutral scientific hub for standardization, developing organoids that are reproducible, reliable, and easily accessible for medicinal and biological research. By establishing protocols tested directly on models that replicate the structure and function of human organs, the center will reduce reliance on animal testing, generate more precise results, and minimize variability in outcomes. A First-of-Its-Kind Research At the heart of the SOM Center is a powerful combination of: - Artificial Intelligence (AI) and Machine Learning (ML) to mine scientific literature and experimental data to optimize protocols in real time. - Advanced Robotics and Imaging to scale organoid production and analyze over 100,000 samples daily. - Heterogeneous Human Cell Sources to ensure organoids reflect real-world biological differences, including age, sex, and genetic ancestry. - Open-Access Digital and Physical Repositories so scientists can access standardized protocols, data, and living organoids everywhere.",1
"The center will initially focus on organoid models of the liver, lung, heart, and intestine, with plans to expand into the brain, thymus, and other disease-specific models. The SOM Center is designed to serve a wide range of users: - Scientists and Researchers across academic institutions, industry, and government. - Regulatory Agencies (e.g., FDA) looking for reliable, reproducible human-relevant models for safety assessments. - Clinicians and Precision Medicine Experts seeking patient-specific models. The Broader Scientific Community, including intramural (within NIH) and extramural (outside NIH) researchers, industry partners, and educators. Policies To ensure consistency, transparency, and broad scientific benefit, the following policies will guide SOM Center access and use: - Open Science Policy: All protocols, data, and models will be openly shared via FAIR principles to maximize community benefit and reuse. - Affordable Access: Physical organoids and digital resources will be made available at minimal cost to NIH-funded and other qualified investigators. - Regulatory Alignment: All models and data will be validated using standards, e.g. those recognized by the U.S. Food and Drug Administration, the Organization for Economic Co-operation and Development and Interagency Coordinating Committee on the Validation of Alternative Methods, to ensure their suitability in regulatory submissions, including Investigational New Drug (IND) filings.",1
"- Ethical and Inclusive Use: The SOM Center prioritizes heterogeneity in human cell lines (age, sex, ancestry), community engagement, and bioethical oversight to ensure models are representative and equitable. - Training and Use Compliance: Users must complete relevant training modules and adhere to standard operating procedures to ensure reproducibility and ethical use. - Data Contribution Encouraged: Collaborating researchers are encouraged to contribute their results (including negative data) to enhance collective learning and protocol refinement. Contact Affordable access to protocols and organoids will be available for qualified researchers nationally. Contact somcenter@nih.gov for more information. This page last reviewed on",1
"NIH Organization NIH Organization The National Institutes of Health is made up of 27 different components called Institutes and Centers. Each has its own specific research agenda, often focusing on particular diseases or body systems. All but three of these components receive their funding directly from Congress, and administrate their own budgets. NIH leadership plays an active role in shaping the agency’s research planning, activities, and outlook. The Office of the Director is the central office, responsible for setting policy for NIH and for planning, managing, and coordinating the programs and activities of all the NIH components. - NIH Organization chart - Program descriptions for the Institutes and Centers - Institute and Center Web sites - Institute and Center mailing addresses Location Headquarters for the Office of the Director and the Institutes and Centers are located in Bethesda, Maryland, USA. NIH has more than 75 buildings in a campus-like environment over 300 acres. Some research is performed on campus in state-of-the-art laboratory facilities, although more than 80% of research activities are conducted by scientists working in every state and around the world. - Images of the NIH campus in Bethesda, MD and other sites - Visitor information — driving directions, campus maps, shuttle schedules, and parking information - Visitor tours — Visitor Information Center This page last reviewed on",1
"Your Healthiest Self: Wellness Toolkits Each person’s “healthiest self” is different. We have different bodies, minds, living situations, and people influencing our lives. Each area can impact your overall health. This means we each have a unique set of health needs. Use our wellness toolkits to find ways to improve your well-being in any area you’d like. About Your Healthiest Self NIH Wellness Toolkits highlight evidence-based tips for living well and improving your health. It's published by the Office of Communications and Public Liaison in the NIH Office of the Director. Connect with Us To order free print publications in English and/or Spanish: Send your name, mailing address, and quantity for each wellness toolkit to: Email: nihnewsinhealth@od.nih.gov Mailing Address: NIH News in Health Bldg. 31, Rm. 5B52, MSC 2094 Bethesda, MD 20892-2094 Please note: Limit is one per individual. Health professionals please include a quantity for each toolkit in your request. Supplies are limited. This page last reviewed on",1
"Impact of NIH Research Spotlight NIH’s ongoing support of high-risk, high-reward research has led to a wide range of innovations that revolutionized science. NIH works to turn scientific discoveries into better health for all. As the largest public funder of biomedical and behavioral research in the world, NIH is the driving force behind decades of advances that improve health, revolutionize science, and serve society more broadly. Evidence of the varied, long-term impacts of NIH activities comes from a variety of sources, ranging from studies on specific health topics, to broader analyses of NIH as a whole. Explore the sections below to discover more about how NIH provides value for the public’s investment. - Improving Health ImageDiscoveries emerging from NIH-supported research have led to new ways to prevent, diagnose, and treat illness, ultimately improving the health of the nation and the world. - Revolutionizing Science ImageNIH fuels the biomedical research enterprise—cultivating world-class scientists and catalyzing new scientific fields, tools, and resources that have changed how science is done. - Serving Society ImageNIH-supported research leads to improvements in health that can bolster the economy, improve productivity, and reduce the costly burden of illness. NIH funding also supports jobs and innovations that advance the biotechnology sector.",1
"Learn More About NIH - Research Matters — weekly update of recent NIH research highlights - NIH RePORT — reports, data, and analyses of NIH research activities - NIH Clinical Trials — overview of NIH-funded clinical trials and how you can participate - Celebration of Science: NIH Highlights — spotlighting remarkable advances from NIH-supported scientists - NIH Home Page — learn how NIH and its 27 institutes and centers work - NIH Catalyst — bimonthly NIH newsletter that showcases the scientific research conducted at the NIH - NIH Record — biweekly NIH newsletter that covers issues of significance to NIH staff, contractors, and trainees - NIH History Office & Stetten Museum — discover the scientific, legislative, and social history of the National Institutes of Health NIH Research News Search Impact of NIH Research This page last reviewed on",1
"Accessibility Accessibility The National Institutes of Health (NIH) is making every effort to ensure that the information available on our website is accessible to all. If you use special adaptive equipment to access the Web and encounter problems when using our site, please contact us via our Ask NIH online form and we will attempt to provide the information to you in a suitable format. It would be helpful if you can be as specific as possible when describing the information you seek. If you prefer to call, our main number is 301-496-4000, or you can first review our list of toll-free numbers. To learn more about the regulations governing the accessibility of federal electronic information products, visit the United States Access Board or the official Section 508 page. Document Viewers Notice to Limited English Proficient Individuals NIH is renewing its commitment to providing meaningful access to its programs and activities for people with limited English proficiency (LEP). In accordance with Executive Order 13166, “Improving Access to Services for Persons with Limited English Proficiency,” the information translated on the nih.gov site and on the sites of its Institutes and Centers is free of charge to the public. This page last reviewed on",1
"The NIH Director Biography of Jay Bhattacharya, M.D., Ph.D. Jayanta ""Jay"" Bhattacharya, M.D., Ph.D., took the helm as 18th director of the National Institutes of Health, the nation’s medical research agency, on April 1, 2025. President Trump nominated Dr. Bhattacharya for the position on Nov. 26, 2024, and the U.S. Senate confirmed him on March 25, 2025. Dr. Bhattacharya, a renowned doctor, researcher, health economist, previously held a tenured professorship in the medical school at Stanford University in California. His research focused on population aging and chronic disease, particularly on the health and well-being of vulnerable populations. He has published over 170 research papers in peer-reviewed journals in medicine, epidemiology, health policy, economics, statistics, science policy, and public health, as well as a leading textbook on health economics. During the pandemic, Dr. Bhattacharya coauthored the Great Barrington Declaration, which called for opening schools and lifting lockdowns while better protecting older populations who were most vulnerable to the disease. Dr. Bhattacharya held numerous additional appointments at Stanford University, including courtesy appointments at the Stanford Institute for Economic Policy Research, the Stanford Freeman Spogli Institute and Stanford’s Hoover Institution, and Economics department. Previously, he conducted research at the National Bureau of Economic Research and the SPHERE Institute, a policy research firm.",1
"Before joining Stanford, he was an economist at the RAND Corporation and worked as a visiting economics professor at the University of California, Los Angeles. Dr. Bhattacharya is a longtime NIH grantee and has served as a standing member of multiple NIH review committees. He earned his bachelor’s and master’s degrees in economics from Stanford University. He then completed medical school and earned a Ph.D. in economics also from Stanford University. This page last reviewed on",1
"Nondiscrimination Notice Nondiscrimination Notice The National Institutes of Health (NIH) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. HHS does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. NIH: - Provides free aids and services to people with disabilities to communicate effectively with us, such as: - Qualified sign language interpreters - Written information in other formats (large print, audio, accessible electronic formats, other formats) - Provides free language services to people whose primary language is not English, such as: - Qualified interpreters - Information written in other languages If you need these services, contact the U.S. Department of Health and Human Services (HHS) at 1-877-696-6775. If you believe that NIH has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with the U.S. Department of Health and Human Services, Office for Civil Rights, electronically through the Office for Civil Rights Complaint Portal, or by mail or phone at: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) This page last reviewed on",1
"Frequently Asked Questions Frequently Asked Questions Can’t find an answer to your question? Contact us via our Ask NIH online form. Health Information The NIH Health Information page provides access to Institute and Center resources based on scientific investigation. The National Institutes of Health (NIH) has no official role in policing the quality of health information found on the Internet. Nevertheless, we can offer some advice. - Web information should not be used as an alternative to seeking professional medical help. Don't use the information you find to make a self-diagnosis. - Don't use information found on the Web for self-treatment, especially in cases of serious illness. - Use the information you find to become an informed patient. Discuss what you have learned with your medical care providers. - When reviewing information you have uncovered, look for dates — how old is the information? - Be a critical consumer, ask questions: Has this document been updated? Is there a point-of-contact for the information? Are there any references? Has the information been peer reviewed (critically examined by credentialed professionals)? - Remember that the distinction between a paid ad and public service announcements may not be obvious on the Web. - Federal, State and even local government often provide health information. Look at the domain name of the site you have found — sites ending in GOV and ORG generally reflect Federal or State sources or non profit organizations.",1
"- Be particularly cautious when you see claims that a product: cures a wide range of ills, promises a quick fix, or seems too good to be true. As a public agency, NIH is committed to ensuring that accurate information reaches the diverse American public. How NIH Brings Health and Science to the Public explains how NIH communicates science and health information to patients, families, scientists, industry, teachers and students, health professionals, and the press. The NIH Web site does not offer personalized medical advice to individuals about their condition or treatment. The resources on this site should not be used as a substitute for professional medical care and we urge you to work with your medical care providers for answers to your personal health questions. If you have a medical question, please visit the Health Information on the NIH Web site. You should also visit MEDLINEplus. If you have questions that relate to specific foods, or prescription, or over-the-counter drugs, you should visit the Food and Drug Administration (FDA). NIH is a medical research organization. As such, we only enroll patients who are participating in one of our clinical studies. These trials span a wide range of diseases and conditions. For information about clinical trials. No. However, please visit Healthfinder for information on choosing quality care. NIH's National Library of Medicine provides a guide to over 9,000 prescription and over-the-counter medications on its MEDLINEplus Web site.",1
"For the latest information on drug approvals and safety warnings, consult the Food and Drug Administration (FDA) Web site. For information about drug abuse and addiction, visit the National Institute on Drug Abuse (NIDA). You can visit NIH Clinical Research Trials and You to learn about clinical trial basics, read volunteer and researcher stories, find ways to connect with clinical trials, and locate other educational resources for the public and health care providers. The National Center for Complementary and Alternative Medicines (NCCAM). NCCAM conducts and supports basic and applied research and training and disseminates information on complementary and alternative medicine to practitioners and the public. The mission of National Center for Complementary and Integrative Health (NCCIH) is to define, through rigorous scientific investigation, the usefulness and safety of complementary and integrative health interventions and their roles in improving health and health care. The NIH Clinical Center provides an opportunity for healthy volunteers to participate in medical research studies (sometimes called protocols or trials). Healthy volunteers provide researchers with important information for comparison with people who have specific illnesses. Every year, nearly 3,500 healthy volunteers participate in studies at NIH. Visit the Clinical Research Volunteer Program to learn about the benefits of volunteering.",1
"Some NIH Institutes have established special on-line areas to provide statistical information. Visit the following links for information on cancer, complementary and alternative medicine, deafness and communication disorders, dental health, diabetes, digestive diseases, kidney and urologic diseases, obesity, drug abuse, eye disease, and mental health. - Cancer - Complementary and Alternative Medicine - Deafness and Other Communication Disorders - Dental Health - Diabetes and Digestive and Kidney Diseases - Drug Abuse - Eye - Mental Health Statistics Information from CDC: Data Tools and Statistics — provided by the National Library of Medicine You can find information about NIH's bio-defense efforts at the NIAID Biodefense. For general information about emergency preparedness, we recommend which is operated by our partner agency, the Centers for Disease Control and Prevention (CDC). Grants and Funding Information regarding funding opportunities from NIH may be found on the Grants Page.This page provides information about NIH grant and fellowship programs, policy changes, administrative responsibilities of awardees. Research Portfolio Online Reporting Tools provided access to reports, data, and analyses of NIH research activities. Visit our Research Training Opportunities page. This site brings together information about the intramural and extramural training opportunities offered by all of NIH's Institutes and Centers.",1
"NIH LRPs are a vital component of our nation's efforts to attract health professionals to careers in clinical, pediatric, health disparity, or contraceptive and infertility research. Visit for all the details and to complete an online application for NIH Loan Repayment benefits. Check out NIH's estimates of funding for various research, condition and disease categories. You can read about NIH's research, condition and disease categorization process. News and Events You can read about the latest research advances on the News and Events page. A list of selected research highlights from the previous year is available. A historical list of these research highlights is available from the Office of History. The NIH Calendar of Events lists NIH-sponsored meetings and other meetings of interest to both employees and the general public. It is updated daily and the listed meetings are free and open to the public. Scientific Resources NIH Image is a public domain image processing and analysis program for the Macintosh. It was developed at the Research Services Branch (RSB) of the National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH). The HHS Office of Research Integrity (ORI) promotes integrity in biomedical and behavioral research supported by the U. S. Public Health Service (PHS) at about 4,000 institutions worldwide.",1
"ORI monitors institutional investigations of research misconduct and facilitates the responsible conduct of research through educational, preventive, and regulatory activities. Visit the NIH Stem Cell information page. About NIH Founded in 1887, the National Institutes of Health today is one of the world's foremost medical research centers, and the Federal focal point for medical research in the United States. The NIH, comprising 27 separate Institutes and Centers, is one of eight health agencies of the Public Health Service which, in turn, is part of the U.S. Department of Health and Human Services. Simply described, the goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold. The NIH mission is to uncover new knowledge that will lead to better health for everyone. NIH works toward that mission by conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helping in the training of research investigators; and fostering communication of medical and health sciences information. Follow this link for a list of organizational charts for each NIH Institute or Center. The main campus of the National Institutes of Health (NIH) is located in Bethesda, Maryland.",1
"Our main mailing address is: National Institutes of Health Building 1 1 Center Drive Bethesda, Maryland 20892 Information about how to get to NIH. NIH scientists conduct their research in laboratories located on the main campus in Bethesda, and in several field units across the country and abroad. The NIH also has facilities in the Rockville, Maryland area and the NCI Frederick Cancer Research and Development Center (FCRDC) at Fort Detrick in Frederick, MD. The National Institute of Environmental Health Sciences' main facility is located in Research Triangle Park (RTP) in North Carolina. Other laboratory facilities include the NIH Animal Center in Poolesville, MD; the National Institute on Aging's Gerontology Research Center in Baltimore, MD; the Division of Intramural Research of the National Institute on Drug Abuse, also in Baltimore; the National Institute of Allergy and Infectious Diseases' Rocky Mountain Laboratories in Hamilton, MT, and several smaller field stations. Maps, driving directions and links to popular campus locations are located on our Visitor page. Information about entering campus and its buildings, parking, using campus transportation and current security measures. To find out if NIH is open, see OPM's Washington, D.C. Area Operating Status Web site. Our mailing address is: National Institutes of Health Building 1 1 Center Drive Bethesda, Maryland 20892 Toll-free Health Info lines may be found at The main number for NIH is 301-496-4000.",1
"Mailing address: Director, NIH 9000 Rockville Pike MSC 0148 Bethesda, Maryland 20892 E-mail: execsec1@od.nih.gov Web site: Links to Congressional Testimonies about the NIH budget are available. More information about the NIH budget can be found on the Office of Budget site. A number of Web pages have been developed to help you do business with NIH. If you are a small business, bookmark the HHS Office of Small and Disadvantaged Business Utilization page to take advantage of monthly seminars on ""Conducting Business with NIH."" Information about contracts and other business opportunities can also be found at the Office of Acquisition Management and Policy. Information regarding Freedom of Information Act (FOIA) requests. Our Information Quality site contains guidelines, policy and instructions on requesting a correction. Jobs at NIH Information about employment opportunities at NIH may be found at Information about the Summer Internship Program in Biomedical Research may be found at NIH Website The NIH Web site at www.nih.gov is maintained by the Office of Communications and Public Liaison (OCPL), which is part of the Office of the Director, NIH. Collectively, large segments of NIH Web space are owned and operated by each of the 27 Institutes and Centers that comprise NIH. The purpose of the NIH Web site is to support the mission of our agency. NIH conducts scientific investigation in pursuit of fundamental knowledge about the nature and behavior of living systems.",1
"NIH applies that knowledge to extend healthy life and reduce the burdens of illness and disability. As part of our mission we direct programs for the collection, dissemination, and exchange of information in medicine and health, including the development and support of medical libraries and the training of medical librarians and other health information specialists. The NIH Web site serves the public by offering ready access to: - Clinical studies; - Health and wellness information; - Information on obtaining research funding; - Research resources and library resources; - News, events, and educational activities related to NIH and its mission; - Scientific program, policy, and planning documents; - General information about the agency, its history, organizational structure, staff, and facilities. For more information about the NIH Web site, contact the OD OCPL Digital Communications Branch Phone: 301-435-2932 E-mail: olib@mail.nih.gov Yes, NIH does have a privacy notice, it can be found at The NIH Web site is not just one site but a large collection of sites — over 150 servers. Some areas are updated daily while others may not be updated for weeks or months. Most of the information on our site is in the public domain and can be used without charge or restriction. There are a few exceptions.",1
"For example, some resources, such as the Interactive Health Tutorials found on NIH's National Library of Medicine Website, as well as images on the NIH Web site have been licensed by a third party and are restricted in their use. Generally, copyrighted materials will include a copyright statement. If in doubt, please write to the contact point for that site. In addition, the word mark NIH…Turning Discovery Into Health® is a registered trademark of the U.S. Department of Health and Human Services. Another item restricted in its use is the NIH logo. The NIH logo is designed to signify official NIH products, activities, events, representatives, and facilities. It should never be used to promote or suggest endorsement of non-NIH products, events, or services. It should never be used by outside parties to misrepresent the purpose, character, policies, or mission of our agency. Also, some materials that can be ordered from our site are subject to cost-recovery fee; however, in most cases, a single copy of any NIH publication can be ordered for free. While you can reuse content found on our site, please note that many of our on-line health publications are continually updated as we learn more about that specific disease or condition. Occasionally, sites that copy and re-post our materials fail to check for updates, which results in out-of-date information being offered to users. For that reason, we urge you to link to our resource documents rather than re-posting.",1
"If you do re-post, please check back periodically to see if there are revisions. The NIH logo is designed to signify official NIH products, activities, events, representatives, and facilities. It should never be used to promote or suggest endorsement of non-NIH products, events, or services. It should never be used by outside parties to misrepresent the purpose, character, policies, or mission of our agency. For more information about the NIH logo, contact logo@nih.gov. Unless noted otherwise, it is safe to assume that information posted on public Web sites within the ""NIH.GOV"" domain are considered to be ""in the public domain."" As such, you are free to establish links to NIH on-line resources. In establishing such links, we do ask that you avoid creating the impression that NIH is endorsing or promoting any particular product or service. As a Federal agency, NIH cannot endorse or promote commercial or individual interests or services. This includes adding links and logos from non-NIH entities. In some cases, where the information serves the public good and is consistent with our mission, we may include an outside link to an external resource; however, these need to be examined on a case-by-case basis. In general, the web developer of each particular site determines when links to outside entities are justified. Please visit the NIH Flickr site to view free-to-use NIH health research images, b-roll, infographics, and videos.",1
A list of Selected NIH Education and Awareness Campaigns is available at This page last reviewed on,1
"List of Institutes and Centers List of Institutes and Centers NIH Institutes - National Cancer Institute (NCI) NCI leads a national effort to eliminate the suffering and death due to cancer. Through basic and clinical biomedical research and training, NCI conducts and supports research that will lead to a future in which we can prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases. - National Eye Institute (NEI) The National Eye Institute’s mission is to conduct and support research, training, health information dissemination, and other programs with respect to blinding eye diseases, visual disorders, mechanisms of visual function, preservation of sight, and the special health problems and requirements of the blind. - National Heart, Lung, and Blood Institute (NHLBI) The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.",1
"The NHLBI stimulates basic discoveries about the causes of disease, enables the translation of basic discoveries into clinical practice, fosters training and mentoring of emerging scientists and physicians, and communicates research advances to the public. - National Human Genome Research Institute (NHGRI) NHGRI is devoted to advancing health through genome research. The Institute led NIH’s contribution to the Human Genome Project, which was successfully completed in 2003 ahead of schedule and under budget. Building on the foundation laid by the sequencing of the human genome, NHGRI’s work now encompasses a broad range of research aimed at expanding understanding of human biology and improving human health. In addition, a critical part of NHGRI’s mission continues to be the study of the ethical, legal and social implications of genome research. - National Institute on Aging (NIA) NIA leads a national program of research on the biomedical, social, and behavioral aspects of the aging process; the prevention of age-related diseases and disabilities; and the promotion of a better quality of life for all older Americans. - National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIAAA conducts research focused on improving the treatment and prevention of alcoholism and alcohol-related problems to reduce the enormous health, social, and economic consequences of this disease.",1
"- National Institute of Allergy and Infectious Diseases (NIAID) NIAID research strives to understand, treat, and ultimately prevent the myriad infectious, immunologic, and allergic diseases that threaten millions of human lives. - National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIAMS supports research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases, the training of basic and clinical scientists to carry out this research, and the dissemination of information on research progress in these diseases. - National Institute of Biomedical Imaging and Bioengineering (NIBIB) The mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is to transform through engineering the understanding of disease and its prevention, detection, diagnosis, and treatment. - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NICHD leads research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and optimize abilities for all. - National Institute on Deafness and Other Communication Disorders (NIDCD) NIDCD conducts and supports biomedical research and research training on normal mechanisms as well as diseases and disorders of hearing, balance, smell, taste, voice, speech, and language that affect 46 million Americans.",1
"- National Institute of Dental and Craniofacial Research (NIDCR) NIDCR provides leadership for a national research program designed to understand, treat, and ultimately prevent the infectious and inherited craniofacial-oral-dental diseases and disorders that compromise millions of human lives. - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) The mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases, to improve people’s health and quality of life. - National Institute on Drug Abuse (NIDA) The mission of the National Institute on Drug Abuse (NIDA) is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health. - National Institute of Environmental Health Sciences (NIEHS) The mission of the National Institute of Environmental Health Sciences is to discover how the environment affects people in order to promote healthier lives.",1
"- National Institute of General Medical Sciences (NIGMS) The National Institute of General Medical Sciences (NIGMS) supports basic research that increases our understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. NIGMS also supports research in specific clinical areas that affect multiple organ systems: anesthesiology and peri-operative pain; clinical pharmacology common to multiple drugs and treatments; and injury, critical illness, sepsis, and wound healing. NIGMS-funded scientists investigate how living systems work at a range of levels—from molecules and cells to tissues and organs—in research organisms, humans, and populations. Additionally, to ensure the vitality and continued productivity of the research enterprise, NIGMS provides leadership in supporting the training of the next generation of scientists, broadening participation in the scientific workforce, and developing research capacity throughout the country. - National Institute of Mental Health (NIMH) NIMH provides national leadership dedicated to understanding, treating, and preventing mental illnesses through basic research on the brain and behavior, and through clinical, epidemiological, and services research. - National Institute on Minority Health and Health Disparities (NIMHD) NIMHD has a long history, beginning in 1990 as an Office and later designated a Center in 2000.",1
"The mission of NIMHD is to lead scientific research to improve minority health and eliminate health disparities. To accomplish its mission, NIMHD plans, reviews, coordinates, and evaluates all minority health and health disparities research and activities of the National Institutes of Health; conducts and supports research in minority health and health disparities; promotes and supports the training of a diverse research workforce; translates and disseminates research information; and fosters innovative collaborations and partnerships. - National Institute of Neurological Disorders and Stroke (NINDS) The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. To accomplish this goal the NINDS supports and conducts basic, translational, and clinical research on the normal and diseased nervous system. The Institute also fosters the training of investigators in the basic and clinical neurosciences, and seeks better understanding, diagnosis, treatment, and prevention of neurological disorders. - National Institute of Nursing Research (NINR) The mission of the National Institute of Nursing Research (NINR) is to lead nursing research to solve pressing health challenges and inform practice and policy—optimizing health and advancing health equity into the future.",1
"- National Library of Medicine (NLM) NLM collects, organizes, and makes available biomedical science information to scientists, health professionals, and the public. The Library’s Web-based databases, including PubMed/Medline and MedlinePlus, are used extensively around the world. NLM conducts and supports research in biomedical communications; creates information resources for molecular biology, biotechnology, toxicology, and environmental health; and provides grant and contract support for training, medical library resources, and biomedical informatics and communications research. NIH Centers - NIH Clinical Center (CC) The NIH Clinical Center, America’s research hospital, provides a versatile clinical research environment enabling the NIH mission to improve human health by investigating the pathogenesis of disease; conducting first-in-human clinical trials with an emphasis on rare diseases and diseases of high public health impact; developing state-of-the-art diagnostic, preventive, and therapeutic interventions; training the current and next generations of clinical researchers; and, ensuring that clinical research is ethical, efficient, and of high scientific quality. - Center for Information Technology (CIT) CIT incorporates the power of modern computers into the biomedical programs and administrative procedures of the NIH by focusing on three primary activities: conducting computational biosciences research, developing computer systems, and providing computer facilities.",1
"- Center for Scientific Review (CSR) CSR is the portal for NIH grant applications and their review for scientific merit. CSR oversees and implements peer review for over 75% of the more than 88,000 applications submitted to NIH each year, as well as for some other components of HHS. The mission of CSR is to see that NIH grant applications receive fair, independent, expert, and timely scientific reviews — free from inappropriate influences — so NIH can fund the most promising research. - Fogarty International Center (FIC) FIC promotes and supports scientific research and training internationally to reduce disparities in global health. - National Center for Advancing Translational Sciences (NCATS) The mission of NCATS is to catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. - National Center for Complementary and Integrative Health (NCCIH) The mission of NCCIH is to define, through rigorous scientific investigation, the usefulness and safety of complementary and integrative health interventions and their roles in improving health and health care. This page last reviewed on",1
"NIH Clinical Research Trials and You “Why should I participate in a clinical trial?” It’s your involvement that helps researchers to ultimately uncover better ways to treat, prevent, diagnose and understand human disease. This page last reviewed on An official website of the United States government Here’s how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock () or means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. It’s your involvement that helps researchers to ultimately uncover better ways to treat, prevent, diagnose and understand human disease. You can help raise public awareness of clinical trials with these promotional materials to connect individuals to ClinicalResearchTrials.nih.gov. This page last reviewed on An official website of the Department of Health and Human Services",1
"NIH...Turning Discovery Into Health® The 21st Century National Institutes of Health Created in 1887 as a one-room laboratory on Staten Island, NY, NIH was officially designated by Congress in 1930. Since then, the agency has grown to be the world’s largest source of medical research funding and the driving force behind decades of advances that have expanded fundamental scientific knowledge and improved health. NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and to apply that knowledge to enhance health, lengthen life, and reduce illness and disability. To carry out this mission, NIH supports: - Basic research...to fuel progress - Translational research...to move basic discoveries forward - Clinical research...to turn discoveries into prevention, treatments, and cures - A creative and diverse workforce...since people are our most important resource - A balanced research portfolio...to ensure high return on investment for U.S. taxpayers Revolutionary ideas often come from unexpected directions. Many concepts and tools central to understanding and improving health have come from basic, untargeted research. NIH not only supports these basic advances but also conducts the clinical and translational research that transforms discoveries into medical practice. This page last reviewed on",1
"Freedom of Information Act Office Notice to FOIA Requesters Please submit all requests through our online portal rather than mail, fax, or courier, to ensure timely logging of your request. If you need to submit a payment, to ensure that it can be processed in a timely manner, please use pay.gov. Welcome The NIH FOIA office generally handles three different categories of requests: - requests for information maintained by the Office of the Director, NIH - requests that involve trans NIH issues or initiatives unless a specific IC has responsibility - requests for information that will not be released because it is protected by one or more of the FOIA's nine exemptions or three exclusions While all requests may be sent to the NIH FOIA Office, each of NIH's separate Institutes and Centers has its own FOIA Coordinator. Requesters should direct requests for information about a specific NIH component to that component. A list of the FOIA Coordinators for each component is available at this site for your convenience. Background/Overview The Freedom of Information Act (“FOIA”), 5 U.S.C. 552, provides individuals with a right to access to records in the possession of the federal government. The government may withhold information pursuant to the nine exemptions and three exclusions contained in the Act. This page last reviewed on",1
"NIH Institute and Center Contact Information NIH Institute and Center Contact Information National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 Phone: 301-496-4000 E-mail: NIH Institutes National Cancer Institute (NCI) NCI Public Inquiries Office 9609 Medical Center Drive Building 9609 MSC 9760 Bethesda, MD 20892-9760 Phone: 1-800-422-6237 E-mail: National Eye Institute (NEI) National Eye Institute Information Office 31 Center Drive MSC 2510 Bethesda, MD 20892-2510 Phone: 301-496-5248 E-mail: 2020@nei.nih.gov National Human Genome Research Institute (NHGRI) Building 31, Room 4B09 31 Center Drive, MSC 2152 9000 Rockville Pike Bethesda, MD 20892-2152 Phone: 301-402-0911 E-mail: National Heart, Lung, and Blood Institute (NHLBI) Building 31, Room 5A52 31 Center Drive, MSC 2486 Bethesda, MD 20892 Phone: 301-592-8573 E-mail: nhlbiinfo@nhlbi.nih.gov National Institute on Aging (NIA) Building 31, Room 5C27 31 Center Drive, MSC 2292 Bethesda, MD 20892 Aging information: 1-800-222-2225 Alzheimer’s disease information: 1-800-438-4380 E-mail: niaic@nia.nih.gov National Institute on Alcohol Abuse and Alcoholism (NIAAA) 5635 Fishers Lane, MSC 9304 Bethesda, MD 20892-9304 Phone: 301-443-3860 E-mail: niaaaweb-r@exchange.nih.gov The National Institute of Allergy and Infectious Diseases (NIAID) NIAID Office of Communications and Government Relations 5601 Fishers Lane, MSC 9806 Bethesda, MD 20892-9806 Phone: 1-866-284-4107 E-mail: ocpostoffice@niaid.nih.gov National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Information Clearinghouse National Institutes of Health 1 AMS Circle Bethesda, MD 20892-3675 Arthritis, musculoskeletal, and skin diseases: 1-877-22-NIAMS Osteoporosis and other bone diseases: 1-800-624-BONE E-mail: NIAMSinfo@mail.nih.gov National Institute of Biomedical Imaging and Bioengineering (NIBIB) 6707 Democracy Blvd., Suite 202 Bethesda, MD 20892-5469 Phone: 301-496-3500 E-mail: info@nibib.nih.gov Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Office of Communications 31 Center Drive Building 31, Room 2A32, MSC 2425 Bethesda, MD 20892-2425 Phone: 1-800-370-2943 E-mail: NICHDInformationResourceCenter@mail.nih.gov Please send any grant-related correspondence to: Grants Management Branch 6710B Rockledge Drive, Room 3302 Bethesda, MD 20892-7004 Express Mail/Courier Service: Bethesda, MD 20817 National Institute on Drug Abuse (NIDA) 6001 Executive Boulevard, Room 5213 Bethesda, MD 20892-9561 Phone: 1-877-NIDA-NIH E-mail: The National Institute on Deafness and Other Communication Disorders (NIDCD) NIDCD Office of Health Communication and Public Liaison 31 Center Drive, MSC 2320 Bethesda, MD 20892-2320 Phone: 1-800-241-1044 E-mail: nidcdinfo@nidcd.nih.gov National Institute of Dental and Craniofacial Research (NIDCR) NIDCR Public Information and Liaison Branch 31 Center Drive, MSC 2190 Building 31, Room 5B55 Bethesda, MD 20892-2190 Phone: 1-866-232-4528 E-mail: nidcrinfo@mail.nih.gov National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Office of Communications and Public Liaison NIH, Building 31, Room 9A06, 31 Center Drive, MSC 2560 Bethesda, MD 20892-2560 Phone: 1-800-860-8747 E-mail: healthinfo@niddk.nih.gov The National Institute of Environmental Health Sciences (NIEHS) P.O.",1
"Box 12233 Research Triangle Park, NC 27709 Phone: 919-541-3345 E-mail: webcenter@niehs.nih.gov National Institute of General Medical Sciences (NIGMS) 45 Center Drive, MSC 6200 Bethesda, MD 20892-6200 Phone: 301-496-7301 E-mail: info@nigms.nih.gov National Institute of Mental Health (NIMH) Office of Communications 6001 Executive Boulevard, Room 6200, MSC 9663 Bethesda, MD 20892-9663 Phone: 1-866-615-6464 E-mail: nimhinfo@nih.gov National Institute on Minority Health and Health Disparities (NIMHD) 6707 Democracy Boulevard, Suite 800 Bethesda, MD 20892-5465 Phone: 301-402-1366 E-mail: NIMHDinfo@NIMHD.NIH.gov National Institute of Neurological Disorders and Stroke (NINDS) P.O.",1
"Box 5801 Bethesda, MD 20824 Phone: 1-800-352-9424 E-mail: National Institute of Nursing Research (NINR) 31 Center Drive Building 31, Room 5B10 Bethesda, MD 20892-2178 Phone: 301-496-0207 E-mail: info@ninr.nih.gov National Library of Medicine (NLM) 8600 Rockville Pike Bethesda, MD 20894 Phone: 1-888-FIND-NLM E-mail: NIH Centers NIH Clinical Center Office of Communications 10 Center Drive Bethesda, MD 20892 Phone: 301-496-2563 E-mail: Center for Information Technology (CIT) 6555 Rock Spring Drive, 3G04 Bethesda, MD 20817 Phone: 301-496-5703 E-mail: Center for Scientific Review (CSR) 6701 Rockledge Drive MSC 7768 Bethesda MD 20892-7768 Phone: 301-435-1111 E-mail: csrwebmaster@csr.nih.gov Fogarty International Center 31 Center Drive, MSC 2220 Building 31 Bethesda, MD 20892-2220 Phone: 301-496-2075 E-mail: ficinfo@nih.gov National Center for Advancing Translational Sciences (NCATS) 9609 Medical Center Drive, 1E Rockville, MD 20850-9793 Phone: 301-594-8966 E-mail: ncatsinfo@nih.gov National Center for Complementary and Integrative Health (NCCIH) 31 Center Drive, MSC 2182 Building 31, Room 2B-11 Bethesda, MD 20892-2182 Phone: 1-888-644-6226 E-mail: info@nccih.nih.gov This page last reviewed on",1
"Talking With Your Doctor or Health Care Provider Talking With Your Doctor or Health Care Provider Esta página también está disponible en español You can play an active role in your health care by talking with your doctor or health care provider. Clear and honest communication between you and your physician or health care team can help you both make informed choices about your health. It’s important to be honest and upfront about your symptoms even if you feel embarrassed or shy. Have an open dialogue with your doctor or health care provider— ask questions to make sure you understand your diagnosis, treatment, and recovery. Here are a few tips that can help you talk to your doctor or health care provider and make the most of your appointment: - Write down a list of questions and concerns before your appointment. - Consider bringing a close friend or family member with you. - Take notes about what the doctor or health care provider say or ask a friend or family member to take notes for you. - Learn how to access your medical records, so you can keep track of test results, diagnoses, treatments plans, and medications and prepare for your next appointment. - Ask for the doctor’s or health care provider’s contact information and their preferred method of communication. - Remember that nurses and pharmacists are also good sources of information.",1
"How to Talk with your Doctor - Talking With Your Doctor, NIH News in Health - Hablar con su médico, NIH News in Health español Aging - How to Prepare for a Doctor's Appointment, National Institute on Aging (NIA) - Talking With Your Doctor Presentation Toolkit, National Institute on Aging (NIA) Cancer - Questions to Ask Your Doctor about Cancer, National Cancer Institute (NCI) - Preguntas para hacer al doctor acerca del cáncer español - Communication in Cancer Care, National Cancer Institute (NCI) - Comunicación en la atención del cáncer, National Cancer Institute (NCI) español Complementary and Integrative Health - 4 Tips: Start Talking With Your Health Care Providers About Complementary Health Approaches, National Center for Complementary and Integrative Health (NCCIH) Diabetes - Questions to Ask about Your Diabetes Medicines, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Mental Health - Taking Control of Your Mental Health: Tips for Talking With Your Health Care Provider, National Institute of Mental Health (NIMH) This page last reviewed on",1
"Get Involved at NIH Get Involved at NIH NIH encourages and depends on public involvement in federally supported research and activities. NIH’s wide-ranging public efforts include outreach and education, nationwide events, requests for public input on NIH projects, and special programs designed specifically to involve public representatives in clinical research. Public Involvement with NIH NIH engages in a wide range of outreach efforts, including nationwide events, requests for public input on NIH projects, and special programs designed specifically to involve public representatives in the clinical research enterprise. Community Liaison Opportunities The Office of Community Liaison has a long standing partnership with the Bethesda/Chevy Chase community, and is dedicated to serving the interests and well-being of the NIH neighborhood and its neighbors. Volunteer - NIH Clinical Center: Volunteer Opportunities Volunteer Training, FAQs, Contact Us - NLM History of Medicine Volunteer Program Volunteer Training, FAQs, Contact Us - Volunteering Throughout the Federal Government Find opportunities throughout the federal government on USA.gov — Type ""volunteering"" into the search box. Clinical Studies Clinical studies are medical research studies in which people participate as volunteers. Clinical research studies (sometimes called trials or protocols) are a means of developing new treatments and medications for diseases and conditions.",1
"- Clinical Research Trials and You Learn about clinical trials, how to participate, and how clinical research helps NIH advance science and improve health. - Clinical studies conducted at NIH Participate in clinical studies at the NIH Clinical Center. - Nationwide clinical trials Easy access to information on publicly and privately supported clinical studies on a wide range of diseases and conditions. - Office of Advocacy Relations The National Cancer Institute's Office of Advocacy Relations works serves as a conduit between NCI and the cancer advocacy community. Healthy Volunteers Healthy volunteers provide researchers with important information for comparison with people who have specific illnesses. Every year, nearly 3,500 healthy volunteers participate in studies at NIH. Learn how to become a healthy volunteer at NIH. NIH Office of Science Education Explore the Office of Science Education's resources for the public. NIH Outreach and Education NIH Communications There are communication offices at each of our 27 Institutes and Centers. The Office of Communications & Public Liaison (OCPL) in the Office of the Director speaks for NIH as a whole. NIH communication offices provide information on NIH programs and activities to the public, scientific community, medical profession, and the media.",1
"- NIH News — current press releases - NIH Research Matters — weekly research news - NIH News in Health — monthly consumer health newsletter - NIH Calendar of Events — scientific meetings - Selected NIH Education and Awareness Campaigns - NIH Record — employee newsletter - Freedom of Information Act Office (FOIA) - Visitor tours Scientific Research and Training Opportunities The NIH sponsors programs for students in - high school; - college/university; - graduate school and medical/dental school; as well as researchers doing postbaccalaureate work. See also the Foundation for Advanced Education in the Sciences (FAES), a non-profit organization sponsoring continuing medical education for physicians. Science Education for All Ages Our STEM Teaching Resources site offers free STEM education materials (grades pre-K through 12) created by the institutes and centers within the National Institutes of Health (NIH) and recipients of the NIH Science Education Partnership Award (SEPA) program. Small Business Opportunities If you're a small business interested in contracting at NIH, please start by reading the information provided by our parent Agency, the Department of Health and Human Services. The HHS Office of Small and Disadvantaged Business Utilization is fully dedicated to supporting every small business entity (which includes minority, women-owned, veteran-owned, service-disabled veteran-owned and HUBZone companies), in their pursuit of health-related contracts.",1
"Visit Research Opportunities for Small Businesses (SBIR/STTR) to learn about NIH, CDC, and FDA research funding opportunities for qualified United States small businesses to engage in Research/Research and Development (R/R&D) that has the potential for commercialization. Check out the OSDBU Calendar of Events for Conferences, Workshops, Seminars and Expos. Additional Resources - National Institutes of Hope: Help Us Help You No matter who you are, NIH needs your help. Here are just a few of the many things you can do to advance our mission of hope. - Tribal Guidance Tribal consultation policy, points of contact, and advisory committee charter. Related Links NIH Foundation — identifies and develops opportunities for innovative public-private partnerships involving industry, academia, and the philanthropic community The Children's Inn at NIH — a private, non-profit, family-centered residence for pediatric outpatients at the NIH and for their families Friends of Patients at the NIH — a non-profit, charitable organization that provides emergency financial assistance to NIH patients and their families Conferences, Workshops, Seminars and Expos Doing Business with the Department of Health and Human Services This page last reviewed on",1
"Safety, Regulation & Guidance Safety, Regulation & Guidance - Memo from NIH Associate Director for Science Policy on Biosafety Stewardship Month, October 1, 2015 - FAQ on Biosafety Stewardship Month - Recommendations of the Advisory Committee to the Director, CDC, Concerning the NIH Intramural Laboratory Safety Program, May 4, 2015 - Next Steps: Biosafety and Biosecurity at the National Institutes of Health (NIH) - Fact Sheet: Biosafety and Biosecurity in the United States, December 16, 2014 - NIH Director’s memo to IBC chairs, contacts, and biological safety officers, August 28, 2014 - Ensuring Biosafety and Biosecurity in U.S. Laboratories, Office of Science and Technology Policy, August 28, 2014 - Enhancing Biosafety and Biosecurity in the United States, The White House, August 18, 2014 - Biological & Chemical Safety (Compliance) - Mercury Free Campaign - NIH Office of Animal Care and Use - Radiation Safety - Scientific Equipment & Instrumentation Services - Waste Management - Guidelines for the Conduct of Research at NIH, May 2007 This page last reviewed on",1
"Disclaimers Disclaimers Endorsement Disclaimer — Links to Other Sites Our Web site has links to many other federal agencies, and in a few cases we link to private organizations. You are subject to that site's privacy policy when you leave our site. We proudly comply with 508 accessibility regulations, but we cannot be responsible for Section 508 compliance (accessibility) on other federal or private Web sites. Reference in this Web site to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the U.S. Government or National Institutes of Health (NIH). NIH is not responsible for the contents of any ""off-site"" Web page referenced from this server. Endorsement Disclaimer — Pop-Up Advertisements When visiting our Web site, your Web browser may produce pop-up advertisements. These advertisements were most likely produced by other Web sites you visited or by third party software installed on your computer. The National Institutes of Health (NIH) does not endorse or recommend products or services for which you may view a pop-up advertisement on your computer screen while visiting our site. Information Disclaimer The information provided using this Web site is only intended to be general summary information to the public. It is not intended to take the place of either the written law or regulations.",1
"It is not NIH’s intention to provide specific medical advice to users of the NIH Web site, instead we provide users with information to help them better understand their health, diagnosed conditions, and the current approaches related to treatment, prevention, screening, and supportive care. NIH urges users to consult with a qualified health care professional for diagnosis and answers to their personal medical questions. Press releases and other materials meant for public use will not be posted to the NIH Web site unless they were developed by or for NIH. Intrusion Detection This site is maintained by the U.S. Government. It is protected by various provisions of Title 18, U.S. Code. Violations of Title 18 are subject to criminal prosecution in federal court. For site security purposes and to ensure that this service remains available to all users, we employ software programs to monitor traffic to identify unauthorized attempts to upload or change information, or otherwise cause damage. In the event of authorized law enforcement investigations, and pursuant to any required legal process, information from these sources may be used to help identify an individual. This page last reviewed on",1
"Lasker Clinical Research Scholars An Historic Intramural-Extramural Partnership to Nurture the Next Generation of Clinical Researchers The National Institutes of Health, the nation’s premier agency for biomedical and behavioral research, in partnership with the Lasker Foundation, is pleased to announce the Lasker Clinical Research Scholars Program, an historic “intramural-extramural” partnership to nurture the next generation of clinical researchers. The program supports a small number of exceptional clinical researchers in the early stages of their careers to promote their development to fully independent positions. Successful candidates are designated as Lasker Clinical Research Scholars. Lasker Scholars receive a unique combination of NIH funding for clinical research for up to 10 years. In the first phase of the program, Scholars will receive appointments for 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent budgets. In the second phase, successful Scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or the Scholar can be considered to remain as an investigator within the intramural program. Lasker Scholars will have access to the NIH Clinical Center, the nation's largest hospital devoted entirely to clinical research.",1
"Through an arrangement with the Lasker Foundation, Scholars will have the opportunity to participate in selected activities, including attendance at the Lasker Breakfast and Award Luncheon, and participation in annual scientific meetings. The program honors the contributions of Mary and Albert Lasker to the NIH and to the overall biomedical community. This page last reviewed on",1
"The NIH Director Biography of Jay Bhattacharya, M.D., Ph.D. Jayanta ""Jay"" Bhattacharya, M.D., Ph.D., took the helm as 18th director of the National Institutes of Health, the nation’s medical research agency, on April 1, 2025. President Trump nominated Dr. Bhattacharya for the position on Nov. 26, 2024, and the U.S. Senate confirmed him on March 25, 2025. Dr. Bhattacharya, a renowned doctor, researcher, health economist, previously held a tenured professorship in the medical school at Stanford University in California. His research focused on population aging and chronic disease, particularly on the health and well-being of vulnerable populations. He has published over 170 research papers in peer-reviewed journals in medicine, epidemiology, health policy, economics, statistics, science policy, and public health, as well as a leading textbook on health economics. During the pandemic, Dr. Bhattacharya coauthored the Great Barrington Declaration, which called for opening schools and lifting lockdowns while better protecting older populations who were most vulnerable to the disease. Dr. Bhattacharya held numerous additional appointments at Stanford University, including courtesy appointments at the Stanford Institute for Economic Policy Research, the Stanford Freeman Spogli Institute and Stanford’s Hoover Institution, and Economics department. Previously, he conducted research at the National Bureau of Economic Research and the SPHERE Institute, a policy research firm.",1
"Before joining Stanford, he was an economist at the RAND Corporation and worked as a visiting economics professor at the University of California, Los Angeles. Dr. Bhattacharya is a longtime NIH grantee and has served as a standing member of multiple NIH review committees. He earned his bachelor’s and master’s degrees in economics from Stanford University. He then completed medical school and earned a Ph.D. in economics also from Stanford University. This page last reviewed on",1
"An official website of the United States government Here’s how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock () or means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Know Your Blood Pressure Numbers High blood pressure is a risk for heart disease. Knowing your numbers is the first step to controlling it. The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives. Featured Resources & Initiatives Image Explore NIH’s groundbreaking initiatives and programs that are advancing biomedical research, accelerating scientific discovery, and improving health for all Americans.",1
"Mission and Goals Mission and Goals NIH invited input on a proposed update to the NIH mission statement via Request for Information. View the RFI Summary Report on the analysis of public comments and the RFI Responses. NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The goals of the agency are: - to foster fundamental creative discoveries, innovative research strategies, and their applications as a basis for ultimately protecting and improving health; - to develop, maintain, and renew scientific human and physical resources that will ensure the Nation's capability to prevent disease; - to expand the knowledge base in medical and associated sciences in order to enhance the Nation's economic well-being and ensure a continued high return on the public investment in research; and - to exemplify and promote the highest level of scientific integrity, public accountability, and social responsibility in the conduct of science.",1
"In realizing these goals, the NIH provides leadership and direction to programs designed to improve the health of the Nation by conducting and supporting research: - in the causes, diagnosis, prevention, and cure of human diseases; - in the processes of human growth and development; - in the biological effects of environmental contaminants; - in the understanding of mental, addictive and physical disorders; and - in directing programs for the collection, dissemination, and exchange of information in medicine and health, including the development and support of medical libraries and the training of medical librarians and other health information specialists. This page last reviewed on",1
"Health Info Lines Health Info Lines | For information on… | Call… | |---|---| | AIDS/HIV Treatment, Prevention and Research ** | 800-HIV-0440* | | Aging ** | 800-222-2225* | | Alcohol Abuse and Alcoholism | 301-443-3860 | | Allergy and Infectious Diseases ** | 866-284-4107* | | Alzheimer's Disease ** | 800-438-4380* | | Anesthesia | 301-496-7301 | | Arthritis and Musculoskeletal and Skin Diseases ** | 877-22-NIAMS* | | Safe to Sleep: Reduce the Risk of SIDS and Other Sleep-Related Infant Deaths** | 800-505-CRIB (2742)* | | Basic Research on Cells, Proteins, and Genes | 301-496-7301 | | Burns | 301-496-7301 | | Cancer ** | 800-4-CANCER* | | Child Health and Human Development ** | 800-370-2943* | | Clinical Center Patient Recruitment ** | 800-411-1222* | | Clinical Research Volunteer Program ** | 301-496-4763 | | Complementary and Alternative Medicine ** | 888-644-6226* | | Deafness and Other Communication Disorders ** It’s a Noisy Planet.",1
"Protect Their Hearing | 800-241-1044* | | Drug Abuse and Addiction ** NIDA DrugPubs | 877-NIDA-NIH (643-2644) | | Environmental Causes of Disease | 919-541-3345 | | eRA Commons Help Desk | 866-504-9552* 301-402-7469 301-451-5936 (TTY) | | Eye Diseases ** | 301-496-5248 | | Extramural Research Grants | 301-435-0714 | | Genetic and Rare Diseases ** | 888-205-2311* | | Global Health | 301-496-2075 | | Grants Information (General Info) Contact Awarding Institute/Center for Specific Grant/Award Questions | 301-435-0714 | | Heart, Lung, and Blood** | 1-877-NHLBI4U (645-2448) | | Human Genome Research | 301-402-0911 | | Mental Health and Mental Illness* | 866-615-NIMH (6464)* | | National Institute of Diabetes and Digestive and Kidney Diseases Health Information Center** | 800-860-8747* | | National Library of Medicine | 888-346-3656* | | Neurological Disorders ** | 800-352-9424* | | Nursing Research | 301-496-0207 | | Oral Health ** | 301-402-7364 | | Osteoporosis and Related Bone Diseases ** | 800-624-BONE* | | Patient Recruitment and Public Liaison Office ** | 800-411-1222* | | Physical Trauma | 301-496-7301 | | Schizophrenia Research ** | 888-674-6464* | | Sepsis | 301-496-7301 | | Smoking Cessation, NCI's Smoking Quitline ** | 877-44U-QUIT* | | Stroke ** | 800-352-9424* | | Women's Health (Research) Office of Research on Women’s Health, NIH | 301-402-1770 | | Women's Health (Information) Office of Women’s Health, Department of Health and Human Services | 800-994-9662* 888-220-5446 (TTD) | | * = toll-free **= Personal bilingüe disponible para información en Español | This page last reviewed on",1
Skip to main content Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select.,1
Select language Select language English العربية 中文 Français Русский Español Home Health Topics All topics A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Resources Fact sheets Facts in pictures Multimedia Podcasts Publications Questions and answers Tools and toolkits Popular Dengue Endometriosis Excessive heat Herpes Mental disorders Mpox Countries All countries A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Regions Africa Americas Europe Eastern Mediterranean South-East Asia Western Pacific WHO in countries Data by country Country presence Country cooperation strategies Country office profiles Strengthening country offices Newsroom All news News releases Statements Campaigns Events Feature stories Press conferences Speeches Commentaries Photo library Headlines Emergencies Focus on Cholera Coronavirus disease (COVID-19) Greater Horn of Africa Israel and occupied Palestinian territory Mpox Sudan Ukraine Latest Disease Outbreak News Situation reports Rapid risk assessments Weekly Epidemiological Record WHO in emergencies Surveillance Alert and response Operations Research Funding Partners Health emergency appeals International Health Regulations Independent Oversight and Advisory Committee Data Data at WHO Data hub Global Health Estimates Mortality Health inequality Dashboards Triple Billion Progress Health Inequality Monitor Delivery for impact COVID-19 dashboard Data collection Classifications SCORE Surveys Civil registration and vital statistics Routine health information systems Harmonized health facility assessment GIS centre for health Reports World Health Statistics UHC global monitoring report About WHO About WHO Partnerships Committees and advisory groups Collaborating centres Technical teams Organizational structure Who we are Our work Activities Initiatives General Programme of Work WHO Academy Funding Investment in WHO WHO Foundation Accountability External audit Financial statements Internal audit and investigations Programme Budget Results reports Governance Governing bodies World Health Assembly Executive Board Member States Portal Home / Activities Unfortunately we don't have any results matching your criteria.,1
"Operations In today’s globalized world, there are myriad opportunities for the rapid spread of diseases and other threats to health security. In the event of an emergency, public health emergency operation centres are a place for emergency management personnel to coordinate operational information and resources. WHO’s Public Health Emergency Operations Centre Network (EOC-NET) promotes best practices and standards for emergency operation centres and builds Member States’ capacity to rapidly respond and detect to public health emergencies as mandated by the International Health Regulations. WHO’s Strategic Health Operations Centre (SHOC) is the heart of this network. SHOC monitors global public health events around the clock and facilitates international collaboration during public health emergencies. Following the detection of a potential major public health event, SHOC provides the communications platform to obtain further information from the affected country and other authoritative sources. Once that information is received, SHOC uses emergency management tools to support risk assessments and any required WHO response. Beyond response operations, SHOC is involved in identifying and tracking resources and appraising public health threats.WHO uses an Incident Management System (IMS) to organize and manage each emergency response.",1
"Every individual working in emergencies for WHO (including non-WHO staff who deploy as part of the response team) must be familiar with the IMS structure and roles. News All →Publications Emergency response framework (ERF), Edition 2.1 Handbook for developing a public health emergency operations centre: part A Handbook for developing a public health emergency operations centre: part A Handbook for developing a public health emergency operations centre: part C Handbook for developing a public health emergency operations centre: part C Framework for a Public Health Emergency Operations Centre Framework for a Public Health Emergency Operations Centre Summary report of systematic reviews for public health emergency operations centres Summary report of systematic reviews for public health emergency operations centres WHO's Operational Update on Health Emergencies All →WHO's Operational Update on Health Emergencies, published monthly, highlights WHO’s work on preparedness and emergency response, combating health... 60-day ceasefire plan for Gaza With the initiation of the first phase of the ceasefire in Gaza, humanitarian needs remain dire.",1
"In the current situation, it is crucial to scale up humanitarian... WHO's Operational Update on Health Emergencies - July and August 2025 WHO's Operational Update on Health Emergencies, published monthly, highlights WHO’s work on preparedness and emergency response, combating health... WHO's Operational Update on Health Emergencies, published monthly, highlights WHO’s work on preparedness and emergency response, combating health... The WHO Dubai Global Logistics Hub Our work",1
"The WHO Library is the world’s leading library on public health. It provides access to knowledge from WHO as well as to other sources of scientific literature produced around the world. WHO Library resources and expertise also provide scientific evidence and knowledge to low- and middle- income countries through a set of low-cost/high-use initiatives. Networks and partnerships are an essential component in ensuring that our global initiatives reach a world-wide audience. Using a suite of collaborative tools, librarians and information specialists have a close understanding of country realities and needs. This helps keep focus on adequate and cost-effective information and knowledge sharing solutions. The WHO Library holds and stores all the published information produced by WHO, including proceedings of the World Health Assembly and Executive Board, monographs, periodicals, unpublished technical documents, press releases, fact sheets and administrative documents of the governing bodies. Practical information WHO Library visits and reference services are limited as the organization’s main building, in which the WHO Library was located, is currently under renovation that will last until end of 2024. During this time, WHO Library print collections will remain inaccessible to users. Contact us World Health Organization WHO Library and Digital Information Networks Avenue Appia 20 1211 Geneva 27 Switzerland",1
Skip to main content Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select.,1
Select language Select language English العربية 中文 Français Русский Español Português Home Health Topics All topics A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Resources Fact sheets Facts in pictures Multimedia Podcasts Publications Questions and answers Tools and toolkits Popular Dengue Endometriosis Excessive heat Herpes Mental disorders Mpox Countries All countries A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Regions Africa Americas Europe Eastern Mediterranean South-East Asia Western Pacific WHO in countries Data by country Country presence Country cooperation strategies Country office profiles Strengthening country offices Newsroom All news News releases Statements Campaigns Events Feature stories Press conferences Speeches Commentaries Photo library Headlines Emergencies Focus on Cholera Coronavirus disease (COVID-19) Greater Horn of Africa Israel and occupied Palestinian territory Mpox Sudan Ukraine Latest Disease Outbreak News Situation reports Rapid risk assessments Weekly Epidemiological Record WHO in emergencies Surveillance Alert and response Operations Research Funding Partners Health emergency appeals International Health Regulations Independent Oversight and Advisory Committee Data Data at WHO Data hub Global Health Estimates Mortality Health inequality Dashboards Triple Billion Progress Health Inequality Monitor Delivery for impact COVID-19 dashboard Data collection Classifications SCORE Surveys Civil registration and vital statistics Routine health information systems Harmonized health facility assessment GIS centre for health Reports World Health Statistics UHC global monitoring report About WHO About WHO Partnerships Committees and advisory groups Collaborating centres Technical teams Organizational structure Who we are Our work Activities Initiatives General Programme of Work WHO Academy Funding Investment in WHO WHO Foundation Accountability External audit Financial statements Internal audit and investigations Programme Budget Results reports Governance Governing bodies World Health Assembly Executive Board Member States Portal Home / Multimedia Multimedia 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 Unfortunately we don't have any results matching your criteria.,1
"Mpox (monkeypox) Campaigns Events Multimedia Newsletters Quizzes Spotlights The European Health Report 2024 Ukraine emergency Second European Programme of Work WHO updates guidance to better inform decisions on clean air and climate change mitigation policies Europe’s hidden HIV crisis Influenza season underway across the WHO European Region: WHO calls for vigilance and vaccination Public Health Wales becomes WHO collaborating centre for digital health equity Regional Director Statement – Humanity must hold the pen: the European Region can write the story of ethical AI for health Statement – Safe water, sanitation and hygiene is a matter of survival, dignity and prosperity Statement – Healing hands, hurting minds Statement – The climate crisis is a health crisis – and the European Region is in the hot seat 1000 medical evacuations from Gaza: WHO thanks European Region countries who have offered care Building resilience in Ukraine: as full-scale war continues Arūnas’ journey: breaking free from alcohol harm Breaking the silence: 4 lives transformed by access to hearing care WHO Course on Policy and Leadership in Mental Health: building capacity for systemic change in Europe WHO/Europe’s Executive Course in HRH Leadership and Management to focus on Eastern Partnership countries “Better health begins in the regions: building bridges, creating solutions” – 30th annual meeting of the Regions for Health Network RODOG Congress 2025: strengthening regional cooperation on childhood cancer European countries unite behind new WHO strategy to harness innovation for public health Shaping health futures together: NSA engagement for EPW2 and Ageing is Living Enhancing Bulgaria’s readiness for radiological emergencies – thermoluminescent dosimeter handover and training Crucial training programme accelerates Georgia’s national emergency medical team preparedness for WHO verification Partnerships Improving health and well-being through nature Improving primary health care for children and adolescents Incorporating innovation and digital health to improve quality of care and patient safety Strengthening long-term care systems Ageing Child and adolescent health and well-being Climate change Vaccines and immunization",1
"Harmonized Health Facility Assessment (HHFA) Publications 10 November 2022 Harmonized health facility assessment (HHFA): quick guide This short guide aims to provide a quick overview of the Harmonized Health Facility Assessment (HHFA). It summarizes the key technical, planning and implementation... The HHFA Comprehensive guide serves as the main reference document for planning and implementing a country HHFA. This guide will promote understanding... The Harmonized Health Facility Assessment (HHFA) is a comprehensive, standardized health facility survey that provides objective information on the availability... Additional health facility survey resources 29 October 2019 Master Facility List Resource Package: guidance for countries wanting to strengthen their Master Facility... CitationWorld Health Organization. (2019). Master facility list resource package: guidance for countries wanting to strengthen their master...",1
Countries All countries which are Members of the United Nations may become members of WHO by accepting its Constitution. Other countries may be admitted as members when their application has been approved by a simple majority vote of the World Health Assembly. Territories which are not responsible for the conduct of their international relations may be admitted as Associate Members upon application made on their behalf by the Member or other authority responsible for their international relations. Members of WHO are grouped according to regional distribution (194 Member States). A B C D M N O Q S - Saint Kitts and Nevis - Saint Lucia - Saint Vincent and the Grenadines - Samoa - San Marino - Sao Tome and Principe - Saudi Arabia - Senegal - Serbia - Seychelles - Sierra Leone - Singapore - Slovakia - Slovenia - Solomon Islands - Somalia - South Africa - South Sudan - Spain - Sri Lanka - Sudan - Suriname - Sweden - Switzerland - Syrian Arab Republic T U Y,1
Countries All countries which are Members of the United Nations may become members of WHO by accepting its Constitution. Other countries may be admitted as members when their application has been approved by a simple majority vote of the World Health Assembly. Territories which are not responsible for the conduct of their international relations may be admitted as Associate Members upon application made on their behalf by the Member or other authority responsible for their international relations. Members of WHO are grouped according to regional distribution (194 Member States). A B C D M N O Q S - Saint Kitts and Nevis - Saint Lucia - Saint Vincent and the Grenadines - Samoa - San Marino - Sao Tome and Principe - Saudi Arabia - Senegal - Serbia - Seychelles - Sierra Leone - Singapore - Slovakia - Slovenia - Solomon Islands - Somalia - South Africa - South Sudan - Spain - Sri Lanka - Sudan - Suriname - Sweden - Switzerland - Syrian Arab Republic T U Y,1
"Over 800 institutions in over 80 countries supporting WHO programmes WHO collaborating centres are institutions such as research institutes, parts of universities or academies, which are designated by the Director-General to carry out activities in support of the Organization's programmes. Currently there are over 800 WHO collaborating centres in over 80 Member States working with WHO on areas such as nursing, occupational health, communicable diseases, nutrition, mental health, chronic diseases and health technologies. Background The idea of using national institutions for international purposes dates back to the days of the League of Nations, when national laboratories were first designated as reference centres for the standardization of biological products. As soon as WHO was established, it appointed more reference centres, starting in 1947 with the World Influenza Centre in London for worldwide epidemiological surveillance. As early as 1949, the Second World Health Assembly laid down the policy (which has been constantly followed since) that the Organization should not consider ""the establishment, under its own auspices, of international research institutions"" and the ""research in the field of health is best advanced by assisting, coordinating and making use of the activities of existing institutions"".",1
"All WHO collaborating centres, irrespective of their type of work, have been designated under that policy, which has undoubtedly enhanced national participation in the Organization's activities. Definition By definition, a WHO collaborating centre is an institution designated by the Director-General of WHO to form part of an international collaborative network set up by WHO in support of its programme at the country, intercountry, regional, interregional and global levels. In line with the WHO policy and strategy of technical cooperation, a WHO collaborating centre also participates in the strengthening of country resources, in terms of information, services, research and training, in support of national health development. Designation is made with the agreement of the head of the establishment to which the institution is attached or with that of the director of the institution, if it is independent, and after consultation with the national government. An institution is designated initially for a term of four years; the designation may be renewed for the same or a shorter period. Designation is independent of financial support being given to the institution by WHO. Grants may be made to any institution that is able to perform a specific task connected with WHO's programme but this has no relevance to the eligibility or ineligibility of an institution for designation.",1
"Not eligible for designation as WHO collaborating centres are, for example, networks, working groups, partnerships and programmes; or nongovernmental organizations and similar bodies with a membership structure, including professional associations or foundations. For collaboration with nongovernmental organizations, please refer to the Principles governing relations between WHO and Nongovernmental organizations contained in the Basic Documents. Functions and role The functions of the WHO collaborating centres are diverse, and may include the following: - collection, collation and dissemination of information; - standardization of terminology and nomenclature, of technology, of diagnostic, therapeutic and prophylactic substances, and of methods and procedures; - development and application of appropriate technology; - provision of reference substances and other services; - participation in collaborative research developed under the Organization's leadership, including the planning, conduct, monitoring and evaluation of research, as well as promotion of the application of the results of research; - training, including research training; and - the coordination of activities carried out by several institutions on a given subject. The WHO collaborating centres are an essential and cost-effective cooperation mechanism, which enables the Organization to fulfill its mandated activities and to harness resources far exceeding its own.",1
"WHO gains access to top centres worldwide and the institutional capacity to ensure the scientific validity of global health work. Through these global networks, the Organization is able exercise leadership in shaping the international health agenda. Conversely, designation as a WHO collaborating centre provides institutions with enhanced visibility and recognition by national authorities, calling public attention to the health issues on which they work. It opens up improved opportunities for them to exchange information and develop technical cooperation with other institutions, in particular at international level, and to mobilize additional and sometimes important resources from funding partners. The main role of the WHO collaborating centres is to provide strategic support to the Organization to meet two main needs: - Implementing WHO's mandated work and programme objectives - Developing and strengthening institutional capacity in countries and regions. Management and evaluation The management of collaboration with a centre is the responsibility primarily of the responsible officer within the technical programme that initiated the designation. Interaction between technical units in regions and headquarters ensures that the centre's collaboration is available to the whole Organization. In each WHO regional office, as at headquarters, focal points are designated to manage and coordinate statutory information and procedures on WHO collaborating centres.",1
"Overall guidelines and schedules have also been developed for the management and monitoring of collaboration with the centres, these are common to all regions and programmes. Successful collaboration requires that particular attention be paid to the joint preparation of the centre's terms of reference and work plans. This should involve the institution, the regional office and the technical unit concerned in headquarters. The work plan should comprise clearly defined objectives and expected results, explicitly related to WHO's activities as set out in its programme budget. WHO will dedicate its own staff time and other resources, although not necessarily direct financial support, to ensure that collaboration can develop successfully. Monitoring takes place on a continuing basis and at the end of each twelve month period a WHO collaborating centre must submit a report on the implementation of activities with the concerned programme in WHO. This report should reflect progress achieved in respect of the work plan, underlining possible difficulties and formulating suggestions for improvements for future course of cooperation. A final evaluation takes place at the end of the four-year designation period. It includes an assessment of WHO's support for, and actual use of, collaboration with the centre.",1
"No decision may be made on redesignation of any centre until completion of a thorough evaluation of its past performance and the continued relevance of this collaboration in view of WHO's evolving needs and policy. To facilitate management, cooperation and networking, a global information system on all WHO collaborating centres has been developed, to be accessible worldwide to WHO staff, WHO collaborating centres, and eventually Member States and the public health community at large. Exchange of experience and collaboration between centres is supported by regular meetings at country and regional levels and on specific topics.",1
"Situation at a glance Description of the situation In 2025, from 1 January to 2 November, a total of 20 412 suspected diphtheria cases, including 1 252 deaths (an average case fatality ratio [CFR] – 6.1 %) have been reported across eight Member States in the WHO African Region (Algeria, Chad, Guinea, Mali, Mauritania, Niger, Nigeria, and South Africa). Of these suspected cases, 9 864 (48.3%) cases have been confirmed through laboratory testing, epidemiological linkage, or clinical diagnosis. Laboratory confirmation was conducted for 5.7% (n = 1 177) of the suspected cases. Women, children aged 5–18 years, and young adults under 30 years are the most affected, confirming that the immunity gap extends well beyond early childhood. The situation has further deteriorated in Mali, Mauritania, and Niger, in recent weeks, with increasing case numbers and geographic spread of the outbreaks reported in these countries. The resurgence of diphtheria across multiple countries in the WHO African Region constitutes a serious public health concern which led to its grading as a grade 2 emergency under the Emergency Response Framework of WHO. Timely case detection, coordinated response, and clinical management remain critical to limiting transmission and reducing the high fatality rates observed in recent outbreaks. However, response efforts are being hampered by a global shortage of DAT and limited laboratory diagnostic capacity.",1
"Effective outbreak control requires comprehensive, multi-sectoral action across all response pillars including emergency coordination, laboratory confirmation, enhanced surveillance and case finding, clinical management with life-saving DAT and appropriate antibiotics (in accordance with WHO guidelines), infection prevention and control (IPC). Sustained vaccination efforts, coupled with risk communication and community engagement (RCCE) are essential to interrupt transmission and protect high-risk populations. In addition, preventing the recurrence of diphtheria outbreaks in the African Region will require strengthened health systems, particularly through robust routine immunization coverage. Summary of individual country situations from 1 January to 2 November 2025 Algeria Algeria reported a diphtheria outbreak in October 2025 in Skikda province, with 13 suspected cases and two deaths (CFR 15%). Eight of the suspected cases were laboratory-confirmed, and none of the confirmed cases had received diphtheria vaccination. The outbreak affected both children and adults, with males accounting for 62.5% of confirmed cases. A previous outbreak in southern Algeria, reported in 2024, involved over 900 suspected cases and 119 deaths (CFR 13%).",1
"According to WHO/UNICEF estimates of national immunization coverage (WUENIC) for 2024, Algeria has high national immunization coverage (98% for the first Diphtheria-Tetanus toxoid-Pertussis [DTP] dose and 92% for the third), however geopolitical instability in neighboring countries has led to mass displacement into southern Algeria, where vaccination coverage among refugees is low. The lack of data since May 2025 and limited information sharing are key challenges to assessing the full scope of the outbreak. Chad From 1 January to 2 November 2025, Chad reported 4 462 suspected diphtheria cases and 47 deaths (CFR 1.1%), with only four laboratory-confirmed cases. The significant amount of suspected diphtheria cases compared to the limited number of laboratory-confirmed cases highlights the challenge in the country to obtain a laboratory-confirmed diagnosis. The outbreak affects 27 out of 215 health districts across 7 of 23 provincial health delegations, with active transmission ongoing in three regions. Most cases are among children aged 3–13 years, and vaccination status is unknown for the vast majority. Chad faces a complex humanitarian crisis marked by conflict, displacement, and food insecurity. The country hosts over 1.4 million refugees, including more than 870 000 Sudanese refugees and 300 000 Chadian returnees.",1
"The health system is overwhelmed, and multiple infectious disease outbreaks, including yellow fever, measles, cholera, and hepatitis E, are occurring simultaneously. WHO, UNICEF, and MSF are supporting response efforts, but challenges include delayed reporting, insufficient case management kits, and logistical constraints. A request has been submitted to Gavi for vaccine supply and operational funding for mass immunization campaigns. According to WUENIC, the DTP coverage in 2024 was 84% for the first dose and 68% for the third dose. Guinea Guinea has experienced a resurgence of diphtheria since June 2025, with 476 suspected cases and 123 deaths. The CFR among the suspected cases is 25.8%, the highest among affected countries. The outbreak has affected four of 38 prefectures (11%), with human-to-human transmission concentrated in the Kankan region, particularly in Siguiri district, which accounts for over 80% of reported cases and fatalities. Laboratory confirmation remains limited, with only 70 cases confirmed. The outbreak follows a major event in 2023 that affected multiple regions and led to over 4 500 suspected cases. Guinea’s response is hampered by delayed presentation to health facilities, and insufficient resources for clinical management and community engagement. The outbreak is occurring in gold mining areas with high population mobility, increasing transmission risk.",1
"According to WUENIC in Guinea for 2024, the immunization coverage remains low (77% for the first DTP dose and 63% for the third), and urgent needs include DAT supply, improved clinical pathways, and expanded vaccination efforts. Mali From 1 January to 2 November 2025, Mali has reported 430 suspected diphtheria cases and 29 deaths (CFR 6.7%), with 46 laboratory-confirmed cases. The outbreak has affected seven out of 11 regions (64%), including the capital city Bamako, with the number of affected districts increasing from three to 30 out of 75 in less than six weeks, representing a rapid geographic expansion. Mali is experiencing a complex humanitarian crisis driven by conflict, climate related disruptions, and limited access to basic services. In 2025, 6.4 million people required humanitarian assistance. Displacement and restricted access to healthcare have contributed to low immunization coverage among vulnerable populations. According to WUENIC in 2024, estimates show 91% coverage for the first DTP dose and 82% for the third. Challenges include underreporting, limited availability of DAT, and logistical constraints. The outbreak response is hindered by concurrent emergencies and overstretched health services. Mauritania From 1 January to 2 November 2025, Mauritania has reported 849 suspected cases of diphtheria and 33 deaths (CFR 4%), with 318 confirmed cases.",1
"After an initial delay, the outbreak was officially declared on 25 September 2025 and has rapidly expanded across 11 out of 53 departments (21%). An upsurge of cases has been observed since late September. The most affected age groups are children and adolescents aged 5–19 years, and women account for 60% of suspected cases. Only 10% of cases have documented vaccination history. Mauritania hosts the largest refugee camp for Malians, with over 118 000 refugees, mostly women and children. The outbreak coincides with a Rift Valley fever outbreak in some of the same regions. Response efforts are challenged by limited resource mobilization, weak active case finding, and insufficient community sensitization. Reactive vaccination campaigns have been initiated, but gaps remain in funding, logistics, and healthcare worker training. According to WUENIC in 2024, the immunization coverage is relatively high (95% for the first DTP dose and 86% for the third), but subnational disparities persist. Niger From 1 January to 2 November 2025, Niger has reported 1 926 suspected diphtheria cases and 122 deaths CFR (6.3%), with 765 laboratory-confirmed cases. The outbreak has affected 34 out of 72 health districts (47%) across eight regions, with most cases concentrated in Agadez, Diffa and Zinder. Compared to 2024, there have been fewer reported cases and deaths, but transmission remains active.",1
"Niger is facing a protracted humanitarian crisis driven by insecurity, climate related disruptions, economic pressures, and displacement. An estimated 2.6 million people require humanitarian assistance. According to WUENIC in 2024, the immunization coverage is relatively high (95% for the first DTP dose and 86% for the third), but recent outbreaks highlight gaps in vaccine access and delivery. A vaccination campaign in September 2025 achieved high coverage, and a second round is planned. Challenges include limited diagnostic and treatment capacity, insufficient vaccine quantities, low public awareness, and funding constraints. Nigeria Nigeria continues to report the highest number of diphtheria cases in the African Region. From 1 January to 2 November 2025, 12 150 suspected cases have been reported, with 8 587 confirmed and 884 deaths (CFR 7.2%). Confirmed cases have been reported from 240 Local Government Areas across 30 states. Most cases are clinically compatible, with only 3% confirmed by laboratory testing. The outbreak has disproportionately affected children and adolescents, with low vaccination coverage contributing to the spread. In Nigeria more than 2 million children are under-immunized, including those with zero-doses, highlighting the high risk of further spread. Reactive campaigns have been conducted in Imo, Kaduna and Lagos, targeting health workers and priority populations. The outbreak overlaps with areas targeted by the Big Catch-up initiative.",1
"Challenges include delayed laboratory confirmation, poor IPC practices, limited information, education and communication materials, and vaccine shortages. Discussions with Gavi are ongoing to secure additional support. According to WUENIC in 2024, the estimates show 71% coverage for the first DTP dose and 67% for the third. South Africa From 1 January to 26 October 2025, South Africa has reported 106 diphtheria cases, including 66 laboratory-confirmed respiratory cases, two laboratory-confirmed cutaneous cases, one probable respiratory case, and 37 asymptomatic carriers. The outbreak has affected 5 of 9 provinces (55%), highlighting the involvement of multiple provinces. Most cases and carriers are from the Western Cape, with additional clusters in Limpopo, Gauteng, KwaZulu-Natal, and Mpumalanga. CFR among probable and confirmed respiratory diphtheria cases was 18% (12/67). Most respiratory cases occurred in adults aged 18 years and older. Clusters have been documented among vulnerable populations, including individuals in correctional facilities. According to WUENIC in 2024, the immunization coverage remains below 80% in most provinces (76% for the first DTP dose and 74% for the third), and immunity gaps are widening. The outbreak response is challenged by competing priorities, limited human resources, and limited global supply of diphtheria antitoxin. Detailed case investigations and in-depth risk assessments are needed to guide targeted interventions.",1
"Geographical distribution of diphtheria outbreaks in the WHO African Region, January 2025 until 2 November 2025 Table 1. Summary of reported ongoing diphtheria outbreaks in the WHO African region, January – 2 November 2025 Table 2. Summary of vaccination coverage by diphtheria-affected country (WUENIC, 2024) Epidemiology Diphtheria is a severe infectious disease caused by the gram-positive bacterium Corynebacterium diphtheriae or, less commonly, toxigenic strains of other Corynebacterium species. Infection may lead to respiratory disease, cutaneous disease, or an asymptomatic carrier state. The primary mode of transmission rests on close contact with infectious material from respiratory secretions or from skin lesions. The only known reservoir for C. diphtheriae are humans. As a result, asymptomatic carriers play a critical role in infection transmission. Immunity (either via natural infection or vaccine induced) provides protective immunity against the disease but does not prevent carriage. The disease can affect all age groups; however, unvaccinated or partially vaccinated individuals, including children, are most at risk. Respiratory diphtheria typically presents two to five days after exposure with sore throat, malaise, cervical lymphadenopathy, and low-grade fever. Oropharyngeal involvement is most common, but infection may extend to the nasopharynx, larynx, and tracheobronchial tree.",1
"Characteristic findings include adherent gray pseudomembranes on the respiratory tract mucosa that often bleed when removed. Severe cases can result in airway obstruction with neck swelling, hoarseness, stridor, or palatal paralysis. Toxin-mediated complications from toxigenic strains may include myocarditis, neurologic deficits, and kidney injury. Cutaneous diphtheria presents as chronic, nonhealing sores or shallow ulcers covered by a dirty gray membrane, though the appearance is non-specific. In addition to supportive care, treatment is based on the appropriate administration of DAT and antibiotics (azithromycin or penicillin). Full primary series and required booster doses. DAT administration against diphtheria has been effective in reducing the deaths and illness from diphtheria dramatically. Diphtheria is fatal in 5 to 10% of cases, with a higher mortality rate in young children. However, in settings with poor access to DAT, the CFR can be as high as 40%. Public health response WHO, together with its partners, continues to support national authorities in responding to ongoing diphtheria outbreaks across affected countries. Assistance focuses on both technical and operational needs. At the country level, the scope of response operations varies according to available capacities, but core interventions remain consistent.",1
"These include enhanced surveillance through active case finding and timely reporting; adequate clinical management, including the appropriate use of antitoxin and antibiotics; risk communication and community engagement to improve public awareness and encourage care-seeking; and capacity-building efforts such as training and dissemination of evidence-based guidelines. Country-specific actions and priority needs differ, ranging from strengthening surveillance and coordination to scaling up vaccination, laboratory capacity, and medical supplies. Despite these efforts, multiple challenges continue to hinder the effectiveness of outbreak control. Competing health priorities have contributed to long-standing immunity gaps, reflected in persistently low vaccination coverage, especially in fragile settings. Similarly, case management capacity is also limited due to scarcity of diphtheria antitoxin and late presentation of patients, resulting in high case fatality rates, especially in vulnerable, marginalized and hard-to-reach populations. In some settings, surveillance systems remain fragile, resulting in delayed detection and incomplete reporting. Limited laboratory capacity further complicates the response, with shortages of diagnostic supplies, weak specimen transport systems, and restricted technical expertise leading to delayed confirmation and underestimation of outbreak magnitude.",1
"WHO risk assessment Diphtheria is a major public health problem in the African region despite substantial efforts on immunization activities over the past three decades. Between 2000 and 2024, 75 789 diphtheria suspected cases were reported in the Region with the majority being reported from 2023 to 2024. In 2023-2024, Algeria, Chad, Gabon, Guinea, Mali, Mauritania, Niger, Nigeria and South Africa reported resurgence of diphtheria outbreaks with approximately 57 000 suspected cases and 2000 deaths (CFR of 3.5%) recorded. The countries most affected were Guinea, Niger and Nigeria. Most cases reported were children under fifteen years and female. Over 50% of suspected cases were non-vaccinated or with unknown vaccination status. Since the beginning of 2025 and as of 2 November 2025, eight countries in the Region have reported a total of 20 412 suspected diphtheria cases, including 1 252 deaths (with an average case fatality ratio [CFR] of 6%). Most cases are among children and young adults, with women slightly more affected than men. Laboratory confirmation remains low due to shortages of diagnostic supplies and limited testing capacity. The global shortage of DAT, and a variable clinical capacity to provide this essential treatment, poses an additional challenge to effective case management.",1
"Many of the affected countries are fragile, conflict-affected or have system vulnerabilities where health systems are overstretched, routine services are disrupted and access to essential services is limited. These settings are characterized by low routine immunization coverage, high population mobility, and crowded living conditions, especially among displaced populations. The resurgence of diphtheria in these countries is further compounded by disruptions caused by the COVID-19 pandemic, which led to significant declines in vaccine uptake and widened immunity gaps. At the regional level, the public health risk is assessed as high due to the potential for further geographic expansion of outbreaks, high fatality rates, insufficient resources for outbreak control, and weak surveillance and laboratory systems. The humanitarian context in several affected countries, including Chad, Mali, Niger, and Nigeria, increases the likelihood of sustained transmission and complicates response efforts. At the global level, the public health risk is considered low. Most countries outside the African Region have established immunization programs and adequate surveillance systems. However, the possibility of international spread through travel cannot be ruled out, particularly if susceptible individuals are exposed. Strengthened global surveillance and risk communication are therefore essential to mitigate this risk. The confidence in the available information is assessed as moderate.",1
"While data collection and reporting have improved in some countries, gaps remain in laboratory confirmation, case classification, and timely sharing of epidemiological updates. WHO advice Diphtheria is a vaccine-preventable bacterial disease caused by Corynebacterium diphtheriae. It primarily affects the upper respiratory tract and can produce a toxin that leads to severe systemic complications, including myocarditis, kidney failure, and neurological damage. The disease spreads via close contact with respiratory secretions or skin lesions. Areas with low immunization coverage, overcrowding and limited access to healthcare services are at higher risk of increased transmission and may experience outbreaks Considering the ongoing diphtheria outbreaks in the WHO African Region, WHO encourages Member States to strengthen preparedness and response capacities. This includes enhancing surveillance systems to improve case detection and reporting, expanding laboratory capacity for timely confirmation of cases, and improving clinical management and infection prevention and control. Supplementary immunization activities should be prioritized to close immunity gaps, particularly among children/adolescents and displaced populations. Community engagement and risk communication efforts must be intensified to raise awareness, promote health-seeking behavior, and ensure adherence to control measures.",1
"WHO also recommends the establishment of contingency stockpiles of diphtheria antitoxin, antibiotics, and laboratory supplies at regional hubs in Dakar and Nairobi. These stockpiles will enable rapid deployment of essential materials to the affected countries when needed. Regional and global advocacy efforts should be strengthened to mobilize funding and political support for outbreak response. WHO will continue to support Member States through technical assistance, resource mobilization, and coordination with partners. WHO will continue to work across all levels of the organization to identify and implement appropriate mechanisms to support affected countries and mitigate the impact of the outbreaks. WHO does not recommend any restriction on travel to or trade with the countries named in this report, based on the information available on the current event. Further information - World Health Organization. Clinical management of diphtheria: guideline. 2024 Feb 2. Available from: - World Health Organization. Diphtheria: fact sheet. [cited 2025 Feb 17]. Available from: - World Health Organization. Guidance on safe and supportive care in community care centres for individuals with mild mpox in camps for internally displaced persons or refugees. Available from: - World Health Organization. Diphtheria, tetanus toxoid and pertussis (DTP) vaccination coverage. Available from: - World Health Organization Africa Region. Fragile, conflict-affected and vulnerable (FCV) countries.",1
"Available from: - World Health Organization. Infection prevention and control and water, sanitation, and hygiene measures for diphtheria in health-care settings: operational guide. 2023. Available from: - World Health Organization; UNICEF. WHO/UNICEF estimates of national immunization coverage (WUENIC). Available from: - Bita Fouda AA, et al. Resurgence of diphtheria outbreaks in the African Region 2023–2024. Pan Afr Med J. 2025;51(1). Available from: Citable reference: World Health Organization (21 November 2025). Disease Outbreak News; Diphtheria in the African Region. Available at:",1
"Key facts - Nearly 1 in 7 people in the world live with a mental disorder. - Mental disorders can severely disrupt daily life and cause long-term suffering if left untreated. - There are many different types of mental disorders. - Effective prevention and treatment options exist. - Most people do not have access to effective care. A mental disorder is characterized by a clinically significant disturbance in an individual’s cognition, emotional regulation, or behaviour. It is usually associated with distress or impairment in important areas of functioning. There are many different types of mental disorders. Mental disorders may also be referred to as mental health conditions. The latter is a broader term covering mental disorders, psychosocial disabilities and (other) mental states associated with significant distress, impairment in functioning, or risk of self-harm. This fact sheet focuses on mental disorders as described by the International Classification of Diseases 11th Revision (ICD-11). In 2021, nearly 1 in every 7 people (1.1 billion) around the world were living with a mental disorder, with anxiety and depressive disorders the most common (1). While effective prevention and treatment options exist, most people with mental disorders do not have access to effective care. Many people also experience stigma, discrimination and violations of human rights.",1
"Anxiety disorders In 2021, 359 million people were living with an anxiety disorder including 72 million children and adolescents (1). Anxiety disorders are characterised by excessive fear and worry and related behavioural disturbances. Symptoms are severe enough to result in significant distress or significant impairment in functioning. There are several different kinds of anxiety disorders, such as: generalized anxiety disorder (characterised by excessive worry), panic disorder (characterised by panic attacks), social anxiety disorder (characterised by excessive fear and worry in social situations), separation anxiety disorder (characterised by excessive fear or anxiety about separation from those individuals to whom the person has a deep emotional bond), and others. Effective psychological treatment exists, and depending on the age and severity, medication may also be considered. Depression In 2019, 280 million people were living with depression, including 23 million children and adolescents (1). Depression is different from usual mood fluctuations and short-lived emotional responses to challenges in everyday life. During a depressive episode, the person experiences depressed mood (feeling sad, irritable, empty) or a loss of pleasure or interest in activities, for most of the day, nearly every day, for at least two weeks.",1
"Several other symptoms are also present, which may include poor concentration, feelings of excessive guilt or low self-worth, hopelessness about the future, thoughts about dying or suicide, disrupted sleep, changes in appetite or weight, and feeling especially tired or low in energy. People with depression are at an increased risk of suicide. Yet, effective psychological treatment exists, and depending on the age and severity, medication may also be considered. Bipolar disorder In 2021, 37 million people experienced bipolar disorder, including 3.8 milion adolescents aged 10–19 years (1). People with bipolar disorder experience alternating depressive episodes with periods of manic symptoms. During a depressive episode, the person experiences depressed mood (feeling sad, irritable, empty) or a loss of pleasure or interest in activities, for most of the day, nearly every day. Manic symptoms may include euphoria or irritability, increased activity or energy, and other symptoms such as increased talkativeness, racing thoughts, increased self-esteem, decreased need for sleep, distractibility, and impulsive reckless behaviour. People with bipolar disorder are at an increased risk of suicide. Yet effective treatment options exist including psychoeducation, reduction of stress and strengthening of social functioning, and medication. Post-Traumatic Stress Disorder (PTSD) PTSD may develop following exposure to an extremely threatening or horrific event or series of events.",1
"It is characterised by all of the following: 1) re-experiencing the traumatic event or events in the present (intrusive memories, flashbacks, or nightmares); 2) avoidance of thoughts and memories of the event(s), or avoidance of activities, situations, or people reminiscent of the event(s); and 3) persistent perceptions of heightened current threat. These symptoms persist for at least several weeks and cause significant impairment in functioning. Effective psychological treatment exists. Schizophrenia Schizophrenia affects approximately 23 million people or 1 in 345 people worldwide (1). People with schizophrenia have a life expectancy nine years below that of the general population (2). Schizophrenia is characterised by significant impairments in perception and changes in behaviour. Symptoms may include persistent delusions, hallucinations, disorganised thinking, highly disorganised behaviour, or extreme agitation. People with schizophrenia may experience persistent difficulties with their cognitive functioning. Yet, a range of effective treatment options exist, including medication, psychoeducation, family interventions, and psychosocial rehabilitation. Eating disorders In 2021, 16 million people experienced eating disorders including almost 3.4 million children and adolescents (1). Eating disorders, such as anorexia nervosa and bulimia nervosa, involve abnormal eating and preoccupation with food as well as prominent body weight and shape concerns.",1
"The symptoms or behaviours result in significant risk or damage to health, significant distress, or significant impairment of functioning. Anorexia nervosa often has its onset during adolescence or early adulthood and is associated with premature death due to medical complications or suicide. Individuals with bulimia nervosa are at a significantly increased risk for substance use, suicidality, and health complications. Effective treatment options exist, including family-based treatment and cognitive-based therapy. Disruptive behaviour and dissocial disorders In 2021, 41 million people, including children and adolescents, were living with conduct-dissocial disorder (1). This disorder, also known as conduct disorder, is one of two disruptive behaviour and dissocial disorders, the other is oppositional defiant disorder. Disruptive behaviour and dissocial disorders are characterised by persistent behaviour problems such as persistently defiant or disobedient to behaviours that persistently violate the basic rights of others or major age-appropriate societal norms, rules, or laws. Onset of disruptive and dissocial disorders, is commonly, though not always, during childhood. Effective psychological treatments exist, such as cognitive problem-solving and/or social skills training, and often involve parents, caregivers, and teachers.",1
"Neurodevelopmental disorders Neurodevelopmental disorders are behavioural and cognitive disorders, that arise during the developmental period, and involve significant difficulties in the acquisition and execution of specific intellectual, motor, language, or social functions. Neurodevelopmental disorders include disorders of intellectual development, autism spectrum disorder, and attention deficit hyperactivity disorder (ADHD) amongst others. ADHD is characterised by a persistent pattern of inattention and/or hyperactivity-impulsivity that has a direct negative impact on academic, occupational, or social functioning. Disorders of intellectual development are characterised by significant limitations in intellectual functioning and adaptive behaviour, which refers to difficulties with everyday conceptual, social, and practical skills that are performed in daily life. Autism spectrum disorder (ASD) constitutes a diverse group of conditions characterised by some degree of difficulty with social communication and reciprocal social interaction, as well as persistent restricted, repetitive, and inflexible patterns of behaviour, interests, or activities. Effective treatment options exist including psychosocial interventions, behavioural interventions, occupational and speech therapy. For certain diagnoses and age groups, medication may also be considered.",1
"Risk factors At any one time, a diverse set of individual, family, community, and structural factors may combine to protect or undermine mental health. Although most people are resilient, people who are exposed to adverse circumstances – including poverty, violence, disability, and inequality – are at higher risk. Protective and risk factors include individual psychological and biological factors, such as emotional skills as well as genetics. Many of the risk and protective factors are influenced through changes in brain structure and/or function. Health systems and social support Health systems have not yet adequately responded to the needs of people with mental disorders and are significantly under resourced. The gap between the need for treatment and its provision is wide all over the world; and is often poor in quality when delivered. For example, only 29% of people with psychosis (3) and only one third of people with depression receive formal mental health care (4). People with mental disorders also require social support, including support in developing and maintaining personal, family, and social relationships. People with mental disorders may also need support for educational programmes, employment, housing, and participation in other meaningful activities. WHO response WHO’s Comprehensive Mental Health Action Plan 2013–2030 recognizes the essential role of mental health in achieving health for all people.",1
"The plan includes four major objectives: - to strengthen effective leadership and governance for mental health; - to provide comprehensive, integrated and responsive mental health and social care services in community-based settings; - to implement of strategies for promotion and prevention in mental health; and - to strengthen information systems, evidence, and research for mental health. WHO's Mental Health Gap Action Programme (mhGAP) uses evidence-based technical guidance, tools and training packages to expand services in countries, especially in resource-poor settings. It focuses on a prioritized set of conditions, directing capacity building towards non-specialized health-care providers in an integrated approach that promotes mental health at all levels of care. The WHO mhGAP Intervention Guide 2.0 is part of this programme, and provides guidance for doctors, nurses, and other health workers in non-specialist health settings on assessment and management of mental disorders. References 1) 2021 Global Burden of Disease (GBD) [online database]. Seattle: Institute for Health Metrics and Evaluation; 2024 ( accessed 13 August 2025). (2) Yung NCL, Wong CSM, Chan JKN, Chen EYH, Chang WC. Excess mortality and life-years lost in people with schizophrenia and other non-affective psychoses: an 11-year population-based cohort study. Schizophr Bull. 2021;47(2):474–84 ( (3) Mental health atlas 2020. Geneva: World Health Organization; 2021 ( Licence: CC BY-NC-SA 3.0 IGO.",1
"(4) Moitra M, Santomauro D, Collins PY, Vos T, Whiteford H, Saxena S, et al. The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: a systematic review and Bayesian meta-regression analysis. PLoS Med. 2022;19(2):e1003901. doi:10.1371/journal.pmed.1003901.",1
"Worldwide, the number of additional people expected to be enjoying better health and wellbeing is projected to be 1.5bn (1.2bn – 1.8bn) by 2025 compared to 2018. Universal health coverage Worldwide, the number of additional people expected to be covered by essential services and not experiencing financial hardship is projected to be 585m (526.1m – 639.5m) by 2025 compared to 2018. Health emergencies protection Worldwide, the number of additional people expected to be protected from health emergencies is projected to be 776.9m (647.4m – 912.5m) by 2025 compared to 2018. The triple billion targets provide a unified approach to accelerating progress towards the achievement of the health-related Sustainable Development Goals. Estimates are calculated with 90% uncertainty intervals (UI) and presented as the upper and lower bounds in the closed brackets after the mean estimate. Welcome to your gateway to all public health data. These databases and platforms provide access to understandable and timely data, transforming lives by making health and inequality data findable, browsable, and usable. WHO dashboards deliver critical insights and dynamic visualizations on priority health topics and empower users to explore trends, identify patterns, and make informed decisions to improve health.",1
"16 Days of Activism against Gender-Based Violence 2025 Planning for tomorrow’s digital health: strategic training for francophone countries in the WHO African and Eastern Mediterranean regions GATE Summit 2025: Accelerating access to assistive technology (dates to be confirmed) World AIDS Day 2025 – Overcoming disruption, transforming the AIDS response 7th Meeting of the Montreux Collaborative on fiscal space, public financial management and health financing Fourth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement WHO EPI-WIN webinar: UNiTE to end digital violence: why digital safety is a gender and public health imperative in emergencies World AIDS Day 2025: Geneva commemoration event From evidence to action: WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults Campaigns WHO Regional Committee meetings",1
"Contact IOAC Membership The Committee consists of up to 12 members drawn from national governments, NGOs, the UN system, donors, the private sector, academia, and civil society, with extensive experience in a broad range of disciplines. Members serve in their personal capacity and exercise their responsibilities with full regard for the paramount importance of independence.",1
"Chair Director of the Doctorate and Research in Public Health Program at St. Joseph University in Beirut and former Director General of the Lebanese Ministry of Public Health Members of the committee Chair of the Kofi Annan Foundation Board, and former Secretary General of the International Federation of Red Cross and Red Crescent Former Chief Medical Officer, Australia Visiting Professor, Institute of Global Health Innovation, Imperial College London, former Director General for Public and International Health, HMG UK Chair of the Global Advisory Board for WomenLift Health Former Commissioner of the Korea Disease Control and Prevention Agency (KDCA) President, Refugees International Director-General of the Center for Vaccine Development Chief Public Health Officer, Public Health Agency of Canada Former members Professor Emeritus, Graduate School of Public Health, St.Luke’s International University, Tokyo United States Ambassador-at-Large for Global Women’s Issues Director of the Health Regulatory Science Platform, a division of the Wits Health Consortium at the University of the Witwatersrand Professor for Global Initiatives at Keio University Executive Director, WHO Health Emergencies Programme",1
"Key facts - Dengue is a viral infection caused by the dengue virus (DENV), which is transmitted to humans through the bite of infected mosquitoes. - About half of the world's population is now at risk of dengue, with an estimated 100–400 million infections occurring each year. - Dengue is found in tropical and sub-tropical climates worldwide, mostly in urban and semi-urban areas. - While many DENV infections are asymptomatic or produce only mild illness, DENV can occasionally cause more severe cases, and even death. - Prevention and control of dengue rely on vector control. There is no specific treatment for dengue/severe dengue, and early detection and access to proper medical care greatly lower fatality rates of severe dengue. Overview Dengue (break-bone fever) is a viral infection that is spread from mosquitoes to people. It is more common in tropical and subtropical than in temperate climates. Most people who get dengue do not have symptoms. For those who do, the most common symptoms are high fever, headache, body aches, nausea and rash. Most get better in 1–2 weeks. Some develop severe dengue and need care in a hospital. In severe cases, dengue can be fatal. You can lower your risk of dengue by avoiding mosquito bites, especially during the day. Dengue is treated through pain management as there is no specific treatment currently. Symptoms Most people with dengue have mild or no symptoms and will get better in 1–2 weeks. Rarely, dengue can be severe and lead to death.",1
"If symptoms occur, they usually begin 4–10 days after infection and last for 2–7 days. Symptoms may include: - high fever (40°C/104°F) - severe headache - pain behind the eyes - muscle and joint pains - nausea - vomiting - swollen glands - rash. Individuals who are infected for the second time are at greater risk of severe dengue. The symptoms of severe dengue often come after the fever has gone away and may include: - severe abdominal pain - persistent vomiting - rapid breathing - bleeding gums or nose - fatigue - restlessness - blood in vomit or stool - being very thirsty - pale and cold skin - feeling weak. People with these severe symptoms should seek care immediately. After recovery, people who have had dengue may experience fatigue for several weeks. Diagnostics and treatment Laboratory-based and point of care diagnostics are critical to control and manage dengue, yet global disparities in laboratory capabilities present significant challenges. The diagnostic algorithms, testing strategies and test methodologies employed vary, depending on the capabilities of national laboratory systems. The wide range of available tests – including nucleic acid amplification tests (NAATs), enzyme-linked immunosorbent assays (ELISAs) and rapid diagnostic tests (RDTs) – vary significantly in quality and performance.",1
"Laboratory testing for arboviruses can be accomplished through either direct detection methods such as virus isolation, molecular detection of nucleic acid or antigen testing, including rapid diagnostic tests (RDTs) within the first week of illness. There is no specific treatment for dengue, although pain can be managed with medication such as paracetamol (acetaminophen). Non-steroidal anti-inflammatory medicines such as ibuprofen and aspirin should be avoided as they can increase the risk of bleeding. For people with severe dengue, hospitalization is often necessary. Global burden The incidence of dengue has grown dramatically worldwide in recent decades, with the number of cases reported to WHO increasing from 505 430 cases in 2000 to 14.6 million in 2024. The vast majority of cases are asymptomatic or mild and self-managed, and hence the actual numbers of dengue cases are under-reported. The disease is now endemic in more than 100 countries. In 2024, more cases of dengue were recorded than ever before in a 12-month period, affecting over 100 countries on all continents. During 2024, ongoing transmission, combined with an unexpected spike in dengue cases, resulted in a historic high of over 14.6 million cases and more than 12 000 dengue-related deaths reported. The Region of the Americas contributed a significant proportion of the global burden, with over 13 million cases reported to WHO.",1
"Several factors are associated with the increasing risk of spread of the dengue epidemic, including the changing distribution of the responsible vectors (chiefly Aedes aegypti and Aedes albopictus), especially in previously dengue-naive countries; climate change leading to increasing temperatures, high rainfall and humidity; fragile and overburdened health systems; limitations in surveillance and reporting; and political and financial instabilities in countries facing complex humanitarian crises and high population movements. One modelling estimate indicates 390 million dengue virus infections per year, of which 96 million manifest clinically(1).A recent study on the prevalence of dengue estimates that 5.6 billion people are at risk of infection with dengue and other arboviruses(2). From January to July 2025, over 4 million cases and over 3000 deaths have been reported to WHO from 97 countries.Dengue is spreading to new areas, including the European and Eastern Mediterranean regions. In 2024, 308 cases were reported to WHO from three European countries (France, Italy and Spain) and an additional 1291 cases and four deaths were recorded in the French overseas territories of Mayotte and Réunion. Transmission Transmission through the mosquito bite The dengue virus is transmitted to humans through the bites of infected female mosquitoes, primarily the Aedes aegypti mosquito.",1
"Other species within the Aedes genus can also act as vectors, but their contribution is normally secondary to Aedes aegypti. After feeding on a DENV-infected person, the virus replicates in the mosquito midgut before disseminating to secondary tissues, including the salivary glands. The time it takes from ingesting the virus to actual transmission to a new host is termed the extrinsic incubation period (EIP). The EIP takes about 8–12 days when the ambient temperature is 25–28°C. Variations in the EIP are not only influenced by ambient temperature but also by several other factors – such as the magnitude of daily temperature fluctuations, the virus genotype, and the initial viral concentration – which can also alter the time it takes for a mosquito to transmit the virus. Once infectious, a mosquito can transmit the virus for the rest of its life. Human-to-mosquito transmission Mosquitoes can become infected by people who are viremic with DENV. This can be someone who has a symptomatic dengue infection, someone who is yet to have a symptomatic infection (those who are pre-symptomatic), and also someone who shows no signs of illness (those who are asymptomatic). Human-to-mosquito transmission can occur up to 2 days before someone shows symptoms of the illness, and up to 2 days after the fever has resolved.",1
"The risk of mosquito infection is positively associated with high viremia and high fever in the patient; conversely, high levels of DENV-specific antibodies are associated with a decreased risk of mosquito infection. Most people are viremic for about 4–5 days, but viremia can last as long as 12 days. Maternal transmission The primary mode of transmission of the DENV between humans involves mosquito vectors. There is evidence, however, of the possibility of maternal transmission (i.e. from a pregnant mother to her baby). At the same time, vertical transmission rates appear low, with the risk of vertical transmission seemingly linked to the timing of acquiring the dengue infection during pregnancy. When a mother does have a dengue infection when she is pregnant, babies may suffer from pre-term birth, low birthweight and fetal distress. Other transmission modes Rare cases of transmission via blood products, organ donation and transfusions have been recorded. Similarly, transovarial transmission of the virus within mosquitoes has also been recorded. Risk factors Previous infection with DENV increases the risk of an individual developing severe dengue. Urbanization (especially rapid, unplanned urbanization), is associated with dengue transmission through multiple social and environmental factors: population density, human mobility, access to reliable water source, water storage practices, etc.",1
"Community risks to dengue also depend on population knowledge, attitudes and practices towards dengue, as exposure is closely related to behaviours such as water storage, plant-keeping and self-protection against mosquito bites. Routine vector surveillance and control activities and targeted community engagement greatly enhance resilience. Vectors can adapt to new environments and climate. The interaction between the dengue virus, the host and the environment is dynamic. Consequently, disease risks may change and shift with climate change in tropical and subtropical areas, in combination with increased urbanization and population movement. Prevention and control The mosquitoes that spread dengue are active during the day. To lower your risk of getting dengue, protect yourself from mosquito bites by using: - clothes that cover as much of your body as possible; - mosquito nets, ideally sprayed with insect repellent, if sleeping during the day; - window screens; - mosquito repellents (containing DEET, Picaridin or IR3535); and - coils and vaporizers. To prevent mosquitoes from breeding: - implement environmental management and modification practices to stop mosquitoes from accessing egg-laying habitats; - dispose of solid waste properly and remove artificial habitats that can hold water; - cover, empty and clean domestic water storage containers on a weekly basis; and - apply appropriate insecticides to water storage outdoor containers.",1
"If you get dengue, it’s important to: - rest; - drink plenty of liquids; - use acetaminophen (paracetamol) for pain; - avoid non-steroidal anti-inflammatory medication such as ibuprofen and aspirin; and - watch for severe symptoms and contact your doctor as soon as possible if you notice any. Currently, one vaccine (QDenga) is available and licensed in some countries. However, it is recommended only for those aged 6–16 years in high transmission settings. Several additional vaccines are under evaluation.",1
"WHO response WHO responds to dengue by: - supporting countries in the confirmation of outbreaks through its collaborating network of laboratories; - providing technical advice and guidance to countries for the effective management of dengue outbreaks; - supporting countries to improve their reporting systems and capture the true burden of the disease; - providing training on clinical management, diagnosis and vector control at the country and regional levels in collaboration with its collaborating centres; - formulating evidence-based strategies and policies; - supporting countries to develop dengue prevention and control strategies and adopt the Global Vector Control Response (2017–2030) and the Global Arbovirus Initiative (2022–2025); - reviewing and making recommendations on the development of new tools, including insecticide products and application technologies; - gathering official records of dengue and severe dengue from over 100 Member States; and - publishing guidance and handbooks for surveillance, case management, diagnosis, dengue prevention and control for Member States. References - Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–507. doi: 10.1038/nature12060 - Lim A, Shearer FM, Sewalk K, Pigott DM, Clarke J, Ghouse A, et al. The overlapping global distribution of dengue, chikungunya, Zika and yellow fever. Nat Commun. 2025;16(1):3418. doi: 10.1038/s41467-025-58609-5.",1
"All for Health, Health for All is WHO’s third investment case and has been produced alongside the Fourteenth General Programme of Work (GPW 14) to capture the impact of a fully funded WHO over the period 2025–2028. Why invest in WHO? Investing in the World Health Organization is an investment in the health of all people, at all ages, everywhere. Since 1948, WHO has played a pivotal role in advancing global health, ensuring equitable access to essential health services, responding to health emergencies, and setting standards for all areas of health. WHO has made some remarkable achievements including the eradication of smallpox, reductions in child mortality, and significant progress in combating diseases like malaria and tuberculosis. WHO offers unparalleled global reach, legitimacy and expertise. It translates science and evidence into proven, affordable and effective solutions and action for physical and mental health. With presence in more than 150 countries, across all regions of the world, it works hand-in-hand with its 194 Member States, partners, health workers and communities to build the systems and implement interventions needed to keep people healthy and achieve health for all. WHO supports countries to make healthy choices the easiest choices for their citizens, from promoting healthy diets and creating tobacco- and pollution-free environments, to scaling up access to safe life-saving tools like vaccines, diagnostics and treatments.",1
"WHO coordinates humanitarian action in emergencies, scales up in-country action for people in need, and quickly mobilizes support through trusted and committed global networks. And WHO is the only global convening place where all countries and partners committed to health come and work together for the well-being of everyone, everywhere, no matter age, income levels, gender or birthplace.",1
"Global immunization efforts have led to an 88% drop in measles deaths between 2000 and 2024, according to a new report from the World Health Organization (WHO). Nearly 59 million lives have been saved by the measles vaccine since 2000. However, an estimated 95 000 people, mostly children younger than 5 years of age, died due to measles in 2024. While this is among the lowest annual tolls recorded since 2000, every death from a disease that could be prevented with a highly effective and low-cost vaccine is unacceptable. Despite fewer deaths, measles cases are surging worldwide, with an estimated 11 million infections in 2024 – nearly 800 000 more than pre-pandemic levels in 2019. “Measles is the world's most contagious virus, and these data show once again how it will exploit any gap in our collective defences against it,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Measles does not respect borders, but when every child in every community is vaccinated against it, costly outbreaks can be avoided, lives can be saved, and this disease can be eliminated from entire nations.” Measles cases in 2024 increased by 86% in the WHO Eastern Mediterranean Region, 47% in the European Region, and 42% in South-East Asian Region compared with 2019. Notably, the African Region experienced a 40% decline in cases and 50% decline in deaths over this period, partly due to increasing immunization coverage.",1
"While recent measles surges are occurring in countries and regions where children are less likely to die due to better nutrition and access to health care, those infected remain at risk of serious, lifelong complications such as blindness, pneumonia, and encephalitis (an infection causing brain swelling and potentially brain damage). Immunization coverage insufficient to protect all communities In 2024, an estimated 84% of children received their first dose of the measles vaccine, and only 76% received the second, according to WHO/UNICEF estimates. This is a slight improvement from the previous year, with 2 million more children immunized. According to WHO guidance, at least 95% coverage with two measles vaccine doses is required to stop transmission and protect communities from outbreaks. More than 30 million children remained under-protected against measles in 2024. Three-quarters of them live in the African and Eastern Mediterranean regions, often in fragile, conflict-affected or vulnerable settings. The Immunization Agenda 2030 (IA2030) Mid-Term Review, also released today, stresses that measles is often the first disease to resurge when vaccination coverage drops. Growing measles outbreaks are exposing weaknesses in immunization programmes and health systems globally, and threatening progress towards IA2030 targets, including measles elimination.",1
"Rising number of outbreaks In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic. All regions except the Americas had at least one country experiencing a large outbreak in 2024. The situation changed in 2025 with numerous countries in the Americas battling outbreaks. Efforts to scale up measles surveillance have improved WHO and countries' abilities to identify and respond to outbreaks, and for some countries to achieve elimination. In 2024, more than 760 laboratories participating in the Global Measles and Rubella Laboratory Network (GMRLN) tested over 500 000 samples, an increase of 27% from the previous year. However, deep funding cuts affecting GMRLN and country immunization programmes are feared to widen immunity gaps and drive further outbreaks in the coming year. Securing sustainable domestic financing and new partners is now a critical challenge to advancing efforts toward a world free of measles. Striving for a measles-free world The world’s elimination goal, as laid out in IA2030, remains a distant one. By the end of 2024, 81 countries (42%) had eliminated measles, only three additional countries since before the pandemic.",1
"Additional progress has been made in 2025 with Pacific island countries and areas verified in September 2025, and Cabo Verde, Mauritius and Seychelles verified this month, becoming the first countries in the WHO African Region to be verified for measles elimination. This brings the total number of countries that have eliminated measles to 96. The Region of the Americas regained measles elimination status in 2024 for the second time – the only region to ever be verified – but it lost the status again in November 2025 due to ongoing transmission in Canada. Measles has resurged in recent years, even in high-income countries that once eliminated it, because immunization rates have dropped below the 95% threshold. Even when overall coverage is high nationally, pockets of unvaccinated communities with lower coverage rates can leave people at risk and result in outbreaks and ongoing transmission. To achieve measles elimination, strong political commitment and sustained investment is needed to ensure all children receive two doses of the measles vaccine and surveillance systems can rapidly detect outbreaks. The IA2030 Mid-Term Review calls on countries and partners to strengthen routine immunization, surveillance and rapid outbreak response capabilities, and to deliver high-quality, high-coverage campaigns when routine immunization is not yet sufficient to protect every child.",1
"Note to editors WHO uses statistical modelling to estimate measles cases and deaths each year, based on cases reported by countries, and revises the previous year's estimates to assess disease trends over time. WHO is a founding member of the Measles & Rubella Partnership (M&RP), a global initiative to stop measles and rubella. Under the umbrella of Immunization Agenda 2030 and guided by the Measles and Rubella Strategic Framework 2030, M&RP’s mission includes addressing the decline in national vaccination coverage, hastening the recovery of the measles backsliding resulting from COVID-19 pandemic, and accelerating progress towards creating a world free of measles and rubella. The partnership also includes American Red Cross, the Gates Foundation, Gavi, the Vaccine Alliance, the U.S. Centers for Disease Control and Prevention (CDC), United Nations Foundation, and UNICEF. Measles elimination is defined as the absence of endemic measles virus transmission in a region or other defined geographical area for more than 12 months. Conversely, a country is no longer considered to be measles free if the virus returns, and transmission is sustained continuously for more than a year. The Immunization Agenda 2030 global monitoring framework defines large or disruptive outbreaks as having ≥20 cases per one million population in a 12-month period.",1
"Health Inequality Monitor Explore health inequality monitoring evidence, tools, resources and training Health Inequality Data Repository Disaggregated data – which show how health or other aspects of life are experienced by people of different ages, economic status, education levels, place of residence, sex, and other characteristics – are a vital part of advancing equity. Disaggregated data can serve as an evidence base for equity-oriented policies, programmes and practices that aim to close existing gaps and achieve good health and well-being for all. The Health Inequality Data Repository contains datasets of disaggregated data covering diverse topics and dimensions of inequality, from a variety of publicly available data sources. It aims to make disaggregated data more accessible and navigable to diverse global audiences. Please note that some datasets are from external published sources and are therefore not WHO official estimates. Please refer to the Indicator Metadata for more information about the data. More information about the Health Inequality Data Repository is available here. Access datasets Download the data in Excel (.xlsx) format using the links in the sections below or access the data programmatically using an API. Go to section:",1
"Health topics Abortion Abuse of older people Addictive behaviour Adolescent health Ageing Ageism Air pollution Alcohol Anaemia Antimicrobial resistance Assistive technology Biological weapons Biologicals Blood products Blood transfusion safety Brain health Breastfeeding Buruli ulcer (Mycobacterium ulcerans infection) Cancer Cardiovascular diseases Cervical cancer Chagas disease (American trypanosomiasis) Chemical incidents Chemical safety Chikungunya Child growth Child health Childhood cancer Children's environmental health Cholera Chronic respiratory diseases Climate change Clinical trials Commercial determinants of health Common goods for health Complementary feeding Congenital disorders Contraception Coronavirus disease (COVID-19) Crimean-Congo haemorrhagic fever Deafness and hearing loss Deliberate events Dementia Dengue and severe dengue Depression Diabetes Diagnostics Diarrhoea Digital health Diphtheria Disability Dracunculiasis (Guinea-worm disease) Drought Drowning Drugs (psychoactive) Earthquakes Ebola virus disease Echinococcosis Electromagnetic fields Emergency and critical care Energy and health Environmental health Epilepsy Eye care, vision impairment and blindness Female genital mutilation Financial protection Floods Food fortification Food safety Foodborne diseases Foodborne trematode infections Gender and health Genomics Global health ethics Health accounts Health budget Health economics Health equity Health financing Health impact assessment Health Laws Health promoting schools Health promotion Health security Health systems governance Health taxes Health technology assessment Health workforce Healthy diet Heatwaves Hendra virus infection Hepatitis HIV Hospitals Human African trypanosomiasis (sleeping sickness) Human genome editing Human rights Hypertension In vitro diagnostics Infant nutrition Infection prevention and control Infertility Influenza (avian and other zoonotic) Influenza (seasonal) Infodemic Intellectual property and trade International Health Regulations Landslides Lassa fever Lead poisoning Leishmaniasis Leprosy (Hansen disease) Lymphatic filariasis (Elephantiasis) Malaria Malnutrition Marburg virus disease Maternal health Measles Medical devices Medicines Meningitis Mental health Micronutrients Middle East respiratory syndrome coronavirus (MERS-CoV) Mpox Mycetoma, chromoblastomycosis and other deep mycoses Neglected tropical diseases Newborn health Nipah virus infection Noncommunicable diseases Nursing and midwifery Nutrition Obesity Occupational health Onchocerciasis (river blindness) One Health Oral health Oxygen Palliative care Patient safety Pertussis Physical activity Plague Pneumonia Poliomyelitis (polio) Primary health care Quality of care Rabies Radiation Radiation emergencies Radon Refugee and migrant health Rehabilitation Research Respiratory syncytial virus Rift Valley fever Road traffic injuries Scabies Schistosomiasis (Bilharzia) Self-care for health and well-being Sepsis Severe Acute Respiratory Syndrome (SARS) Sexual and reproductive health and rights Sexual health Sexually transmitted infections (STIs) Smallpox Snakebite envenoming Social determinants of health Soil-transmitted helminthiases Stillbirth Substandard and falsified medical products Suicide prevention Sustainable development Syphilis Taeniasis and cysticercosis Tetanus Tick-borne encephalitis Tobacco Trachoma Traditional, Complementary and Integrative Medicine Transplantation Travel and health Tropical Cyclones Tsunamis Tuberculosis Typhoid Ultraviolet radiation Universal health coverage Urban health Vaccines and immunization Violence against children Violence against women Volcanic eruptions Water, sanitation and hygiene (WASH) WHO Pandemic Agreement Wildfires Women's health Yaws (Endemic treponematoses) Yellow fever Zika virus disease",1
"Health topics Abortion Abuse of older people Addictive behaviour Adolescent health Ageing Ageism Air pollution Alcohol Anaemia Antimicrobial resistance Assistive technology Biological weapons Biologicals Blood products Blood transfusion safety Brain health Breastfeeding Buruli ulcer (Mycobacterium ulcerans infection) Cancer Cardiovascular diseases Cervical cancer Chagas disease (American trypanosomiasis) Chemical incidents Chemical safety Chikungunya Child growth Child health Childhood cancer Children's environmental health Cholera Chronic respiratory diseases Climate change Clinical trials Commercial determinants of health Common goods for health Complementary feeding Congenital disorders Contraception Coronavirus disease (COVID-19) Crimean-Congo haemorrhagic fever Deafness and hearing loss Deliberate events Dementia Dengue and severe dengue Depression Diabetes Diagnostics Diarrhoea Digital health Diphtheria Disability Dracunculiasis (Guinea-worm disease) Drought Drowning Drugs (psychoactive) Earthquakes Ebola virus disease Echinococcosis Electromagnetic fields Emergency and critical care Energy and health Environmental health Epilepsy Eye care, vision impairment and blindness Female genital mutilation Financial protection Floods Food fortification Food safety Foodborne diseases Foodborne trematode infections Gender and health Genomics Global health ethics Health accounts Health budget Health economics Health equity Health financing Health impact assessment Health Laws Health promoting schools Health promotion Health security Health systems governance Health taxes Health technology assessment Health workforce Healthy diet Heatwaves Hendra virus infection Hepatitis HIV Hospitals Human African trypanosomiasis (sleeping sickness) Human genome editing Human rights Hypertension In vitro diagnostics Infant nutrition Infection prevention and control Infertility Influenza (avian and other zoonotic) Influenza (seasonal) Infodemic Intellectual property and trade International Health Regulations Landslides Lassa fever Lead poisoning Leishmaniasis Leprosy (Hansen disease) Lymphatic filariasis (Elephantiasis) Malaria Malnutrition Marburg virus disease Maternal health Measles Medical devices Medicines Meningitis Mental health Micronutrients Middle East respiratory syndrome coronavirus (MERS-CoV) Mpox Mycetoma, chromoblastomycosis and other deep mycoses Neglected tropical diseases Newborn health Nipah virus infection Noncommunicable diseases Nursing and midwifery Nutrition Obesity Occupational health Onchocerciasis (river blindness) One Health Oral health Oxygen Palliative care Patient safety Pertussis Physical activity Plague Pneumonia Poliomyelitis (polio) Primary health care Quality of care Rabies Radiation Radiation emergencies Radon Refugee and migrant health Rehabilitation Research Respiratory syncytial virus Rift Valley fever Road traffic injuries Scabies Schistosomiasis (Bilharzia) Self-care for health and well-being Sepsis Severe Acute Respiratory Syndrome (SARS) Sexual and reproductive health and rights Sexual health Sexually transmitted infections (STIs) Smallpox Snakebite envenoming Social determinants of health Soil-transmitted helminthiases Stillbirth Substandard and falsified medical products Suicide prevention Sustainable development Syphilis Taeniasis and cysticercosis Tetanus Tick-borne encephalitis Tobacco Trachoma Traditional, Complementary and Integrative Medicine Transplantation Travel and health Tropical Cyclones Tsunamis Tuberculosis Typhoid Ultraviolet radiation Universal health coverage Urban health Vaccines and immunization Violence against children Violence against women Volcanic eruptions Water, sanitation and hygiene (WASH) WHO Pandemic Agreement Wildfires Women's health Yaws (Endemic treponematoses) Yellow fever Zika virus disease",1
"Emergency news All →Our emergency work in focus All →Publications All →National health emergency alert and response framework This multi-hazard Health Emergency Alert and Response Framework provides guidance for coordinating emergency response in countries, under the global Health... Therapeutics and COVID-19: living guideline, August 2025 The WHO Therapeutics and COVID-19: living guideline contains recommendations for the use of therapeutics in the treatment of COVID-19. It is... The COVID-19 Clinical management: living guidance contains the most up-to-date WHO recommendations for the clinical management of people with COVID-19.... NAPHS for all: a country implementation guide for national action plan for health security (NAPHS) A national action plan for health security (NAPHS) is a country-owned, multi-year, joint planning process that can improve the implementation of IHR core... Documents All →From 1 January to 26 October 2025, a cumulative total of 565 404 cholera cases and 7074 deaths were reported from 32 countries across five WHO regions,... Public Health Situation Analysis - South Sudan As of September 2025, the humanitarian outlook remains alarming, with growing needs far outpacing the capacity of aid agencies to respond.",1
"South Sudan... WHO Rapid Risk Assessment - Diphtheria, African Region v.1 This Rapid Risk Assessment (RRA) aims to assess the risk of diphtheria at the regional level, considering the public health impact, the risk of geographical... Public Health Situation Analysis - oPt The fragile Gaza ceasefire announced on 9 October 2025 marked a momentous but precarious juncture in the ongoing conflict.3 The ceasefire remains in place... More about our work in emergencies",1
"The Global Health Observatory Explore a world of health data WHO's annual World Health Statistics reports present the most recent health statistics for the WHO Member States and each edition supersedes the previous one. All reports are available for download in Adobe PDF and excel when applicable. Download the reports World health statistics 2025: monitoring health for the SDGs, sustainable development... World health statistics 2024: monitoring health for the SDGs, sustainable development... World health statistics 2023: monitoring health for the SDGs, sustainable development... World health statistics 2022: monitoring health for the SDGs, sustainable development... World health statistics 2021: monitoring health for the SDGs, sustainable development... World health statistics 2020: monitoring health for the SDGs, sustainable development... World health statistics 2019: monitoring health for the SDGs, sustainable development goals The World Health Statistics series is the World Health Organization’s (WHO’s) annual compilation of health statistics for its 194 Member States.... World health statistics 2018: monitoring health for the SDGs, sustainable development goals The World Health Statistics series is WHO’s annual compilation of health statistics for its 194 Member States.",1
"The series is produced by the WHO... World health statistics 2017: monitoring health for the SDGs, sustainable development goals The World Health Statistics series is WHO’s annual compilation of health statistics for its 194 Member States.",1
"The series is produced by the WHO... World health statistics 2016: monitoring health for the SDGs, sustainable development goals The 17 Sustainable Development Goals (SDGs) of the 2030 Agenda integrate all three dimensions of sustainable development (economic, social and environmental)... World health statistics 2015 The World Health Statistics series is WHO’s annual compilation of health-related data for its 194 Member States, and includes a summary of the progress made... World health statistics 2014 The World Health Statistics series is WHO’s annual compilation of health-related data for its 194 Member States, and includes a summary of the progress made... World health statistics 2013 More than a decade after world leaders adopted the Millennium Development Goals (MDGs) and associated targets substantial progress has been made in reducing child... World health statistics 2012 The World Health Statistics series is WHO’s annual compilation of health-related data for its 194 Member States1 and includes a summary of the... World health statistics 2011 The World Health Statistics series is WHO’s annual compilation of health-related data for its 193 Member States, and includes a summary of the progress... World health statistics 2010 The World Health Statistics series is WHO’s annual compilation of health-related data for its 193 Member States, and includes a summary of the progress... World health statistics 2009 World Health Statistics 2009 contains WHO’s annual compilation of data from its 193 Member States, and includes a summary of progress towards the... World health statistics 2008 World Health Statistics 2008 presents the most recent available health statistics for WHO’s 193 Member States.",1
"This fourth edition includes 10 highlights... World health statistics 2007 World health statistics 2007 presents the most recent health statistics for WHO’s 193 Member States. This third edition includes a section with... World Health Statistics 2006 World Health Statistics 2006 presents the most recent statistics since 1997 of 50 health indicators for WHO’s 192 Member States. This second edition... World health statistics 2005 The World Health Organization (WHO) collects and summarizes a wide range of quantitative data from a variety of health domains through country offices,...",1
"Health topics Abortion Abuse of older people Addictive behaviour Adolescent health Ageing Ageism Air pollution Alcohol Anaemia Antimicrobial resistance Assistive technology Biological weapons Biologicals Blood products Blood transfusion safety Brain health Breastfeeding Buruli ulcer (Mycobacterium ulcerans infection) Cancer Cardiovascular diseases Cervical cancer Chagas disease (American trypanosomiasis) Chemical incidents Chemical safety Chikungunya Child growth Child health Childhood cancer Children's environmental health Cholera Chronic respiratory diseases Climate change Clinical trials Commercial determinants of health Common goods for health Complementary feeding Congenital disorders Contraception Coronavirus disease (COVID-19) Crimean-Congo haemorrhagic fever Deafness and hearing loss Deliberate events Dementia Dengue and severe dengue Depression Diabetes Diagnostics Diarrhoea Digital health Diphtheria Disability Dracunculiasis (Guinea-worm disease) Drought Drowning Drugs (psychoactive) Earthquakes Ebola virus disease Echinococcosis Electromagnetic fields Emergency and critical care Energy and health Environmental health Epilepsy Eye care, vision impairment and blindness Female genital mutilation Financial protection Floods Food fortification Food safety Foodborne diseases Foodborne trematode infections Gender and health Genomics Global health ethics Health accounts Health budget Health economics Health equity Health financing Health impact assessment Health Laws Health promoting schools Health promotion Health security Health systems governance Health taxes Health technology assessment Health workforce Healthy diet Heatwaves Hendra virus infection Hepatitis HIV Hospitals Human African trypanosomiasis (sleeping sickness) Human genome editing Human rights Hypertension In vitro diagnostics Infant nutrition Infection prevention and control Infertility Influenza (avian and other zoonotic) Influenza (seasonal) Infodemic Intellectual property and trade International Health Regulations Landslides Lassa fever Lead poisoning Leishmaniasis Leprosy (Hansen disease) Lymphatic filariasis (Elephantiasis) Malaria Malnutrition Marburg virus disease Maternal health Measles Medical devices Medicines Meningitis Mental health Micronutrients Middle East respiratory syndrome coronavirus (MERS-CoV) Mpox Mycetoma, chromoblastomycosis and other deep mycoses Neglected tropical diseases Newborn health Nipah virus infection Noncommunicable diseases Nursing and midwifery Nutrition Obesity Occupational health Onchocerciasis (river blindness) One Health Oral health Oxygen Palliative care Patient safety Pertussis Physical activity Plague Pneumonia Poliomyelitis (polio) Primary health care Quality of care Rabies Radiation Radiation emergencies Radon Refugee and migrant health Rehabilitation Research Respiratory syncytial virus Rift Valley fever Road traffic injuries Scabies Schistosomiasis (Bilharzia) Self-care for health and well-being Sepsis Severe Acute Respiratory Syndrome (SARS) Sexual and reproductive health and rights Sexual health Sexually transmitted infections (STIs) Smallpox Snakebite envenoming Social determinants of health Soil-transmitted helminthiases Stillbirth Substandard and falsified medical products Suicide prevention Sustainable development Syphilis Taeniasis and cysticercosis Tetanus Tick-borne encephalitis Tobacco Trachoma Traditional, Complementary and Integrative Medicine Transplantation Travel and health Tropical Cyclones Tsunamis Tuberculosis Typhoid Ultraviolet radiation Universal health coverage Urban health Vaccines and immunization Violence against children Violence against women Volcanic eruptions Water, sanitation and hygiene (WASH) WHO Pandemic Agreement Wildfires Women's health Yaws (Endemic treponematoses) Yellow fever Zika virus disease",1
"Launch of WHO book ""Health inequality monitoring: harnessing data to advance health equity"" 11 December 2024 Health equity is the absence of unfair, avoidable or remediable differences in health among population groups, defined by social, economic, demographic or geographic characteristics. Health inequalities are measurable differences in health across population subgroups. Monitoring health inequalities provides evidence on who is being left behind and informs health policies, programmes and practices that aim to close existing gaps and achieve health equity. Contact: inequality_monitoring@who.int ""Health inequality monitoring: harnessing data to advance health equity"" is a contemporary, all-in-one guide to strengthen the impact of health inequality monitoring practices. This software application enables the interactive exploration and comparison of health inequalities. Use HEAT to explore the data within the Health Inequality Data Repository. Use HEAT Plus to upload and work with your own inequality data. The toolkit helps you to easily explore patterns of inequality using disaggregated data and summary measures of inequality, to compare inequality between settings, and to create and export customized graphs, maps and tables.",1
"Since 1948, we have been the United Nations agency dedicated to advancing health for all. We champion health and a better future for all Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance to live a healthy life. Who we are Founded in 1948, WHO is the United Nations agency that connects nations, partners and people to promote health, keep the world safe and serve the vulnerable – so everyone, everywhere can attain the highest level of health. What we do WHO leads global efforts to expand universal health coverage. We direct and coordinate the world’s response to health emergencies. And we promote healthier lives – from pregnancy care through old age. Our Triple Billion targets outline an ambitious plan for the world to achieve good health for all using science-based policies and programmes. Where we work Working with 194 Member States across 6 regions and on the ground in 150+ locations, the WHO team works to improve everyone’s ability to enjoy good health and well-being. Who we work with Collaboration is at the heart of all we do. From governments and civil society to international organizations, foundations, advocates, researchers and health workers, we mobilize every part of society to advance the health and security of all.",1
"How we are governed WHO’s work remains firmly rooted in the basic principles of the right to health and well-being for all people, as outlined in our 1948 Constitution. The World Health Assembly is the decision-making body of WHO and is attended by delegations from all Member States. Accountability and funding We are committed to the principle of accountability – a core value for an organization that is entrusted by countries and other donors to use limited resources effectively to protect and improve global health. Our history and future WHO’s work remains firmly rooted in the principles of equity, integrity and inclusion outlined in our Constitution. WHO’s Transformation agenda modernizes our ways of working, while strengthening our connection and collaboration with the Member States and communities we serve. WHO offers a diverse, multicultural environment for professionals seeking to advance health as a basic human right.",1
- A Adolescent and young adult health - B - C Cardiovascular diseases (CVDs) Chagas disease (also known as American trypanosomiasis) Child mortality (under 5 years) Chronic obstructive pulmonary disease (COPD) Civil registration and vital statistics Commercial determinants of health Community-based health insurance Coronavirus disease (COVID-19) - D Depressive disorder (depression) - E El Niño Southern Oscillation (ENSO) - F Family planning/contraception methods - G - H Human papillomavirus and cancer - I Infant and young child feeding - J - L - M Middle East respiratory syndrome coronavirus (MERS-CoV) Migraine and other headache disorders Millennium Development Goals (MDGs) - N - O Occupational health: health workers Older children and young adolescent mortality (5 to 14 years) - P Podoconiosis (non-filarial lymphoedema) Post COVID-19 condition (long COVID) Post-traumatic stress disorder - Q - R Refugee and migrant mental health - S Self-care for health and well-being Sexually transmitted infections (STIs) Soil-transmitted helminth infections - T - U - V - W - Y - Z,1
"WHO is a specialized United Nations agency with a constitutional mandate as the Directing and Coordinating authority on international health work. Procurement is a critical function in support of the effective discharge of the WHO mandate. In order to fulfill its mandate and achieve its vision, WHO must procure a significant volume of goods and services. On average, WHO buys over US$ 1 billion worth of goods and services every year to maintain operations in the field and to react to upcoming and recurring demands. As a public organization entrusted with donor funds and committed to supporting developing economies, the objective of procurement activities within WHO is the timely acquisition of goods and services while adhering to guiding principles. Compliance with WHO Codes and Policies A Contractor entering into a contract with WHO is expected to read, accept and agree to comply with the WHO Policies and UN Supplier of Conduct, available as follows: WHO Policies: (i) the WHO Code of Ethics; (ii) the WHO Policy on Preventing and Addressing Sexual Misconduct; (iii) the WHO policy on Preventing and Addressing Abusive Conduct; (iv) the WHO Code of Conduct for responsible Research; (v) the WHO Policy on Preventing and Addressing Retaliation ; and (vi) the WHO Policy on Prevention, Detection and Response to Fraud and Corruption.",1
"Documents and reports Contact WHO Supply Department Please direct any general questions or comments concerning procurement at WHO to our feedback mailbox on following address: procurement@who.int For information or to raise questions on specific procurement actions, please refer to the contact information listed in the procurement notice or in the bidding documents. Contacting the focal points directly is the best way to ensure a timely response.",1
"Promoting compliance, risk management and ethics The WHO Office of Compliance, Risk Management and Ethics (CRE) promotes transparency and management of corporate-level risk, within the framework of WHO’s ethical principles. To this end, CRE promotes the practice of the ethical principles derived from the international civil service standards of conduct for all WHO staff and associated personnel. CRE provides clear and action-oriented advice in a secure and confidential environment where individuals can freely consult on ethical issues. The aim is to help individuals in performing their duties professionally and fairly, and to manage their personal affairs in a way that does not interfere with their official responsibilities. The Office of Compliance, Risk Management and Ethics (CRE) offers the following services: - Confidential ethics advice - Promotion of ethics awareness and education - Promotion of ethics standards - Protection of staff from retaliation for reporting wrongdoing - Administration of declarations of interest for staff and external experts - Authorization of outside activities WHO Policy on Preventing and Addressing Abusive Conduct Principal Risks WHO policy on prevention, detection and response to fraud and corruption WARNING: WHO would like to stress to all contractors and collaborators that WHO has zero tolerance towards sexual exploitation and abuse.",1
"Each contractor and collaborator is expected to take all appropriate measures to prevent and respond to sexual exploitation or abuse of anyone by its employees or any other persons engaged by the contractor or collaborator to perform any services under the agreement with WHO. Each contractor and collaborator is expected to refrain from, and to take all reasonable and appropriate measures to prohibit its employees and other persons engaged by it from engaging in any sexual exploitation or abuse as described in the Policy. Each contractor and collaborator is expected to promptly report to WHO and respond to, in accordance with the terms of the Policy, any actual or suspected violations of the Policy of which the contractor or collaborator becomes aware. In case of violation of the Policy, WHO may decide to: - terminate any contract with the contractor or collaborator immediately upon written notice to the contractor or collaborator, without any liability for termination charges or any other liability of any kind; and/or - exclude the contractor or collaborator from participating in any ongoing or future tenders and/or entering into any future contractual or collaborative relationships with WHO. WHO shall be entitled to report any violation of the above-mentioned provisions to WHO’s governing bodies and other UN agencies. If you have questions please contact the WHO CRE/Ethics Unit at ethicsoffice@who.int",1
"Health topics Abortion Abuse of older people Addictive behaviour Adolescent health Ageing Ageism Air pollution Alcohol Anaemia Antimicrobial resistance Assistive technology Biological weapons Biologicals Blood products Blood transfusion safety Brain health Breastfeeding Buruli ulcer (Mycobacterium ulcerans infection) Cancer Cardiovascular diseases Cervical cancer Chagas disease (American trypanosomiasis) Chemical incidents Chemical safety Chikungunya Child growth Child health Childhood cancer Children's environmental health Cholera Chronic respiratory diseases Climate change Clinical trials Commercial determinants of health Common goods for health Complementary feeding Congenital disorders Contraception Coronavirus disease (COVID-19) Crimean-Congo haemorrhagic fever Deafness and hearing loss Deliberate events Dementia Dengue and severe dengue Depression Diabetes Diagnostics Diarrhoea Digital health Diphtheria Disability Dracunculiasis (Guinea-worm disease) Drought Drowning Drugs (psychoactive) Earthquakes Ebola virus disease Echinococcosis Electromagnetic fields Emergency and critical care Energy and health Environmental health Epilepsy Eye care, vision impairment and blindness Female genital mutilation Financial protection Floods Food fortification Food safety Foodborne diseases Foodborne trematode infections Gender and health Genomics Global health ethics Health accounts Health budget Health economics Health equity Health financing Health impact assessment Health Laws Health promoting schools Health promotion Health security Health systems governance Health taxes Health technology assessment Health workforce Healthy diet Heatwaves Hendra virus infection Hepatitis HIV Hospitals Human African trypanosomiasis (sleeping sickness) Human genome editing Human rights Hypertension In vitro diagnostics Infant nutrition Infection prevention and control Infertility Influenza (avian and other zoonotic) Influenza (seasonal) Infodemic Intellectual property and trade International Health Regulations Landslides Lassa fever Lead poisoning Leishmaniasis Leprosy (Hansen disease) Lymphatic filariasis (Elephantiasis) Malaria Malnutrition Marburg virus disease Maternal health Measles Medical devices Medicines Meningitis Mental health Micronutrients Middle East respiratory syndrome coronavirus (MERS-CoV) Mpox Mycetoma, chromoblastomycosis and other deep mycoses Neglected tropical diseases Newborn health Nipah virus infection Noncommunicable diseases Nursing and midwifery Nutrition Obesity Occupational health Onchocerciasis (river blindness) One Health Oral health Oxygen Palliative care Patient safety Pertussis Physical activity Plague Pneumonia Poliomyelitis (polio) Primary health care Quality of care Rabies Radiation Radiation emergencies Radon Refugee and migrant health Rehabilitation Research Respiratory syncytial virus Rift Valley fever Road traffic injuries Scabies Schistosomiasis (Bilharzia) Self-care for health and well-being Sepsis Severe Acute Respiratory Syndrome (SARS) Sexual and reproductive health and rights Sexual health Sexually transmitted infections (STIs) Smallpox Snakebite envenoming Social determinants of health Soil-transmitted helminthiases Stillbirth Substandard and falsified medical products Suicide prevention Sustainable development Syphilis Taeniasis and cysticercosis Tetanus Tick-borne encephalitis Tobacco Trachoma Traditional, Complementary and Integrative Medicine Transplantation Travel and health Tropical Cyclones Tsunamis Tuberculosis Typhoid Ultraviolet radiation Universal health coverage Urban health Vaccines and immunization Violence against children Violence against women Volcanic eruptions Water, sanitation and hygiene (WASH) WHO Pandemic Agreement Wildfires Women's health Yaws (Endemic treponematoses) Yellow fever Zika virus disease",1
"Copyright, Licensing and Permissions WHO supports open access to the published output of its activities as a fundamental part of its mission and a public benefit to be encouraged wherever possible. WHO’s open access applies to: - all publications published by WHO CC BY-NC-SA 3.0 IGO; - articles or chapters published in non-WHO publications that are authored or co-authored by WHO staff CC BY 3.0 IGO or CC BY-NC 3.0 IGO; - articles or chapters published in non-WHO publications that are authored or co-authored by individuals or institutions funded in whole or in part by WHO CC BY 3.0 IGO or CC BY-NC 3.0 IGO. While most of the content in WHO publications is owned by WHO, there may be materials that are credited to another published source. Permission will normally be required from the originating publisher to reproduce such materials. Please refer to the copyright notice in the publication concerned for complete information. Permissions and licensing Permission from WHO is not required for the use of WHO materials issued under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Intergovernmental Organization (CC BY-NC-SA 3.0 IGO) licence. It is important to note that: • WHO publications cannot be used to promote or endorse products, services or any specific organization. • WHO logo cannot be used without written authorization from WHO. • WHO provides no warranty of any kind, either expressed or implied.",1
"In no event shall WHO be liable for damages arising from the use of WHO publications. The CC BY-NC-SA 3.0 IGO licence allows users to freely copy, reproduce, reprint, distribute, translate and adapt the work for non-commercial purposes, provided WHO is acknowledged as the source using the following suggested citation: [Title]. [Place of publication]: World Health Organization; [Year]. Licence: CC BY-NC-SA 3.0 IGO. The use of WHO materials that are not available under the CC BY-NC-SA 3.0 IGO licence is subject to permission being granted by WHO. Some of the uses of such materials are: • reproduction and translation of figures, tables, maps, photos, etc. • reprint and translation of complete works. • licensing of materials or other technical information in electronic database products and services. To request permission to use such materials, please complete the following permissions form. Translations and adaptations If you create an adaptation or a translation of a WHO publication available under the CC BY-NC-SA 3.0 IGO licence, the following disclaimer should be included, as applicable: For translations: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition “[Title]. Geneva: World Health Organization; [Year]. Licence: CC BY-NC-SA 3.0 IGO” shall be the binding and authentic edition”. For adaptations: “This is an adaptation of an original work “[Title].",1
"Geneva: World Health Organization (WHO); [Year]. Licence: CC BY-NC-SA 3.0 IGO”. This adaptation was not created by WHO. WHO is not responsible for the content or accuracy of this adaptation. The original edition shall be the binding and authentic edition”. The adaptation or translation must be licensed under the same or similar licence terms. Note that the CC BY-NC-SA 3.0 IGO licence can only be used by organizations established by a treaty or other instrument governed by international law and possessing its own international legal personality, and that are not subject to national laws, such as United Nations agencies, Intergovernmental organizations and International Organizations. Similar licences that could be used are the CC BY-NC-SA 3.0 licence or the CC BY-NC-SA 4.0 licence. Commercial uses Permission is required for commercial uses and licensing of WHO materials, such as using the material in the context of a commercial activity. Requests can be made by completing the following permissions form. Licensing of WHO Classifications - the International Statistical Classification of Diseases and Related Health Problems (ICD), - the International Classification of Functioning, Disability and Health (ICF), - and the International Classification of Health Interventions (ICHI).",1
"These Classifications are now available on the ICD-11 platform They are licensed under the Creative Commons Attribution-NoDerivs 3.0 IGO (CC BY-ND 3.0 IGO) license and may be used for commercial and non-commercial purposes, provided there is no adaptation of the codes and the work is appropriately cited. Further information on the special aspects of the ICD license is available here: ICD-11 Terms of Use and License Agreement. You can also access the codes via an API by registering here Proposals for amendments to ICD-11 can be submitted through our website WHO grants Governments, eventually represented by the relevant institutions, the translation rights of ICD-11, and other Classifications. Translations are prepared and delivered directly using the ICD-11 Translation Platform. Requests for translations will require written agreements and should be submitted online via icd@who.int. For further information, visit",1
"At Yale Medicine, we care. As the clinical practice for the Yale School of Medicine, Yale Medicine’s doctors play multiple roles in advancing the practice of medicine – from treating and caring for patients, to developing new cures through innovative research, to educating future doctors. We are the largest academic multispecialty practice in New England. Our doctors and researchers work together to achieve the best care possible. Yale Medicine offers specialist expertise, advanced and innovative technology and a multidisciplinary approach. We deliver exceptional medical care in a nurturing environment to each of our patients, every day. Why Choose Yale Medicine? The Yale Medicine difference: Our values set us apart. Our doctors are guided by five key values that drive everything we do. - We are innovative. We translate leading scientific research into medical practice. - We are human. We treat people, not just conditions. - We are collaborative. We nurture health together, giving you the time and attention you deserve. - We are inquisitive. We're smart enough to know that we can always know more. - We are passionate. We bring our best every day; it's not just what we do, it's who we are. Here when you need us. We are expanding to ensure that we’re right where you need us. We currently offer more than 220 specialized clinical services in close to 200 locations throughout Connecticut, New York and Rhode Island.",1
"And we offer telehealth too, making our specialty care easily available no matter where you live. Whatever your needs, wherever you are, know that our doctors work as a team to provide the care you need. We take the time to listen. We know that you are the most important member of your health care team; we develop care plans with you, instead of for you. Our collaborative approach ensures you receive the care you need, before, during and after each visit. Partnerships built to advance medicine. At Yale Medicine, our doctors are focused on advancing medicine for the good of our patients, colleagues and community. Yale Medicine specialists collaborate with the Yale School of Medicine and Yale New Haven Health to provide the best possible care. As specialists working at an academic medical center, Yale Medicine doctors - Develop new cures through clinical trials - Access the extraordinary centers and equipment of Yale New Haven Hospital, one of the largest and best-known hospitals in the United States - Train other doctors in the latest treatments and techniques - Educate the next generation of doctors Collectively we treat some of the most complex cases from around the world.",1
"Our partners include: - Yale New Haven Hospital, the flagship of the Yale New Haven Health System and world-renowned for providing extraordinary care - Yale New Haven Children’s Hospital, which includes campuses in New Haven and Bridgeport, as well as Pediatric Specialty Centers in Greenwich, New Haven, Norwalk, Trumbull and Old Saybrook - Smilow Cancer Hospital, a leader in personalized cancer care, regularly recognized for excellence by U.S. News & World report - VA Connecticut Healthcare System, providing inpatient and ambulatory care for veterans - Connecticut Mental Health Center, one of the oldest community health centers in the United States - Yale New Haven Psychiatric Hospital, a world leader in clinical care, research and education, recognized as one of the top psychiatric hospitals in the country by U.S. News & World Report RSS FeedsCopy Link Yale Medicine EditorialCopy Link Learn more about the Yale Medicine Editorial Team Contact UsCopy Link Yale Medicine Leadership Nancy J. Brown MDMurat Günel MD, FACS, FAHA, FAANSMargaret McGovern MD, PhDAndrea Bradley MHA, CHC, CHPCIain Burchell Arnim Dontes MBABerthe Erisnor Patrick A. Kenney MDRajlakshmi Krishnamurthy MDRichard A Martinello MDYollanda London MPHDeborah Rhodes MD, FACPLee Schwamm MDGlynn Stanton Nicole Wise",1
"Patient Tools We want everything about your experience with Yale Medicine to be as easy and convenient as possible. The Patient Tools section of our website is designed to provide you with the information and resources you need, from scheduling an appointment, to preparing for both in-person and telehealth visits, to getting a second opinion from a Yale Medicine specialist. If you have questions that aren't answered on our website, please contact our Yale Medicine Coordination, Appointment, Referral & Engagement (CARE) Center at 1-877-YALEMDS (877-925-3637). Self-Schedule an AppointmentCopy Link Yale Medicine is pleased to provide the convenience of self-scheduling to new and returning patients. Paperless BillingCopy Link Yale Medicine and Yale New Haven Health are pleased to provide you with a secure, convenient, and eco-friendly way to view your bills. Beginning January 3, 2023, we’re going paperless (for MyChart users). If you have a MyChart account, instead of receiving a paper bill by mail each month, you will receive an email, text, and/or MyChart notification when you have a new balance available for viewing. Prepare for Your VisitCopy Link You can make the most of your visit by being an active participant. At Yale Medicine, we encourage you to raise questions and concerns, and provide your physicians with information that will help them to take care of you.",1
"TelehealthCopy Link Yale Medicine Telehealth is at the forefront of innovative and convenient ways for you to connect with your doctor using your tablet, mobile phone, or computer.",1
"Paying Your Bill Questions? If you have questions about your bill, please call our Central Billing Line at 1-800-826-9922 or email patient.services@yale.edu. We are available Monday through Friday from 8:30 am to 5:00 pm. We are going paperless on January 3, 2023 To deliver a more secure, convenient, and eco-friendly way to view your bills, Yale Medicine and Yale New Haven Health will switch to paperless billing for MyChart users starting January 3, 2023. Instead of receiving a paper bill by mail each month, you will receive an email, text, and/or MyChart notification when you have a new balance available for viewing. You can opt out and change back to paper statements beginning January 3. If you are not a MyChart user, you can sign up at See detailed information and frequently asked questions about the switch to paperless billing. For any questions related to these changes, please call Yale Medicine at 203-785-4216 or 800-826-9922.",1
"Have a Sore Throat? 3 Things You Should Know Whether it’s a dull ache when you swallow or a burning pain that won’t quit, having a sore throat is never pleasant. But depending on its cause, relief may be as simple as sipping tea—or it could require a visit to your doctor. “A sore throat is really a symptom, and not a diagnosis. How it feels may depend on what caused it, and everybody’s going to experience it a little bit differently,” says Alissa Chen, MD, MPH, a Yale Medicine internal medicine specialist. “To one person, it might be a scratchy feeling. To another, it could feel swollen or painful. Or maybe you only notice it when you are eating. In broad terms, a sore throat means you have pain or discomfort at the back of your throat.” Often, that discomfort is a temporary nuisance that will resolve on its own. But sometimes, it might be a sign of a more serious illness and require treatment. What are the most common causes of sore throat? Most sore throats stem from infections, either viral or bacterial. Common viral culprits include influenza, COVID-19, respiratory syncytial virus (RSV), mononucleosis, and even the common cold. Bacterial infections, on the other hand, often involve group A streptococcus bacteria, commonly referred to as strep. It’s most common in children ages 5 through 15, but adults can get it, too. A viral sore throat is typically accompanied by respiratory symptoms including stuffy nose, cough, and other cold-like symptoms.",1
"Strep throat, by contrast, rarely features these. It tends to appear suddenly with fever and significant throat pain. Swallowing foods and liquids can be uncomfortable, and you might also notice white patches or streaks on your tonsils or swollen lymph nodes in your neck. “When someone starts to have a sore throat that is new, the main things we are thinking about is infection. If it’s an adult, most likely it will be a virus, though sometimes it’s bacterial,” Dr. Chen explains. “And the way we usually distinguish between them depends on a few things. First, if it’s a virus, it usually will affect more than their throat. It might start there, but there are often other symptoms like cough, runny nose, or maybe chills and a fever. But if it’s strep, the pain is usually localized to the throat, which may look very red and there may be enlarged tonsils and lymph nodes, too.” If your symptoms suggest strep, a health care provider will likely perform a rapid strep test in the office by using a swab to take a sample from the back of the throat. If the results are negative, a follow-up culture may be sent to a lab for further testing and to rule out a false-negative result. If the test confirms strep throat, antibiotics can clear it up quickly—often easing symptoms within a day or two. Most viral sore throats, meanwhile, clear on their own within about a week. Can allergies and gastric reflux cause sore throat, too?",1
"If your sore throat lingers for more than a week or feels just as bad as when it started, something else could be to blame, including seasonal allergies and gastroesophageal reflux disease (GERD), Dr. Chen says. “With allergies, postnasal drip can irritate the throat and cause pain. With reflux, stomach acid can inflame the throat,” Dr. Chen says. “A physical exam helps us figure it out. If I see mucus in the back of the throat, especially if there is a cobblestone pattern down the back of the throat—that can be telling of allergy.” If GERD or allergies are causing your sore throat, using acid-suppressing medication for reflux, or antihistamines or nasal sprays for allergies, may help relieve symptoms. Lifestyle tweaks, such as avoiding trigger foods or allergens and keeping your throat well-hydrated, can further reduce irritation. What’s the best treatment for a sore throat? If a sore throat is caused by a virus, the best medical treatment is taking a nonsteroidal anti-inflammatory (NSAID) pain reliever such as ibuprofen. “This will help the inflammation at the back of the throat. But for those who can’t take NSAIDs, you can also try acetaminophen. It doesn’t reduce the inflammation as well, but it does help pain,” Dr. Chen says.",1
"Additionally, keeping the air around you moist with a humidifier, drinking plenty of fluids, including warm tea, and gargling with a warm saltwater solution can all help, as can throat drops, especially those with benzocaine, such as Cepacol or Chloraseptic, Dr. Chen adds. “I advise people to try tea with honey, but only to the point that it is helpful. If you try it and it does nothing, then don’t bother,” Dr. Chen says. “None of these things will make you get better sooner, but it makes you feel better. And feeling better is important, of course.” While most sore throats are caused by minor infections, certain red flags deserve immediate attention. Seek care if you have trouble swallowing, difficulty breathing, a bulge in your throat, or a muffled voice, especially if speaking suddenly takes extra effort. These can signal a more serious bacterial infection or an abscess behind the throat. “It's also important to visit a health care provider anytime you feel you may need help, even if it seems like just a sore throat. I’m happy to see patients for whatever reason and they shouldn’t hesitate to come in,” Dr. Chen says.",1
"Yes, Stress Can Hurt Your Heart: 3 Things to Know [Originally published: Feb. 12, 2024. Updated: Nov. 20, 2025.] Virtually everyone has experienced stress at one time or another—a feeling of emotional or physical tension that can come from any event or thought that makes you feel frustrated, angry, or nervous. But did you know that stress can affect your body—especially your heart? Many people have experienced short-term stress, a physiological and psychological reaction to a specific event that goes away quickly, such as giving a speech or hitting the brakes to avoid an oncoming car. Chronic stress, however, is a consistent sense of feeling pressured and overwhelmed over a long period of time—it could result from a toxic work environment, for instance, or caregiving, or being unable to pay your bills. “Stress is sometimes underrecognized as a risk factor for heart disease,” says Rachel Lampert, MD, a Yale Medicine cardiologist. In fact, some experts go further to say that stress is a leading risk factor for heart disease—the biggest killer in the United States—up there with unhealthy diet, physical inactivity, smoking, excessive alcohol use, and obesity.",1
"We spoke to Dr. Lampert; Yale Medicine cardiologist Erica Spatz, MD, director of the Yale Medicine Preventive Cardiovascular Health Program; and Allison Gaffey, PhD, a Yale Medicine psychologist who specializes in cardiology—all of whom have particular interests in the effects of stress on the heart, both clinically and in their research. Below, they discuss the connection between stress and heart health, as well as strategies for keeping your heart healthy. 1. There are many ways stress can affect the heart. There are several pathways through which stress can lead to heart disease. “Long-term—or chronic—stress can cause higher levels of inflammation in the body that contribute to increases in plaque buildup in the arteries—and that can lead to such problems as coronary artery disease,” says Dr. Lampert. Coronary artery disease can lead to heart attack, abnormal heart rhythms, and heart failure. Also, stress drives an increase in catecholamines, hormones made in the adrenal glands. One catecholamine is adrenaline, the “fight or flight” hormone, which increases mental alertness during stressful situations. But adrenaline also causes the heart to beat faster and raises blood pressure. Too much of that, over time, can eventually damage the heart. Prolonged elevations of another stress hormone, called cortisol, also increase blood pressure, as well as blood sugar, cholesterol, and triglycerides.",1
"For a person living with chronic stress, the result can be chest pain, irregular heartbeats, shortness of breath, and an increased risk of heart attack and stroke. Short-term stress can have an impact as well. “For example, in people who already have a buildup of plaque in their arteries, the surge of adrenaline can sometimes contribute to a plaque rupturing, resulting in a blood clot that could grow large enough to block blood flow completely and cause a heart attack,” Dr. Lampert says. In people with pre-existing heart problems, such as arrhythmias (abnormal heart rhythms), sudden stress can exacerbate their symptoms, Dr. Lampert adds. But stress can also have indirect effects on the heart. “When people feel they cannot escape the circumstances of their chronic stress, they may cope by turning to unhealthy behaviors,” says Gaffey. “We know that stress is associated with behaviors such as unhealthy diet, smoking, and increased use of alcohol.” These behaviors can lead to such health issues as high cholesterol and hypertension, which are primary risk factors for heart disease, she adds. 2. Stress affects people in different ways. When it comes to stress, everyone is different—and the same is true with heart disease, Gaffey explains.",1
"“What is considered to be a stressor or what is stressful for one person versus another is subjective—there's also a lot of variability in the effects of that challenge, depending on your past experiences and how you have learned to cope with the emotional effects,” she says. To that end, some people who have experienced significant stress will develop heart disease, while others won’t, adds Dr. Lampert. “This is similar to cancer,” she says. “Among people who smoke, some don't get cancer, and others do. Why is that? It is a combination of their genetic vulnerability, environment, and lifestyle—and how all those factors work together in the development of disease.” A study in The Lancet showed that people who reported high stress, a history of depression, and other psychosocial factors were 2.5 times more likely to have a heart attack than those who had low stress or no history of depression, Gaffey says. Other research has linked stress and heart disease in groups that have experienced discrimination, including women, people from particular ethnic or racial backgrounds, and those with mental health disorders. Not all symptoms during stress are due to heart problems, Dr. Lampert adds.",1
"Stress can also cause symptoms, such as a racing heart, “that are just how your body normally feels when you're overwhelmed.” Most importantly, anyone experiencing new or recurrent symptoms should talk to their doctor to figure out to what extent a heart issue might—or might not—be causing the symptom, she says. 3. Talk to your health care provider about your level of stress. Anyone concerned about their stress levels should talk about it when they visit their primary care provider or, if they have one, their cardiologist. “I talk a lot about stress with patients,” says Dr. Spatz. “We want to know how stress from their family, job, or community has impacted them. And how that may be contributing to their blood pressure, their weight, and, ultimately, to their risk of developing heart disease.” “During these appointments, it’s important to raise the issue of stress because a provider may not always ask you about your current life circumstances, stressors, or stress level,” Gaffey says. “But they can share helpful recommendations, resources, and tools to help people better manage their stress.” Those might include increased physical activity, yoga, and other relaxation techniques; improvements to sleep hygiene; spending time with others; psychotherapy; social work resources or aid with health care access; and even medication to help with ongoing symptoms of depression or anxiety.",1
"For people who already have a heart problem—perhaps they've even had a heart attack—research has shown that participating in a cardiac rehabilitation program results in reductions in stress, as well as depression and anxiety. In addition, some cardiology clinics now offer psychological support for people experiencing mental health issues, which can be stress-related. Yale Medicine currently offers a Heart and Vascular Psychology and Wellbeing Clinic, a pilot program that provides visits with a psychologist in the same office where people visit their cardiologist. The type of stress reduction that works best is different for everyone, Dr. Lampert adds. Some people find meditation or yoga helps; others may prefer a walk in the woods or a run. “It’s whatever works to keep your stress levels in check,” she says.",1
"Notice Informing Individuals About Nondiscrimination and Accessibility Requirements Discrimination is Against the Law. Yale Medicine complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin (including limited English proficiency and primary language), age, disability, or sex (consistent with the scope of sex discrimination described at 45 CFR § 92.101(a)(2)). Yale Medicine does not exclude people or treat them less favorably because of race, color, national origin, age, disability, or sex. Yale Medicine: - Provides people with disabilities reasonable modifications and free appropriate auxiliary aids and services to communicate effectively with us, such as: - Qualified sign language interpreters - Written information in other formats (large print, audio, accessible electronic formats, other formats). - Provides free language assistance services to people whose primary language is not English, which may include: - Qualified interpreters - Information written in other languages. If you need reasonable modifications, appropriate auxiliary aids and services, or language assistance services, contact us at 203-785-2140 or YMPatientAdvocacy@yale.edu. If you believe that Yale Medicine has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Title: - Senior Director of Compliance, Section 1557 Coordinator.",1
"Mailing address: - Yale Medicine Compliance P.O. Box 7309 New Haven CT 06519-0309 Telephone: - 203-785-2140 Email: You can file a grievance in person, by mail, or by email. If you need help filing a grievance, the Section 1557 Coordinator is available to help you. You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights, electronically through the Office for Civil Rights Complaint Portal, available at or by mail or phone at: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Complaint forms are available at This notice is available at Yale Medicine’s website: ATTENTION: If you speak a language other than English, free language assistance services are available to you. Appropriate auxiliary aids and services to provide information in accessible formats are also available free of charge. Call 1-203-785-2140 or speak to your provider. [Spanish / Español] ATENCIÓN: Si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. También están disponibles de forma gratuita ayuda y servicios auxiliares apropiados para proporcionar información en formatos accesibles. Llame al 1-203-785-2140 (TTY: 1-203-785-2140) o hable con su proveedor. [Portuguese / Português] ATENÇÃO: Se você fala Português, serviços gratuitos de assistência linguística estão disponíveis para você.",1
"Auxílios e serviços auxiliares apropriados para fornecer informações em formatos acessíveis também estão disponíveis gratuitamente. Ligue para 1-203-785-2140 (TTY: 1-203-785-2140) ou fale com seu provedor. [Polish / POLSKI] UWAGA: Osoby mówiące po polsku mogą skorzystać z bezpłatnej pomocy językowej. Dodatkowe pomoce i usługi zapewniające informacje w dostępnych formatach są również dostępne bezpłatnie. Zadzwoń pod numer 1-203-785-2140 (TTY: 1-203-785-2140) lub porozmawiaj ze swoim dostawcą. [Chinese / 中文 ] 注意：如果您說[中文]，我們可以為您提供免費語言協助服務。也可以免費提供適當的輔助工具與服務，以無障礙格式提供資訊。請致電 1-203-785-2140（TTY：1-203-785-2140）或與您的提供者討論。 [Italian / Italiano] ATTENZIONE: se parli Italiano, sono disponibili servizi di assistenza linguistica gratuiti. Sono inoltre disponibili gratuitamente ausili e servizi ausiliari adeguati per fornire informazioni in formati accessibili. Chiama l'1-203-785-2140 (tty: 1-203-785-2140) o parla con il tuo fornitore. [French / Français] ATTENTION: Si vous parlez Français, des services d'assistance linguistique gratuits sont à votre disposition. Des aides et services auxiliaires appropriés pour fournir des informations dans des formats accessibles sont également disponibles gratuitement. Appelez le 1-203-785-2140 (TTY: 1-203-785-2140) ou parlez à votre fournisseur.",1
"[Haitian Creole / Kreyòl Ayisyen] ATANSYON: Si w pale Kreyòl Ayisyen, gen sèvis èd aladispozisyon w gratis pou lang ou pale a. Èd ak sèvis siplemantè apwopriye pou bay enfòmasyon nan fòma aksesib yo disponib gratis tou. Rele nan 1-203-785-2140 (TTY: 1-203-785-2140) oswa pale avèk founisè w la. [Russian / РУССКИЙ] ВНИМАНИЕ: Если вы говорите на русский, вам доступны бесплатные услуги языковой поддержки. Соответствующие вспомогательные средства и услуги по предоставлению информации в доступных форматах также предоставляются бесплатно. Позвоните по телефону 1-203-785-2140 (TTY: 1-203-785-2140) или обратитесь к своему поставщику услуг. [Vietnamese / Việt] LƯU Ý: Nếu bạn nói tiếng Việt, chúng tôi cung cấp miễn phí các dịch vụ hỗ trợ ngôn ngữ. Các hỗ trợ dịch vụ phù hợp để cung cấp thông tin theo các định dạng dễ tiếp cận cũng được cung cấp miễn phí. Vui lòng gọi theo số 1-203-785-2140 (Người khuyết tật: 1-203-785-2140) hoặc trao đổi với người cung cấp dịch vụ của bạn. [Arabic / العربية ] تنبيه: إذا كنت تتحدث اللغة العربية، فستتوفر لك خدمات المساعدة اللغوية المجانية. كما تتوفر وسائل مساعدة وخدمات مناسبة لتوفير المعلومات بتنسيقات يمكن الوصول إليها مجانًا. اتصل على الرقم 1-203-785-2140 (1-203-785-2140) أو تحدث إلى مقدم الخدمة"". [Korean / 한국어] 주의: [한국어]를 사용하시는 경우 무료 언어 지원 서비스를 이용하실 수 있습니다. 이용 가능한 형식으로 정보를 제공하는 적절한 보조 기구 및 서비스도 무료로 제공됩니다. 1-203-785-2140 (TTY: 1-203-785-2140)번으로 전화하거나 서비스 제공업체에 문의하십시오.",1
"[Albanian / SHQIP] VINI RE: Nëse flisni [shqip], shërbime falas të ndihmës së gjuhës janë në dispozicion për ju. Ndihma të përshtatshme dhe shërbime shtesë për të siguruar informacion në formate të përdorshme janë gjithashtu në dispozicion falas. Telefononi 1-203-785-2140 (TTY: 1-203-785-2140) ose bisedoni me ofruesin tuaj të shërbimit. [Hindi / हिंदी ] ध्यान दें: यदि आप हिंदी बोलते हैं, तो आपके लिए निःशुल्क भाषा सहायता सेवाएं उपलब्ध होती हैं। सुलभ प्रारूपों में जानकारी प्रदान करने के लिए उपयुक्त सहायक साधन और सेवाएँ भी निःशुल्क उपलब्ध हैं। 1-203-785-2140 (TTY: 1-203-785-2140) पर कॉल करें या अपने प्रदाता से बात करें। [Taglog] PAALALA: Kung nagsasalita ka ng Tagalog, magagamit mo ang mga libreng serbisyong tulong sa wika. Magagamit din nang libre ang mga naaangkop na auxiliary na tulong at serbisyo upang magbigay ng impormasyon sa mga naa-access na format. Tumawag sa 1-203-785-2140 (TTY: 1-203-785-2140) o makipag-usap sa iyong provider. [Greek / Ελληνικά] ΠΡΟΣΟΧΗ: Εάν μιλάτε ελληνικά, υπάρχουν διαθέσιμες δωρεάν υπηρεσίες υποστήριξης στη συγκεκριμένη γλώσσα. Διατίθενται δωρεάν κατάλληλα βοηθήματα και υπηρεσίες για παροχή πληροφοριών σε προσβάσιμες μορφές. Καλέστε το 1-203-785-2140 (TTY: 1-203-785-2140) ή απευθυνθείτε στον πάροχό σας. Last Updated: 11/20/2024",1
"A C Cancer Center - Brain Tumor Center - Cancer-Infectious Diseases (Cancer-ID) Program - Cardio-Oncology Program - Center for Breast Cancer - Center for Gastrointestinal Cancers - Center for Thoracic Cancers - Early Onset Cancer Program - Early Phase Clinical Trial Program - Endocrine Cancers Program - Gynecologic Oncology Program - Head & Neck Cancers Program - Liver Cancer Program - Medical Oncology and Hematology - Ocular Oncology - Onco-Dermatology Program - Pediatric Hematology & Oncology Program - Prostate & Urologic Cancers Program - Psycho-Oncology Program at Smilow Cancer Hospital - Sarcoma Program - Sexuality, Intimacy & Menopause Program - Skin & Kidney Cancer Program - Smilow Cancer Genetics & Prevention Program - Smilow Cancer Screening & Prevention Program - Smilow Integrative Medicine Program - Smilow Interventional Oncology Program - Smilow Multidisciplinary Pain Program - Smilow Palliative Care Program - Smilow Survivorship Clinic - Smilow Tobacco Treatment Program",1
"Find a Clinician We have 1,869 clinicians; help us direct you to the best care team - Accepting New Patients - Appointments Available - Telehealth Available Locations Insurance Aetna, Aetna Medicare, Anthem Exchange, Anthem BC/BS, Anthem Medicare, Cigna, Cigna Medicare Advantage, ConnectiCare, ConnectiCare Exchange, ConnectiCare Medicare, Consumer Health Network (CHN) PPO, Great West Healthcare, Harvard Pilgrim Health Care, Medicaid, Medicare, Multiplan, Oxford, PHCS, TRICARE, TRICARE for Life, UnitedHealthcare, UnitedHealthcare Medicare, US Family Health Plan, Veteran Choice Program (VCP), WellCare of Connecticut Medicare Advantage, Worker's Compensation (all carriers registered with the State of Connecticut, Yale-New Haven Hospital, and Yale University, including Consumer Health Network (CHN), and Prime Health Services, Inc.)Specialist in high-risk pregnancy care focusing on autoimmune and cardiac disorders, diabetes, and maternal-fetal health with a strong background in maternal and fetal inflammation research and renal disease prognosis in critically ill patients.",1
"- Accepting New Patients - Appointments Available - Telehealth Available Locations Departments Insurance Aetna, Aetna Medicare, Anthem Exchange, Anthem BC/BS, Anthem Medicare, Cigna, Cigna Medicare Advantage, ConnectiCare, ConnectiCare Exchange, ConnectiCare Medicare, Consumer Health Network (CHN) PPO, Great West Healthcare, Harvard Pilgrim Health Care, Medicaid, Medicare, Multiplan, Oxford, PHCS, TRICARE, TRICARE for Life, UnitedHealthcare, UnitedHealthcare Medicare, US Family Health Plan, Veteran Choice Program (VCP), WellCare of Connecticut Medicare Advantage, Worker's Compensation (all carriers registered with the State of Connecticut, Yale-New Haven Hospital, and Yale University, including Consumer Health Network (CHN), and Prime Health Services, Inc.)Specialist in high-risk pregnancy care focusing on autoimmune and cardiac disorders, diabetes, and maternal-fetal health with a strong background in maternal and fetal inflammation research and renal disease prognosis in critically ill patients.",1
"- Accepting New Patients - Appointments Available - Telehealth Available Locations Departments Insurance Aetna, Aetna Medicare, Anthem Exchange, Anthem BC/BS, Anthem Medicare, Cigna, Cigna Medicare Advantage, ConnectiCare, ConnectiCare Exchange, ConnectiCare Medicare, Consumer Health Network (CHN) PPO, Great West Healthcare, Harvard Pilgrim Health Care, Medicaid, Medicare, Multiplan, Oxford, PHCS, TRICARE, TRICARE for Life, UnitedHealthcare, UnitedHealthcare Medicare, US Family Health Plan, Veteran Choice Program (VCP), WellCare of Connecticut Medicare Advantage, Worker's Compensation (all carriers registered with the State of Connecticut, Yale-New Haven Hospital, and Yale University, including Consumer Health Network (CHN), and Prime Health Services, Inc.)Neuroradiology expert specializing in diagnosing brain, spine, and neck conditions using advanced imaging techniques like MRI and CT scans, and performing guided lumbar punctures and myelography. - Accepting New Patients Departments Neuroradiology expert specializing in diagnosing brain, spine, and neck conditions using advanced imaging techniques like MRI and CT scans, and performing guided lumbar punctures and myelography. - Accepting New Patients Expert in aortic and limb preservation procedures using a combination of endovascular and open surgical solutions, committed to patient and family support with a focus on treatable and reversible vascular conditions.",1
"- Accepting New Patients - Appointments Available - Telehealth Available Locations Insurance Aetna, Aetna Medicare, Anthem Exchange, Anthem BC/BS, Anthem Medicare, Cigna, Cigna Medicare Advantage, ConnectiCare, ConnectiCare Exchange, ConnectiCare Medicare, Consumer Health Network (CHN) PPO, Great West Healthcare, Harvard Pilgrim Health Care, Medicaid, Medicare, Multiplan, Oxford, PHCS, TRICARE, TRICARE for Life, UnitedHealthcare, UnitedHealthcare Medicare, US Family Health Plan, Veteran Choice Program (VCP), WellCare of Connecticut Medicare Advantage, Worker's Compensation (all carriers registered with the State of Connecticut, Yale-New Haven Hospital, and Yale University, including Consumer Health Network (CHN), and Prime Health Services, Inc.)Expert in aortic and limb preservation procedures using a combination of endovascular and open surgical solutions, committed to patient and family support with a focus on treatable and reversible vascular conditions.",1
"- Accepting New Patients - Appointments Available - Telehealth Available Locations Departments Insurance Aetna, Aetna Medicare, Anthem Exchange, Anthem BC/BS, Anthem Medicare, Cigna, Cigna Medicare Advantage, ConnectiCare, ConnectiCare Exchange, ConnectiCare Medicare, Consumer Health Network (CHN) PPO, Great West Healthcare, Harvard Pilgrim Health Care, Medicaid, Medicare, Multiplan, Oxford, PHCS, TRICARE, TRICARE for Life, UnitedHealthcare, UnitedHealthcare Medicare, US Family Health Plan, Veteran Choice Program (VCP), WellCare of Connecticut Medicare Advantage, Worker's Compensation (all carriers registered with the State of Connecticut, Yale-New Haven Hospital, and Yale University, including Consumer Health Network (CHN), and Prime Health Services, Inc.)- Accepting New Patients - Appointments Available - Telehealth Available Locations Insurance Aetna, Aetna Medicare, Anthem Exchange, Anthem BC/BS, Anthem Medicare, Cigna, Cigna Medicare Advantage, ConnectiCare, ConnectiCare Exchange, ConnectiCare Medicare, Consumer Health Network (CHN) PPO, Great West Healthcare, Harvard Pilgrim Health Care, Medicaid, Medicare, Multiplan, Oxford, PHCS, TRICARE, TRICARE for Life, UnitedHealthcare, UnitedHealthcare Medicare, US Family Health Plan, Veteran Choice Program (VCP), WellCare of Connecticut Medicare Advantage, Worker's Compensation (all carriers registered with the State of Connecticut, Yale-New Haven Hospital, and Yale University, including Consumer Health Network (CHN), and Prime Health Services, Inc.)",1
"The Importance of Iron in Pregnancy: What Women Should Know Getting enough iron in your diet might not be the first thing on your mind when you learn you’re pregnant, but this mineral is essential for a healthy pregnancy. Women of reproductive age naturally lose iron monthly during menstruation, so many enter pregnancy with low iron levels. As pregnancy progresses, the body’s need for iron increases even more. Iron deficiency is common in pregnancy, affecting approximately 15% to 20% of women, and it becomes more widespread as pregnancy advances. According to one recent study, 84% of pregnant women experience iron deficiency during their third trimester. Iron deficiency can lead to anemia, a more serious condition that can cause heart issues and complications during pregnancy and postpartum. “Iron deficiency anemia is associated with serious adverse outcomes including low birth weight, preterm birth, postpartum hemorrhage, stillbirth, neonatal death, and growth problems,” says Tulin Ozcan, MD, a Yale Medicine maternal–fetal medicine specialist. “Plus, the rapidly developing brain is at particular risk of iron deficiency, and neurocognitive impairment can occur.” Fortunately, there are proven ways to prevent iron deficiency and iron deficiency anemia in pregnancy. One key recommendation from the Centers for Disease Control and Prevention is universal iron supplementation for pregnant women.",1
"“The typical American diet, along with a woman’s own iron reserves, are insufficient sources for the increased iron requirements during pregnancy,” Dr. Ozcan explains. “The typical diet contains 15 milligrams of elemental iron per day while the recommended daily dietary allowances should be 27 milligrams. Therefore, routine iron supplementation is recommended using prenatal vitamins for all pregnant women.” To monitor iron levels, doctors screen for deficiencies throughout pregnancy—typically at the first prenatal appointment and then again between weeks 24 and 28. What’s the difference between iron deficiency and anemia? It can be confusing to distinguish between iron deficiency and iron deficiency anemia. Iron deficiency is the depletion of total-body iron. In other words, the body has dipped below its ideal iron levels, but it may be hard to notice symptoms, which can include fatigue, difficulty focusing, and hair and nail changes. In contrast, iron deficiency anemia occurs when the shortage becomes significant enough to reduce the production of healthy red blood cells and hemoglobin. As a result, the body cannot effectively deliver enough oxygen to its cells, tissues, and organs. Iron deficiency anemia is considered the “end stage” of the iron deficiency process and is the leading cause of anemia. Common symptoms include extreme fatigue and weakness, pale skin, shortness of breath, headaches and dizziness, chest pain and rapid heartbeat, and cold hands and feet.",1
"The main causes of iron deficiency and anemia are low dietary iron intake and insufficient iron absorption. These are increased during periods of life when iron requirements are particularly high, such as rapid growth in infants, preschool children and adolescents, as well as during the reproductive years in women, especially during pregnancy and postpartum. “Iron is a crucial component of hemoglobin, a protein found in red blood cells that carries oxygen from the lungs to the rest of the body,” Dr. Ozcan explains. “It is also a part of many essential non-hemoglobin proteins that are involved in DNA replication and repair, energy production, and immune response.” How is iron deficiency detected? To assess iron stores, doctors typically measure a protein in the blood called ferritin, which is considered the best marker for iron deficiency. However, some health experts disagree on the exact definition of iron deficiency. While the World Health Organization sets the threshold for low iron at 15 micrograms per liter of ferritin, some argue this cutoff is too low. In the United States, routine screening for low ferritin is not always part of adult checkups, though it is standard during pregnancy.",1
"George Goshua, MD, MSc, a Yale Medicine hematologist–oncologist, recently published research on the benefits and costs of screening adult women for iron deficiency in the American Journal of Hematology, concluding that adjusting the diagnostic bar for iron deficiency upward to 25 micrograms per liter of ferritin and introducing routine screening for women of reproductive age could be a highly cost-effective public health policy. How much iron does a pregnant woman need? During pregnancy, additional iron is needed to support the growing fetus, maternal needs, and to compensate for blood loss during delivery. While experts may disagree on the exact cutoff for ferritin levels during pregnancy, clinicians generally consider levels below 30 micrograms per liter as indicative of iron deficiency in pregnancy. How is iron deficiency treated in pregnancy? All pregnant women are advised to take a prenatal vitamin that includes iron. If ferritin levels are low and other blood tests point to iron deficiency anemia, doctors recommend an additional oral iron supplement in the form of pills or liquid. Research suggests that taking an iron supplement every other day is just as effective as taking it every day—and may be gentler on the digestive system. If iron supplementation is not tolerated or is ineffective, a doctor may recommend an iron infusion delivered intravenously. Taking action to maintain healthy iron levels during pregnancy is vital for both mother and baby.",1
"If you have concerns about fatigue, weakness, or any symptoms of low iron, be sure to discuss them with your health care provider.",1
"Terms of Use, Privacy Statement & Public Notices Acceptance of Terms Please read these Terms of Use (the “Terms”) carefully before accessing or participating in any website or other online platform or service available on or through medicine.yale.edu, yalemedicine.org or other Yale School of Medicine or Yale Medicine sites (the “Site” or “Sites”). The Terms are an enforceable agreement between Yale University (“Yale”) and you, the user of the Sites, whether you are a student, faculty member, staff member, alumnus/a, group, association, corporation, patient, caregiver, physician, referring physician, or other individual or organization. Terms such as “we”, “our” and “us” refer to Yale University. By using and accessing the Sites, you acknowledge that you have read the Terms and agree to be bound by and comply with them. If you do not agree to be bound by and comply with the Terms, you are not authorized to use the Sites. Yale reserves the right to modify the Terms at any time in its sole discretion, and will publish notice of any such modifications on this site. Any modified Terms are effective immediately upon posting. By continuing to access any Site after Yale posts notification of modified Terms, you agree to be bound by and comply with them. If you do not agree to the Terms, please do not enter the Sites. If you are not yet eighteen years of age, a parent or guardian may agree to be bound by the Terms on your behalf.",1
"Nothing in the Terms overrides the application of other rules and policies of Yale or other agreements between you and Yale. For example, your use of the Site is also subject to: - Privacy Statement for Yale Websites - HIPAA Notice of Privacy Practices - The Yale Information Technology Appropriate Use Policy - If you enter into any other agreement with Yale, for example regarding health plan coverage, then the Terms are in addition to the terms of such other agreement. Neither your acceptance of the Terms, nor visiting any Site, guarantees that you are eligible to receive coverage under any plan offered through any Site or otherwise. Medical Information The Sites are intended for a United States audience. If you live outside the United States, you may see information on the Sites about products or therapies that are not available or authorized in your country.",1
"Use of the Site, Submissions & Monitoring Code of Conduct - Interfering with the operation of the Sites, or, restricting, disrupting or inhibiting any other user from using and enjoying the Sites and services; - Posting or otherwise transmitting any unlawful, fraudulent, threatening, harassing, libelous, defamatory, discriminatory, obscene, or similarly objectionable or harmful material or information of any kind; - Posting or otherwise transmitting any advertisement, promotion, or solicitation of goods or services for commercial or partisan political purposes; - Posting or otherwise transmitting any information or software that contains a virus, worm, time bomb, Trojan horse, or other harmful or disruptive component that may compromise the security of the Sites; - Posting, transmitting or otherwise using materials in violation of another party’s copyright, privacy, publicity or other proprietary right, or the terms of any contractual agreement or fiduciary relationship; - Using the Sites or services for any commercial, partisan political or unlawful purposes; - Copying, scraping, downloading, exporting, storing or otherwise capturing any data obtained via the Sites without proper written authorization by Yale; - Modifying, adapting, sublicensing, translating, selling, reverse engineering, decompiling, or disassembling any portion of the Sites; - Misrepresenting your identity, or, sharing or otherwise transferring user account information to any person other than the registered user authorized by Yale to use such account; - Accessing or attempting to access any portion of the Sites to which you have not been explicitly granted access; - Directly or indirectly authorizing anyone else to take actions prohibited in this section; or - Otherwise using the Sites or any services, information and content available on or through the Sites in violation of the Terms or applicable law.",1
"Submissions to the Site by You Where authorized, you may submit any text, images, data, information, content or other materials (collectively, “Materials”) to the Sites. In doing so, such Materials will be considered non-personal and non-confidential (except as otherwise described in the Privacy Policies or an applicable Yale privacy statement), and you hereby grant to Yale a royalty-free, perpetual, irrevocable, non-exclusive, sublicensable, assignable, worldwide right and license to link to, use, reproduce, transmit, modify, adapt, practice, publish, display, perform, distribute, translate, and create derivative or collective works from, any such Materials, in whole or in part, throughout the world in any media, including all intellectual property rights therein, unless otherwise agreed in writing with Yale. You acknowledge and agree that any Materials submitted by users of any Site represent the opinions of the specific author and are not statements of advice, opinion or information of Yale. Any such Materials is no substitute for your own research and should not be relied upon for any purpose. By submitting Materials to any Site, you certify ownership authority to grant such rights to Yale and acknowledge that the burden of determining whether any such Materials are protected by copyright rests solely with you.",1
"Further, you are solely responsible for Materials submitted by you, and Yale assumes no responsibility or liability for Materials submitted by you or any other visitor to the Sites. We may, but are not obligated to, restrict or remove any and all Materials that we determine in our sole discretion violates the Terms or is otherwise harmful to us, other Site visitors or any third party. We reserve the right to remove Materials you submit at any time, but you understand that we may preserve and access a backup-copy, and we may disclose such Materials if required to do so by law or in a good faith belief that such access, preservation or disclosure is required by law or in the best interests of Yale. Any Materials you submit will be routed through the Internet and you understand and acknowledge that you have no expectation of privacy with regard to any such Materials. Never assume that you are anonymous and cannot be identified by your submissions. You hereby grant Yale and any of its sublicensees the right to use the name that you submit in connection with the Materials, if they choose.",1
"You represent and warrant that you own or otherwise control all of the rights to the Materials submitted by you; that such Materials are accurate; that use of such Materials does not violate the Terms, and will not cause injury to any person or entity; and that you will indemnify Yale and its officers, trustees, employees, representatives and agents for all third-party claims resulting from Materials you submit. Use of Password-Protected Areas on the Site Certain areas of the Sites are protected by usernames and passwords and may be accessed only by members of the Yale community. All user names are subject to review and approval by Yale. If you have a user name and password for accessing any Site, you agree not to share them with any other person, including any person who may have his or her own user name and password. You agree that the user name and password for your account is personal to you only, and you will not access or attempt to access any other user’s account, or misrepresent or attempt to misrepresent your identity, while using the Sites or any services. You are responsible for all uses of your user name and password to gain access to any Site and for all activity under them, including the use of any information or material obtained by using them.",1
"Yale may terminate your account or authorization to access any Site and/or services at any time, without notice, for conduct that Yale believes violates the Terms or other applicable policies, rules or regulations of Yale. If you become aware of any unauthorized use of your account, another user’s account or any other portion of the Sites, you agree to notify the Yale School of Medicine Communications Office by telephone at (203) 785-5824, email at ysm.editor@yale.edu, or in writing at: Yale School of Medicine Office of Communications, 1 Church St, Suite 300, New Haven, CT 06510, and to provide prompt reasonable assistance at the request of Yale and/or its representatives to address any violations of the Terms as determined by Yale. Content Monitoring Links & Embedded Content Links to Yale's Site Links from Yale to Third-Party Sites Embedded Third-Party Content - Google: - YouTube: - Vimeo: Copyright & Trademark Notice Copyright Yale University 2024. All Rights Reserved. Notice and Procedure for Making Claims of Copyright Infringement Yale intends that all information and content on the Sites respect the copyright and other proprietary rights of third parties. However, Yale cannot monitor the copyright ownership of all such material. If you believe that any material posted on the Sites infringes your copyright, then you may request the removal of those materials from the Site in accordance with the Copyright Act, 17 U.S.C. § 512(c)(3), and the procedures described below.",1
"A notice of infringing material that complies with the Copyright Act, 17 U.S.C.",1
"§ 512(c)(3) (“Notice”) must be sent to the agent Yale has designated with the Copyright Office: Chief Information Security Officer Yale University 150 Munson Street (25 Science Park) Room 132 New Haven, CT 06511 Tel: (203) 436-5872 Fax: (203) 436-8292 copyright@yale.edu To comply with the Copyright Act, your Notice must be in writing and must include the following: - A physical or electronic signature of the person authorized to act on behalf of the owner of an exclusive right that is allegedly infringed; - Identification of the copyrighted work claimed to have been infringed, or, if multiple copyrighted works are covered by a single notification, a representative list of such works; - Identification of the material that is claimed to be infringing or to be the subject of infringing activity and that is to be removed or access to which is to be disabled, and information reasonably sufficient to permit Yale to locate the material; - Information reasonably sufficient to permit Yale to contact you, such as an address, telephone number, and, if available, an electronic mail address at which you may be contacted; - A statement that you have a good-faith belief that use of the material in the manner complained of is not authorized by the copyright owner, its agent, or the law; and - A statement that the information in the notification is accurate and made under penalty of perjury, and that you are the owner, or authorized to act on behalf of the owner, of an exclusive right that is allegedly infringed.",1
"When Yale receives a Notice that complies with the Copyright Act, it will remove the identified material immediately. Yale will promptly take reasonable steps to inform the user who posted the allegedly infringing material (the “alleged infringer”) of the Notice and subsequent removal. The alleged infringer may then provide Yale with a counter-notice (“Counter-Notice”) that the initial infringement notice was erroneous. Such Counter-Notice must be in writing and must include: - A physical or electronic signature of the alleged infringer; - Identification of the material removed or to which access has been disabled and the location at which the material appeared before it was removed or access to it was disabled; - A statement under penalty of perjury that the alleged infringer has a good-faith belief that the material was removed or access to it disabled as a result of error; - The alleged infringer’s name, address, and telephone number; and - A statement of consent to jurisdiction in federal district court and that the alleged infringer consents to service of process from the complaining party or its agent. Upon receipt of a Counter-Notice, Yale will notify you of the Counter-Notice and restore the material within 10 to 14 business days of receipt of the Counter-Notice, unless you inform Yale that you have filed an action seeking a court order to restrain the allegedly infringing party from engaging in infringing activity relating to the material on the Site.",1
"Yale Trademark Notice Warranties, Liability & Indemnification Disclaimers of Warranties The Sites and services, information and content available on or through any of them are provided “as is” and “as available.” Yale does not warrant that the Sites or any such services, information or content will be uninterrupted or error-free. There may be delays, omissions, interruptions and inaccuracies in such services, information and content. Yale makes no representations or warranties about the accuracy, completeness, timeliness, reliability or non-infringement thereof, including user content, or of any services, information or content available through links to other websites. Yale reserves the right to correct any errors or omissions in the Sites. If you rely on any services, information and/or content available on or through the Sites, you do so entirely at your own risk. You specifically acknowledge that Yale is not liable for the defamatory, offensive or illegal conduct of other users or third parties, and that the risk of injury from this type of conduct rests entirely with you. Your sole remedy for dissatisfaction with any Site or any services, information and/or content available on or through any Site is to stop using the Site and/or those services, information and content.",1
"To the maximum extent permitted under law, Yale disclaims all express or implied warranties with respect to the Sites and any services, information and content that are available on or through them, including without limitation, any warranty of merchantability, fitness for a particular purpose (even if that purpose has been disclosed) and non-infringement. Although Yale intends to take reasonable steps to prevent the introduction of viruses, worms, “Trojan horses” or other malicious code to the Sites, Yale does not guarantee or warrant that the Sites, or any services, information and content that may be available on or through the Sites, are free from such destructive features. Yale is not liable for any damages or harm attributable to such features. It is up to you to take any and all precautions to ensure that the services, information and content you access and use from any Site or any hyperlinked website is free of such items of a destructive nature.",1
"Limitation of Liability Under no circumstances will Yale or its officers, trustees, employees, representatives or agents be liable for any direct, indirect, incidental, consequential, special, punitive, or exemplary damages (including, but not limited to, procurement of substituted services or materials; loss of use, data, revenues or profits; or business interruption) arising in any way out of or in connection with your use of any Site or any services, information or content available on or through the Sites or the Terms, however caused and regardless of the theory of liability, whether in tort (including negligence of any kind), contract, statutory, or any other legal or equitable theory, even if advised of the possibility of such damages. Some states do not allow the limitation of liability for certain kinds of damages, so some of these limitations or exclusions may not apply to you. Indemnification - your breach of the Terms; - your violation of the Code of Conduct (as set forth above); or - your activities in connection with any Site or Site-related services. General Agreement & Choice of Forum General Choice of Law/Forum Selection Privacy Statement Yale is committed to protecting your privacy and the confidentiality of your medical information. This Privacy Statement describes the collection and use of information about you on Yale School of Medicine and Yale Medicine websites, and supplements the Yale University Privacy Statement.",1
"Please review these carefully as they form a part of these Terms of Use and are fully incorporated herein. Patient Privacy Please review our Patient Rights on the Yale HIPAA site if you are looking for information about your Patient Rights or the Notice of Privacy Practices. Cookies & Collected Data Information we collect automatically: We collect information about you automatically as you navigate through or use our Sites. Information collected automatically may include usage details, IP addresses, session replay and recording technology (recording your movements, clicks, etc. on our Sites), and information collected through cookies, web beacons, pixels tags, and other tracking technologies. As you navigate through and interact with our Sites, we may use automatic data collection technologies (such as session replay and tracking technologies referred to above) to collect certain information about your equipment, browsing actions, and patterns, specifically: - Usage Details. Details of your visits to our Sites, such as traffic data, location, logs, referring/exit pages, date and time of your visit to or use of our Sites, error information, clickstream data, and other communication data and the resources that you access and use on or in the Sites. - Device Information. Information about your computer, mobile device, and Internet connection, specifically your IP address, operating system, browser type, and App version information. - Location Data.",1
"Information about your location collected through Geolocation technology. The information we collect automatically may include personally identifiable information (“Personal Data”) or we may maintain or associate information we collect with Personal Data we collect in other ways or receive from third parties. It helps us to improve the Sites and to deliver a better and more personalized service by enabling us to: - Estimate usage patterns and usage volume of our Sites; - Improve the relevance and accuracy of our Sites information and content - Store information about your preferences, allowing us to customize our Sites according to your individual interests; and - Recognize and/or authenticate you when you return to our Sites. The technologies we use for this automatic data collection may include: - Cookies (or browser cookies). We and our service providers may use cookies, web beacons, and other technologies to receive and store certain types of information whenever you interact with our Sites through your computer or mobile device. A cookie is a small file or piece of data sent from a website and stored on the hard drive of your computer or mobile device. On your computer, you may refuse to accept browser cookies by activating the appropriate setting on your browser, and you may have similar capabilities on your mobile device in the preferences for your operating system or browser.",1
"However, if you select this setting you may be unable to access or use certain parts of our Sites. Unless you have adjusted your browser or operating system setting so that it will refuse cookies, our system will issue cookies when you direct your browser to our Website or use our App. Trackers and other tools from the following providers are used on this website: - Adobe Customer Journey Analytics We use Adobe Customer Journey Analytics, a web analytics service which deploys cookies and tracks search behavior so that we can continuously optimize our websites. - Call Rail Our site uses call tracking software to evaluate what content on our website prompted someone to call us. - Clarity Microsoft Clarity is an analytics product that allows us to track and analyze anonymized user behavior to improve the experience of using our websites. - Conversion Linker Google Adsense Conversion Linker is used to track the effectiveness of our web advertisements - LinkedIn We use the LinkedIn Insight Tag to track visits to our sites from LinkedIn posts and articles. - Reddit Our site uses Reddit Pixel to assess the effectiveness of related Reddit ad campaigns. - SiteImprove SiteImprove is a web analytics tool we use to identify and resolve usability and/or accessibility issues on our websites. - X (formerly Twitter) We use X advertising cookies to track the effectiveness of X ad campaigns.",1
"- Yale We also employ our own cookies to optimize website performance and track website search behavior so we can continuously improve our websites. - Adobe Customer Journey Analytics - Pixels and Web Beacons. Pages on our Sites, or our e-mails, may contain small electronic files known as web beacons (also referred to as clear gifs, pixel tags, and single-pixel gifs) that permit us, for example, to count users who have visited those pages or opened an e-mail and for other related Sites statistics (for example, recording the popularity of certain Sites content, evaluating content on our Sites that prompt follow-up calls to us, tracking visits to our posts and articles on third-party sites, assessing the effectiveness of our marketing strategies on third-party sites, showing certain Sites content relevant to you, and verifying system and server integrity). We work with outside vendors to safeguard and deidentify health information while also enabling our technical staff to enhance user experience through these analytics tools. - Do Not Track Signals. Some web browsers permit you to broadcast a signal to websites and online services indicating a preference that they “do not track” your online activities. At this time, we do not honor such signals. Questions & Contacts - If you are concerned about your patient privacy rights, please contact the Yale HIPAA Privacy Officer at 203-432-5919 or hipaa@yale.edu.",1
"- If you have an issue relating to a Yale School of Medicine or Yale Medicine website, email us at ysm.editor@yale.edu, and we will forward your concern to the appropriate unit for response or resolution. - Please read our Privacy Policy about the collection, use and protection of information about you on the Sites. These Terms of Use were last updated on October 1, 2024. Public Notices December, 2024 Yale University intends to submit a Certificate of Need Application to the Office of Health Strategy pursuant to § 19a-638 of the Connecticut General Statutes for the acquisition of a dual positron emission tomography and magnetic resonance imaging scanner to be used for human research only. The estimated total capital expenditure for the project is $6,050,000. The proposed location for the scanner is 15 York Street, New Haven, CT 06519.",1
"Blood Pressure Goal: 120/80 Is the Number Your Doctor Wants to See In 2017, leading medical groups lowered the threshold for “normal” blood pressure to reduce the risk of heart attack and stroke, two of the leading causes of death in the United States and worldwide. Now, new research points to another powerful benefit of these stricter guidelines: a 15% drop in dementia risk when blood pressure is under tighter control. A large study in rural China published in Nature Medicine showed that blood pressure below 130/80 mm Hg (millimeters of mercury) not only lowered the risk of dementia, but also reduced cognitive impairment by 16%. High blood pressure, also known as hypertension, can damage small blood vessels in the brain, and is associated with cognitive decline and memory problems. This study is the first to definitively show that lowering blood pressure to these levels can truly decrease the likelihood of dementia. This, says Christopher Howes, MD, a Yale Medicine cardiologist, is important not only because high blood pressure is associated with many other health conditions, but because there are few proven ways to reduce the risk of dementia. “We have some medicines that can maybe slow down the progression of Alzheimer’s disease, but we don’t have many ways to prevent dementia,” he says.",1
"“Now we have this real objective data that shows people who had high blood pressure and were on therapy for it have a lessened likelihood of dementia.” Plus, high blood pressure is an important risk factor for coronary artery disease, Dr. Howes adds. “Treating high blood pressure and elevated cholesterol levels are two cornerstones to cardiovascular health, he says. “We have effective medications for both conditions. We need to work aggressively with our patients to achieve the desired target levels.” What is ‘normal’ blood pressure? Blood pressure, which is most commonly measured using a cuff wrapped around the upper arm, is the force of circulating blood against artery walls. The top, or systolic, number measures the pressure of the heart contracting. The bottom, or diastolic, figure measures the force of the heart relaxing. Currently, the American Heart Association (AHA) and the American College of Cardiology (ACC) define normal blood pressure of systolic pressure (top number measuring the force when the heart contracts) as less than 120 and diastolic (bottom number measuring the force when the heart relaxes) as less than 80. Elevated blood pressure is 120-129/80; stage 1 hypertension is 130-139/80-89; stage 2 hypertension is 140/90 or above. When and why did the recommended numbers change? If you’re over a certain age and have been paying attention to blood pressure goals over the years, you may understandably be confused by shifting targets.",1
"Medical professionals have changed their thinking as more research has emerged about the benefits of maintaining a certain blood pressure. As a result, those numbers have been trending downward. “The confusion over targets has been not just for patients, but for physicians, too,” Dr. Howes says. For perspective, Dr. Howes recounts how decades ago, the unofficial advice was to add 100 to your age, and that should be your systolic blood pressure number. “This is terrifying—I remember being a young physician 30 years ago and having an 80-year-old patient tell me his blood pressure was normal because it was 180,” he says. Then, 140/90 became the cutoff for high blood pressure embraced by experts, while 130/80 was recommended for people with diabetes or chronic kidney disease. In 2015, a large study showed that tighter control—around or below 120 systolic—significantly reduced heart attacks and strokes. In 2017, the AHA and ACC redefined high blood pressure as 130/80 or above. “Twenty-five years ago, if someone was 140/90, we were happy. But everyone needs to get 140/90 out of our brains. It’s not a good number. That means you have high blood pressure and you need medication and we also need to start talking about lifestyle changes,” Dr. Howes says. “Because now we know that getting the blood pressure to 120/80 is ideal.” How can I lower my blood pressure?",1
"The most recent blood pressure guideline, released in 2025 by the AHA and ACC and endorsed by 11 other health care organizations, reiterates the 2017 goals. In addition to incorporating evidence that lower blood pressure is linked to decreased dementia risk, it offers updated guidance on using medications that can benefit heart health, including the possible addition of GLP-1 agonists such as semaglutide (Ozempic) and tirzepatide (Mounjaro) in people who are overweight or obese. The guideline offers advice on maintaining healthy blood pressure, including: Reduce salt intake: Too much sodium in your diet leads to excess fluid and volume in your blood vessels, driving up blood pressure. The AHA recommends limiting your daily sodium intake to ideally below 1,500 mg daily. One way to do this is to consider salt substitutes that contain potassium chloride. “Table salt is sodium chloride and is a ubiquitous product in the world. Replacing it with potassium chloride still flavors food and doesn’t have the sodium,” Dr. Howes says. “Supplementing with potassium chloride will have an incremental benefit for lowering blood pressure.” However, Dr. Howes cautions that people who have kidney disease should speak with their physician before using potassium chloride, as they may have trouble clearing potassium from their blood.",1
"Keep physically active: The guideline recommends increasing physical activity to at least 75 to 150 minutes each week, including aerobic exercise and/or resistance training such as lifting weights or using body weight or other methods for resistance training. “In the past, the focus had been swimming, walking, bike riding, jogging, and while those are all still great, we now know that other activities like resistance training—think exercises such as planks and lunges—are maybe as beneficial,” Dr. Howes says. Limit alcohol: Ideally, adults looking to lower their blood pressure should avoid alcohol altogether, the guideline says. For those who choose to drink, men should limit themselves to two drinks per day and women to one. “There’s been a lot of discussion about alcohol in the last 12 to 18 months and there’s been a movement to decrease or eliminate alcohol consumption to lower cancer rates and hypertension,” Dr. Howes says. Maintain or achieve a healthy weight: A goal of at least a 5% weight reduction is recommended in people who are overweight or obese. And if the weight loss is significant, people should check in with their physician, Dr. Howes advises. “I had a patient on three medicines for his blood pressure. He came in to see me and his blood pressure was 90/60. It turned out he’d been on a weight-loss medication, too, and had lost 40 pounds, and he’d stopped drinking alcohol,” he says. “So, of course, I decreased his blood pressure medications.",1
He’s the poster child of what the experts recommend.”,1
"When Kids are Obsessed with Skin Care Products Maybe your elementary-schooler is suddenly obsessed with creating a skin-care routine: one that includes exfoliants, serums, moisturizers, and masks. Or perhaps your teen’s bathroom counter now looks like a beauty influencer’s “shelfie.” While these routines seem to promise soft, luminous skin, dermatologists say none of this is necessary—and sometimes can be harmful—to a young person’s delicate, sensitive, still-developing skin. Yale Medicine dermatologist Kathleen Suozzi, MD, says most kids need no more than a gentle cleanser, water, simple moisturizer, and a mineral-based sunscreen (not a chemical one). “If they don’t have a condition such as acne or eczema, their skin care should be aimed at protecting and supporting the ideal skin environment they have at their age,” she says. But that kind of advice hasn’t slowed the adolescent skin care craze. Dr. Suozzi, who is involved in a study surveying middle and high school students to learn more about what’s fueling the trend, says she’s astonished by its reach. “Our research has shown that 20% of preteens and teens surveyed spend upwards of $50 a month on products they don’t need—and will sometimes layer on five or more of those products,” she says. The behavior attracted the attention of Connecticut Attorney General William Tong, who in 2024 sent out a statement urging parents to exercise caution around letting their kids use anti-aging skin care products.",1
"He also sent a letter to the beauty retailer Sephora USA, questioning the company’s marketing and promotion of certain products to children. Why are kids and teens so obsessed with skin care? Dr. Suozzi’s early research points to a familiar influence: social media. Platforms like TikTok and Instagram are filled with young “skinfluencers”—teenagers and younger children who review beauty products and show off multistep routines to peers their own age. “Videos called ‘hauls,’ where influencers unpackage and try out their purchases, became especially popular during the pandemic,” Dr. Suozzi says. “Skin care really works well in this format because you can literally watch someone’s face seemingly transform on screen as they’re applying products,” she adds. The products are also easy for kids to find and buy, Dr. Suozzi adds. “You can go into a cosmetics store or even a drugstore and see products that tweens and teens are interested in placed at their eye level on the shelves in areas where the store is going to get higher traffic.” Yann Poncin, MD, a psychiatrist at Yale Child Study Center, says the psychology behind the trend runs deeper. “Adolescence is very much about developing an identity. Kids this age are discovering themselves, finding themselves, and trying on different identities. Peers are incredibly important and there is a focus on appearance. And skin care apparently is one thing young teens are gravitating to.” How is adolescent skin different than adult skin?",1
"Children’s skin is thinner, softer, and more delicate than an adult’s skin, making it more sensitive to irritants. “Barrier function is immature in children’s skin, making this demographic more prone to irritation from products. In addition, adult skin has mature sebaceous glands that produce sebum, a natural oil that protects the skin and creates a protective layer,” Dr. Suozzi explains. “Children don’t have that same protection yet.” Skin changes significantly during puberty, when hormonal shifts start to drive the production of sebum and the skin gradually becomes more resilient. “Postpubescent skin is going to act more like adult skin, so you’re going to have less sensitivity,” Dr. Suozzi says. But before that, using harsh or active ingredients that decrease sebum production—such as strong acids, retinoids, or fragrances—can strip the protective layer, damage the skin barrier and, in younger kids, even cause atopic dermatitis or allergic reactions. What skin care ingredients are harmful to young skin? The issue is not so much the products, but the ingredients in some of them, says Dr. Suozzi. She mentions that many of the youngsters she has surveyed either don’t know or can’t name ingredients in the products they use or are considering. “This is really important, because there are a lot of things that are frequently used in products for mature skin that kids not only don’t need, but that can be harmful for them,” says Dr. Suozzi.",1
"“In terms of durable changes in the skin, it’s more of a local irritant problem that we're seeing, or a temporary disruption in the skin barrier. But prolonged use of certain skin care products could predispose a person to facial eczema or a longer-lasting inflammatory condition,” she says. Dr. Suozzi highlights some ingredients commonly found in adult formulas that can cause irritation or allergic reactions in children, including: - Fragrance and perfumes, which are a common cause of allergic contact dermatitis and skin irritation. - Alcohols, which strip the natural skin barrier, the protective layer on the outermost surface of the skin, and cause dryness. Examples include denatured alcohol, isopropyl alcohol, and ethanol. - Harsh acids or chemical peels, which cause redness and peeling to thin, sensitive skin. Avoid glycolic acid, salicylic acid, and strong AHAs/BHAs. - Retinoids and retinol, which can cause skin irritation. Both are used to treat acne, but are not appropriate for pediatric use without a prescription. - Chemical sunscreens, which include filters such as oxybenzone or octinoxate that can be irritating for kids. There is also concern that they could cause hormonal disruption in children. Mineral sunscreens containing zinc oxide or titanium dioxide are safer. - Parabens and formaldehyde-releasing preservatives, which can cause irritation. Avoid methylparaben, DMDM hydantoin, and quaternium-15. - Pore-clogging or comedogenic oils, which can worsen acne.",1
"Avoid coconut oil, cocoa butter, and lanolin. Note that even essential oils, which many people believe are safe because they are natural, can pose risks, says Dr. Suozzi. Essential oils can trigger allergic reactions or phototoxicity, characterized by a sensitivity to sunlight. Examples include citrus, tea tree, peppermint, and lavender. Likewise, some natural physical exfoliants and scrubs can cause microtears and inflammation in the skin. Avoid apricot kernel or walnut shell scrubs. Dr. Suozzi recommends limiting child and adolescent skin care routines to no more than three products at a time. Occasional sheet masks for fun are fine, she adds—just not for daily use. “Sheet face masks tend to have a lot of ingredients in them,” she says. “But they can be fun. If kids are doing this once a month with friends, it's probably not harmful. The things that are most likely to irritate your skin are the ones you’re applying more frequently.” Can a child or teen’s skin care obsession lead to a mental health concern? Trying new products with friends can be harmless fun—but obsession is another story. One question to consider is how deeply a child or teen is involved with skin care, Dr. Poncin says. “It’s a question of degree,” he says, noting that playing around with products with friends from time to time shouldn’t be a concern.",1
"“It may be important to pay attention to if they start to feel compelled to do the skin care routine, whether they’re a young influencer posting videos online or a kid who is following those videos closely, and feels that's the new norm and they have to do these things. That's where it becomes problematic.” Some young boys and girls aspire to become social media influencers themselves, and skin care products are a way to do it, Dr. Poncin adds. “A lot of kids will give this a shot and then quickly give up,” he says. “But positive online feedback can intensify the pressure. So they try more products and make more videos, and it mixes in with their sense of not being good-looking enough.” He says this becomes a problem when they are spending too much time on it to the point where it’s affecting their everyday life. “When it starts to affect grades, sleep, or friendships, it can develop into a real mental health issue,” Dr. Poncin warns. How parents can respond to their skin care-obsessed kids Taking action that is too aggressive can backfire, says Dr. Poncin, adding that it’s important for parents to accept that kids go through different phases and try things. “In many cases we just need to guide them in the right direction as far as what’s healthy and what’s not, and make sure that whatever they’re doing doesn’t cross into an obsession or negative body image.” He also urges parents to monitor social media habits.",1
"“If their behavior becomes compulsive or isolating, step in,” he says. “Ask: Is it interfering with schoolwork or relationships?” Dr. Suozzi also suggests parents talk to their children about skin care from a health standpoint, without making them feel bad about whatever routine they’ve developed. “Embrace the science,” she says. “Educate them by telling them what ingredients they should be looking for on the packages. They can bring that to their experience when they go to the store.” There’s also a healthy message there, she says. “They can celebrate the skin they’re in, celebrate that perfect skin they have as a kid.” It may not be the filtered image of perfect skin they may see on social media—there may be a blemish or even an acne lesion—but that’s a normal part of growing up, Dr. Suozzi says. “But for most kids, it’s the best skin they’ll ever have,” she adds. “They don’t need to fix it—they just need to care for it gently and appreciate it.”",1
"Meet Pooja Khatri, MD: A Leader in Stroke and Neurological Care Pooja Khatri, MD, a world expert on stroke, became interested in medicine at an early age, inspired in part by her father. Growing up in India, Dr. Khatri’s father dreamed of becoming a scientist, but had to choose a more practical path of mechanical engineering to support his family. Later, after moving his family to Chicago, he inspired his daughter’s passion for science, helping her with science projects and nurturing her curiosity about the brain. Her pivotal moment came when she visited a remote village in India where the only available doctor was a veterinarian. Witnessing the lack of access to medical care strengthened her resolve to become a physician and help people directly. That’s a short version of Dr. Khatri’s early journey—one that ultimately led her to Yale School of Medicine, where she now serves as chair of the Department of Neurology, and chief of neurology at Yale New Haven Hospital and the Yale New Haven Health System. Her story mirrors the transformation in neurological care over the past few decades, particularly in stroke treatment, where her own research has shaped major advances. She notes that there has been other remarkable progress in understanding and treating such common neurological conditions as Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and other disorders of the brain and nervous system.",1
"“People who have just gotten a new diagnosis don’t always realize how much neurological care has changed in recent decades,” Dr. Khatri says. “There are treatments available now that didn’t exist in the past, making neurological diseases more treatable than many people realize.” Dr. Khatri brings extensive experience to her role as chair, including serving as director of the national coordinating center of StrokeNet, the main infrastructure for National Institutes of Health (NIH)-funded multicenter stroke trials. With two decades of continuous NIH funding and more than 300 publications, she has shaped the field of acute stroke care. Before joining Yale Medicine, Dr. Khatri served as vice chair and division chief in the Department of Neurology and Rehabilitation Medicine at the University of Cincinnati, and director of the vascular neurology division and of the multidisciplinary University of Cincinnati stroke team, which serves 2.5 million people in a tristate area. Dr. Khatri takes the helm at Yale’s neurology department during a transformational time: the upcoming Adams Neuroscience Center, which will feature two patient care towers in New Haven, is scheduled to finish construction and open in 2027. The center will provide personalized neurological care, including medical, surgical and emerging therapies, while driving new discoveries that expand what’s possible in the treatment of brain and nervous system disorders.",1
"Here, Dr. Khatri shares her vision for the future of neurology at Yale Medicine. What motivated you to join Yale and what excites you most about this new role? A few things played into this decision. I’d been a very dedicated stroke clinician and researcher, and I led the stroke program at the University of Cincinnati and StrokeNet, which is a national endeavor, but I felt ready to take on something new. I was drawn to Yale’s leadership and their vision for integrating clinical care, research, and education—all areas I’m passionate about. Ultimately, it’s about providing the best care for patients. My goal is to make Yale as patient-centered and accessible as possible, ensuring consistent quality across the entire health system—not just in one location or building. Can you share more about your early experiences and influences that led you to pursue a career in neurology? My father was a huge influence. He worked on my first science projects with me, and I ended up going to an international science fair, which was really exciting for me as a kid. He was unhappy that I wanted to go to Stanford, far from home, but proudly supported my decision to become a neuroscientist. I knew there was still so much uncharted territory around the brain, and that was fascinating to me—and I knew that was where I was headed in some capacity. In my third year of college, I went to India on a study abroad program.",1
"An orphanage near where I was staying offered to let me go with them to some of the outlying villages. I didn't know what I was signing up for, but it turned out that they were bringing a veterinarian to provide medical care for humans. We were riding in a jeep with the veterinarian and swarms of people held up their kids, asking questions about what to do. Seeing that lack of access firsthand made me realize I wanted to help people directly—through both clinical care and research. Does your passion for science go back to your father? Absolutely. He was born in what is now Pakistan, and during the 1947 Partition, his family fled their home and had to rebuild their lives from nothing. Despite those hardships, he nurtured a deep love of science and passed that on to me. Both of my parents gave me incredible inspiration. My mom modeled academic strength as one of the first female graduates from India’s most prestigious MBA program and my father especially pushed me to pursue my scientific potential. That drive—and the desire to help others—has stayed with me throughout my career. Neurology often deals with difficult diseases. Where do you see hope for patients? In my career, I’ve seen stroke go from a disease with limited treatments to a potentially reversible disease.",1
"If someone gets to the hospital fast enough—within hours of symptom onset for most people—and is given a clot-busting drug such as tissue plasminogen activator (tPA) or a procedure called mechanical thrombectomy, we can often reverse the damage. Many patients recover almost completely in the emergency department. We have even been able to help people having the most severe strokes, so that more patients are much better within hours of their hospitalization. That message really needs to get out there—and not just for stroke. We have some really exciting therapies now for other neurological conditions. We finally have drugs that can change disease progression in people with Alzheimer’s disease, for example. We are much better at managing Parkinson’s disease. Multiple sclerosis is no longer the disabling disease it once was. Where are you focusing your current research and how might it help patients in the future? My research has focused on improving acute stroke treatment and patient recovery. I’m especially excited about clinical trials of newer medications that could transform emergency stroke care. For example, I’m excited about a novel drug that works better than our standard “clot-busting drugs.” People may have heard of tPA, which is given for ischemic stroke; in 2025, the Food and Drug Administration approved the use of tenecteplase (TNK), which more hospitals are using now with better results.",1
"My team is now studying another promising drug in clinical trials called TS23, which releases the brakes on the tPA made by our own bodies and may avoid some of the side effects of tPA and TNK. I’m involved in leading VERIFY, a national clinical trial validating biomarkers to predict motor recovery after a stroke. If a patient is in the hospital and paralyzed on one side of the body, we want to know, based on the data we gather using transcranial magnetic stimulation and MRI, what their mobility will be in three months—who will be able to move their arm and who will not. This could give us an opportunity to make better-informed, individualized decisions on therapies and rehabilitation approaches for particular patients and inform more efficient clinical trials in this space. We need to do more research into helping patients get back the quality of life they had before they had a stroke, or as close as possible. We are able to make a big impact with what we do in those first 24 hours in the emergency department, and we have some strong data to suggest that we can make those same kinds of impacts with neuro-recovery strategies. But we need to fully prove the approaches. The work in biomarker validation ties into my broader interest in improving trial designs to get answers more quickly for patients. I am excited about our first platform trial in stroke, called STEP.",1
"Platform trials let us address multiple clinical trial questions at once more efficiently, both in terms of statistics and operations. STEP is focused on optimizing the care of patients with the most severe types of strokes. You’ve done extensive work internationally. Will that continue at Yale? Yes. My first professional trip to India opened the door to long-term collaborations and advocacy in global stroke care. I later served as secretary of the World Stroke Organization. I then got involved with the American Heart Association and helped build the first primary stroke center certifications in the Middle East/North African region. It’s deeply fulfilling work, and while my primary focus now is learning my new job at Yale, I’ll continue to support those efforts whenever possible. My research portfolio including StrokeNet remains active in my new role, and this includes co-chairing the Global Alliance of Independent Networks focused on Stroke trials (GAINS) to help build and partner with clinical trial networks across the world to share best practices and expand access to stroke research worldwide. How do you balance your demanding career and your personal life? One of my secrets to success is my wonderful husband, who has been a stay-at-home dad. When I’m not working, I love spending time with my family. Lately I’ve been focusing on strength training, which we all need to do as we get older. And then, for me, it's really about my relationships.",1
"I make time available for my friends and my family. I try to work in a visit with a friend whenever I can. My work also gives me a lot of joy, so that certainly motivates me to work more than most people. But I will say there is no doubt that you are going to be a better doctor if you are taking care of your own wellbeing, and your mental health and happiness. Balance and wellbeing are key to sustaining compassion in medicine.",1
"Do You Need a Rabies Shot? Human cases of rabies are rare in the United States—fewer than five people develop the disease per year—but exposure to an animal that might be infected with the fatal viral disease is an understandably worrisome, and far more common, situation. Every year, about 100,000 people receive a rabies vaccination after contact with a potentially infected animal—often a bat, raccoon, skunk, fox, or unvaccinated dog. Sean Grogan, DO, MS, a Yale Medicine emergency medicine physician and fellow in wilderness medicine, knows the concern firsthand. A few years ago, Dr. Grogan awoke to find a bat flying around his bedroom. When he tried to catch the bat, it scratched him. “The benefit of catching the bat is that it can then be tested for rabies, but I strongly recommend against trying to do this yourself. Let animal control do the catching instead of risking what happened to me,” Dr. Grogan says. Rabies spreads primarily through saliva from bites and scratches from an infected animal and attacks the central nervous system. Without timely medical care, it can progress to severe brain disease and is almost always fatal within four weeks of symptom onset, which can take months to years to present. If you’re exposed, it’s important to head to your nearest emergency department (ED) for post-exposure prophylaxis, which includes wound care and a series of vaccines. Fortunately, the rabies vaccine is extremely effective.",1
"“You just need to get treatment soon enough,” Dr. Grogan says. How is rabies transmitted? Worldwide, dogs are responsible for more than 95% of the estimated 70,000 human deaths from rabies each year. In the U.S., however, widespread vaccination among dogs means more than 90% of rabid animals live in the wild, with bats being the primary carriers. Rabies is most often spread through saliva, typically via a bite. But scratches can transmit the virus, too. “The reason scratch is in the list of reasons people need a vaccine is that most animals clean themselves regularly, so if they are licking part of their body and then they scratch you with it, it can have saliva on it,” Dr. Grogan explains. “And the thing with bats is that their teeth are so small that they can bite you and you may not see the bite mark at all.” What are the symptoms of rabies? The initial symptoms of rabies look like the flu and include fever, headache, and weakness. Within two weeks of the first symptoms, people may experience anxiety, confusion, insomnia, seizures, and inflammation in the brain. “The classic presentation has the nickname of ‘encephalitic rabies,’ due to abnormal, hyperactive behavior,” Dr. Grogan says. “And when it’s become more severe, one of the hallmark symptoms is hydrophobia, or a deathly fear of water. People stop drinking because they get these horrific pharyngeal spasms when they drink.” Once rabies causes brain involvement, it’s almost always fatal.",1
"“There have been some rare case reports of people surviving it, but they usually have significant neurological issues,” he says. What should I do if an animal that might have rabies bites or scratches me? If an animal that could possibly have rabies bites or scratches you, the first step is to take care of the wound, if you have one. “Wash it vigorously with hot, soapy water. That helps reduce the viral load significantly,” Dr. Grogan says. Then go immediately to the nearest ED. In some instances—for example, if you are certain the animal did not touch you—it is appropriate to call your local health department for guidance. “If they can safely catch the bat, or whatever animal it is, you might not need treatment,” he says. “They usually observe the animal or kill it to take a look at its brain and test for rabies.” The animal’s behavior is also a clue when it comes to determining risk. “If you are holding an animal and trying to feed it or pet it and it bites you, that is considered ‘provoked.’ But if you are bitten out of nowhere, with the animal coming at you, that is an unprovoked attack—it’s abnormal behavior, and might be an indication of rabies,” he adds. How and when is the rabies vaccine given? At the ED, a doctor will determine if you need post-exposure prophylaxis. The rabies vaccine comes in two main types: one grown in human cells and another grown in chick embryo cells. After the initial rabies vaccine injection, doses are given on days three, seven, and 14.",1
"Some people may also receive an injection of human rabies immune globulin (HRIG), which provides immediate antibodies against the virus, before the first vaccine dose. People who were previously vaccinated only need two vaccine doses and do not need HRIG. “The vaccine gives your body a template so it can make its own antibodies for the rabies virus,” Dr. Grogan explains. “But that takes time, so the immune globulin neutralizes the virus right away.” The vaccine is injected in the shoulder, while the immune globulin is injected as close to the wound as possible. When the vaccine is deemed medically necessary, health insurance usually covers the cost. Can you get the vaccine as a precaution? Yes. Pre-exposure prophylaxis vaccination is recommended for people who work directly with animals that could have rabies—such as veterinarians or wildlife workers—or for travelers visiting parts of the world where the disease is common and access to emergency medical care is limited. For this type of vaccination, two doses are given and protection lasts for up to three years. What happens to a dog if it bites you? When someone comes to urgent care or the hospital because of a dog bite and they are concerned about rabies exposure, doctors often ask the patient if they know the dog and if they have the phone number of the owner. “People are often worried that they’re going to get the dog in trouble and the dog will be put down, but that’s usually not the case,” Dr. Grogan says.",1
“It’s really so that the dog’s owner or veterinarian can be contacted to confirm the dog’s vaccination status and ensure that the animal is healthy and observed appropriately.”,1
"For Medical Professionals Connecting you with world-class care When healthcare providers refer patients to Yale Medicine, we know they come to us for our specialist expertise, cutting-edge technology, and multidisciplinary approach. Your trust in us, and our commitment to ongoing communication with you, allows us to work together to ensure your patients receive the best care possible.",1
"Refer a PatientCopy Link Call the CARE Center (1-877-YALEMDS) Find out more about our specialties - Allergy & ImmunologyLearn more - Bariatric & Minimally Invasive SurgeryLearn more - Cardiac SurgeryLearn more - Cardiovascular MedicineLearn more - Colorectal SurgeryLearn more - DermatologyLearn more - Digestive DiseasesLearn more - EndocrinologyLearn more - General Surgery, Trauma & Surgical Critical CareLearn more - Infectious DiseasesLearn more - Medical Oncology and HematologyLearn more - NephrologyLearn more - NeurologyLearn more - NeurosurgeryLearn more - Obstetrics, Gynecology & Reproductive SciencesLearn more - OphthalmologyLearn more - Orthopaedics & RehabilitationLearn more - OtolaryngologyLearn more - Pediatric SurgeryLearn more - Spine CenterLearn more - Pulmonary, Critical Care & Sleep MedicineLearn more - RheumatologyLearn more - Surgical OncologyLearn more - Transplant & ImmunologyLearn more - Vascular Surgery & Endovascular TherapyLearn more - Thoracic SurgeryLearn more Video Spotlight Patient Referrals Referrals for adult patients can be made using the following options: - Epic electronic medical record - Calling the CARE Center (1-877-YALEMEDS) - Calling Y Access (Inpatient transfer service, 888-YNHH-BED) Research and Clinical Trials To view a full listing of available studies and learn more about clinical research at Yale, visit www.yalestudies.org. If you are looking to bring clinical research into your practice, we’re here to help.",1
Stay Connected Visit our Video Library and subscribe to receive the latest videos from Yale Medicine.,1
"About MyChart MyChart is designed to put you, the patient, at the center of your healthcare. You can use MyChart to make appointments, communicate with your healthcare provider and see test results and notes from your visit. If you already have a MyChart account, you can log in with your username and password below. Sign Up for MyChart MyChart, our secure online patient portal, gives you access to all of your Yale health information whenever you need it, wherever you may be. Sign up today. To sign up for MyChart you need an activation code, which you can get in one of three ways: - Find one on your after-visit summary - Request one at your next appointment - Request one online If you already have an activation code, sign up now. Need more information? Learn more about our terms and conditions.",1
